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Synopsis 
Regulated adherence of monocytes to extracellular matrix macromolecules is a prerequisite for their 
accumulation at sites of pulmonary infection and inflammation. To begin to assess the pathobiological 
importance of alterations in monocyte adherence to extracellular matrix in inflammatory lung diseases, the 
adherence properties of monocytes from patients with an inflammatory lung disease (bronchiectasis) and healthy 
subjects to a representative matrix component (fibronectin) were compared. Spontaneous adherence of 
monocytes from the control subjects was 20 to 25%, whereas that of the patients' cells was 2 to 3-fold higher 
and correlated with the severity of airway inflammation. Endotoxin (LPS) and cytokines from areas of airway 
disease are likely to be responsible for the observed monocyte activation since: 1) LPS was detected in plasma 
from all of the patients but none of the control subjects; and 2) LPS and cytokines produced dose-related 
increases in the adherence of normal monocytes in vitro. Monocyte adherence to fibronectin was substantially 
mediated by CD11/CD18 integrins, via both RGD-dependent and RGD-independent mechanisms. These data 
indicate that signals arising from foci of pulmonary inflammation are likely determinants of the accumulation 
of monocytes in the lungs of patients with chronic inflammatory lung diseases. 
There was a striking relationship between the adherence properties of monocytes and functions that are 
of biological importance at sites of inflammation. Spontaneously adherent monocytes had an "inflammatory 
effector" phenotype, non-adherent cells had an "immune modulatory" phenotype and monocytes that could 
stimulated to adhere by LPS (LPS-adherent cells) had an intermediate phenotype. In addition, only the adherent 
monocyte subpopulations were replete with HLE and these cells contained a substantial (10 to 11-fold) molar 
excess of HLE compared with the physiological inhibitor of this enzyme Maturation in vitro 
increased the accumulation of by all of the monocyte subpopulations. In contrast, pro- 
inflammatory mediators up-regulated accumulation by only the spontaneously adherent cells, 
probably by translational or post-translational mechanisms. 
In conclusion, these data indicate that monocytes are heterogeneous in their ability to accumulate at sites 
of infection and inflammation. In addition, the capacity of monocytes to adhere to fibronectin is related to 
monocyte functions that are of biological importance at sites of infection and inflammation. Furthermore, LPS 
released from foci of infection, may induce the accumulation of monocytes with an inflammatory effector 
phenotype, and may thereby promote resolution of tissue infection. Alternatively, LPS may promote the 
recruitment of monocytes with capacity to contribute to HLE-mediated tissue injury. 
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Chapter 1 
Introduction 
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1.1 Introduction 
Monocytes and macrophages are a family of phagocytic cells that are widely distributed throughout the 
body and are generally referred to as the mononuclear phagocyte system because of their common origin, and 
similar morphology and function. Mononuclear phagocytes have been known since the time of Ellie Metchnikoff 
(1845-1916) mainly for their property of phagocytosis which enables them to eliminate pathogens and other 
unwanted materials. However, recent research has demonstrated clearly that these cells play a pivotal role in 
processes as fundamental as inflammation, the induction and regulation of specific immune responses and tissue 
remodelling and repair. There are several basic properties of this cell line that enable it to participate in such 
varied reactions. First, mononuclear phagocytes are highly mobile and have the capacity to adhere to various 
biological Substrates, functions that enable them to be recruited into sites of inflammation. Second, these cells 
secrete a large number of soluble mediators that modulate the function of many different types of cells. Third, 
mononuclear phagocytes ingest and degrade various materials including senescent cells and tissue debris. Finally, 
mononuclear phagocytes can be activated by the external environment which generally results in an increase in 
their functional properties. 
i t  is clear that mononuclear phagocytes play a critical role in host defence; however, these cells may 
also injure the host while exercising their defensive role. For example, these cells have been shown to contribute 
to tissue damage by releasing proteolytic enzymes (80,409), toxic oxygen metabolites (79,89), pro-fibrotic 
cytokines (291,415) and other mediators (382,445). Moreover, mononuclear phagocytes have been implicated 
in the pathogenesis of several inflammatory and degenerative diseases including chronic obstructive pulmonary 
disease (80,223,333), pulmonary fibrosis (17,382,415), rheumatoid arthritis (65), systemic lupus erythematosus 
(17), sarcoidosis (17), and atherosclerosis (58,189,387). 
To understand the pathogenesis of these diseases, it is necessary to identify the factors that regulate 
mononuclear phagocyte recruitment and function at sites of inflammation. Recruitment of monocytes from the 
vasculature involves directional migration of monocytes in response to chemoattractant factors released from 
inflamed sites, and reversible adherence of monocytes to endothelial cells. The next barriers that monocytes 
encounter, as they migrate into sites of inflammation, are the extracellular matrix components of the basement 
membrane and the subendothelial space. It is clear that regulated and reversible adherence of monocytes to 
extracellular matrix macromolecules is also a prerequisite for the accumulation of these cells at sites of tissue 
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inflammation (172,423); however, little is known about the biological and pathological factors that regulate 
monocyte adherence to extracellular matrix, or the mechanisms involved. 
To begin to address the pathobiological importance of alterations in monocyte adherence to extracellular 
matrix in inflammatory lung diseases, the adherence properties of monocytes from healthy donors and patients 
with an inflammatory lung disease (bronchiectasis) to a representative extracellular matrix component 
(fibronectin) were compared. In addition, the effects upon monocyte adherence of various signals (LPS and 
cytokines) that are likely to be released at sites of infection and inflammation were assessed. The role of 
CD11/CD18 integrins in mediating monocyte adherence to fibronectin was investigated. Finally, the possibility 
was tested that there is a relationship between the adherence properties of monocytes and phenotypes that relate 
to important biological and pathological activities at sites of infection and inflammation. 
The introductory section of this thesis describes the historical aspects of mononuclear phagocytes, their 
ontogeny, morphology and functions. The literature on the adherence properties of mononuclear phagocytes 
is summarised. Finally, the potential role of mononuclear phagocytes in the pathogenesis of a common chronic 
inflammatory disease of the lungs (pulmonary emphysema) is discussed. 
1.2. Historical Aspects of the Mononuclear Phagocyte System 
Macrophages were first described in 1882 by Elie Metchnikoff in Messina, Italy (306). Metchnikoff 
observed large cells phagocytosing tissue debris in starfish larvae, and subsequently named these cells 
macrophages, a term derived from the Greek for "big eaters". Schilling, in 1912, was the first to identify the 
monocyte clearly in the peripheral blood (222). However, it was not until 1925 that the relationship between 
monocytes and macrophages was established when Lewis (274) demonstrated that cultured monocytes 
transformed into macrophages, epithelioid cells and multinucleate giant cells (274). This relationship was 
Supported further in 1939 by the experiments of Ebert and Florey (149). These investigators used a rabbit ear 
chamber model to show that monocytes containing phagocytosed carbon particles migrated from the blood into 
connective tissue and transformed into tissue macrophages. More recent research using tritiated thymidine and 
chimeric studies have confirmed these observations and revealed the bone marrow origin of mononuclear 
Phagocytes, and their secretory and immune regulatory functions (217,457). 
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1.3. Ontogeny of Mononuclear Phagocytes 
The mononuclear phagocyte cell line originates in the bone marrow as the granulocyte-monocyte colony 
forming unit (CFU-GM) which is a common committed cell for the granulocyte and monocyte-macrophage 
pathways. The cell is induced to differentiate into a monoblast by glycoprotein hormones called colony 
stimulating factors (416). Monoblasts differentiate into promonocytes, the first morphologically identifiable cell 
in the series (458), and promonocytes differentiate into monocytes. The process of differentiation from the 
committed stem cell to the mature monocyte takes about six days, and the cells go through three to four cell 
divisions between the monoblast and monocyte stage. The mature monocyte is released from the bone marrow 
into the circulation within 24 hours. Kinetic studies in man have shown that monocytes have a circulating half 
life of about three days (491). In contrast to neutrophils, humans do not have a pool of marginating monocytes 
progenitor 
progenitor 
(236). 
There is no evidence that monocytes are predestined for any particular tissue once they leave the bone 
marrow; rather, migration of monocytes into tissues appears to be a random phenomenon in the absence of 
inflammation (236). Once in the tissues, monocytes do not re-enter the circulation; rather, they undergo 
transformation into tissue macrophages without further cell division (458). The terminal stage of differentiation 
in the mononuclear phagocyte line is believed to be the multinucleated giant cell which is found characteristically 
in granulomatous inflammatory diseases such as tuberculosis, sarcoidosis and Crohn's disease (113). 
Precise data on the average life-span of tissue macrophages are not available. However, an estimate 
of the life span of human macrophages has been provided by the studies of Thomas and coworkers (439). These 
investigators demonstrated that in patients receiving bone marrow transplants for aplastic anaemia or leukaemia, 
host macrophages gradually disappeared from their tissues and were replaced by donor macrophages by 
approximately three months after transplantation. 
1.4 Morphology, Metabolism and Surface Receptors 
Mono Masts 
There are no special features that allow monoblasts to be recognised. Monoblasts are assumed to be 
the immediate precursors of promonocytes, but they are indistinguishable from myeloblasts. 
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Promonocytes 
Promonocytes represent 3% of marrow cells. They are round cells, 12 to 18 in diameter, with an 
indented or irregularly shaped nucleus. The cytoplasm contains a conspicuous Golgi complex but relatively few 
cisternae of the endoplasmic reticulum. The first type of cytoplasmic granule (peroxidase positive or primary 
lysosome) appears in the early promonocyte stage. Peroxidase positive granules contain peroxidase, lysosomal 
enzymes, acid phosphatase and aryl sulphatase (267). The second type of cytoplasmic granule (peroxidase 
negative) appears in more mature promonocytes and monocytes (332). Promonocytes are facultative anaerobes; 
that is, they obtain their metabolic energy from glycolysis. Promonocytes are actively dividing cells and they 
are capable of phagocytosis and adherence to glass surfaces (267). These cells contain non-specific esterases 
in addition to the lysosomal enzymes listed above, and they have surface receptors for the Fc component of IgG 
and complement component C3 (213). 
Monocytes 
Monocytes represent 3 to 8% of peripheral blood leukocytes. These cells measure 12 to 15 in 
diameter and possess a characteristic kidney-shaped nucleus. The cytoplasm contains a well-developed Golgi 
apparatus, numerous lysosomal granules and microtubules, and actin-containing filaments which are cross-linked 
by actin-binding protein and myosin. Their metabolism is similar to that of promonocytes. Monocytes are 
slowly motile, exhibit phagocytic activity and have a strong tendency to adhere and spread on glass surfaces 
(267). In contrast to promonocytes, monocytes do not undergo cell division. Monocytes give a positive reaction 
for non-specific esterases that is inhibited by sodium fluoride (502). These cells contain peroxidase, acid 
phosphatase, lysozyme, aryl sulphatase, ß glucuronic acid and other hydrolytic enzymes. Monocytes express 
HLA-DR antigens on their surface (302,421) along with receptors for the Fc component of IgG, complement 
component C3 (213) and insulin (402). 
Macrophages 
Macrophages measure 20 to 80 in diameter and contain a large vacuolated nucleus often with 
prominent nucleoli. Their cytoplasm contains a large well-developed Golgi apparatus, abundant rough 
endoplasmic reticulum and ribosomes, large mitochondria, microtubules, microfilaments, numerous lysosomes 
rich in hydrolytic enzymes and a sub-plasmalemmal actin-myosin system. The transition from monocyte to 
macrophage is associated with increases in: 1) the number of lysosomes and mitochondria; 2) the activity of 
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mitochondrial enzymes and the rate of cellular respiration; 3) phagocytic activity; 4) protein synthesis; and 5) 
the capacity to interact with lymphocytes (267). In contrast, maturation of mononuclear phagocytes is associated 
with a reduction in peroxidase content and mature macrophages possess little or no peroxidase activity (458). 
Macrophages are also facultative anaerobes, with the notable exception of the pulmonary alveolar 
macrophage (see below). Macrophages are highly motile and have marked phagocytic activity. In contrast to 
monocytes, macrophages have been shown to proliferate in response to certain stimuli in vitro (136,267). 
Macrophages express receptors for the Fc component of IgG (134,455), C3 (180) and insulin (30). Both 
monocytes and macrophages express receptors for IgE which is relevant to host immunity to various parasites 
(133,303). Some macrophages express HLA-DR antigens and can function as antigen presenting cells for 
lymphocytes (section 1.7.2.). The expression of HLA-DR antigen varies with the type of macrophage; only 15% 
of peritoneal macrophages express HLA-DR antigen compared with 50% of spleen and thymus macrophages 
(37,118). 
Macrophages are widely distributed throughout the body but are particularly prominent in the spleen, 
lymph nodes, liver (Kupffer cells), peritoneum, skin (Langerhans cells) and pulmonary alveoli. Macrophages 
resident in different tissues have widely differing morphological and functional properties (table 1). It has been 
postulated that the profile of local stimuli, to which macrophages are exposed in a particular tissue, influences 
their composition and metabolism, and thereby accounts for their diversity of form and function (112). 
Pulmonary alveolar macrophages 
One type of macrophage of particular interest is the pulmonary alveolar macrophage. These cells reside 
at an air-tissue interface within the alveolus with direct exposure to inhaled microbes and environmental toxins. 
AS a result of this aerobic environment, these cells have developed a predominantly aerobic metabolism (267). 
in comparison with other types of macrophages, pulmonary alveolar macrophages have a greater number of 
mitochondria and lysosomes, and an increased content of mitochondrial and lysosomal enzymes. in addition, 
their respiratory rate that is greater than that of any other mammalian phagocyte (267). These features are 
consistent with the prominent antimicrobial function of the pulmonary alveolar macrophage. 
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Table 1 
Types of Macrophages and their Prominent Functions 
Tissue Important Functions 
Spleen Removal of aged and damaged erythrocytes, leukocytes and 
platelets from the circulation (267) 
Antigen presentation to lymphocytes (267) 
Antigen presentation to lymphocytes (267) Lymph nodes 
Bone marrow (nurse cells) Highly phagocytic cells 
(111) 
Synthesis of iron binding proteins (143) 
Important source of iron for developing normoblasts 
Liver (Kupffer cells) Removal of microbes, endotoxins, antigens, immune 
complexes, colloid suspensions, chylomicrons and aged 
erythrocytes from the circulation (121) 
Bone resorption during bone remodelling (267) Bone (osteoclasts) 
Brain (microglial cells) Function unknown 
Lung alveoli (pulmonary alveolar 
macrophages) Antigen presentation to lymphocytes 
Removal of inhaled microbes and inert particles 
Clearance of surfactant from the alveoli (331) 
Pleura and peritoneum Little known 
May function as "roller bearings" to facilitate the movements 
of parietal and visceral membranes (7) 
Antigen presentation to lymphocytes (1782) 
Important roles in cell-mediated immune responses (eg 
delayed contact hypersensitivity) and contact sensitivity 
Epidermis (Langerhans cells) 
(417) 
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1.5. Secretory Products of Mononuclear Phagocytes 
While early studies of mononuclear phagocyte function focussed predominantly on the phagocytic 
activity of these cells, research in the last two decades has highlighted the importance of their secretory function. 
Monocytes and macrophages release an enormous number of biologically active substances into their local milieu 
including proteins, lipids, oxygen and nucleotide metabolites. These products are important both in the local 
environment in mediating inflammation, tissue repair, antimicrobial, tumouricidal and immune regulatory 
functions, and also in systemic responses such as the acute phase response. Some of these factors are listed in 
table 2. 
1.6. Activation of Mononuclear Phagocytes 
Activation of mononuclear phagocytes is defined as the morphological, biochemical and functional 
changes that the cells undergo in expressing enhanced antimicrobial, immune regulatory and tumouricidal 
function compared with the baseline values of resident and unstimulated cells (116,339). Over 50 structural and 
functional alterations occur in activated macrophages, some of which are shown in table 3. 
Activation of mononuclear phagocytes can be induced by many factors including lymphocyte mediators 
(128,379), bacterial products (32,141), allergens (339), phagocytosed particles (370), immune complexes (465), 
complement components (400), viruses (380), IgE (133) and phorbol esters (207). However, only lymphokines 
can be considered the ultimate activators of mononuclear phagocytes since they induce the full spectrum of 
changes associated with mononuclear phagocyte activation including increased antimicrobial activity (116). 
The changes that mononuclear phagocytes undergo during activation include increased capacity for 
adherence and spreading on a substratum (370) and an increase in the number of phagolysosomes and endocytic 
vesicles (207). The secretion of enzymes is markedly increased, particularly that of the neutral proteinases 
including plasminogen activator (456), collagenase (483) and elastase (482). in contrast, the secretion of 
lysozyme is not altered by activation of mononuclear phagocytes (116). There is also an increase in the 
Phagocytic activity of mononuclear phagocytes which is related to an increase in the number and avidity of Fc 
receptors (48). Although complement-coated erythrocytes bind equally well to resident and activated 
mononuclear phagocytes, they are ingested only by cells that have been activated (116). 
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Table 2 
Secretory Products of Mononuclear Phagocytes 
A. Enzymes 
Lysozyme (178) Anti-proteinases: 
Neutral proteinases: (312) 
D. Inhibitors of enzymes and cytokines 
plasminogen activator (456) (210) 
elastase (482) (39) 
collagenase (483) 
angiotensin convertase (418) 
plasminogen activator inhibitor (99) 
coilagenase inhibitor (478) 
tissue inhibitor of metalloproteinases (76) Acid hydrolases (325): 
proteinases: plasmin inhibitors (255) 
esterases phospholipase inhibitors: 
lipases lipomodulin (52) 
ribonucleases IL-1 inhibitors (378) 
phosphatases 
glycosidases E. Complement Components 
cathepsins (38.1 73,325,485) 
Deaminase: Classical pathway: 
arginase (262) C1, C4, C2, C3, C5 
Alternative pathway: 
B. Polypeptide Hormones factor B 
factor D 
and -1ß (288) properidin 
interleukin-6 (335) Inhibitors: C3b inhibitor 
interleukin-8 (435) 
tumour necrosis factor- (42) 
(168) 
platelet derived growth factor (313) 
transforming growth factor-6 (131) 
fibroblast activating factors (142) 
fibroblast growth factors (51) 
insulin-like activity (166) 
erythropoietin (376) 
granulocyte-macrophage colony 
stimulating factor (356) 
granulocyte colony stimulating 
factor (244) fibronectin (374) 
D. Oxygen Metabolites transferrin (191) 
superoxide anion (147) 
hydrogen peroxide (328) 
hydroxyl radical (474) 
hypohalous acids (252) 
F. Coagulation factors 
Intrinsic pathway: 
Extrinsic pathway: 
VII (98) 
plasminogen activator (456) 
plasminogen activator inhibitors (456) 
G.  Binding Proteins 
IX, X, V, prothrombin (345) 
thrombospondin (221) 
transcobalamin II (373) 
H. Bioactive Lipids 
leukotrienes B4, C, D and E (163275) 
prostaglandins and and 
thromboxane (348.403) 
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Activation of mononuclear phagocytes is associated with a reduction in the expression of the plasma 
membrane-associated ectoenzymes 5’ nucleotidase (151) and adenosine monophosphatase (243). The latter 
changes may be due to the increased pinocytosis and membrane internalisation that is associated with cellular 
activation (481). 
Glucocorticosteroids inhibit macrophage activation by rendering macrophages unresponsive to 
lymphokines (295). Steroids also inhibit neutral proteinase secretion. However, it is not clear whether this is 
the result of a direct action of steroids on the macrophage or because steroids inhibit lymphocytes that produce 
mediators of macrophage function (480). Steroids also inhibit mononuclear phagocyte maturation (440) and the 
accumulation of these cells at sites of inflammation (338). 
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Table 3 
Characteristics of Activated Mononuclear Phagocytes 
A. Morphological D. Functional (236,267) 
Increases in: Increases in: 
cell size (267) pinocytosis 
adhesiveness and spreading (370) phagocytosis 
cytoplasmic granules (207) intracellular microbicidal activity 
ruffling of plasma membrane (236) chemotaxis 
pseudopod formation (236) antigen presentation 
tumouricidal activity 
E. Receptor Expression 
Increases in: 
B. Biochemical 
Increases in: 
respiratory burst (236) 
glucose metabolism (116) 
adenyl cyclase activity (267) 
calcium ion influx (267) 
Decreases in plasma membrane: 
Fc receptors (48) 
CR1 and CR3 (386) 
CD11/CD18 antigens (130) 
IL-2 receptors (454) 
MHC class II antigens' (433,469) 
5' nucleotidase (151) 
adenosine monophosphatase (243) 
Decreases in: 
MHC class il antigens' (277,422,427) C. Secretory 
increased secretion of 
plasminogen activator (456) 
elastase (482) 
coilagenase (483) 
complement components (236) 
acid hydrolases (236) 
arghase (236) 
fibronectin (236) 
interleukin-1 (420) 
interleukin-6 (201) 
tumour necrosis factor-a (493) 
Secretion not changed: 
lysosome (116) 
The effect of cellular activation on MHC class II antigen expression by mononuclear phagocytes depends upon the nature of the stimulus. 
interleukin-4, granulocyte-macrophage colony stimulating factor and granulocyte colony stimulating factor induce the 
expression of MHC class II antigen by mononuclear phagocytes. In contrast, prostaglandin E, and endotoxin inhibit class II MHC antigen 
expression by mononuclear phagocytes. 
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1.7. Functions of Mononuclear Phagocytes 
1.7.1. Phagocytic and Antimicrobial Functions 
The mononuclear phagocyte plays a prominent role in the host defense against many microbes by using 
its well-developed phagocytic function to assist neutrophils in the ingestion and killing of various species of 
bacteria and fungi. Moreover, mononuclear phagocytes are the first line of defense against facultative and 
obligate intracellular parasites such as Mycobacteria, Legionella, Listeria, Brucella, Chlamydia, Toxoplasma and 
Leishmania spp (267). Mononuclear phagocytes also eliminate viruses and virus-infected cells (112). 
The process of phagocytosis consists of three phases: attachment; ingestion; and killing (267). During 
the initial attachment phase, the mononuclear phagocyte binds to the microbe by non-specific surface receptors. 
However, attachment is enhanced greatly if the microorganism has been opsonised by immunoglobulin or by 
C3b (which is generated by activation of the complement system) since mononuclear phagocytes possess surface 
receptors that specifically recognise the Fc component of Ig and C3b. Following attachment, the ingestion phase 
occurs by the extension of pseudopods which enclose the microorganism in a membranous vacuole. Contraction 
of the cell's actin filaments results in the internalisation of the vacuole to form a phagosome. The killing phase 
involves both oxygen-dependent and oxygen-independent mechanisms (170). Oxygen-dependent mechanisms, 
which are discussed below, involve the production and intracellular release of reactive oxygen species such as 
superoxide anion, hydrogen peroxide and hydroxyl radicals (21). Oxygen-independent mechanisms, which are 
probably less important, involve fusion of the primary lysosomes with the phagosome, followed by the discharge 
of lysosome, acid hydrolases and complement components into the phagolysosome which has been formed (170). 
As a result of this fusion step, the phagolysosome is acidified and the acid hydrolases initiate the digestion phase. 
The energy required for phagocytosis by mononuclear phagocytes is derived from anaerobic glycolysis, with the 
notable exception of the alveolar macrophage which relies heavily on aerobic glycolysis. 
Oxygen-dependent microbial killing: The respiratory burst of mononuclear phagocytes 
When mononuclear phagocytes are triggered by a phagocytic or pharmacological stimulus, they rapidly 
consume a large amount of oxygen and metabolise large quantities of glucose via the hexose monophosphate 
shunt (22). The purpose of this respiratory burst is to generate a number of reactive oxygen metabolites with 
the potential to inhibit the growth of, or to kill microorganisms and neoplastic cells. These products of oxygen 
include superoxide anion, hydrogen peroxide, hydroxyl radicals and oxidised halogens. 
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The respiratory burst results from activation of the NADPH oxidase respiratory complex which is a 
series of electron transporting molecules (26,388). The overall reaction is to transfer electrons from the high 
energy state of glucose to oxygen. The electrons from glucose are initially incorporated into reduced ß- 
nicotinamide adenine dinucleotide phosphate (NADPH). The electrons are then transferred down an electron 
transport chain of redox molecules, resulting in the one electron reduction of oxygen (O,) to form superoxide 
anion (347): 
+ NADPH ------> + + H' 
Most of this superoxide anion dismutates rapidly to produce oxygen and hydrogen peroxide 
(383): 
2 0  2 + ------> + O, 
At the same time, glucose is metabolised through the hexose monophosphate shunt to regenerate the 
NADPH that has been consumed by the superoxide anion-forming system. Superoxide anion and hydrogen 
peroxide are not used directly by the cells for microbial killing, since hydrogen peroxide is only weakly 
microbicidal and superoxide anion is completely innocuous (22). Rather, these products are used to produce 
the true microbicidal oxidants of phagocytes which are divided into two classes: oxidised halogens and oxidising 
radicals. The production of oxidised halogens starts with the myeloperoxidase-catalysed oxidation of a halide 
ion by hydrogen peroxide to form hypohalous acid (250). For example, chloride ion is oxidised to 
hypochlorous acid 
C1' + H' + ------> HOCl + 
myeloperoxidase 
Hypochlorous acid, the prototype of the oxidised halogens, is an extremely powerful microbicidal agent. 
It is also the precursor of the chloramines another group of microbicidal oxidised halogens, which are 
formed by the reaction between hypochlorous acid and ammonia or amines (475): 
HOCl + ------> RNHCl + 
Oxidising radicals, the other class of microbicidal oxidants, are formed in reactions involving superoxide 
anion. The hydroxyl radical (OH.) is made by the Haber-Weiss reaction which is a reaction between superoxide 
anion and hydrogen peroxide catalysed by metal ions (23): 
+ ------ > OH. + OH- + O, 
Fe a Cu 
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Enzymes involved in the respiratory burst 
Two of the enzymes involved in the generation of reactive oxygen metabolites are studied in this thesis: 
the NADPH oxidase system and myeloperoxidase. 
1. The NADPH oxidase system 
In 1964 a membrane-associated pyridine nucleotide oxidase was described, which was thought to be the 
enzyme responsible for the respiratory burst by catalysing the production of superoxide anion from oxygen, using 
NADPH as the electron donor (389). However, in recent years it has become clear that the "NADPH oxidase" 
is a series of electron transporting proteins rather than a single enzyme. 
The terminal oxygen-binding component of the oxidase system is cytochrome b-245 which is a 
heterodimer composed of a 23 kD a chain and a heavily glycosylated 76 to 92 kD ß chain (405). The 
cytochrome is located in the plasmalemma of mononuclear phagocytes and becomes incorporated into the wall 
of the phagocytic vesicle as it is formed by an invagination of this membrane (405,407). The function of a redox 
molecule is largely dependent upon its midpoint potential (at which it is balanced between oxidation and 
reduction) and this governs its bioenergetic stature in the hierarchy of components in an electron transport chain. 
At 245 mV this cytochrome has the lowest midpoint potential of any mammalian cytochrome b, which provides 
it with the capacity to reduce oxygen directiy to form superoxide anion (495). However, cytochrome b-245 is 
not the only component of the electron transport chain since cytochromes are not able to receive electrons 
directly from NADPH (406). There is evidence to suggest that: 1) a 65 to 67 kD membrane-associated 
flavoprotein binds to and links NADPH with cytochrome b-245 (238); and 2) the cofactor is flavin adenine 
dinucleotide (251,388). In addition, two cytosolic proteins (a 47 kD phosphoprotein and a 65 kD protein) may 
be involved in the electron transport chain since both proteins translocate into the membrane upon activation 
Of the oxidase system (72,198). Moreover, Babior and coworkers (24) have identified at least 10 other proteins 
that may be involved in the electron transport chain. 
One unifying theory of the electron transport chain has been proposed by Segal (406). He proposed 
that upon activation of the cell, the 65 kD cytosolic protein moves into the membrane and functions either as 
the proximal NADPH-binding flavoprotein, or intercalates into the chain distal to the 65 to 67 kD membrane 
protein with these characteristics. Activation of the cell also results in phosphorylation of the 47 kD cytosolic 
protein and movement of this protein into the membrane where it could attach to a binding site on cytochrome 
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b-245. The 47 kD protein may be an electron-transporting molecule or could play a structural or regulatory role 
in the activation of the chain. Electrons are thus transported across the membrane from the NADPH-binding 
protein, which projects into the cytosol, to cytochrome b-245 which projects into the lumen of the phagocytic 
vacuole where oxygen is reduced to form superoxide anion. 
2. Myeloperoxidase 
Monocytes contain large amounts of myeloperoxidase (MPO) which accounts for about 5% of their total 
cellular protein content (405). MPO is located within the lysosomal granules of promonocytes and monocytes. 
Following phagocytosis of microorganisms, lysosomal granules fuse with the phagocytic vesicle and discharge 
their content of enzymes, including MPO, into the phagolysosome. As described above, MPO catalyses the 
oxidation of halide ions by hydrogen peroxide to form hypohalous acids. Although these potent oxidising and 
halogenating agents are toxic to microorganisms, it is unclear whether this is the major physiological pathway. 
It has been postulated that the chief function of MPO may be to degrade hydrogen peroxide to water by a 
caialase-like activity (405). 
microbiocidal 
MPO does not appear to be essential for activity since hereditary deficiency of this enzyme 
is usually associated with good health. In addition, the transition from monocytes to macrophages is 
accompanied by almost a complete loss of granule-associated MPO, but there is no concomitant loss of 
antimicrobial function. However, this may be because MPO is part of a very efficient and broad spectrum 
killing mechanism and organisms that are particularly susceptible to oxidised halogens have not yet evolved into 
human pathogens. It is also possible that macrophages obtain some MPO from monocytes or neutrophils either 
directly or following phagocytosis of damaged cells (306). 
Other phagocytic functions of mononuclear phagocytes 
Another important phagocytic function of mononuclear phagocytes is to remove damaged or aged cells 
from the circulation. Macrophages lining the sinusoids of the spleen have a particularly important role in 
ingesting senescent erythrocytes which are removed from the circulation at a rate of 0.9% per day (267). 
Erythrocytes circulating through the spleen pass through fenestrations in the basement membrane between sinus 
endothelial cell and collect in the splenic sinuses. Successful passage through this filtration system requires 
normal deformability of the erythrocyte. Cells with abnormal deformability, such as aged cells and cells from 
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patients with hereditary spherocytosis, are unable to pass through and these cells are removed by macrophages. 
Macrophages also recognise changes in the erythrocyte surface membrane that are induced by immunoglobulin 
coating chemical injury, trauma, parasitic inclusions and the ageing process (111,292,369). The destruction of 
erythrocytes occurs mainly by osmotic lysis, fragmentation and erythrophagocytosis (472). The globin moiety 
of the phagocytosed erythrocyte is then converted to amino acids and bilirubin by the enzyme haem oxygenase. 
A similar phenomenon occurs in the liver and bone marrow. 
Mononuclear phagocytes also remove aged platelets, megakaryocyte nuclei and aged or damaged 
leukocytes from the circulation (111). In addition, macrophages recognise and ingest intact senescent neutrophils 
at sites of inflammation, and may thereby limit the degree of tissue injury and promote resolution of the 
inflammatory response (397). Other phagocytic functions of mononuclear phagocytes include the removal of 
inorganic particles that are inhaled into the lungs such as elements of cigarette smoke and dust particles. In 
addition, these cells ingest tissue debris which is an important step in the normal debridement of wounds (236). 
Macrophages have been identified early in fetal development. It is thought that these cells remove the tissue 
debris that is generated as one maturing tissue replaces another in the process of tissue remodelling during 
embryogenesis (1 12,236). 
1.7.2. Immunological Functions 
A second well-defined function of mononuclear phagocytes is their interaction with lymphocytes in the 
immune response. This interaction is essential for the development of cellular and humoral immunocompetence 
and has two major components (267). The first component involves the induction of a response to antigen, and 
is called the afferent or inductive limb of the immune response. The efferent or effector limb of the immune 
response includes the expression of cell-mediated immunity, and the secretion of mediators with immune 
regulatory functions such as interleukin-1 (IL-1), tumour necrosis factor-a (TNF) and interferon-y (IFN). 
The afferent limb 
The role of mononuclear phagocytes in the induction of specific immune responses is complex and 
involves both B and T lymphocytes. B lymphocytes and certain T lymphocytes, in particular T-helper (T4) cells, 
are unable to recognise and bind to free antigen. For recognition to occur, antigen must be expressed along with 
MHC class II products on the surface of cells called antigen presenting cells (454). Although several classes of 
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MHC type II antigens have been identified including HLA-DP, HLA-DQ, HLA-DR and HLA-DS 
(176,355,454,488), HLA-DR antigens have been studied the most thoroughly. 
A proportion of mononuclear phagocytes express HLA-DR antigens and, therefore, act as antigen 
presenting cells for lymphocytes along with the non-phagocytic dendritic cells in blood, lymph and other tissues, 
and Langerhans cells in the skin (454). Foreign proteins are internalised by mononuclear phagocytes and 
undergo intracellular processing (11,506) which is thought to alter the protein so that it acquires an affinity for 
an HLA-DR antigen (20,69). The processed protein is then displayed on the cell surface along with the HLA- 
DR antigen. The T cell antigen receptor recognises and binds to this complex which, in turn, induces IL-1 
production by the munonuclear phagocyte (264). The antigen-HLA-DR antigen complex, together with IL-1, 
stimulate the T cell to express interleukin-2 (IL-2) receptors and release IL-2 (280,454). The binding of IL-2 
to its receptor stimulates the proliferation of T4 cells and initiates a cascade of activation steps resulting in: 
1) the release of lymphokines from T4 cells which activate macrophages to kill intracellular 
microorganisms; 
2) activation of cytotoxic T (T8) lymphocytes; 
3) activation of B lymphocytes by T4 cells to produce antibody; and 
4) the generation of an inflammatory reaction (454). 
The efferent limb 
Macrophage involvement in the effector limb of the immune response includes increased microbial 
killing tumouricidal activity, the delayed hypersensitivity reaction of tuberculosis and granulomatous 
hypersensitivity, and the rejection of allograph organs (267). To achieve optimal killing or inactivation of 
pathogenic organisms, macrophages must be activated. This activation is induced by lymphokines which are 
released by activated T lymphocytes such as migration inhibition factor, macrophage activation factor and a 
mononuclear phagocyte chemotactic factor (379,399). During this effector stage, macrophages exhibit increased 
phagocytosis and microbial kiiiing, and secrete a wide variety of biologically active molecules that influence both 
limbs of the immune response (384). 
The participation of mononuclear phagocytes in antibody-dependent cell-mediated cytotoxic events is 
thought to be important in the killing of tumour cells and in immunity to protozoa and nematodes. Mononuclear 
Phagocytes bind to antibody-coated tumour cells and parasites such as Schistosomes, Leishmania, Trypanosoma 
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and Plasmodium spp by their Fc receptors for IgG (286,324). This is followed by the secretion of enzymes and 
reactive oxygen metabolites which ultimately causes the mononuclear phagocyte to become cytotoxic for the 
target cells (326). 
1.7.3. Inflammation 
The acute phase response is a systemic inflammatory reaction to infection or injury. It is characterised 
by fever, tachycardia, shock and changes in the concentration of some circulating proteins such as C reactive 
protein and fibrinogen. At least three monocyte product are thought to be important in this response: IL-1, 
TNF, and interleukin-6 (IL-6), (137,445). 
Il-1 is thought to mediate fever by stimulating the release of prostaglandin E in the hypothalamus which 
resets the hypothalamic thermoregulatory center (40,137). IL-1 also mediates the accelerated catabolism of 
muscle protein and the negative nitrogen balance that are associated with acute infection and inflammation 
(18,420). 
TNF regulates the synthesis of acute phase proteins (127) and is also an endogenous pyrogen (138). In 
addition, TNF is thought to be responsible, in part, for the disseminated intravascular coagulation and multi- 
system failure seen in endotoxic shock. This hypothesis is supported by two observations. First, plasma TNF 
concentrations correlate with the degree of shock in patients with meningococcal septicaemia (464). Second, 
antibody to TNF limits experimental endotoxic shock (446). 
IL-6 has been implicated recently in mediating the acute phase response since serum concentrations of 
IL-6 correlate with C-reactive protein levels and fever in patients with severe bums (335). Peripheral blood 
monocytes are the main source of IL-6 which is the main inducer of acute phase protein production in cultured 
hepatocytes (95). 
In addition to their systemic effects in inflammation, IL-1 and TNF also induce local effects at 
inflammatory foci including: i )  the recruitment of Ieukocytes into sites of inflammation; 2) the modulation of 
multiple functions of neutrophils such as degranulation and the generation of reactive oxygen metabolites; and 
3) the proliferation of fibroblasts and increased synthesis of collagen by these cells (420,493). 
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1.7.4. Tumouricidal Function 
Mononuclear phagocytes infiltrate tumours (150,494) and are probably one of the main host defenses 
against tumours that arise spontaneously (199). Mononuclear phagocytes use both antibody-independent and 
antibody-dependent mechanisms to kill tumour cells. 
Antibody-independent mechanisms 
Activated macrophages are non-specifically cytotoxic to tumour celi lines in vitro (2). The nature of 
the tumour antigen to which the macrophage binds is not known, but tumour recognition triggers a cytotoxic 
response that is a non-phagocytic and contact-mediated event. A later step in the process involves the secretion 
of effector substances such as neutral proteinases, arginase, thymidine, components of complement, hydrogen 
peroxide and other toxic oxygen metabolites (5,326). Mononuclear phagocytes also release TNF which produces 
haemorrhagic necrosis of murine tumour cells (94) and is an important mediator of the cytotoxicity of human 
monocytes for tumour cells in vitro (162). 
Antibody-dependent mechanisms 
Mononuclear phagocytes also kill tumour cells by an antibody-dependent cytolytic mechanism (286,324). 
Tumours are recognised by specific antibodies that bind to target cell antigen (324). Mononuclear phagocytes 
bind to these antibodies by their Fc receptors and this stimulates the release of reactive oxygen metabolites 
resulting in tumour cell lysis (326). 
1.75. Wound healing, tissue repair and remodelling 
Mononuclear phagocytes debride wounds by releasing proteinases such as collagenase and elastase, and 
by ingesting tissue debris (482,483). Monocytes and macrophages also participate in tissue remodelling and 
repair by releasing substances that stimulate fibroblast proliferation and neovascularisation (271,272). 
Osteoclasts, which are thought to belong to mononuclear phagocyte system, participate in the remodelling of 
bone (298,326). 
1.7.6. Haemopoiesis 
Part of the acute response to infection and injury is a peripheral blood leukocytosis. Mononuclear 
phagocytes play an important role in inducing increased leukopoiesis in response to these stresses by secreting 
19 
haemopoietic growth factors such as granulocyte-macrophage colony stimulating factor (GM-CSF) and 
macrophage colony stimulating factor (M-CSF), (416). These colony stimulating factors stimulate the formation 
a d  growth of colonies of granulocytes and monocytes from committed progenitor cells (305,458). Mononuclear 
phagocytes also stimulate haemopoiesis indirectly by releasing IL-1 and TNF which induce T lymphocytes to 
produce haemopoietic growth factors such as GM-CSF and interleukin-3 (IL-3), (416). 
Mononuclear phagocytes play a role in erythropoiesis. The role of the mononuclear phagocyte in iron 
metabolism is well established. When aged erythrocytes are removed from the circulation by mononuclear 
phagocytes, the iron component of haemoglobin is recycled. Most of the iron is transported back to the bone 
marrow by the iron transport protein transferrin, some of which is synthesised by macrophages (143). In 
addition, bone marrow macrophages serve as a source of iron for developing normoblasts (111). Finally, 
macrophages produce erythropoietin, a glycoprotein hormone that stimulates erythropoiesis (376). 
1.7.7. Blood Coagulation 
The host response to infections, tumours or injury may be to activate the coagulation system within the 
circulation resulting in disseminated intravascular coagulation. Mononuclear phagocytes activate the blood 
coagulation process in response to bacterial endotoxin, immune complexes, complement components and other 
stimuli by synthesising and expressing tissue thromboplastin, which is the most potent activator of the extrinsic 
coagulation pathway (460,461). Moreover, it has been shown that mononuclear phagocytes from patients with 
meningococcal septicaemia (346). and tumours of the lung (152) and breast (19) synthesise increased amounts 
of tissue thromboplastin in vitro when compared with cells from healthy subjects. In addition, monocyte 
products such as IL-1 and TNF induce the production of tissue thromboplastin by endothelial cells, and thereby 
potentiate the thrombogenic state (45,329). Mononuclear phagocytes also secrete plasminogen activator (456), 
plasmin inhibitor (326), prostaglandins (263), thromboxane (403) and platelet activating factor (85), all of which 
have an important role in the coagulation cascade, and in fibrin formation and degradation. 
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1.8 Monocyte Heterogeneity 
In contrast to tissue macrophages, peripheral blood monocytes were initially considered to be a 
homogeneous population of cells. In recent years it has become increasingly clear that while monocytes share 
certain morphological and functional characteristics, they are by no means uniform in this respect. A large 
number of studies have documented the nature and extent of monocyte heterogeneity, and have suggested 
mechanisms by which this heterogeneity may have arisen. 
Freshly-isolated monocytes have been shown to be heterogeneous with respect to physical properties 
such as size and density, the expression of surface receptors and various functional properties. Such differences 
have been exploited to separate subpopulations of monocytes. The following account summarises the literature 
on subpopulations of monocytes based on differences in: 1) size and volume; 2) density; 3) surface protein 
expression; 4) function; and 5) enzyme content. 
1.8.1. Separation of Monocyte Subpopdations Based on Differences in Cell Size or Volume 
Both counter current centrifugal elutnation (CCE) and density gradient centrifugation have been 
employed to separate monocyte subpopulations on the basis of differences in cell size. Two major 
subpopulations have been identified: "small" and ''large'' monocytes with mean cell diameters of 7 to 8 and 
8 to 10 respectively (9,16,108). 
Antimicrobial functions 
"Large" monocytes have been shown to possess greater antimicrobial function when compared with 
"small" monocytes. For example, "large" monocytes are more responsive to chemotactic stimuli than "small" 
monocytes (110). In addition, "large" cells are more phagocytic with respect to ingestion of carbonyl iron (16), 
opsonised sheep erythrocytes (218) and latex beads (108) compared with "small" monocytes. The differences 
in phagocytic activity between "small" and "large" monocytes may reflect differences in Fc receptor expression 
Since it has been reported that "large" monocytes are predominantly Fc receptor positive, whereas "small" 
monocytes are predominantly Fc receptor negative (337). However, other investigators failed to confirm the 
latter finding (9,299,401). Differences in the generation of oxidants by "small" and "large" monocytes have also 
been reported. "Large" monocytes produce 1.5-fold more superoxide anion in response to opsonised zymozan 
(503) and release up to 6-fold more hydrogen peroxide under basal conditions when compared with "small cells" 
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(452). Moreover, "large" cells produce more hydrogen peroxide in response to LPS and IFN than "small" 
monocytes (452). "Large" monocytes have also been shown to contain 1.4 to 2-fold more peroxidase activity 
(9,503) and a greater number of peroxidase positive granules (9) than "small" monocytes. 
Biochemical markers 
Differences in biochemical markers have been described. "Small" monocytes have a lower acid 
phosphatase content (10), lower peroxidase activity (10,503) and a lower total protein content (10) than "large" 
cells. However, Akiyama and coworkers demonstrated that "small" and "large" monocytes express similar 
amounts of 5' nucleotidase (9) and alkaline phosphodiesterase (10) which are markers of monocyte activation. 
Cytokine production 
Differences in cytokine release by "large" and "small" monocytes have been described. Akiyama and 
coworkers (10) demonstrated that when cultured under basal conditions, "small" and "large" cells produce similar 
amounts of IL-1, IFN, TNF and prostaglandin but "small" cells produce slightly more colony 
stimulating factor (CSF) than "large" cells. These investigators also reported that when monocytes are stimulated 
with polyriboinosinic:polyribocytidylic acid (polyI:polyC), "small" cells release 3-fold more IFN and 30% more 
CSF, but 2-fold less when compared with "large" cells (10). The pattern of IL-1 production by stimulated 
monocytes depends upon the nature of the stimulus. Akiyama and coworkers (10) reported that polyI:poly C 
stimulates the "small" cells to produce 4-fold more IL-1 than the "large" cells. in contrast, LPS induces similar 
increases in IL-1 production by "small" and "large" cells, and GM-CSF stimulates greater IL-1 production by 
"large" cells when compared with "small" monocytes (218). 
Immune effector functions 
"Small" and "large" monocyte subpopulations also differ with respect to several immune effector 
functions. Norris et al. (337) demonstrated that oniy "large" monocytes lyse erythrocyte target cells in antibody- 
dependent cellular cytotoxicity (ADCC) assays. Akiyama et al. (10) confirmed that "large" monocytes exhibit 
greater ADCC than "small" cells and demonstrated that "large" cells are more effective than "small" cells at 
mediating mitogen-induced T lymphocyte proliferation. The latter investigators also showed that a greater 
proportion of "large" cells express CD11b/CD18 surface antigen and the receptor for poke weed mitogen 
(PWM) compared with "small" cells but no differences in HLA-DR antigen expression by these monocyte 
subsets were detected. in contrast, Esa et al. (158) reported that "small" cells express fewer HLA-D and HLA- 
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DR molecules than "large" cells. Esa and coworkers also demonstrated that: 1) "small" cells are more 
efficient at presenting soluble and particuíate antigens to lymphocytes than "large" cells; and 2) lymphocytes 
activated with antigen-pulsed "large" cells exhibit more suppressor cell activity than those activated with antigen- 
pulsed "small" cells. 
Tumouricidal function 
Differences in tumouricidal activity between "large" and small" monocytes have been reported. 
Normann and coworkers (336) found that only "small" monocytes express native tumouricidal activity. 
Moreover, "small" cells can be activated by lymphokines and LPS for tumour cell kilIing whereas "large" cells 
are resistant to activation for this function. In contrast, Inamura et al. (218) did not detect any differences 
between "large" and "small" monocytes in cytotoxicity against allogeneic tumour cells when the monocytes were 
cultured under either basal conditions, or in the presence of LPS or GM-CSF. 
1.8.2. Separation of Monocyte Subpopulations Based on Differences in Density 
The technique of sedimentation of monocytes through discontinuous gradients of bovine or human 
serum aIbumin (246,357,501) or Percoll (153) has been widely used to separate monocytes subpopulations on 
the basis of differences in their density. Two major subpopulations have been identified using these techniques: 
"low" and "high" density cells. 
Morphology 
Morphological differences between the "low” and "high" density subsets have been reported. Monocytes 
within the "high" density fraction possess mainly round or ovoid nuclei and have few, if any, membrane 
pseudopodia (64). In contrast, monocytes in the "low" density fraction possess folded or indented nuclei and 
have numerous membrane pseudopodia (64). It has been postulated that these morphological differences 
represent differences in cytoplasmic or membrane fluidity between the subpopuíations (64,144). 
Biochemical markers 
"High" and "low" density monocyte subpopuíations differ with respect to several biochemical markers. 
It has been reported that the "high" density cells express high non-specific esterase activity, high 5' nucleotidase 
activity, high peroxidase activity and low acid phosphatase activity, whereas the "low" density cells express low 
non-specific esterase activity, low 5' nucleotidase activity, low peroxidase activity and high acid phosphatase 
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activity (164,357). 
Receptor expression 
Differences in the expression of surface receptors have been reported. "High" density cells express 
greater amounts of Fc and C3 receptors compared with "low" density cells (401). 
production of soluble mediators 
Differences in the synthesis of soluble mediators by "low" and "high" density cells have been 
demonstrated. A thymocyte IL-1-like activity is produced in larger amounts by "high" density monocytes when 
compared with "low" density cells (154,246). However, there is controversy regarding production by the 
monocyte subpopulations since production by the "high" density cells has been reported to be equal to 
(165), greater than (153,246) and lower than (357,501) that of the "low" density cells. 
Immune effector functions 
Density-defined subpopulations of monocytes also differ with respect to several immune effector 
functions. Schreiber and coworkers (401) reported that "high" density monocytes have a greater capacity to 
support PWM-induced B-cell differentiation compared with "low" density cells (401). However, Figdor et al. 
(164) demonstrated that "high" density monocytes are less capable of inducing the proliferation of lymphocytes 
in mixed leukocyte cultures than "low" density cells and this difference is not due to differences in HLA-DR 
antigen expression between the monocyte subsets. Figdor and coworkers (164) also reported that"high" density 
monocytes are more active with respect to ADCC than "low" density cells. 
Khansari and coworkers (246) reported that the functional activities of the two subpopulations are 
mutually antagonistic. These investigators demonstrated that "high" density cells enhance the production of 
immunoglobulins by B lymphocytes in response to PWM. In contrast, the "low" density subset not only lack this 
activity but activeiy suppress the background response that is generated in the absence of added monocytes, and 
the response that is produced in cultures containing "high" density cells. Khansari and coworkers postulated that 
this effect is due in part to high basal production of by the "low" density subset. 
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Relationship between size and density-defined subpopulations of monocytes 
In view of the relationship between cell size and density, Dougherty et ai. (144) postulated that there 
is a relationship between the size and density-defined subpopulations of monocytes discussed above. These 
investigators proposed that: 1) the "small" monocytes are the same subpopulation as the "high" density cells and 
the "large" monocytes are identical to the "low" density cells; and 2) there are two major subpopulations of 
monocytes, "small, high" density celis and "large, low" density celis. However, this hypothesis has not yet been 
tested. 
The properties of the size and density-defined monocyte subpopulations are summarised in table 4. 
While there is general agreement about the various biochemical and functional characteristics of the two 
monocyte subpopulations, there is some disagreement between different laboratories as to their precise 
phenotype (table 4). in particular, discrepant results have been reported for the following monocyte functions: 
1) immune effector functions such as HLA-DR antigen expression (10,158,164) and the capacity to 
induce lymphocyte proliferative responses (9,164,246,401); 
2) tumouricidal activity (218,336,501); 
3) the release of biologically active mediators such as IL1 (10,154,246) and PGE2 (153,165,357); and 
4) Fc receptor expression (9,299,337,401). 
A number of different procedures were used to isolate monocytes for the studies listed above including 
CCE, density gradient centrifugation and adherence to tissue culture plastic. The variety of monocyte isolation 
procedures used may account for the discrepant results reported by these investigators. This possibility is 
supported by the following observations. 
1) The initial population of monocytes from which the subpopulations were derived may differ since 
the yield of monocytes is always less than 100% and varies considerably with the isolation procedure 
used (146,219,442). 
2) Some gradient media, such as ficoll-Hypaque, are frequently contaminated with endotoxin (190). 
Endotoxin has been shown to affect many aspects of monocytes function including HLA-DR antigen 
expression (504), and the production of TNF (43,106), (153) and IL-1 (185,245). 
3) The temperature at which monocytes are incubated during isolation varies considerably with the 
method used. For example, monocytes are incubated at room temperature throughout the CCE method 
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whereas the density gradient centrifugation method involves an adherence step which is conducted at 
37°C. incubation temperature has been shown to affect the expression of several surface receptors by 
monocytes including CR3, CR1 and HLA-DR antigen (146,160,421). 
4) The number of contaminating lymphocytes and natural killer cells in the monocyte preparations 
vanes with the isolation procedure used (164,258) and this may contribute to differences in immune 
effector and tumouricidal functions of the monocyte subpopulations in different studies. 
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Table 4 
Functional Heterogeneity of Size and Density Defined Monocyte Subpopulations 
small/high density large/low density 
Function monocytes monocytes References 
A. Biochemical Markers 
non-specific esterase activity high low Figdor et al. (164) 
acid phosphatase activity low high P i c k e r  e t  a l .  ( 3 5 7 )  
low high Akiyama et al. (10) 
total protein content low high Akiyama et al. (10) 
5’ nucleotidase activity equal equal Akiyama et al. (9) 
higher lower Picker et al. (357) 
alkaline phosphodiesterase equal equal Akiyama et al. (10) 
B. Antimicrobial Functions 
chemotactic activity lower higher Arensen et al. (16) 
phagocytosis lower higher Arensen et al. (16) 
lower higher Inamura et al. (218) 
lower higher Chiu et al. (108) 
equal equal Akiyama et al. (9) 
Yasaka et al. (503) Superoxide production lower higher 
hydrogen peroxide production lower higher Turpin et al. (452) 
peroxidase activity lower higher Yasaka et al. (503) 
lower higher Akiyama et al. (9) 
Figdor et al. (164) higher lower 
C. Immune Effector Functions 
ADCC inactive active Norris et al. (337) 
lower activity higher activity Akiyama et al. (9) 
higher activity lower activity Figdor et al. (164) 
equal equal McCarley et al. (299) 
induction of lymphocyte 
proliferation lower capacity higher capacity Figdor et al. (164) 
capacity to support PWM-induced 
B cell differentiation greater lower 
effect on PWM-induced Ig 
production by B cells enhancement 
effect on mitogen-induced T cell 
proliferative responses lower higher Akiyama e t  a l . (9)  
antigen presentation more efficient less efficient Esa et al. (158) 
Schreiber et al. (401) 
suppression Khansari et al. (246) 
Normann et al. (336) 
higher lower Wykoff et al (501) 
Inamura et al. (218) 
D. Tumouricidal activity present absent 
equal equal 
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Table 4 (continued) 
small/high density large/low density 
Function monocytes monocytes References 
E. Production of Soluble Mediators 
IL-1 production 
- basal equal equal Akiyama et al. (10) 
higher lower Khansari et al. (246) 
- polyI:polyC stimulated Akiyama et al. (10) - GM-CSF stimulated lower higher Inamura et al. (218) 
-LPS equal equal Inamura et al. (218) 
IFN production: 
- basal - poly I:polyC stimulated 
CSF production: 
- basal - polyI: polyC stimulated 
basal production 
-basal equal equal Akiyama et al. (10) 
4-fold higher than large cells 
higher lower Elias et al. (154) 
equal equal Akiyama et al. (10) 
Akiyama et al. (10) 3-fold higher than large cells 
Akiyama et al. (10) 
Akiyama et al. (10) 
slightly higher than large cells 
30% higher than large cells 
Figdor et al. (165) 
Khansari et al. (246) 
substantial amounts Picker et al. (357) 
Wykoff et al. (501) 
Akiyama et al. (10) 
equal equal 
small amounts 
5-6 fold greater than low density cells 
4-10 fold lower than low density cells 
- LPS stimulated substantially greater minimal amounts Elias et al. (153) 
- polyI:polyC stimulated 2-fold lower than large cells 
F. Receptor Expression 
Fc receptor expression negative positive Norris et al. (337) 
equal equal McCarley e t  al .  (299) 
equal equal Akiyama et al. (9) 
higher lower Schreiber et al. (401) 
Schreiber et al. (401) CR3 receptor expression higher lower 
HLA-DR antigen expression equal equal Figdor et al. (164) 
equal equal Akiyama et al. (9) 
lower higher Esa et al. (158) 
PWM receptor lower higher Akiyama et al. (9) 
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1.8.3. Separation of Monocyte Subpopulations Based on Differences in Surface Receptors 
Monocytes have been shown to be heterogeneous with respect to a large number of surface molecules 
including: 1) Fc receptors for IgG (342,437,505) and IgE (303); 2) receptors for complement (212,488); 3) class 
II MHC antigens (175,176,340,488); and 4) receptors for peanut agglutinin (186), PWM (9) and CD4 (436). 
Several research groups have exploited these differences to isolate monocyte subsets that are functionally 
distinct. 
Fc receptor expression 
Differences in the expression of Fc receptor for IgG have been used to isolate Fc receptor positive 
and negative monocyte subsets which differ in their immune regulatory functions. It has been 
reported that only cells enhance PWM-induced immunoglobulin secretion (505). In addition, several 
laboratories have demonstrated that only cells are highly active at presenting antigen to T lymphocytes and 
stimulating both autologous and allogeneic mixed lymphocyte reactions (342,437,505). In contrast, only 
monocytes suppress mitogen- and antigen-induced lymphocyte proliferation effectively (342,437,505). Szabo and 
coworkers (437) postulated that the immunosuppressive activity of the population is related to the fact 
that this subpopulation is the major source of a potent immunosuppressive monokine. 
Differences in tumouricidal activity between the FcR subpopulations have also been identified. Zembala 
et al. (505) demonstrated that only the cells are strongly cytostatic against tumor cells in vitro. In addition, 
the cells are the major TNF-producing population of monocytes (437). 
Complement receptors 
Whisler and coworkers (487) demonstrated that 70% of monocytes express receptors for complement 
and these cells are larger and express higher numbers of FcR than cells that are devoid of complement 
receptors These investigators also demonstrated that the cells secrete 4-fold and 12-fold more IL-1 
than cells when cultured under basal and stimulated conditions, respectively. In addition, monocytes 
support the formation of Staphylococcal protein A-stimulated human B cell colonies more effectively than 
cells. 
Class II MHC antigens 
Monocyte subpopulations differing in class II MHC antigens have been described. On average, 75 to 
91% of freshly-isolated monocytes express HLA-DR antigens, 32% express HLA-DQ, 15% express HLA-DP 
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antigens and 25 to 50% express HLA-DS molecules (175,488). Whisler et al. (488) reported that the HLA-DR 
positive (HLA-DR') monocytes are 2 to 5-fold more effective than HLA-DR negative (HLA-DR-) cells in 
promoting B cell proliferative responses in cultures pulsed with Staphylococcal protein A. In addition, these 
investigators reported that there is a relationship between HLA-DS expression and accessory cell function; HLA- 
DS positive (HLA-DS" cells, which are predominantly HLA-DR, are less effective than HLA-DS negative 
in promothg B cell proliferative responses. These differences could not be attributed to differences 
in the release of IL-1 by the various monocyte subsets. However, Gonwa and coworkers (176) demonstrated 
that: 1) only HLA-DS' cells present antigen to T lymphocytes; and 2) HLA-DS' monocytes are more effective 
at stimulating autologous mixed lymphocyte reaction than HLA-DS- cells (176). In contrast to Whisler and 
coworkers (488), Gonwa et al. did not detect any differences in HLA-DR antigen expression by the HLA-DS' 
and monocyte subsets. 
CD4 expression 
Szabo et al. (436) demonstrated there is a relationship between the expression of CD4, a surface antigen 
of unknown function, and an immune regulatory function of monocytes (436). Monocytes that are devoid of 
cell surface CD4 are less effective at presenting antigen to lymphocytes than cells that express CD4 
(CD4'). Szabo and coworkers also reported that the monocytes produce more than the CD4' 
subset. However, that is unlikely to be the primary cause of the reduced antigen presenting capacity of the 
cells, since the addition of a cyclo-oxygenase inhibitor to the monocytes did not restore their capacity to 
present antigen to that of the CD4' subset. These investigators also demonstrated that the CD4' subset produce 
more TNF than the cells; however, there were no differences in the production of other monokines that 
influence the immune regulatory function of monocytes such as IL-1 and plasminogen activator. 
1.8.4. Separation of Monocyte Subpopulations Based on Differences in Function 
Monocyte subpopulations have been isolated on the basis of differences in their adherence properties. 
Treves and coworkers (450) demonstrated that monocytes are heterogeneous in their capacity to adhere to 
plastic. These investigators identified a subpopulation of monocytes that adheres tightly to plastic, and an 
additional, small subpopulation of monocytes that is loosely adherent to plastic. The loosely-adherent 
subpopulation secrete greater amounts of IL-1 and when cultured under basal conditions when compared 
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with the tightly-adherent monocytes. However, following maturation in vitro for 72 h, the loosely-adherent cells 
lose their capacity to produce more IL-1 than the tightly-adherent cells. Moreover, LPS stimulates both 
subpopulations to produce similar amounts of IL-1. These data suggest that the loosely-adherent cells are 
partially activated either in vivo or during their isolation in vitro Alternatively, the loosely and tightly adherent 
monocyte subpopulations may be different maturational stages of mononuclear phagocytes. 
Chen et al. (107) demonstrated that exposure of mononuclear cells to LPS results in a 3-fold increase 
in the yield of monocytes isolated by adherence to serum-coated plastic. These investigators postulated that 
LPS promotes the recovery of weakly-adherent monocytes. The weakly-adherent cells, which are isolated by 
conducting the adherence assay in the presence of LPS, exhibit enhanced cytolytic activity compared with tightly- 
adherent monocytes that are exposed to LPS following the adherence assay. This difference could not be 
attributed to natural killer cell contamination of the weakly-adherent monocytes. Chen and coworkers postulated 
that weakly-adherent monocytes possess an intrinsically greater cytolytic potential than tightly-adherent cells. 
However, it is also possible that exposure of mononuclear cells to LPS during the monocyte isolation procedure 
induces the production of lymphokines that stimulate monocyte cytolytic activity. 
1.8.5. Subpopulations of Monocytes Based on Differences in Enzyme Content 
Subpopulations of monocytes that differ in their content of proteinases have been identified. Campbell 
and coworkers (81) demonstrated that about 20% of monocytes express marked but localised proteolytic activity 
against fibronectin, even in the presence of proteinase inhibitors. This proteolytic activity is due to the high 
content of serine proteinases (human leukocyte elastase and cathepsin G) within this subpopulation of 
monocytes. Karg et al. (242) showed that monocytes are heterogeneous in their content of serine proteinases 
and peroxidase by combined immunogold localisation and enzyme histochemistry. These investigators reported 
that about 60% of monocytes are completely unstained for HLE, cathepsin G and peroxidase.. A minor 
subpopulation of monocytes (20%) stain intensely for these enzymes and the remainder of the cells vary greatly 
in staining intensity. 
1.8.6. Theories on the Origins of Mononuclear Phagocyte Heterogeneity 
Two theories have been proposed to explain the morphological, biochemical and functional 
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heterogeneity of human mononuclear phagocytes. The first and most widely accepted theory proposes that the 
heterogeneity results from differences in the states of activation or maturationai stages of a single, highly 
dynamic cell lineage (144,146,449). The second theory proposes that an unspecified number of distinct monocyte 
lineages account for the impressive functional diversity of these celis (67,177,487). 
There is a considerable amount of evidence to support the former theory. First, most of the biochemical 
and functional differences observed between the two major monocyte subpopulations are quantitative rather 
than qualitative. Second, many of the characteristics that have been shown to be expressed heterogeneously by 
monocytes are also modulated by cellular activation and/or maturation. For example, the small, dense, FcR- 
subpopulation have features that are characteristic of cells at an early stage along the mononuclear phagocyte 
differentiation pathway. in contrast, most of the functions expressed by the large, low density, FcR' population 
are generally associated with more mature cells. Third, there are rapid increases in the proportion of small 
monocytes in the peripheral blood following extensive cytopheresis (9), as well as conditions associated with a 
monocytosis including parturition (64), psoriasis, eczema and mycosis fungoides (307). These observations 
suggests that the small, low density cells are less mature than the large, high density cells. 
Small monocytes have been shown to develop some of the characteristics of the larger cells when 
induced to differentiate in vitra This is perhaps the most convincing evidence to support the maturation theory. 
For example, Turpin et al. (452) demonstrated that although freshly-isolated small monocytes produce 
substantially lower quantities of hydrogen peroxide than freshiy-isolated large cells, culture of small monocytes 
for 72 h increases their production of hydrogen peroxide to that of freshly-isolated large monocytes (452). 
However, some of the characteristics that are associated with the large celis are also associated with immaturity. 
In particular, peroxidase activity, which is progressively lost as monocytes mature into macrophages, is present 
in greater amounts in large monocytes compared with small cells (9,503). in addition, differentiation of 
monocytes in virto decreases their capacity to act as accessory cells in the generation of lymphocyte proliferative 
responses (287) and increases their cytolytic activity against tumour cells compared with freshly-isolated cells 
(241,318). However, the large, low density cells (which may represent mature monocytes) exhibit greater 
accessory cell function and lower tumouricidal activity than the small, high density monocytes (which may 
represent immature cells), (table 4). Therefore, it is unlikely that the two monocyte subpopulations Simply 
reflect different maturationai stages of the monocytes. 
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The large, low density cells possess many features of cells that have been activated including increased 
phagocytic activity, superoxide production, ADCC and the capacity to present antigen when compared with the 
small, high density cells (table 4). Therefore, it is possible that the large, low density cells represent a 
subpopulation of monocytes that have been activated in vivo or during their isolation and culture in vitro. 
However, some of the characteristics that are associated with the small, high density cells are also associated 
with mononuclear phagocyte activation (including enhanced tumouricidal activity and increased cytokine 
production compared with the large-low density cells). Moreover, the two monocyte subpopulations express 
similar amounts of 5' nucleotidase (9) and alkaline phosphdiesterase (10) which are two markers of monocyte 
activation. Therefore, it is unlikely that the monocyte subpopulations simply reflect differences in the state of 
activation of the cells. 
Although there is no good evidence to date from human studies to support the existence of multiple 
distinct monocyte lineages, data from animal studies have shown that mononuclear phagocytes that are derived 
from individual bone marrow precursors retain certain distinctive characteristics during differentiation in vitro 
For example, Bursuker et al. (67) demonstrated that bone marrow precursor cells from normal mice develop 
into two well-defined types of mononuclear phagocyte colonies with respect to 5' nucleotidase (5’NT) activity. 
This enzyme was found to be a stable marker for resident and inflammatory macrophages which express high 
and low enzyme activity, respectively. Twenty percent of the colonies are small colonies in which the all of the 
cells express high 5’NT activity (high activity colonies), and 70% are large colonies in which all of the cells 
express low 5’NT activity (low activity colonies). The remaining 10% are mixed colonies in which all of the cells 
express low 5’NT activity apart from the cells located at the periphery of the colonies which express high 
activity. Since cells that express high and low enzyme activity are predominantly confined to discrete, 
homogeneous colonies that differ in phenotype, Bursuker and coworkers postulated that both may arise from 
distinct bone marrow precursor cells and that macrophage precursor cells in the bone marrow exhibit an 
inherent heterogeneity (67,68). 
Further studies by these investigators demonstrated that the induction of an acute or chronic 
inflammatory process in mice results in a 7 to 8-fold reduction in the proportion of bone marrow-derived 
mononuclear phagocyte colonies that expressed high 5’NT activity (67,68). in addition, the proportion of 
peritoneal macrophages expressing high 5’NT activity is reduced by 17 and 60-fold in mice with acute and 
33 
chronic inflammatory processes, respectively. Furthermore, bone marrow-derived mononuclear phagocytes of 
the mice bearing inflammation are more actively phagocytic and have greater tumouricidal activity than cells 
from normal mice. Bursuker and coworkers postulated that during inflammation, there is a preferential 
expansion of certain subsets of macrophage precursors, giving rise to mononuclear phagocytes that express 
distinct functional characteristics (67,68). 
Other investigators have also demonstrated heterogeneity of bone marrow precursor cells in animal 
models. Subpopulations of precursor cells that differ in density also vary in their sensitivity to colony stimulating 
factors (70), hydroxyurea (70), and haemolysate (492), indicating that there are differential requirements for 
the proliferation of different precursor cells. Moreover, Walker and coworkers (466) identified separate and 
distinct murine bone marrow precursors for mononuclear phagocytes bearing I region-associated (Ia) 
determinants and those lacking Ia However, Calamai et al. (71) failed to confirm the existence of 
distinct murine mononuclear phagocyte precursors for Ia+ phenotypes (71). Moreover, Bar-Eli and coworkers 
(31) demonstrated that a single progenitor cell can develop the metabolic characteristics of either peritoneal or 
alveolar murine macrophages and that such changes are reversible. 
The situation regarding heterogeneity of human macrophage precursors is even less clear since few 
studies have been performed. Moreover, caution should be exercised in extrapolating data from animal models 
to the human situation. However, two studies have demonstrated heterogeneity among human mononuclear 
phagocyte precursors. Morstyn et al. (315) reported that different colony stimulating factors vary in their 
capacity to support the survival and proliferation of macrophage progenitor cells. Johnson and coworkers (233) 
identified subpopulations of human macrophage precursor cells on the basis of differences in density. These 
subpopulations also differ in their sensitivity to colony stimulating factors, indicating that there are differences 
in their proliferative states. Finally, it has been proposed that distinct subpopulations of human monocytes exist 
on the basis of differences in the expression of HLA-D/DQ (177) and complement receptors (487). -However, 
other studies have failed to confirm these findings (14,160,165). 
In conclusion, on the basis of available data, it would seem likely that most of the functional 
heterogeneity observed in mononuclear phagocytes is the result of differences in maturation stages and/or states 
Of activation of a highiy dynamic cell lineage. However, the existence of functionally distinct subsets of 
monocytes remains a possibility and warrants further investigation. 
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1.9. Adherence Properties of Monocytes 
To participate in the host response to infection or inflammation, it is necessary for monocytes to be 
recruited from the vasculature. Emigration from the vasculature involves reversible adherence of monocytes 
to endothelial cells, a process that has been the focus of considerable recent interest. The next barriers that 
monocytes encounter, as they migrate towards a focus of infection or inflammation, are the subendothelial 
basement membrane and the extracellular matrix (189), both of which contain various adhesive glycoproteins 
such as collagens (259), fibronectin (391) vitronectin (193) and laminin (290). It is clear that adherence to 
extracellular matrix components must be exquisitely regulated (172,423); however, biological and pathological 
factors that regulate this process and the mechanisms involved have not yet been fully elucidated. 
1.9.1. Adherence Receptors 
Monocyte adherence to biologic substrates is mediated by a superfamily of adherence receptors. There 
are three subfamilies of adherence receptors: 1) integrins; 2) members of the immunoglobulin supergene family; 
and 3) selectins. 
1.9.1.1. integrins 
Integrins are a superfamily of transmembrane glycoprotein receptors that mediate both cell-extracellular 
matrix and cell-cell adherence events (392). Integrins are composed of an a and a ß subunit. Their ligand- 
binding site is formed by sequences from both subunits, and their cytoplasmic domains form connections with 
the cytoskeleton. These properties enable integrins to serve as a link between the intracellular cytoplasm and 
the extracellular matrix (392). Eleven a subunits and six ß subunits have been identified to date, and these 
subunits have been shown to be distinct by partial sequencing (392). The a and ß subunits, in various 
combinations, have been shown to form 16 integrins but it is likely that more will be discovered. Each of the 
six ß subunits is able to associate with multiple a subunits and six subfamilies of integrins, therefore, have been 
identified. However, it has become clear recently that a single a subunit can also associate with multiple ß 
subunits. 
The complement of different integrins that is expressed by cultured mammalian cell lines varies from 
two to ten (392). Some integrins are clearly cell type specific. For example, gp IIb/IIIa is expressed exclusively 
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by megakaryocytes and platelets (174), and the ß2 subfamily is expressed only by leukocytes (425). The 
expression of individual integrins appears to be regulated during development of vertebrate species by agents 
that affect growth and differentiation such as TGF-ß (194). It is likely that the proper temporal expression of 
the correct complement of integrins enables cells to find their appropriate adhesive Substrates in the body. 
The ß1 or very late activation antigen (VLA) subfamily of integrins The ß1 integrin subfamily 
includes receptors that bind to extracellular matrix components such as fibronectin, laminin and collagen. These 
receptors are expressed by leukocytes and many non-hemopoietic cell types (1%). Members of the ß1 family 
share a common ß1 chain which associates with six different a chains (a 1 through a 6), (197). The ß1 family 
has been designated the very late activation (VLA) antigens because two members, VLA-1 and VLA-2, appear 
on lymphocytes two to four weeks after antigen stimulation in vitro (1%). However, some VLA molecules are 
expressed under basal conditions by leukocytes, and their expression by non-hemopoietic cells does not require 
activation. Induction of VLA-1,-2, -3, and -5 expression after leukocytes cross the endothelial barrier may be 
of great importance in controlling leukocyte localisation in inflammation (425). 'Some members of the ß1 family, 
such as VLA-3 and VLA-5, recognise Arg-Gly-Asp (RGD) tripeptide sequences within their ligands, and 
synthetic RGD-containing peptides have been shown inhibit the adherence of cells that express these receptors 
to their ligands in vitro (63,359,390). 
The ß2 subfamily or leukocyte integrins Members of the ß2 subfamily of integrins share the 
common ß2 subunit (CD18 antigen). The three members of this family, lymphocyte function associated antigen- 
1 (LFA-1 or CD11a/CD18), Mac-1 (CD11b/CD18) and p150,95 (CD11c/CD18), are involved in mediating the 
adherence of leukocytes to endothelial cells (216). LFA-1 is expressed on all cells of hemopoietic origin but 
Mac-1 and p150/95 are expressed only by myeloid cells (203). The ligands for LFA-1 include the intercellular 
adhesion molecules, ICAM-1 and ICAM-2, which are members of the immunoglobulin superfamily that are 
expressed by endothelial cells (425,426). The LFA-1 molecules of both monocytes and T lymphocytes are also 
essential for their initial interaction in the immune response (145). 
Mac-1 also recognises ICAM-1 (425), but the endothelial determinant recognised by p150,95 has not 
Yet been elucidated. Other known ligands for Mac-1 include fibrinogen (500) and factor X (12,13). In addition, 
Mac-1 binds to C3bi and is an important receptor for phagocytosis (36). However, a second binding site on 
Mac-1, detected by the binding of zymosan and un-opsonised bacteria, must be engaged before particle ingestion 
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occurs (385). Although Mac-1 binding to C3bi is dependent upon the recognition of RGD sequences in this 
ligand (498), other Mac-1-ligand interactions appear to be RGD-independent. P150,95 also has binds to 
fibrinogen has specificity for C3bi and functions as a receptor for phagocytosis (319,425). 
The most concrete demonstration of the important role of the leukocyte integrins comes from the rare 
hereditary condition, leukocyte adhesion deficiency (LAD). This condition is associated with recurrent and 
sometimes life-threatening bacterial and fungal infections (15). LAD is due to a defect in the synthesis of the 
common ß2 subunit resulting in defective expression of all three members of the ß2 family on circulating 
leukocytes (15,249). Leukocytes from patients with LAD fail to adhere to and move through the endothelium 
into sites of tissue injury, and exhibit defective phagocytosis, immune recognition and other functions that depend 
upon cell adherence. 
1.9.1.2. The Immunoglobulin Superfamily 
In addition to the T-cell antigen receptor (CD3), and antigen-independent receptors such as CD2, this 
family includes three endothelial cell receptors that are involved in mediating leukocyte adherence to 
endothelium: 1) intercellular adhesion molecule-1 (ICAM-1); 2) intercellular adhesion molecule-2 (ICAM-2); 
and 3) vascular cell adhesion molecule-1 (VCAM-1), (392,425). ICAM-1 is a ligand for LFA-1 and Mac-1(425) 
and ICAM-2 is a ligand for LFA-1(289,426). VCAM-1 is the endothelial receptor for VLA-4 (155). Ail three 
receptors are expressed in low numbers on unstimulated endothelial cells. The expression of ICAM-1 by 
endothelial cells is increased by their exposure to IL-1, TNF, IFN and LPS in vitra, by a mechanism that is 
dependent on protein synthesis (361,362). Similarly, the expression of VCAM-1 by endothelial cells is increased 
by various cytokines in a long lasting fashion (344). 
1.9.1.3. Selectins 
The three members of this novel class of receptors are involved in leukocyte adherence during 
inflammation and coagulation (47,432). These receptors have structural homology to C-type lectins. Endothelial 
leukocyte adhesion molecule-1 (ELAM-1) is expressed transiently on endothelial cells two to eight hours after 
stimulation with IL-1 and other pro-inflammatory agents (360). This receptor mediates a leukocyte adhesion 
Pathway that is distinct from that mediated by ICAMs and the leukocyte integrins (46,47,282). Leukocyte- 
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endothelial cell adhesion molecule-1 (LECAM-1, LAM-1 or Mel-14) is expressed by the majority of circulating 
leukocytes (182), but is rapidly shed by a proteolytic mechanism when cells are stimulated by several cytokines 
including GM-CSF, TNF, f-MLP, and LTB4 (182,248). It has been postulated that LECAM-1 and ELAM-1 
are involved in an early step in the binding of leukocytes to endothelium prior to trans-endothelial migration 
(425). 
The third member of the family is granule membrane protein-140 (GMP-140, PADGEM or CD62). 
This receptor is expressed by platelets and endothelial cells after stimulation by products of the clotting cascade 
(425). GMP-140 plays a role in mediating the adhesion of neutrophils and monocytes to endothelial cells 
(B5,266). 
1.9.2. Regulation of Monocyte Adherence to Endothelial Cells 
Human monocytes and monocytic tumour cell lines have been shown to adhere to endothelial cell lines 
in vitro including: 1) porcine (135) and bovine (467) aortic endothelial cell monolayers; 2) human vascular 
smooth muscle cell monolayers (139); 3) human microvascular endothelial cell monolayers (139); and 4) human 
umbilical vein endothelial cell (HUVEC) monolayers (86,97,139,156,486). The proportion of monocytes that 
adheres to HUVEC monolayers under basal conditions has been shown to vary from 20% (139) to 65% (365). 
Moreover, several mediators including IL-1, LPS, TNF, PDGF, C5a, f-MLP, LTB4, GM-CSF and IL-3 up- 
regulate the adherence of monocytes to HUVEC monolayers in vitro (139,141,156,216,309,486). 
Several CD18-dependent mechanisms appear to be involved in this process. First, TNF, PDGF, C5a, 
f-MLP and LTB4 increase monocyte adherence to endothelial cells by stimulating the mobilisation of 
intracellular stores of preformed CD18 integrins from peroxidase negative granules of monocytes. This process 
results in a rapid increase in the surface expression of CD18 molecules by monocytes (309). Second, several 
cytokines and ADP stimulate large increases in CD18-dependent adherence to endothelial cells by inducing a 
conformational change in the receptor that increases its affinity for ligand, rather than by increasing receptor 
number (14,156). Third, some mediators act upon endothelial cells to up-regulate monocyte-endothelial cell 
binding. For example, LPS, IL-1 and TNF induce the expression of ICAM-1 (360) and ELAM-1 (46) on 
endothelial cells by a mechanism that is dependent upon synthesis of new proteins. .Finally, some mediators, 
such as LPS and TNF, stimulate monocyte-endothelial interactions by inducing the expression of adherence 
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receptors on both the leukocyte and the endothelial cell (141,309). 
It has become clear recently that receptors other than CD18 are also involved in mediating monocyte- 
endothelial interactions, since several investigators have demonstrated that anti-CD18 antibodies produce only 
partial inhibition of basal and stimulated adherence of monocytes to endothelial cells (86,261,467). Moreover, 
Carlos et al. (86) identified two CD18-independent mechanisms: 1) a CD18-independent, phorbol myristate 
acetate (PMA)-inhibitable mechanism mediates basal monocyte-endothelial cell interactions; and 2) a CD18- 
independent, PMA-insensitive mechanisms is involved in mediating monocyte adherence to LPS-stimulated 
endothelial cells. However, the receptors involved in mediating CD18-independent monocyte-endothelial 
interactions were not investigated in this study. Other possible receptors involved in mediating monocyte 
adherence to endothelial cells include: 1) VLA-4 which binds to VCAM-1 molecules expressed by cytokine- 
activated endothelial cells (425); and 2) LECAM-1 and ELAM-1 which may involved in an early step in the 
binding of monocytes to endothelium (425). 
It is likely that there are mechanisms that act as negative regulators of adherence to ensure the 
Uninterrupted circulation of monocytes. However, there is paucity of information on mediators that down- 
regulate the adherence process. Only one mediator has been shown to inhibit monocyte adherence. Elliott et 
al. (156) demonstrated that interleukin-4 (UA) inhibits basal adherence and IL3 and GM-CSF-stimulated 
adherence of monocytes to endothelial cells and plastic. However, the mechanisms involved were not elucidated. 
1.93. Monocyte Adherence to Fibronectin 
Although it has been shown that mononuclear phagocytes and the promonocytic U937 cell line adhere 
to various matrix components including collagen, laminin and fibronectin in vitro (63,97,414,442), most is known 
about monocyte adherence to fibronectin. 
Fibronectin is a ubiquitous adhesive glycoprotein and is a component of basement membranes and the 
extracellular matrix (316,366). It has a molecular weight of 440 kD and consists of dimers which are linked by 
disulphide bonds near the carboxy terminus. Fibronectin functions via several specialised intramolecular regions 
or domains that interact with other proteins including collagen, fibrin and heparin (215,316). In addition, various 
types of cells (including leukocytes and fibroblasts) bind to the small (11.5 kD) cell-binding domain which is 
located approximately three-quarters of the length of the molecule from the amino terminus. This domain 
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contains the RGD tripeptide sequence that cells recognise. by specific receptors (216,391). 
in addition to being an integral part of all connective tissues, fibronectin is also exists as a freely soluble 
form in plasma at the substantial concentration of 0.3 g/l. A second major form is situated on cells surfaces and 
is loosely termed "cellular fibronectin". Cellular fibronectins are synthesised by fibroblasts, endothelial cells and 
mononuclear phagocytes. This cellular form is relatively insoluble at physiologic pH and becomes organised into 
striking fibrillar arrays on the cell surface and in the extracellular matrix. In addition to its adhesive functions, 
fibronectin modulates cytodifferentiation, cell migration and also functions as a non-immune opsonin for 
mononuclear phagocytes (316,366). 
1.9.4. Regulation of Monocyte Adherence to Fibronectin 
Several investigators have shown that monocytes adhere spontaneously to purified human fibronectin 
in vitro (63,256,390,412). However, only Brown et al. (63) quantified this interaction; these investigators 
demonstrated that 25% of monocytes adhere spontaneously to fibronectin-coated tissue culture plastic. 
Moreover, there is only one report in the literature which documents that monocyte adherence to fibronectin 
can be regulated. Roth et al. (390) showed that exposure of monocytes to LPS stimulates a 2-fold increase. in 
the proportion of adherent cells. However, human monocytes have been shown to adhere spontaneously to 
dishes that have been coated with serum which contains fibronectin, and that this process is up-regulated by C5a, 
f-MLP, LPS and TNF (139,141). 
The effects of mediators on the adherence properties of murine macrophages and the promonocytic 
U937 celi line have been studied. Shaw and Mercurio (414) demonstrated that under basal conditions 
thioglycoll-elicited murine peritoneal macrophages adhere avidly to fibronectin, but exhibit minimal adherence 
to laminin and type IV collagen. Moreover, exposure to LPS and IFN results in a dose-related increase in the 
adherence of murine macrophages to laminin and collagen type IV, but does not alter their adherence to 
fibronectin. Cavender and coworkers (97) showed recently that only 2 to 20% of U937 cells adhere 
spontaneously to fibronectin and that phorbol esters up-regulate this process substantially (97). 
Monocytes have been shown to express three types of fibronectin receptors: VLA-3 (195,470), VLA-4 
(471) and VLA-5 (63,470). VLA-3 and VLA-5 both recognise the RGD sequence in the cell-binding domain 
of the fibronectin molecule (196,358). VLA-4 binds to the CS-1 domain of fibronectin by an RGD-independent 
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mechanisms (471). VLA-5 is thought to be the most important integrin that mediates monocyte adherence to 
fibronectin since specific anti-VLA-5 antibodies inhibit this process, whereas anti-VLA4 antibodies are 
ineffective (63,256). However, the role of VLA-3 in mediating adherence of monocytes to fibronectin has not 
yet been assessed and the possibility remains that other integrins play a role in this process. 
VLA-5 is expressed on the surface of about 50% of freshly-isolated monocytes (256). Singer and 
coworkers (419) demonstrated that preformed VLA-5 is present in the peroxidase negative granules of 
monocytes along with ß2 integrins and receptors for laminin and vitronectin. in addition, these investigators 
showed that LPS stimulates the fusion of peroxidase negative granules with the plasmalemma, resulting in 
increased surface expression of VLA-5. However, the effect of this increased VLA-5 expression by monocytes 
on their adherence to fibronectin was not assessed in this study. 
Integrins other than VLA-5 may also be involved in mediating monocyte adherence to fibronectin since 
specific anti-VLA 5 antibodies and RGD-containing peptides fail to inhibit monocyte adherence to fibronectin 
completely (256). Moreover, antibodies to the common ß1 chain of the VLA integrins also fail to inhibit 
monocyte adherence to fibronectin completely, and antibodies directed against ß3 integrins are ineffective 
(63,256). Together, these data indicate that receptors other than ß1 and ß3 integrins are involved in mediating 
monocyte adherence to fibronectin. The integrins involved in mediating the adherence of stimulated monocytes 
have not yet been determined. Moreover, there is only one report in the literature on the adherence properties 
of monocytes from subjects with disease. Setiadi and coworkers (412) demonstrated that a greater proportion 
of monocytes from patients with diabetes adheres compared with cells from healthy subjects. Although the 
mechanisms were not investigated in this study, the expression of Mac-1 by diabetic monocytes was greater than 
that of cells from healthy subjects. These data suggest that ß2 integrins may also be involved in mediating 
monocyte adherence to fibronectin. 
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1.10. The Potential Role of Mononuclear Phagocytes in the Pathogenesis 
of Chronic Inflammatory Lung Diseases 
There is substantial evidence to suggest that mononuclear phagocytes play a role in the pathogenesis 
of several inflammatory and degenerative conditions including pulmonary fibrosis (382,415), rheumatoid arthritis 
(65), sarcoidosis (17), systemic lupus erythematosus (17) and atherosclerosis (58,189,387). In addition, it has 
been postulated that mononuclear phagocytes may contribute to the destruction of lung parenchyma that is 
characteristic of one chronic inflammatory lung disease (emphysema), (80,223,333). 
1.10.1. Pulmonary Emphysema 
Pulmonary emphysema is the major determinant of airflow obstruction in chronic obstructive lung 
disease (187,321), and represents one of the most important causes of morbidity and mortality in the Western 
world. Pulmonary emphysema is characterised anatomically by destruction of lung parenchyma often involving 
the walls of the respiratory bronchioles (centrilobular emphysema), but extending to true alveoli in panlobular 
disease. 
Historically, tissue destruction in emphysema was largely unexplained until three decades ago, when two 
independent laboratory observations provided compelling evidence that proteolytic destruction of connective 
tissue elements is the signal event in the pathogenesis of this condition. First, Laurell and Eriksson (157,268) 
identified an uncommon inherited deficiency of serum (an important inhibitor of serine 
proteinases), which is associated with early onset familial panlobular emphysema. Second, Gross et a¿. (183) 
demonstrated that intratracheal instillation of the plant protease, papain, produced anatomical derangements 
characteristic of emphysema in rats. The observation made by Gross and coworkers has since been confirmed 
both in the rat and other animals with proteinases other than papain, most notably porcine pancreatic elastase 
(230) and HLE (226,411). Although all of these proteinases exhibit broad substrate specificity, the capacity to 
degrade elastin in vitro is an absolute requirement for producing emphysema in experimental animals. Viewed 
together, these observations suggested that proteolytic mechanisms might be important in the pathogenesis of 
emphysema, and that a critical balance might exist between lung proteinases and their inhibitors. Thus, the 
"proteinase-antiproteinase" or "elastase-antielastase" hypothesis of emphysema was formulated. According to 
the proteinase-antiproteinase hypothesis, injury to elastic fibres in the lung parenchyma is a prerequisite for the 
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development of pulmonary emphysema (223,333). Moreover, the theory predicts that in the healthy lung, a 
balance occurs in which the function of the elastase inhibitors is equal to, or exceeds that of the enzymes. 
Destructive lung disease occurs when this balance is disturbed such that there is a functional excess of enzymes 
relative to their inhibitors. The enzymes, therefore, remain active within the lung, resulting in destruction of 
connective tissue. 
Although the genetic model of deficiency provides compelling evidence for the role of 
elastases in the pathogenesis of emphysema, this condition accounts for only 1 to 2% of all cases of emphysema 
(276). Cigarette smoking is, by far, the most common cause of emphysema, and most patients with emphysema 
have normal serum levels of However, a disturbance in the balance between lung elastases and 
their inhibitors is still believed to play an important role in the pathogenesis of emphysema caused by cigarette 
smoking. 
1.10.2. Human Leukocyte Elastase 
Human leukocyte elastase (HLE) is widely believed to be the most important proteolytic enzyme 
involved in the pathogenesis of emphysema for several reasons: 
1) is the major physiologic inhibitor of HLE and inherited deficiency of is 
associated with early onset familial panlobular emphysema (157,268); 
2) HLE produces emphysema when instilled via the trachea into animals (226,411); 
3) cigarette smokers, who are at risk of developing emphysema, have an increased proportion of 
neutrophils (historically assumed to be the source of HLE) in broncho-alveolar lavage (223) and 
alveolar septae (334); and 
4) Damiano et al. (126) demonstrated that extracellular HLE is found exclusively in association 
with interstitial elastic fibres in emphysematous lungs obtained at surgery. 
Structure HLE is a serine proteinase, that is, a serine residue at position 195 of the enzyme’s primary 
amino acid sequence contributes a nucleophilic hydroxyl group to attack carbonyl carbons of target peptide 
bonds (223). Valine or alanine groups are preferred in the P1 position of the target protein (the amino acid 
contributing the carbon to the peptide bond). The enzyme is single-chain polypeptide of molecular 
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weight 25 kD and consists of 18 to 20% carbohydrate residues (343). The enzyme is active at neutral pH and 
has a strongly basic iso-electric point (pH 10 to 11). It is synthesised primarily in promyelocytes and stored in 
the azurophil granules of neutrophils which contain about 1 to 3 pg per cell (120,477). 
Function During the host inflammatory response, HLE is released from living cells during 
phagocytosis or following cell death, and may contribute to tissue damage by catalysing the hydrolysis of matrix 
macromolecules. A wide variety of important matrix components are susceptible to attack by the enzyme 
including: 1) elastin (225); 2) fibronectin (301); 3) type III collagen, a major supporting component of lung 
connective tissue and blood vessels (284); 4) type IV collagen, an important structural component of epithelial 
and endothelial basement membranes (283); and 5) proteoglycan molecules in the connective tissue ground 
substance (237). In addition, HLE has been shown to hydrolyse several plasma proteins including 
immunoglobulins, clotting factors and complement components (192,223). Activation or inactivation of these 
plasma cascades may have important local and systemic consequences. HLE has also induces lymphocyte 
activation and platelet aggregation (223). 
Although the spectrum of HLE activity presented above indicates that the enzyme is predominantly 
harmful, it is clear that the presence of such large amounts of the enzyme within a major host-defense cell such 
as the neutrophii must reflect an important physiologic role. It is likely that some of these actions (such as 
complement activation) are beneficial to the host. In addition, experimental data investigating the bactericidal 
and bacterial digesting functions of HLE suggest that HLE activity may be beneficial when restricted to the 
phagocytic vacuole (223,341,375). However, regulated extracellular release of HLE may also be beneficial to 
the host since it may enable the neutrophil to: 1) traverse connective tissue barriers; 2) dissolve infected tissues 
to dislodge sequestered microbes; and 3) participate in abscess formation and tissue debridement at sites of 
infection and inflammation (92,223,473). 
1.10.3. Alpha 
is the predominant inhibitor of serine proteinases in serum and is a major proteinase 
inhibitor in the lower respiratory tract. It is a member of a superfamily of serine proteinase inhibitors (serpins) 
that includes antithrombin III, ovalbumin, angiotensinogen, protein C 
inhibitor and C1 esterase inhibitor (341,448). These proteins exhibit 30 to 40% primary structurai homology 
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and have a number of residues around the active inhibitory site that are highly conserved. Each serpin is 
characterised by a specificity for inhibition of individual serine proteinases, although each serpin is also able to 
inhibit other serine proteinases less effectively (448). 
Structure is a small, polar glycoprotein of molecular weight 54 kD that is able to 
diffuse readily through tissues. It consist of a single polypeptide chain consisting of 394 amino acids with three 
carbohydrate side chains attached at asparginine residues 46,83 and 247 (93). It is a highly ordered molecule 
with 30% of its structure in the form of and 40% as ß-pleated sheets (92). The active site of the 
molecule is formed by a methionine residue at position 358 which is situated on a 16 residue exposed loop (92). 
This loop is under considerable tension and holds the molecule in a stressed conformation such that the 358-359 
Met-Ser bond fits precisely into the active site pocket of the serine proteinase. 
Function It is thought that the primary function of is to protect tissues from proteolytic 
enzymes that are released from cells during the inflammatory response. Although is synthesised 
by a number of cell types including mononuclear phagocytes (32,350), neutrophils (148) and Paneth cells in the 
gastrointestinal tract (122), hepatocytes are the major source of plasma in humans (122). 
Approximately 2 g of are synthesised by the liver per day and released into circulation, where this 
protein has a half life of six days. is an acute phase protein, and the normal plasma 
concentration of 20 to 48 (61,123,448) can increase 4-fold in response to inflammation or other stimuli 
such as oestrogen therapy (93). 
The physiologic target for is human leukocyte elastase (92,93). The association rate 
constant (Ka) for has been estimated to be (34). is also able to 
inhibit other serine proteinases, but less efficiently than HLE. A comparison of Ka’s for other serine proteinases 
demonstrates a decreasing order with HLE > chymotrypsin > cathepsin G > anionic trypsin > plasmin > 
thrombin (34). is a suicidal protein that forms a tight 1:1 non-covalent complex with its target 
proteinases. Complex formation renders the enzyme and inhibitor inactive, and the complex is subsequently 
removed from the circulation by the reticuloendothelial system. can be inactivated by two 
mechanisms. First, the active site Met-Ser bond is susceptible to cleavage by neutrophil elastase (92,278). 
Following cleavage, the methionine and serine residues spring apart irreversibly and are found at opposite poles 
of the molecule, resulting in a more stable, relaxed but inactive molecular structure (28). in addition, other 
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poteinases including neutrophil (132) and macrophage (27,28) metailoproteinases, cathepsin L (232) and 
psedomonas aeruginosa elastase (311) can inactivate by cleaving the protein at the active center 
bond or other sites on the exposed loop. 
The second mechanisms involves oxidative inactivation. Methionine contains a sulphur atom that is 
readily oxidised to sulphoxide (231), a derivative that is too large to fit into the active site of serine proteinases. 
Thus, oxidation of renders the molecule 2000-fold less effective as an inhibitor of HLE 
(34,89,224,231,484). Cigarette smoke (87,91,114,224,367) and reactive oxygen metabolites generated by 
stimulated phagocytes (88,89,211) inactivate by this mechanism in vitro, as discussed in 1.10.4. 
This process can be reversed by the enzyme methionine sulphoxide peptide reductase which is found in bacteria 
and neutrophils (90). 
Gene structure The is located on the long arm of chromosome 14 at position q31-31.2 
(265). The gene is about 12.2 kb in length and there are two promoter regions; a promoter for mononuclear 
phagocytes is located about 2 kb upstream from the other, which is the hepatocyte promoter (349). The 
promoters are tissue specific, that is, the monocyte promoter does not function in hepatocytes and vice-versa. 
Trans-activating factors are required to activate the promoters in a tissue specific manner. The genomic 
sequence contains seven exons: IA, IB, IC, II, III, IV and V. Messenger RNA (mRNA) produced by 
hepatocytes contains exons IC, II, III, IV and V. Messenger RNA produced by mononuclear phagocyte differs 
from hepatocyte mRNA in that it contains additional exons. There are two distinct mononuclear phagocyte 
mRNA species (349); one species contains ail seven exons, the other results from exclusion of exon IB. It has 
been postulated that exons IA and IB are transcribed but not translated into protein. Since untranslated mRNA 
reduces the efficiency of translation, it is likely that the additional exons influence the rate of translation (239). 
Although monocytes express only 1% of the amount of mRNA that is produced by 
hepatocytes (381) and do not contribute significantly to serum levels of (260), mononuclear 
phagocytes may be an important local source of this protein in the vicinity of the cells at sites of inflammation. 
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1.10.4. Theories on the Pathogenesis of Emphysema 
Cigarette smoking is thought lead to emphysema both by increasing the elastase burden and reducing 
the anti-elastase screen in the lower respiratory tract. 
Increased Elastase Burden 
Cigarette smoke has been shown to cause the accumulation of neutrophils within the lower airspaces, 
thus increasing the HLE burden of the lower respiratory tract. Broncho-alveolar lavage fluid from healthy 
smokers contains 10 times the normal number of neutrophils (206). Similarly, the lung septae of cigarette 
smoke-exposed humans contain twice the normal number of neutrophils, most of which are sequestered within 
the vascular space (281). 
The recruitment of neutrophils into the lungs of cigarette smokers is thought to be mediated by several 
mechanisms. First, cigarette smoke stimulates alveolar macrophages to release factors that are chemotactic for 
neutrophils (214,304). Second, nicotine, a constituent of cigarette smoke, causes directed migration of 
neutrophils at concentrations similar to those found in the blood of cigarette smokers (444). Third, proteolytic 
fragments of collagen and elastin which are generated by proteinases released by recruited phagocytes, are 
chemotactic for leukocytes in vitro (364,410), and may thereby perpetuate the accumulation of neutrophils in 
the lung in vivo. 
Reduced Anti-Elastase Screen 
Although the lung of cigarette smokers have an increased burden of neutrophils in the lower respiratory 
tract compared with non-smokers, the concentration of in the lungs of smokers should be sufficient 
to protect the alveolar walls. It has been postulated that oxidation of occurs in cigarette smokers 
(87,171,224). Since oxidised is a less effective inhibitor of HLE than the native protein, this would 
decrease the lower respiratory tract HLE inhibitory capacity, thus increasing the susceptibility of the lung to 
elastolytic destruction and the development of emphysema. 
There are two mechanisms by which oxidative inactivation of may occur in cigarette 
smokers. First, oxidants in cigarette smoke cause this directly in vitro (91,114,224,367). However, physiological 
concentrations of plasma proteins inhibit smoke-induced oxidation of in vitro (74), indicating that 
this mechanism may not be important in vivo. Second, toxic oxygen radicals and myeloperoxidase released by 
activated neutrophils and alveolar macrophages also inactivate in vitro (88,89,105). Since 
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phagocytes are present in increased numbers in smokers, these oxidants pose an additional oxidant stress to lung 
Studies on the presence of inactivated in broncho-alveolar lavage samples from smokers 
have yielded conflicting results (3,57,78,91,171,429-431). However, it is important to bear in mind that the 
extracellular matrix is located within the interstitium of the lung, which is separated from the airspaces by an 
alveolar epithelium. This epithelium is normally effective in restricting the passage of hydrophobic molecules 
(179). Although cigarette smoke may impair the integrity of this epithelium, the quantities and function of 
proteinases and anti-proteinases in broncho-alveolar lavage (which samples the alveolar lining fluid) may bear 
little resemblance to those in the interstitium. Better methods for sampling microenvironments within the lung 
are needed to resolve this controversial issue. 
It is possible that oxidants released by lung phagocytes result in localised oxidative inactivation of a,- 
antitrypsin. It has been postulated that oxidants released by stimulated phagocytes create a zone of oxidised al- 
antitrypsin around them (88,92). If this occurs, HLE released by neutrophils would thus be able to degrade 
connective tissue virtually unopposed. However, connective tissue breakdown by HLE would be limited to this 
microenvironment because oxygen radicals have a short half life and do not diffuse to any great extent. Outlying 
tissue would continue to be protected by native 
1.10.5. Potential Role of Mononuclear Phagocytes in the Pathogenesis of Emphysema. 
Most research into the pathogenesis of emphysema has focussed on the role of the neutrophil since the 
lungs of smokers contain increased numbers of neutrophils (223,334) which are assumed to be the source of 
HLE in tissues. However, the most striking change in the lung inflammatory cell population in human smokers 
is the massive increase in mononuclear phagocytes in broncho-alveolar lavage. Moreover, mononuclear 
phagocytes constitute the vast majority of the inflammatory cells in the respiratory bronchiolitis which is a 
universal finding in human cigarette smokers (334). This airway inflammation is located at precisely the site 
of the earliest structural lesions in centrilobular emphysema in smokers. Given the increase in mononuclear 
phagocytes at strategic locations in human cigarette smokers, it is possible that mononuclear phagocytes play an 
important role in the pathogenesis of emphysema. Several mechanisms may be involved: 
1) Activated macrophages from the lungs of cigarette smokers release factors that are chemotactic for 
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neutrophils, and may thereby increase the elastase burden in the lower respiratory tract (214,304). 
2) Reactive oxygen metabolites that are released by mononuclear phagocytes may contribute to the 
localised oxidation of and thereby reduce the anti-elastase screen (89,211). 
3) Monocytes have been shown recently to contain HLE (81,167,408) and these cells also synthesise 
and secrete (350,351). Thus, the balance between the release of HLE and 
by monocytes, as these cells are recruited into the lung and pass through the interstitial space, might 
be an important determinant of lung elastin injury and resultant emphysema. 
4) Mononuclear phagocytes synthesise and release other enzymes such as a metalloelastase and 
cathepsin L, both of which have been shown to cleave (27,28,232) and damage connective 
tissue components such as elastin in vitro (294,409). Moreover, mononuclear phagocytes synthesise and 
secrete other inhibitors of elastases such as (490) and tissue inhibitor of 
metalloproteinases (76). These inhibitors may contribute to the anti-elastase screen in the lower 
respiratory tract. 
1.10.6. Mononuclear Phagocyte Elastases 
Monocytes have been shown to contain HLE within peroxidase positive granules (81,242). in addition, 
HLE is expressed on the surface of monocytes (269,508). Although synthesis of HLE by mature monocytes 
has been suggested by the results of biosynthetic labelling and immunoprecipitation studies (32), more recent 
data indicate that monocytes do not contain measurable amounts of mRNA for HLE (438). These latter data 
indicate that synthesis of HLE has been completed prior to release of mature cells from the bone marrow. 
Although monocytes contain only 3 to 7% of the amount of HLE contained in neutrophils, (81,167,408), 
they release a greater proportion in response to stimulation (81). HLE released by monocytes has been shown 
to degrade various matrix components including elastin and fibronectin in vitro (81,228,269). In particular, 
Campbell et al. (81) demonstrated that stimulation of monocytes with phorbol ester results in extensive HLE- 
mediated degradation of a fibronectin Substrate. However, these investigators also showed that in the presence 
of only 20% of the cells express marked but localised proteolytic activity. These data indicate 
that a minor subpopulation of monocytes is rich in HLE and may participate in extracellular events formerly 
associated with neutrophil derived-HLE. 
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As monocytes mature into macrophages, HLE is progressively lost and is replaced by a macrophage 
elastase which is a metalloenzyme (223,396). The macrophage-specific enzyme also has elastin-degrading activity 
(409), but is secreted immediately into the extracellular space rather than being stored within the cell. Although 
alveolar macrophages are a less rich source of elastase than monocytes on a cellular basis, the metalloenzyme 
is not inhibited by and may actually inactivate it by proteolytic cleavage (27,28). Moreover, 
alveolar macrophages degrade insoluble elastin in the presence of proteinase inhibitors in vitro (102,104,409), 
and macrophage-derived metalloelastases have been shown to play a prominent role in this process (409). These 
data suggest that the macrophage-derived metalloelastase may also be involved in the pathogenesis of 
emphysema. 
Mononuclear phagocytes may also take up HLE that has been released by neutrophils since HLE has 
been shown to bind to monocyte and macrophage surface receptors, and is rapidly internalised into the 
phagolysosomes (73,82,84). The internalised HLE is released slowly by mononuclear phagocytes, and hypoxic 
injury to the cells accelerates the release of the enzyme (83). Therefore, mononuclear phagocytes may also 
participate in the pathogenesis of emphysema by serving as a vector for neutrophil elastase. 
These data, suggest that mononuclear phagocyte-derived elastases may play a role in the pathogenesis 
of pulmonary emphysema. However, the mechanisms by which mononuclear phagocyte elastases mediate 
proteolysis of matrix components in the presence of proteinase inhibitors in vivo have not been elucidated. 
1.10.7. Expression of by Mononuclear Phagocytes 
Although mononuclear phagocytes have been shown to synthesise and secrete (350,351), 
the absolute amounts of produced by these cells has not been quantified previously. Rather, it 
has been assumed that mononuclear phagocytes produce small quantities of and these cells have 
generally been ignored as playing a relevant role in the normal physiology of in-the lower 
respiratory tract. However, this view may be incorrect for several reasons. First, alveolar macrophages are 
located directly at the site where may play a major role as an inhibitor of HLE (334). Second, 
alveolar macrophages represent about 10% of cells of the alveolar structures and are constantly being renewed 
by the circulating pool of monocytes (53,119). Third, maturation of monocytes into macrophages is associated 
with a three-fold increase in the expression of the gene (312). 
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The expression of by mononuclear phagocytes can be modulated in vitro. Perlmutter 
and coworkers showed that LPS (32), HLE (354) and IL-6 (352) increase the rate of synthesis of 
by human monocytes. Moreover, these mediators up-regulate the synthesis of by monocytes by 
different mechanisms. IL-6 and HLE stimulate increases in steady-state mRNA concentrations 
in monocytes (352,354). In contrast, LPS produces little or no change in monocyte steady-state 
mRNA concentrations, indicating that translational or post-translational mechanisms are involved (32,352). 
However, the absolute amounts of synthesised by mononuclear phagocytes under basal conditions 
or in response these stimuli have not been quantified. Moreover, the effects of other pro-inflammatory 
mediators on gene expression have not been assessed. Finally, the relative amounts of HLE and 
synthesised by mononuclear phagocytes have not been quantified. 
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1-11 OBJECTIVES OF THE THESIS 
The aims of this thesis were 4-fold. 
1) To compare the adherence of monocytes from healthy subjects and patients with an 
inflammatory lung disease (bronchiectasis) to a representative extracellular matrix component 
(fibronectin). 
2) To investigate the physiological and pathological factors that regulate monocyte 
adherence to fibronectin and to assess the role of CD11/CD18 integrins in mediating 
this process. 
3) To assess the relationship between the adherence properties of monocytes and other 
monocyte functions that are of biological importance at sites of infection and inflammation. 
4) To compare the expression of HLE and by adherent and non-adherent 
monocytes to assess whether there is a relationship between the adherence properties of 
monocytes and their potential to cause tissue damage at sites of infection and inflammation. 
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Chapter II 
Methods 
53 
2.1 Cell Isolation 
Monocytes were isolated by four methods: 1) the conventional ficoll-Hypaque density gradient method 
followed by an adherence step (59); 2) the Percoll density gradient method followed by an adherence step (229); 
3) the Nycodenz osmotic and density gradient method (60); and 4) countercurrent centrifugal elutriation (CCE), 
(395). Neutrophils were isolated by the Percoll density gradient technique. Platelets and lymphocytes were 
isolated by CCE. Venous blood was collected into lithium heparin tubes for the ficoll-Hypaque, Percoll and 
CCE isolation methods, and polypropylene tubes containing ethylenediamine tetracetic acid (EDTA, 1.3 g/L 
final concentration) for the Nycodenz method. 
2.1.1. Ficoll-Hypaque Isolation of Monocytes 
For comparison of the yields of monocytes isolated by the ficoll-Hypaque and Nycodenz methods, ficoll- 
Hypaque gradient medium was purchased from Pharmacia, Uppsala, Sweden. For all other experiments, ficoll- 
Hypaque medium was prepared by dissolving 90 g of ficoll in one litre of sterile distilled water and adding 120 
ml of the ficoll solution to 34 ml of Hypaque and 16 ml of sterile distilled water. The ficoll-Hypaque solution 
was then filtered (0.2 filter) and stored at 4°C. The specific gravity of the prepared ficoll-Hypaque solution 
was 1.077 g / d .  
Blood was collected into lithium-heparin tubes and diluted with an equal volume of sterile 0.15 mol/L 
NaCI solution. The diluted blood (30 ml) was layered over ficoll-Hypaque (15 ml) and centrifuged at 900 g for 
30 min at room temperature. The mononuclear cells were harvested and washed twice with 20 ml of sterile 0.15 
mol/L NaCl solution. The cells were re-suspended at 2 x cells/ml in supplemented RPMI 1640 medium 
(RPMI 1640 medium containing 10% [v/v] complement-depleted [by incubation at 37°C for 30 min] fetal calf 
serum [FCS], L-glutamine [2mmol/L] and gentamicin [20 
An adherence step was then performed to separate the monocytes, which are assumed to be adherent 
cells, from the lymphocytes which are assumed to be the non-adherent cells (4,372). Aliquots (1 ml) of the 
mononuclear cell suspension were dispensed into 35 x 10 mm tissue culture dishes that had been pre-coated with 
0.5 ml of purified human serum fibronectin (20 in sterile 0.15 mol/L NaCI solution) at 37°C for 2 h, and 
then washed three times with 2 ml of sterile 0.15 mol/L NaCl solution to remove unbound fibronectin. The 
dishes were incubated for 2 h at 37°C in a humidified atmosphere of 5% CO, and 95% au. The non-adherent 
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cells were removed by washing the dishes four times with 2 ml of sterile 0.15 mol/L NaCl solution. The 
adherent cells were detached by incubating the dishes with sterile 0.15 mol/L NaCI solution containing 5 
mmol/L EDTA for 45 min at 4°C, followed by gentle scraping with a rubber policeman. The dishes were again 
washed three times with 2 ml of sterile 0.15 mol/L NaCl solution, the suspension of previously adherent cells 
was centrifuged (600 g for 5 min at 4°C) and the supernatant was discarded. The cells were re-suspended in 
2 ml of supplemented RPMI medium, counted three times using a haemocytometer and the mean value was 
determined. Complete recovery of the adherent monocytes was confirmed by phase-contrast microscopy of the 
tissue culture dishes. Differential counts on cytocentrifuge preparations (Shandon 2, Shandon, Runcorn, 
Cheshire, U.K.) stained with modified Wright's stain confirmed that the cells were greater than 90% pure. The 
monocytes were 90 to 95% viable, as assessed by exclusion of trypan blue dye. 
2.1.2 Percoll Density Gradient Method for Isolation of Monocytes and Nentrophils 
Blood was collected into lithium-heparin tubes and diluted with an equal volume of sterile 0.15 mol/L 
NaCl solution. 
Monocyte Isolation 
The diluted blood (5 ml) was layered carefully onto the surface of 5 ml of a 54% [v/v] solution of 
Percoll in 0.15 mol/l NaCl solution (density 1.075 g/ml). The gradients were centrifuged at 200 g for 25 min 
at room temperature. The mononuclear cell layer, at the top of the gradient, was collected and the cells were 
washed twice with 20 ml of sterile 0.15 mol/L NaCl solution and centrifuged at 600 g for 5 min. The 
supernatant was discarded and the cells were re-suspended at 2 x cells/ml in supplemented RPMI 1640 
medium. The monocytes were separated from the lymphocytes by an adherence step, and the adherent 
monocytes were detached from the dishes and counted, as described above. Differential counts on 
cytocentrifuge preparations stained with modified Wright's stain confirmed that the cells were greater-than 90% 
pure. The cells were 90 to 95% viable, as assessed by exclusion of trypan blue dye. 
Neutrophil Isolation 
The diluted blood (5 ml) was layered carefully onto the surface of 2 ml of a 54% [v/v] solution of 
Percoll in 0.15 mol/l NaCI solution (density 1.075 g/ml) which had been layered onto 3 ml of 78% [v/v] Percoll 
in 0.15 mol/L NaCl solution (density 1.096 g/ml). The gradients were centrifuged at 200 g for 25 min at room 
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temperature. The neutrophil layer, at the interface of the two Percoll solutions, was collected and the cells were 
washed twice in 20 ml of sterile 0.15 mol/L NaCl solution. The neutrophils were then re-suspended in 
supplemented RPMI 1640 medium and counted using a haemocytometer. Differential counts on cytocentrifuge 
preparations stained with modified Wright’s stain confirmed that the neutrophils were greater than 95% pure 
(the contaminating cells were predominantly eosinophils). The cells were greater than 99% viable, as assessed 
by exclusion of trypan blue dye. 
2.1.3. Nycodenz Isolation of Monocytes 
Blood was collected into 50 ml polypropylene tubes containing EDTA (1.3 g/L final concentration) and 
dextran sedimentation was performed to remove most of the erythrocytes. Four millilitres of a solution of 
dextran T 500 (6% [w/v] in sterile 0.15 mol/L NaCl solution) were added to 40 ml of blood in each 
polypropylene tube and the tubes were left to stand at room temperature for 45 min. The leukocyte rich plasma 
supernatant was layered in 5 ml aliquots over 3 ml of Nycodenz and centrifuged at 600 g for 15 min at 4°C. 
Monocytes suspended in the Nycodenz layer were harvested and washed once with an equal volume of ice-cold 
sterile 0.15 mol/L NaCl solution containing 1 3  g/L EDTA and centrifuged (600 g for 5 min at 4°C). 
Contaminating platelets were removed, as required, by re-suspending the monocytes in 1 ml of sterile 0.15 
mol/L NaCl solution containing 1 3  g/L EDTA, and layering the suspension over 3 ml of autologous plasma. 
The plasma gradients were centrifuged at 150 g for 10 min and the plasma containing the platelets was 
discarded. The monocyte pellet was washed once with 25 ml of ice-cold, sterile 0.15 mol/L NaCl solution and 
re-suspended in 5 ml of supplemented RPMI 1640 medium (see above). The cells were counted four times 
using a haemocytometer and the mean value was calculated. Differential counts on modified Wright’s stained 
cytocentrifuge preparations confirmed that the monocytes were greater than 90% pure. The cells were greater 
than 99% viable, assessed by exclusion of trypan blue dye. 
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2.1.4. Countercurrent Centrifugal Elutriation (CCE) for the Isolation of Monocytes, Lymphocytes and 
platelets 
Monocyte Isolation 
Mononuclear cells were prepared by the ficoll-Hypaque method, as described previously. The cells 
were washed once with 50 ml of sterile 0.15 mol/L NaCI solution and centrifuged at 600 g for 5 min at 4°C. 
The cells were re-suspended in 5 ml of elutriation buffer (0.1% [w/v] human serum albumin, 0.15 mol/L NaCI, 
2.7 mmol/L KCI, 2.3 nmol/L phosphate, 6 mmol/L glucose and 1 mmol/L EDTA; pH 7.4). 
The elutriator rotor (JE-6B rotor with standard chamber, mounted in a Beckman J2-21 centrifuge; 
Beckman Instruments Inc., Palo Alto, California, U.S.A.) was assembled and sterilised with 150 ml of 70% [v/v] 
ethanol, followed by 150 ml of 6% [v/v] The rotor was then rinsed with 400 ml of sterile 0.15 mol/L 
NaCl solution and primed with 200 ml of elutriation buffer. The mononuclear cells, suspended in elutriation 
buffer, were pumped at a flow rate of 8 ml/min into the rotor at a constant 2470 rpm. The flow rate was then 
increased to 17.5 ml/min, and 150 ml were collected. This eluate contained platelets, erythrocytes, lymphocytes 
and a few monocytes. A pure monocyte population was then eluted from the chamber in the subsequent 150 
ml fraction at a flow rate of 22 ml/min. The monocyte suspension was centrifuged for 5 min (600 g at 4°C), 
the cells were washed with 50 ml of sterile 0.15 mol/L NaCI solution and centrifuged for a further 5 min. The 
cells were re-suspended in supplemented RPMI 1640 medium at cells/ml. Differential counts on Wright’s 
stained cytocentrifuged preparations confirmed that the monocytes were greater than 92% pure; the remaining 
cells were predominantly lymphocytes. The cells were greater than 99% viable, as assessed by exclusion of 
trypan blue dye. 
Lymphocyte Isolation 
Mononuclear cells were isolated and pumped into the rotor at a flow rate of 8 ml/min, as described 
above. The flow rate was then increased to 14 ml/min, and 150 ml were collected. This eluate- contained 
platelets, erythrocytes and a few lymphocytes. A pure population of lymphocytes was then eluted from the 
chamber in the subsequent 150 ml fraction at a flow rate of 16 ml/min. The cells were washed in 50 ml of 
sterile 0.15 mol/L NaCI solution and re-suspended in supplemented RPMI 1640 medium at 2 x cells/ml. 
Differential counts on modified Wright’s stained cytocentrifuge preparations confirmed that the lymphocytes 
were greater than 95% pure; the remaining cells were predominantly monocytes. The cells were greater than 
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99% viable, as assessed by exclusion of trypan blue dye. 
platelet Isolation 
The Nycodenz isolation procedure was performed, as described previously. Monocytes and 
contaminating platelets were harvested from the gradients and suspended in elutriation buffer. The cells were 
pumped into the rotor at a flow rate of 8 ml/min at a constant 2470 rpm and 200 ml of eluate were collected 
during this loading procedure. This eluate contained a pure population of platelets. The platelets were then 
washed twice in 50 ml of Hank’s balanced salt solution (HBSS; pH 7.4) re-suspended in 25 ml of HBSS and 
counted using a haemocytometer. Differential counts on cytocentrifuge preparation stained with modified 
Wright’s stain confirmed that the platelets were not contaminated with nucleated cells. 
2.2. Recovery of Monocytes 
The recovery of monocytes by the ficoll-Hypaque and Nycodenz methods was determined by 
comparison with starting material. Sixty-five millilitres of venous blood were drawn from six healthy volunteers. 
Monocytes were isolated from 30 ml of blood by the ficoll-Hypaque method and from 30 ml of blood by the 
Nycodenz method. The remaining 5 ml of blood were collected into tubes containing EDTA (1.3 g/L final 
concentration) and assessed for total leukocyte number using a coulter counter. In addition, the proportion of 
leukocytes that were monocytes was determined morphologically from a blood smear stained with modified 
Wright’s stain and counted independently (300 cells/smear). From these two values the actual number of 
monocytes in the initial peripheral blood sample was obtained. This value was compared to the number of 
monocytes recovered by the ficoll-Hypaque and Nycodenz isolation procedures and the percentage recovery for 
each method was calculated. 
The proportion of monocytes recovered by the conventional ficoll-Hypaque method was 36.5% (i SEM 
7.3%), whereas 69.0% SEM 18.4%) of monocytes were recovered by the Nycodenz method (n = 6). In 
View of the greater recovery (p < 0.025) by the latter method, subsequent studies of monocyte function were 
performed on cells isolated by the Nycodenz method. 
The Nycodenz isolation method failed to recover about 30% of monocytes in the initial blood samples 
which may reflect adherence of cells to the isolation vessels. Alternatively, since monocytes are heterogeneous 
with respect to density (16), it is possible that the fraction of cells of the highest density becomes separated from 
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the remainder during centrifugation through Nycodenz and sediment to the bottom of the test-tube. To test the 
latter possibility, cells in the pellet from the Nycodenz gradient step were suspended in 2 ml of sterile 0.15 
mol/L NaCI solution and subjected to Percoll density gradient centrifugation to separate the mononuclear cells 
from the neutrophils and residual erythrocytes. The cell suspension was layered onto the surface of 2 ml of a 
54% [v/v] Percoll solution in 0.15 mol/L NaCI (density 1.075 g/ml) and the gradients were centrifuged at 200 
g for 25 min at room temperature. The mononuclear cells were harvested and washed in 20 ml of sterile 0.15 
mol/L NaCI solution. Cytocentrifuge preparations of the mononuclear cells were stained for non-specific 
esterase activity, as described below. 
2.3 Assessment of Monocyte Purity 
To confirm that monocytes isolated by the Nycodenz method were greater than 90% pure, smears of 
the cells were made on multi-test slides and allowed to dry overnight. The smears were then stained for: 1) 
non-specific esterase activity (502); and 2) monocyte and lymphocyte markers by immunohistochemistry (117). 
2.3.1. Non-Specific Esterase Staining 
A commercial kit (Sigma, Chemical Co., Poole, Dorset, U.K.) was used to stain smears of Nycodenz- 
The following reagents were provided in the kit and isolated cells for non-specific esterase activity. 
reconstituted, as described below. 
Buffers and reagents 
1. Citrate-acetone-methanol fixative 
Eighteen millilitres of dilute citrate buffer (citrate concentrate diluted 1 in 10 with deionized 
water) were added to 27 ml of acetone and 5 ml of methanol. 
2. Trizmal dilute buffer 
Five millilitres of Trizmal concentrate were added to 45 ml of deionised water. 
3. Alpha-napthyl acetate solution 
One capsule of a-napthyl acetate was dissolved in 2 ml of ethylene glycol monomethyl ether. 
4. Mayer's haematoxylin solution 
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Method 
The slides were fixed in citrate-acetone-methanol fixative for 1 min at room temperature, washed 
thoroughly in deionised water and allowed to dry for 1 h. The Trizmal dilute buffer solution (50 ml) was 
prewarmed to 37°C, and one capsule of Fast Blue RR Salt was added with constant stirring until it was 
completely dissolved. Two millilitres of a-napthyl acetate solution were added, the solution was stirred for 30 
s and decanted into a Coplin jar. The slides were placed in the staining solution and incubated in a water bath 
at 37°C for 30 min, protected from light. The slides were removed from the staining solution, washed for 3 min 
in deionised water, counter-stained for 10 min in Mayer's hematoxylin solution and finally washed in tap water. 
The slides were air dried and examined microscopically. Two hundred cells were counted in successive high- 
magnification fields (x 400) and the percentage of positive cells was determined. 
2.3.2. Immnnohistochemistry 
Smears of Nycodenz-isolated cells were stained by the alkaline phosphatase anti-alkaline phosphatase 
method (117) for: 1) the p150/95 integrin which is expressed by monocytes and macrophages but not by 
lymphocytes (205); and 2) CD22 and CD3 which are pan B and pan T lymphocyte markers, respectively. 
Buffers 
1. Tris-buffered saline (TBS) 
A solution of 0.15 mol/L NaCl and 0.5 mol/L Tris; pH 7.6 
2. Substrate buffer 
Naphthol As-Mx phosphate (20 mg) was dissolved in 2 ml of dimethyl formamide in a glass 
tube and added to 100 ml of 0.1 mol/L Tris HCl; pH 8.2. One hundred microlitres of 0.1 mol/L 
levamnisole were added and the buffer was stored at 4°C. 
3. Fast red Substrate 
Fast red (5 mg) was dissolved in 5 ml of Substrate buffer. 
4. Ammonia water 
A solution of (0.11 mol/L) in tap water. 
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Method 
Smears of Nycodenz-isolated monocytes were fixed in acetone for 2 min at room temperature. The 
smears were incubated for 30 min at room temperature with normal rabbit serum (diluted 1/5 in Tris-buffered 
saline; pH 7.6, [TBS]). The smears were then incubated for 30 min at room temperature with a murine 
monoclonal antibody recognising p150/95 (diluted 1/50 in TBS), or with CD22 and CD3 together (diluted 1/20 
and 1/50 in TBS, respectively). After washing with TBS, the smears were incubated for 30 min with a 
polyclonal rabbit antibody against murine immunoglobulin (RAM; diluted 1/25 in TBS). After further washing 
with TBS, the smears were incubated for 30 min with a complex of alkaline phosphatase and murine 
immunoglobulin to alkaline phosphatase (APAAP; diluted 1/50 in TBS). The smears were washed in TBS and 
the RAM and APAAP cycles were repeated. The complex was developed with the fast-red Substrate solution 
for 10 to 20 min. The smears were washed in TBS followed by tap water and counter-stained in Mayer’s 
Hematoxylin solution. The smears were dipped twelve times in ammonia water, mounted in glycagel and 
viewed under oil immersion. Two hundred cells were counted in successive high-magnification fields (x 400) 
and the percentage of positive cells in each smear was determined. Murine ascites that did not contain 
immunoglobulin to human antigens was used instead of the primary antibody as a negative control. 
2.4 Limulus Amoebocyte Lysate Assay 
2.4.1. Measurement of Endotoxin Concentrations in Reagents and Media 
Bacterial lipopolysaccharide (LPS) has been shown to affect many aspects of leukocyte function 
(188,190,451,468). Since one aim of these studies was to investigate the effects of LPS on monocyte adherence, 
care was taken to minimise LPS contamination during isolation and subsequent culture of the cells. TO confirm 
this, all of the solutions used in the Nycodenz isolation and culture of monocytes were assayed for LPS using 
a commercial limulus amoebocyte lysate assay (220). 
The limulus amoebocyte lysate assay was performed using an aseptic technique. The LPS standard 
curve and test samples were prepared in a laminar flow hood using disposable endotoxin free 12 x 75 mm glass 
test-tubes and sterile disposable plastic pipette tips. 
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Materials 
The following reagents were provided with the commercial kit (Coatest Assay, KabiVitrum, Stockholm, 
Sweden) and reconstituted as follows: 
1. Lyophilised endotoxin from E. coli 0111:B4 
The endotoxin was dissolved in sterile endotoxin-free water to obtain a concentration of 1 
ng/ml and mixed vigorously for 3 min using a Vortex mixer. 
2. Limulus amoebocyte lysate (LAL) 
Each vial of LAL was reconstituted immediately before use with 1.4 ml of sterile endotoxin- 
free water and swirled gently to prevent foaming. The solution was kept at room temperature for 15 
min to allow proper dissolution. 
Substrate buffer (sterile endotoxin-free 0.5 mol/L Tris 500; pH 9.0). 
S-2423, the chromogenic Substrate (Ac-Ile-Glu-Gly-Arg-pNA HCI) 
3. 
4. 
The Substrate (9 mg) was reconstituted with 6.6 mi of sterile endotoxin-free water to a 
concentration of 1.8 mmol/L and stored at 4°C until required. Prior to use in the assay, one volume 
of Substrate solution was added to one volume of Substrate buffer and incubated at 37°C 
Method 
A standard curve was prepared by diluting the stock solution of LPS with endotoxin-free water to give 
final concentrations of O, 10, 25. 50, 75 and 100 pg/ml of LPS. The standards were mixed for 1 min Using a 
Vortex mixer. One hundred microlitres of LPS standard or test sample were pipetted into test-tubes and 
incubated at 37°C for 5 min. An equal volume of LAL solution was added to each test tube, mixed, then 
incubated at 37°C for 10 min. Substrate buffer solution (200 was added and the reagents were mixed. 
Following incubation for 3 min at 37°C, acetic acid (200 of a 20% [v/v] solution) was added to each tube and 
mixed immediately to terminate the reaction. A sample blank was made by adding 200 of substrate buffer 
to 100 of water, 100 pi of LAL and 200 of acetic acid. 
Two hundred microlitres of each standard, test sample or blank were transferred to the wells of a 96- 
well plate. The absorbance values for the standard and test samples were measured (compared with the assay 
blank) at 405 nM. A calibration h e  was derived by h e a r  regression analysis and the results for the test 
samples were obtained by interpolation. Figure 1 shows the standard curve for the limulus amoebocyte lysate 
62 
assay. The within-batch coefficient variation for the assay was 5.5% (n = 3). The lower limit of detection of 
the assay was 10 pg/ml of LPS. 
2.4.2. Measurement of Endotoxin Activity in Plasma from Healthy Subjects and Patients with 
Bronchiectasis 
The LPS concentrations in plasma samples from six healthy subjects and 22 patients with bronchiectasis, 
10 producing mucoid sputum, six producing mucopurulent sputum and six producing purulent sputum (see 2.5.4) 
were measured using the limulus amoebocyte lysate assay. Ten millilitres of venous blood were drawn from 
each subject and collected into sterile lithium heparin tubes. The tubes were centrifuged immediately at 200 
g for 10 min at 4°C. Two millilitres of platelet-rich plasma from each subject were transferred to sterile 
polypropylene tubes, diluted to 20 ml with an endotoxin-free 0.15 mol/L NaCI solution and heated to 75°C for 
5 min to remove non-specific activators and inhibitors of the pro-coagulant enzyme (115). The samples were 
left at room temperature for 15 min then shaken vigorously prior to assay. The commercial limulus amoebocyte 
lysate kit was used to quantify LPS concentrations as described previously, with the following exceptions. 
1) Plasma from six healthy donors was pooled and heat-inactivated, as described above. Two millilitres 
of the pooled plasma were added to 18 ml of endotoxin-free water and the diluted plasma was used as 
the diluent in the assay blank and the LPS standard samples. 
2) The limulus amoebocyte lysate solution was incubated with the standards and samples for 25 min. 
3) The Substrate was incubated with the sample and limulus amoebocyte lysate for 5 min. 
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Figure 1 
Standard Curve for the Limulus Amoebocyte Lysate Assay 
Figure 1 Figure shows the standard curve for the limulus amoebocyte lysate assay. The LPS standard 
samples were prepared from a stock solution of LPS from E. coli 0111:EM in sterile endotoxin-free water. Note 
the linear relationship between LPS concentration and absorbance measured at 405 nM (r = 0.990). The lower 
limit of detection of the assay was 10 pg/ml. Data represent mean values SD; n = 2. 
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2.5 Monocyte Adherence Assay 
2.5.1. Coating of Tissue Culture Dishes with Fibronectin 
To determine the optimal coating concentration of fibronectin for monocyte adherence, tissue culture 
dishes were incubated with 0.5 ml of purified human serum fibronectin at varying concentrations (O to 50 
in sterile 0.15 mol/L NaCI solution) for 2 h at 37°C. The dishes were washed three times with 2 ml of sterile 
0.15 mol/L NaCl solution to remove unbound fibronectin. A coating concentration of 20 of fibronectin 
was found to be optimal for monocyte adherence (see Results), and this concentration, therefore, was used in 
all subsequent experiments. 
2.5.2. Adherence Assay 
Monocytes were suspended at cells/ml in supplemented RPMI 1640 medium (see above) and 1 ml 
aiiquots were dispensed into dishes that had been pre-coated with fibronectin (see above). The dishes were 
incubated for 1 h at 37°C in a humidified atmosphere of 5% CO, and 95% air. Non-adherent monocytes were 
removed by washing the dishes three times with 2 ml of ice-cold, sterile 0.15 mol/L NaCl solution. The non- 
adherent cells were centrifuged at 600 g for 5 min at 4°C, re-suspended in 0.5 ml of supplemented RPMI 1640 
medium and counted using a haemocytometer. The percentage of adherent cells was calculated from the initial 
number of cells and the number of non-adherent monocytes recovered. 
2.5.3. Optimization of the Adherence Assay 
2.5.3.1 Confirmation of the Specificity of Monocyte Adherence to Fibronectin 
The specificity of monocyte adherence to fibronectin was assessed by comparing monocyte adherence 
to tissue culture dishes coated with fibronectin or 25% [w/v] human serum albumin (HSA). in addition, 
fibronectin-coated dishes were incubated for 30 min at 37°C with and without varying concentrations of rabbit 
anti-human fibronectin or non-immune rabbit (0.1, 1, 10 and 100 in HBSS; pH 7.4). The 
dishes were washed three times with 2 ml of HBSS to remove unbound Monocytes from three healthy 
donors were incubated in the dishes for 1 h and the proportion of adherent cells was determined, as described 
above. 
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2.5.3.2. Comparison of Different Sources of Fibronectin 
To compare the adherence of monocytes to fibronectin obtained from different sources, tissue culture 
dishes were coated with: 1) purified human serum fibronectin (20 as described previously; 2) 
complement-depleted (by incubation at 56°C for 30 min) autologous plasma; and 3) complement-depleted 
autologous serum. In each case, the tissue culture dishes were washed three times with 2 ml of sterile 0.15 
mol/L NaCl solution to remove unbound protein. The proportion of adherent monocytes was then determined, 
as described previously. A greater proportion of monocytes adhered to tissue culture dishes that had been 
coated with purified human serum fibronectin compared with dishes coated with autologous serum or plastic 
(see Results). Purified human serum fibronectin, therefore, was used as the adherence substrate for monocytes 
in all subsequent assays. 
2.5.3.3. Effect of Culture Medium Additives 
The effect of culture medium additives on monocyte adherence to fibronectin was assessed. Monocyte 
adherence was tested in RPMI 1640 medium supplemented with: 1) 10% and 25% [v/v] complement-depleted 
(by incubation at 56°C for 30 min) FCS; 2) 10% and 25% [v/v] complement-depleted autologous serum; and 
3) 0.5% [w/v] human serum albumin (HSA). Similar proportions of monocytes suspended in medium containing 
10% [v/v] FCS, 10% (v/v] autologous serum and 0.5% [w/v] HSA adhered to fibronectin (see Results). 
However, the proportion of adherent monocytes was reduced by 30% when the serum concentration was 
increased from 10% [v/v] to 25% [v/v]. All subsequent studies, therefore, were performed on monocytes 
suspended in RPMI 1640 medium supplemented with 10% [v/v] FCS. 
2.5.3.4. Effect of Monocyte Number 
The effect of dispensing different numbers of monocytes into fibronectin-coated dishes on subsequent 
monocyte adherence was assessed. Varying numbers of monocytes suspended in 1 ml of medium (5 x 7.5 
x 2 x and 3 x were incubated in fibronectin-coated dishes for 1 h at 37°C. The absolute 
number of adherent cells was calculated by subtracting the number of non-adherent cells from the initial number 
of cells dispensed into the dish. A linear relationship was observed between the number of cells added and the 
number of cells that adhered to fibronectin (see Results). Therefore, in ail subsequent experiments 1 x to 
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2 x monocytes were added to fibronectin-coated tissue culture dishes. 
2.5.3.5. Effect of Anti-Proteinases on Monocyte Adherence to Fibronectin 
Monocytes contain proteinases that are capable of degrading fibronectin (81). To exclude the possibility 
that degradation of the fibronectin substrate by monocyte-derived proteinases limits monocyte binding, 
monocytes were incubated with and without antitrypsin (250 and -macroglobulin (50 during 
the adherence assay. The proportion of adherent cells was determined, as described previously. 
2.5.3.6. Reproducibility of the Adherence Assay 
To assess the reproducibility of the adherence assay, 5 x monocytes isolated from one subject were 
suspended in 5 mi of medium, 1 mi aliquots were dispensed into five fibronectin-coated dishes and the dishes 
were incubated for 1 h at 37°C. The percentage of monocytes adhering to each dish was determined, as 
described previously. The within-batch coefficient of variation (C.V.) for the assay was then calculated. To 
assess within- and between-donor variability in monocyte adherence to fibronectin, the adherence assay was 
performed on cells isolated from six subjects on six different occasions. 
2.5.3.7. Comparison of the Adherence Properties of Monocytes Isolated by the Nycodenz Method and 
by Countercurrent Centrifugal Elutriation 
To exclude the possibility that either the Nycodenz isolation procedure itself or the presence of 
contaminating platelets altered the adherence properties of Nycodenz-isolated monocytes, the adherence 
properties of monocytes isolated by Nycodenz (with and without the centrifugation through plasma step to 
remove platelets) were compared with those of cells isolated by countercurrent centrifugal elutriation (CCE). 
Ninety millilitres of venous blood were drawn from five healthy donors. Monocytes were isolated from 30 ml 
of blood by the standard Nycodenz method, from 30 ml of blood by the Nycodenz method followed by 
centrifugation through plasma, and from the remaining 30 ml of blood by CCE. The proportion of monocytes 
that adhered to fibronectin was then determined for cells isolated by the three methods. 
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2.6. Comparison of the Adherence Properties of Monocytes from Healthy subjects 
and Patients with Bronchiectasis 
Subjects 
Bronchiectasis was chosen as a model for an inflammatory disease state. Studies were undertaken on 
37 patients with bronchiectasis. The initial diagnosis was based on clinical grounds and confirmed radiologically 
by bronchography. The patients were derived from a large bronchiectasis clinic and they were selected because 
they were clinically stable and had had no evidence of acute infective exacerbations (such as pyrexia, chest pain, 
haemoptysis, or increase in symptoms for at least 2 wk prior to study. Seventeen subjects were male and the 
age range was 36 to 75 yr (median = 63 yr). None of the patients were receiving antibiotics, steroids orally, 
or non steroidal anti-inflammatory drugs at the time of study. None of the patients had a recognised primary 
cause of bronchiectasis (such as ciliary dysfunction or hypogammaglobulinaemia). The patients were subdivided 
into three groups according to the usual nature of the sputum samples that they produce, as described previously 
(447). The patients included 13 who produced mucoid sputum (M) persistently, 13 who usually produced 
mucopurulent sputum (MP) and 11 who produced punilent sputum (P) consistently. The patient groups defined 
by this method have been shown to vary in the severity of lung inflammation, as assessed by protein 
transudation into the lung and elastolytic activity of the sputum (447). The demographic and spirometric data 
on the patients with bronchiectasis are summarised in Appendix 2. 
A total of 16 healthy non-smoking subjects were recruited from hospital staff and studied as controls. 
None of these subjects had a history of lung or other chronic disease or a current infection and none were 
receiving drugs at the time of study. Nine subjects were male and the age range was 23 to 39 yr (median = 
26 Yr). 
2.6.1. Basal Adherence of Monocytes to Fibronectin 
Monocytes were isolated from patients with bronchiectasis (six subjects from each patient group) and 
six healthy control subjects. The cells were re-suspended at in supplemented RPMI 1640 medium and 
incubated under basal conditions for 1 h in fibronectin-coated dishes. The percentage of adherent monocytes 
was determined, as described previously. 
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2.6.2. 
Adherence to Fibronectin 
Effect of Bacterial Lipopolysaccharïde (LPS) and Recombinant Cytokines on Monocyte 
To assess the effect of LPS on monocyte adherence to fibronectin, monocytes from healthy subjects 
were incubated for 1 h at 37°C, both with and without LPS from E. coli 0111: B4 at concentrations ranging from 
0.01 to 10 The percentage of adherent monocytes was calculated, as described previously. To compare 
the effects of LPS from different bacterial species on monocyte adherence to fibronectin, monocytes were 
incubated for 1 h at 37°C with and without LPS purified from E. coli 0111:B4 and from H. influenzae at 
concentrations ranging from 0.01 to 10 
To determine the reproducibility of LPS-stimulated adherence of monocytes to fibronectin, 
monocytes suspended in 1 ml of medium were dispensed into each of five fibronectin-coated dishes and 
incubated for 1 h at 37°C in the presence of 1 of LPS from E. coli 0111:B4. The proportion of adherent 
monocytes was determined and the within-batch coefficient of variation was calculated. To assess within- and 
between-donor variability in LPS-stimulated adherence of monocytes to fibronectin, monocytes isolated from 
four healthy donors on four different occasions were incubated with 1 of LPS from E. coli 0111:B4 during 
the adherence assay and the proportion of adherent cells was determined 
To investigate the effect of LPS on the adherence of monocytes from patients with bronchiectasis, cells 
from patients with bronchiectasis (six patient from each group) were incubated for 1 h at 37°C in fibronectin- 
coated dishes with and without LPS from E. coli 0111:B4 (1 The proportion of adherent cells was 
determined, as described previously. 
To assess the effect of cytokines on monocyte adherence, cells from healthy subjects were incubated 
with and without the following recombinant cytokines during the adherence assay: 1) interieukin-1ß (IL-1,25 
units/ml); 2) tumour necrosis factor-a (TNF, 10, 100, 1000 and 10000 units/ml); 3) interferon y (IFN, 1000 
units/ml); and 4) granulocyte-macrophage colony stimulating factor (GM-CSF, 50 units/ml). To .determine 
whether LPS and cytokines produce additive effects on the adherence of monocytes to fibronectin, monocytes 
were incubated with and without combinations of cytokines together with the optimal concentration of LPS from 
E. coli 0111:B4: 1) TNF (1000 units/ml) and LPS (1 n = 6; and 2) TNF (1000 units/ml), IFN (1000 
units/ml) and LPS (1 n = 6. 
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2.6.3. Effect of Incubation Time on Monocyte Adherence to  Fibronectin 
To assess the effect of incubation time on monocyte adherence to fibronectin, monocytes were incubated 
at 37°C with and without 1 of LPS from E. coli 0111:B4 in fibronectin-coated dishes for 30 min, 1 h, 4 
h and 24 h. The percentage of adherent cells was determined, as described previously. 
2.7. Mechanisms Involved in Monocyte Adherence to Fibronectin 
To determine whether the CD11/CD18 group of integrins plays a role in mediating basal and LPS- 
stimulated adherence of monocytes to fibronectin, monocytes from healthy subjects were incubated with anti- 
CD18, a murine monoclonal antibody (206 subclass immunoglobulin G1 [IgG1]) that reacts with the beta 
chain (CD18 antigen) common to the three members of the CD11/CD18 subfamily of integrins. In addition, 
to assess whether RGD-dependent integrins are involved in mediating LPS-stimulated adherence of monocytes 
to fibronectin, monocytes were also incubated with a synthetic Arg-Gly-AspSer (RGDS) tetrapeptide. 
in preliminary experiments, monocytes cells suspended in 500 of supplemented RPMI 1640 
medium) were pre-incubated with and without varying concentrations of the anti-CD18 antibody (0.4, 1.0,4.0 
and 10 for 15 min at 37°C in sterile polypropylene tubes. The cells were then transferred to fibronectin- 
coated tissue culture dishes and the dishes were incubated for 1 h at 37°C with and without LPS from E. coli 
0111:B4 (1 The percentage of adherent monocytes was determined, as described previously. This 
protocol was repeated for the RGDS peptide (0.025, 0.05, 0.1, 1.0 and 2.0 mg/ml). For the anti-CD18 and 
RGDS inhibition studies, antibody buffer (RPMI 1640 medium dialysed against 0.05 mol/L Tris HCl containing 
15 nmol/L pH 72) and medium alone, respectively, were added to the control wells. Anti-CD18 at 4 
and RGDS at 1 mg/ml were found to be the optimal concentrations for inhibition of monocyte adherence 
(see Results), and these Concentrations, therefore, were used in subsequent experiments. 
As further controls, monocytes were also incubated with Arg-Gly-Glu-Ser (RGES; 1 mg/ml) and the 
following murine monoclonal antibodies: 1) I3, which recognises a non-polymorphic HLA-DR antigen that is 
expressed by greater than 75% of monocytes (40 IgG2 subclass), (443); 2) MY7, which binds to a 
monocyte surface antigen (25 IgG1 subclass), (181); and 3) murine IgG, as a non-binding 
control antibody (50 IgG1 subclass). 
The effect of the anti-CD18 antibody and the RGDS peptide together on monocyte adherence to 
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fibronectin was also assessed. Monocytes (with and without 1 of LPS from E. coli 0111:B4) were 
incubated with anti-CD18 alone (4 RGDS alone (1 mg/ml) and with anti-CD18 and RGDS together 
(4 and 1 mg/ml, respectively) and the proportion of adherent cells was determined. 
To assess the mechanisms involved in the adherence of monocytes from patients with bronchiectasis 
to fibronectin, monocytes from six patients with bronchiectasis (two patients from each subject group) were 
incubated with and without anti-CD18 alone (4 RGDS peptide alone (1 mg/ml) and anti-CD18 and 
RGDS together (4 and 1 mg/ml, respectively). The percentage of adherent cells was then determined. 
2.8. Monocyte Phenotype Evaluations 
2.8.1. Separation of Monocyte Subpopulations 
Further studies were conducted to test the possibility that various functional properties of monocytes 
are related to their capacity to adhere to fibronectin. Monocytes that adhered spontaneously to fibronectin 
(spontaneously adherent monocytes) were isolated by incubating pool monocytes (2 x cells in 1 mi of 
supplemented RPMI 1640 medium) in fibronectin-coated dishes and removing the non-adherent cells after 1 h, 
as described previously. An aliquot (5 x cells) of the monocytes that did not adhere spontaneously to 
fibronectin (non-spontaneously adherent monocytes) was retained. The remaining non-spontaneously 
adherent monocytes cells) were re-suspended in 1 ml of supplemented RPMI 1640 medium and incubated 
in fibronectin-coated dishes for a further 60 min in the presence of LPS from E. coli 0111:B4 (1 ce l ls  
that remained non-adherent (non-adherent monocytes) were separated from the cells that had been induced 
to adhere by LPS (LPS-adherent monocytes) by washing the dishes three times with 2 ml of sterile 0.15 
mol/L NaCI solution. The non-adherent cells were re-suspended in supplemented RPMI 1640 medium and 
counted using a haemocytometer. The number of LPS-adherent monocytes was calculated from the number 
of cells added to the dish and the number of non-adherent monocytesthat were recovered. The four monocyte 
subpopulations (spontaneously adherent, non-spontaneously adherent, LPS-adherent and non-adherent) were 
cultured in supplemented RPMI 1640 medium in separate tissue culture dishes for all subsequent assays. The 
separation of the monocyte subpopulations is shown in the flow diagram (figure 2). 
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Figure 2 
Separation of the Monocyte Subpopulations 
Nycodenz isolated monocytes (pool cells) 
spontaneously adherent monocytes non-spontaneously adherent monocytes 
(subpopulation 1) (subpopulation 2) 
tissue culture dishes 
LPS-adherent monocytes non-adherent monocytes 
(subpopulation 3) (subpopulation 4) 
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2.8.2. Confirmation of the Authenticity of the Monocyte Subpopulations 
To confirm the authenticity of the monocyte subpopdations, the four subpopuiations were separated 
as described above, and subjected to identical second adherence assays. The non-spontaneously adherent and 
non-adherent cells were transferred directly to fibronectin-coated dishes and incubated at 37°C for 1 h; the non- 
spontaneously adherent cells were cultured under basal conditions, and the non-adherent cells were cultured in 
the presence of 1 of LPS from E. coli 0111:B4. The proportion of adherent cells was determined, as 
described previously. 
The spontaneously adherent and LPS-adherent cells from the initial adherence assays were also 
subjected to second adherence assays. These cells were detached by incubating the dishes with sterile 0.15 
mol/L NaCI solution containing 5 mmol/L EDTA for 45 min at 4°C, followed by gentle scraping with a rubber 
policeman. The cells were washed once in 20 ml of sterile 0.15 mol/L NaCl solution and re-suspended in 
supplemented RPMI 1640 medium. The cells were then incubated in fibronectin-coated dishes at 37°C for 1 
h; the spontaneously adherent cells were cultured under basal conditions and the LPS-adherent cells were 
incubated in the presence of LPS from E. coli 0111:B4 (1 The proportion of adherent cells was 
calculated, as described previously. 
2.8.3. Phagocytic activity 
Phagocytic activities of the monocyte subpopulations were assessed by incubating the cells with 3 
diameter latex beads for 40 min at 37°C (41,424). The ratio of beads to monocytes was 75:1. TO control for 
possible effects of LPS on phagocytosis, spontaneously adherent cells were also pre-incubated with LPS from 
E. coli 0111:B4 (1 for 1 h before assessment of their phagocytic activity. Following the phagocytic assay, 
the adherent monocyte subpopulations were detached by gentle scraping with a rubber policeman. 
Cytocentrifuge preparations of the four monocyte subpopulations were stained with modified Wright's stain and 
viewed under oil immersion. Two hundred cells were counted independently in successive high-magnification 
fields. Both the mean number of beads associated with each cell, and the percentage of cells that were positive 
(associated with one or more beads) were determined. The phagocytic index was calculated as follows: 
Phagocytic index (PI) = percentage of positive cells X mean number of beads/cell. Figure 3 shows pool 
monocytes phagocytosing latex beads. 
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2.8.4. Superoxide Anion Generation 
Superoxide anion generation was measured as the superoxide dismutase-inhibitable reduction of 
cytochrome c (25). The monocyte subpopulations were incubated at 37°C in 35 x 10 mm tissue culture dishes 
in 1 ml of Dulbecco's buffer (phosphate buffered saline containing 1 mmol/L and 1 mmol/L with 
cytochrome c (1.25 mg/ml). Control cells were incubated in the presence of superoxide dismutase (50 
Spontaneously adherent and LPS-adherent monocytes were adherent to fibronectin-coated dishes, and the non- 
adherent monocyte subpopulations were incubated in uncoated dishes during the assay. To control for possible 
effects of LPS on superoxide production by monocytes, spontaneously adherent cells were also pre-incubated 
for 1 h with LPS from E. coli 0111: B4 (i prior to assay. After incubation for 1 h, the media samples 
were centrifuged for 5 min at 600 g at 4°C and the cell-free supernatants were transferred to plastic disposable 
cuvettes. Superoxide production was measured as the superoxide dismutase-inhibitable reduction of cytochrome 
c using an extinction coefficient of 21.1 x M-¹cm-¹ at a wavelength of 550 nM (459). The results were 
expressed as nmol of cytochrome c cells/h. reduced The within-batch coefficient of variation for the 
superoxide assay was 5.8% (n = 3). 
2.8.5. Peroxidase Activity 
The peroxidase activity of the monocyte subpopulations was measured as described previously (428). 
The monocyte subpopulations were separated as described above. Culture supematants were harvested and the 
cells were washed once with 1 ml of a 0.15 mol/L NaCl solution. Extracts of the monocyte subpopulations were 
made at 2 x cells/ml in lysing buffer (phosphate buffered saline [PBS] containing 0.04% [v/v] Triton X-100 
and 1 mol/L NaCl; pH 7.4). Extracts of the adherent monocyte subpopulations were prepared within the tissue 
culture dishes and examination of the dishes by phase-contrast microscopy confirmed that all of the cells had 
been lysed. To control for the possible effects of LPS on peroxidase activity, spontaneously adherent monocytes 
were also pre-incubated with LPS from E. coli 0111:B4 (1 for 1 h prior to assay. Extracts of platelets 
were also prepared and assayed for peroxidase activity since Nycodenz-isolated monocytes are contaminated 
variably with platelets. 
Cell extract or culture supernatant (100 was mixed with 900 of Substrate (0.01 mol/L phosphate 
buffer containing 0.017% [w/v] O-dianisidine [3,3'-dimethoxy benzidine] and 0.003% [v/v)] pH 6.0). The 
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change in absorbance was measured immediately in a spectrophotometer (Beckman DU-8; Beckman Instrument 
Co., Irvine, California, U.S.A.) at 460 nM, using 100 of lysing buffer or supplemented RPMI 1640 medium 
and 900 of substrate as the assay blank. The peroxidase activity was expressed as cells, where one 
unit is the amount of enzyme decomposing 1 of peroxide per min. The within-batch coefficient of 
variation for the peroxidase assay was 5.6% (n = 5). 
2.8.6. HLA-DR Antigen Expression by Monocyte Subpopulations 
The indirect immunofluorescence technique was used to label monocytes with 13, which is a murine 
monoclonal antibody that binds to a non-polymorphic HLA-DR antigen expressed by greater than 75% of 
human monocytes (443). Since the binding of i3 by monocytes was analysed initially by epifluorescence 
microscopy, platelet-free monocyte preparations were necessary for these experiments and monocytes, therefore, 
were isolated by CCE. The monocyte subpopdations were separated and the cells were fixed for 5 min at 4°C 
in 1 ml of fixative (PBS containing 1% [w/v] paraformaldehyde, 0.5 mmol/L and 1 mmol/L pH 
7.4). Pool monocytes and the non-adherent monocyte subpopulations were fixed in suspension. The monocyte 
subpopulations that were adherent to fibronectin-coated dishes were fixed within the dishes and then detached 
by gentle scraping with a rubber policeman. Cells (2 x were suspended in 400 of medium (HBSS 
containing 1% [w/v] HSA and 50 of goat IgG; pH 7.4) and incubated for 30 min at 4°C to block 
monocyte Fc receptors. I3 antibody or non-immune murine IgG (as a negative control) were added to the cell 
suspension both at a final concentration of 20 The cells were incubated for a further 30 min at 4°C, then 
washed three times with 500 of medium. The cells were re-suspended in 200 of medium, goat . 
antibody conjugated to FITC was added (170 final concentration) and the cells were incubated at 4°C 
for 30 min. The cells were washed three times in 500 of medium and re-suspended in of medium. 
The samples were analysed initially by phase-contrast and epifluorescence microscopy (Leitz Dialux 20, Ernst 
Leitz Westlar G.M.B.H.). The samples were analysed subsequently by flow cytometry (Ortho B.D., Mountain 
View, California, U.S.A.). Contaminating lymphocytes (5 to 8%) were separated from the monocytes by bit 
map gating on forward angle and 90° light scatter characteristics. Fluorescence data were collected on a three 
decade log scale. Mean log scales were converted to linear fluorescence with calibration curves obtained by 
analysing fluorescent microspheres with both log and linear amplifications. 
to mouse immunoglobulin 
n 
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2.8.7. Total Protein Content 
The protein content of the monocyte subpopulations was quantified by the Sedmak method as described 
previously (404). Monocytes were isolated by CCE for these experiments since Nycodenz-isolated monocytes 
are contaminated variably with platelets and platelets contain protein (1). Extracts of the monocyte 
subpopulations were made at 2 x cells/ml in lysing buffer (phosphate buffered saline [PBS] containing 1 
mol/L NaCI and 0.04% [v/v] Triton X-100; pH 7.4). The cell extracts were frozen to -70°C until analysis. The 
Sedmak reagent was made by diluting 120 mg of Coomassie brilliant blue G250 dye in 200 ml of deionised 
water containing 1.9% [v/v] perchloric acid, and the solution was filtered prior to use. The protein standard 
was made by dissolving bovine serum albumin (BSA) in lysing buffer at a concentration of 1 mg/ml. Serial 
dilutions of the BSA standard were made in lysing buffer to give final concentrations of BSA ranging from 50 
to 400 Fifty microlitres of the BSA standard or test samples were added to 1 ml of Sedmak reagent in 
a test tube and the absorbance of the solution was read in a spectrophotometer (Beckman DU-8; Beckman 
instrument Co., Irvine, California, U.S.A.) at a wavelength of 620 nM using 50 of lysing buffer added to 1 
ml of Sedmak reagent as the assay blank. A calibration line was derived by linear regression analysis and the 
results for the test samples were obtained by interpolation. Figure 4 shows a typical standard curve for the 
Sedmak assay. The within- and between-batch coefficients of variation for the assay were 2.5% (n = 6) and 
6.7% (n = 5), respectively. 
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Figure 4 
Standard Curve for the Sedmak Protein Assay 
Figure 4 Figure shows a typical standard curve for the Sedmak assay which was used to measure the 
total protein content of monocyte extracts. The protein standard for the assay was prepared by making serial 
dilutions of a 1 mg/ml solution of bovine serum albumin (BSA) using the monocyte lysing buffer (PBS 
containing 1 mol/L NaCl and 0.04% [v/v] Triton X-100) as the diluent. Note the linear relationship between 
BSA concentration and absorbance over the range of O to 20 /assay of BSA (r = 0.998). Data represent 
mean SEM; n = 3. 
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2.9. Expression of Human Leukocyte Elastase and Alpha,- Antitrypsin by Monocytes 
2.9.1. Preparation of Cell Extracts 
Extracts of monocytes, neutrophils and platelets were prepared in lysing buffer (PBS containing 0.04% 
[v/v] Triton X-100 and 1.05 mol/L NaCl; pH 7.4). It has been shown previously that 0.04% [v/v] Triton X-100 
in this salt concentration is adequate to extract HLE maximally from whole cells without producing anomalies 
in the immunoassays (81). High salt concentrations are necessary during the preparation and subsequent assay 
of cell extracts due to the relative insolubility of HLE in buffers of low ionic strength (453). Cells were washed 
with 10 ml of sterile 0.15 mol/L NaCl solution and cell extracts were prepared in lysing buffer. Extracts of 
monocytes and neutrophils were prepared at 2 x cells/ml and extracts of platelets were prepared at 2 x 
cells/ml in lysing buffer. Extracts of adherent monocytes were prepared while the cells were adherent to the 
tissue culture dishes and examination of the dishes by phase-contrast microscopy confirmed that all of the cells 
had been lysed. Cell extracts (and culture supernatants) were stored at -70°C until analysis. 
2.9.2. HLE and Content of Monocyte Subpopulations 
Monocytes were isolated by the Nycodenz method, extracts of the monocyte subpopulations were 
prepared (2.9.1.) and assayed for HLE content using an indirect binding ELISA (2.9.4.). To assess whether the 
Nycodenz isolation procedure influences the HLE content of monocytes, monocytes were isolated by both the 
Nycodenz method and CCE, extracts of pool, spontaneously adherent and non-spontaneously adherent cells were 
prepared and assayed for immunoreactive HLE. Extracts of platelets were also assayed for immunoreactive 
HLE since Nycodenz-isolated monocytes are contaminated variably with platelets. The HLE content of pool 
monocytes and neutrophils were also compared. Monocytes and neutrophils were prepared from three donors 
by CCE and Percoll density gradient centrifugation, respectively. Cell extracts were prepared and assayed for 
HLE. The results for these experiments were expressed as ng or pmol cells. 
To compare the content of the monocyte subpopulations it was necessary to isolate 
monocytes by CCE since Nycodenz-isolated monocytes are contaminated variably with platelets and preliminary 
experiments demonstrated that platelets contain (see Results). Extracts of the monocyte 
subpopuiations were prepared (2.9.1) and assayed for using a direct binding ELISA (2.9.5.). The 
results were expressed as ng or pmol cells. 
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2.9.3. Accumulation of by Monocyte Subpopulations 
2.9.3.1. Protocol for Quantifying Accumulation by Monocytes 
A direct binding ELISA (2.9.5.) was used to quantify immunoreactive in monocyte 
extracts and culture supernatants. The amount of measured in monocyte extracts and culture 
supematants using this technique represents the net balance between synthesis and catabolism of this protein 
by the cells. Therefore, the results were expressed as the amount of accumulated rather than 
synthesised by monocytes. 
Monocytes were isolated by the Nycodenz method for these experiments. Although Nycodenz-isolated 
monocytes are contaminated with platelets and platelets were subsequently found to contain (see 
Results), it is unlikely that platelets have the capacity to synthesise de novo since: 1) platelets 
contain negligible amounts of DNA and RNA; and 2) any RNA that is present within platelets is in a 
metabolically inactive from (1). Therefore, to overcome the problem of platelet contamination, the experiments 
were designed as follows. Monocyte subpopulations were cultured in several tissue culture dishes (35 x 10 mm) 
in 1 mi of supplemented RPMI 1640 medium at 37°C in a humidified atmosphere of 5% and 95% air. 
After incubation overnight, cells (i.e. monocytes and contaminating platelets) were harvested from one of the 
dishes (time = O, control cells) and cell extracts were prepared, as described in 2.9.1. Cells in the remaining 
dishes were incubated in fresh medium (1 ml) for up to 48 h with and without pro-inflammatory mediators. 
After incubation for 24 h, cells and culture supernatants were harvested and cell extracts were prepared. 
Culture supematants from the remaining dishes were harvested and the cells were cultured in fresh medium with 
and without pro-inflammatory mediators. After incubation for a further 24 h, the cells and culture supernatants 
were harvested and cell extracts were prepared. 
The content of the cell extract and supernatant samples was quantified using the direct 
binding ELISA (2.9.5.), and all of these results were expressed an ng cells. To determine the 
total amount of accumulated by the monocytes, the values obtained for the cell extracts and 
culture supernatants for each time interval were added together and the value obtained for the time = O, control 
cells (monocytes and their contaminating platelets) was subtracted from this number. The results were then 
expressed as: 1) percentage increase in accumulated by the monocytes (compared with the amount 
of contained within the control, time = O cells) when the monocyte subpopulations were isolated 
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from different donors; or 2) ng accumulated cells, when the monocyte subpopulations were 
isolated from the same donor. 
2.9.3.2. Effect of Culture and Lipopolysaccharide on Accumulation by Monocytes 
The effects of culture and LPS exposure on the accumulation of by the monocyte 
subpopulations were assessed. To obtain a sufficient number of celis for study, a large volume of blood had 
to drawn from the donors and the experiment, therefore, was conducted in two stages. Initially, spontaneously 
adherent and non-spontaneously adherent monocytes were separated from six healthy donors and incubated at 
37°C in tissue culture dishes 1 ml of supplemented RPMI 1640 medium. After overnight culture, extracts of 
the time = O, control cells were prepared and the remainder of the cells were incubated in fresh medium for 
48 h with and without LPS from E. coli 0111:B4 (1 Cells and culture supernatants were harvested at 
24 h intervals and cell extracts were prepared as described in 2.93.1. This protocol was then repeated for LPS- 
adherent and non-adherent monocytes prepared from an additional five healthy donors. The amount of 
antitrypsin that had accumulated in the cells and culture supematants was quantified, as described in 2.9.3.1. 
The results were expressed as percentage increase in the amount of accumulated by monocytes 
compared with the amount of contained within the time = O, control cells. 
To assess the absolute amounts of accumulated by spontaneously adherent and non- 
spontaneously adherent cells, both subpopulations were isolated from 15 healthy donors and incubated at 37°C 
in supplemented RMPI 1640 medium in tissue culture dishes. After overnight culture, extracts of the time = 
O, control cells were prepared. The remaining cells were incubated in fresh medium with and without LPS from 
E. coli 0111:B4 (1 After incubation for 24 h, the celis and culture supernatants were then harvested 
and cell extracts were prepared. The amount of that had accumulated in the cells and culture 
supernatants was quantified as described in 2.9.3.1., and the results were expressed as ng 
accumulated celis. 
2.9.3.3. Effect of Time on Accumniation by Spontaneously Adherent Monocytes 
Spontaneously adherent monocytes from five healthy donors were incubated at 37°C in 1 ml of 
supplemented RPMI 1640 medium in tissue culture dishes. After overnight culture, extracts of time = O, control 
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cells were prepared. The remaining cells were cultured in fresh medium for up to 24 h with and without LPS 
from E. coli 0111:B4 (1 After culture for 6 h, 12 h, and 24 h, cells and culture supernatants were 
harvested and cell extracts were prepared. The amount of that had accumulated in the cells and 
culture supernatants was quantified, as described in 2.9.3.1. The results were then expressed as ng 
accumulated cells. 
2.9.3.4. 
Subpopulations 
Effect of Recombinant Cytokines on Accumulation by Monocyte 
Spontaneously adherent and non-spontaneously adherent monocytes from six healthy donors were 
incubated at 37°C in tissue culture dishes in 1 mi of supplemented RPMI 1640 medium (1 ml). After overnight 
culture extracts of time = O, control cells were prepared. The remaining cells were cultured in fresh medium 
with and without TNF (1000 units/ml), IFN (1000 units/ml) and GM-CSF (10 to 75 units/ml). After incubation 
for 24 h, cells and culture supernatants were harvested and cell extracts were prepared. The amount of 
antitrypsin that had accumulated in the cells and culture supernatants was quantified, as described in 2.9.3.1. 
The results were then expressed as ng accumulated cells. 
2.9.4. Indirect Binding ELISA for Human Leukocyte Elastase 
The indirect binding ELISA for HLE was performed, as described previously (81). 
Materials and Buffers 
1. 
2. Polyclonal sheep anti-human HLE 
3. 
4. 
5. 
6. 
Method 
HLE purified from sputum, as described previously (49) 
Rabbit anti-sheep IgG conjugated to horse radish peroxidase. 
PBS containing 0.6 mol/L NaCl; pH 7.4 
PBS containing 0.6 mol/L NaCl, 0.05% [v/v] Tween 20 and 1% [w/v] BSA. 
Sodium citrate (0.05 mol/L); pH 4.5 
HLE was reconstituted in PBS (containing 0.6 mol/L NaCl; pH 7.4) and the protein content was 
determined spectrophotometrically (Beckman DU-8; Beckman Instrument Co., Irvine, California, U.S.A.) using 
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the extinction coefficient of 9.85 (33). The HLE standard samples were made from a stock solution 
of 1 mg/ml of HLE in PBS containing 0.6 mol/L NaCl. Serial dilutions of the stock solution were made in PBS 
containing 0.05% [v/v] Tween 20 and 1% [w/v] BSA to obtain final concentrations of 160, 80,40, 20, 10 and 
5 ng/ml. The monocyte extracts (2 x cells/ml in PBS containing 1.05 mol/L NaCl and 0.04% [v/v] Triton 
X-100) were diluted in an equal volume of PBS containing 0.15 mol/L NaCl, 0.05% [v/v] Tween 20 and 1% 
[w/v] BSA to adjust the salt concentration to 0.6 mol/L. An additional 1:3 dilution, for assay, was made in PBS 
containing 0.6 mol/L NaCl, 0.05% [v/v] Tween and 1% [w/v] BSA. Sixty-five microlitres of HLE standard, 
diluted celi extract or undiluted culture supernatant and 65 of polyclonal sheep anti-human HLE (10 
were pipetted into polypropylene radioimmunoassay (RIA) vials and incubated overnight at 4°C. 
Ninety-six well microtitre plates were coated with 200 of polyclonal sheep anti-human HLE (5 
in PBS containing 0.6 mol/L NaCl), and the plates were incubated overnight at 4°C. The plates were washed 
three times with PBS containing 0.05% [v/v] Tween 20 to remove unbound protein. The plates were then 
incubated for 1 h at room temperature with 200 of PBS containing 0.05% [viv] Tween 20 and 1% [w/v] BSA 
to block additional protein binding sites. 
After washing the plate three times with PBS containing 0.05% [v/v] Tween 20, 100 of the 
competitive mixtures were transferred to the antigen-coated plates and the plates were incubated at room 
temperature for 2 h. The plates were washed three times and incubated for 90 min at room temperature with 
100 of peroxidase-conjugated rabbit anti-sheep IgG. The plates were washed a further three times and 
developed using 100 of 50 mmol/L sodium citrate buffer (pH 45) containing 0.001% [w/v] o- 
phenylenediamine and 0.03% Iv/vl The plates were incubated at room temperature for 15 to 30 min to 
permit colour development, and the reaction was then terminated by the addition of 50 of 4 mol/L 
Absorbances were read with an automated microtitre plate reader (V-Max Kinetic Microplate Reader, Molecular 
Devices Corp., Paio Alto, California, U.S.A.). A calibration line was constructed by linear regression analysis, 
and the results for the test samples were obtained by interpolation. The results were expressed as ng 
monocytes. Figure 5 shows a typical standard curve for the indirect binding ELISA for HLE. This assay had 
sub-nanogram sensitivity and showed less than 0.2% cross-reactivity with cathepsin G and less than 0.1% cross- 
reactivity with myeloperoxidase (81). The within- and between-batch coefficients of variation for this assay 
were 5.6% (n = 6) and 14.2% (n = 3). 
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Figure 5 
Standard Curve for the HLE Indirect Binding ELISA 
Figure 5 Figure shows a typical standard curve for the HLE indirect binding ELISA. The HLE standard 
samples were prepared from a stock solution of purified HLE dissolved in PBS containing 0.6 mol/L NaCI. 
Note the linear relationship between HLE concentration and absorbance at 490 nM over the range of 0.25 to 
4.0 ng HLE/assay (r = 0.997). Data represent mean SD; n = 3. 
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2.9.5. Direct Binding ELISA 
Sheep anti-human was conjugated to horse radish peroxidase, as described previously 
(323). 
2.9.5.1. Conjugation of Sheep Anti-Human with Horse Radish Peroxidase 
Buffers 
1. 
2. 
3. PBS; pH 7.4 
4. 
5. Sodium periodate, 0.1 mol/L 
6. Sodium borohydride (4 mg/ml) 
Method 
Carbonate-bicarbonate buffer (0.01 mol/L adjusted to pH 9.5 with 0.01 mol/L 
Sodium acetate, 1 mmol/L; pH 4.4 
Glycerol 60% [v/v] in borate buffer, 0.1 mol/L; pH 7.4 with thiomersal 0.02% [w/v] 
Horse radish peroxidase (HRP, 8 mg) was dissolved in 2 ml of distilled water and incubated at room 
temperature for 20 min with 400 of sodium periodate (0.1 mol/L). This solution was then dialysed against 
the 1 mmol/L acetate buffer for 24 h at 4°C. At the same time, 18.3 mg of sheep anti-human 
were dialysed against the carbonate-bicarbonate buffer (0.01 mol/L) for 24 h at 4°C. The HRP and sheep anti- 
human solutions were mixed and incubated at room temperature for 2 h. Fresh sodium 
borohydride (0.2 mi) was added to terminate the reaction. The conjugated antibody was dialysed against PBS 
for 24 h at 4°C, prior to the addition of an equal volume of 60% [v/v] glycerol in 0.1 mol/L borate buffer with 
0.02% [w/v] thiomersal. The conjugated antibody was titrated in the ELISA (see below) to 
determine the optimal concentration. 
2.9.5.2. Direct Binding ELISA for 
This assay was performed as described previously (6). 
Materials and Buffers 
1. 
2. 
Polyclonal sheep anti-human (12.5 m g / d )  
Human standard (2.04 mg/ml) 
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3. 
4. 
5. 
6. Citric acid 0.5 mol/L 
Method 
Carbonate-bicarbonate buffer (0.05 mol/L adjusted to pH 9.6 with 0.05 mol/L 
PBS containing 1% [v/v] haemaccel and 0.1% [v/v] Tween-20; [PBS/haemaccel/Tween] 
Citrate-phosphate buffer (0.1 mol/L adjusted to pH 5.0 with 1 mol/L citric acid) 
Microtitre plates (%-well) were coated with 200 of sheep anti-human antibody diluted 
1/2000 in carbonate-bicarbonate buffer. The plates were incubated overnight at 4°C and then washed three 
times with 200 of PBS/haemaccel/Tween to remove unbound protein. 
The standard samples were prepared by diluting the stock human standard 
solution in PBS/haemaccel/Tween to give final concentrations ranging from 3.2 to 204 ng/ml. Two hundred 
microlitres of the standard samples, test samples or assay blanks (PBS/haemaccel/Tween, lysing 
buffer and supplemented RPMI 1640 medium) were added to the wells and the plates were incubated for 2 h 
at room temperature covered with cling-film. The plates were then washed three times with 
PBS/haemaccel/Tween (200 HRP-conjugated sheep anti-human was diluted 1/100 in 
PBS/haemaccel/Tween and 200 were added to each well. The plates were covered with cling-film and 
incubated for 2 h at room temperature, then washed three times with PBS/haemaccel/Tween. 
Ten milligrams of the Substrate (o-phenylenediamine, OPD) were dissolved in 25 ml of citrate- 
phosphate buffer, 20 of hydrogen peroxide were added and the solution was mixed using a Vortex mixer. 
The Substrate solution (200 was added to each well, and the plates were incubated at room temperature for 
10 to 30 min to allow colour development. The reaction was terminated with 0.5 mol/L citric acid (50 The 
absorbance values of the standards and test samples were measured (compared with the assay blanks) at a 
wavelength of 492 nM. A calibration line was constructed by linear regression analysis and the sample results 
were obtained by interpolation. The results were expressed as: 1) ng or pmol cells (2.9.2); 
or 2) ng cells or percentage increase in the amount of accumulated 
compared with the amount of contained within time = O, control cells (2.9.3.) 
Figure 6 shows a typical standard curve for the direct binding ELISA. The within- and 
between-batch coefficients of variation for the assay were 4.7% (n = 6) and 8.3% (n = 6), respectively. 
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Figure 6 
Standard Curve for the Direct Binding ELISA 
Figure 6 Figure shows a typical standard curve for the direct binding ELISA.’ The 
antitrypsin standard samples were prepared from a stock solution of (2.04 mg/ml). Note the linear 
relationship between concentration and absorbance at 492 nM over the range of 12.75 to 204 ng 
(r = 0.997). Data are mean values SEM; n = 6. 
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2.10. Dot-Blot Analysis of Gene Expression by Monocytes 
Alpha ,-antitrypsin specific messenger RNA (mRNA) concentrations in monocytes were quantified by 
the dot-blot technique using a human genomic DNA probe. A chimeric plasmid containing a 9.6- 
kb human DNA inserted into the EcoR 1 site of pBR332 (PAT 9.6) was provided by Dr N. Kalsheker, 
University of Cardiff, U.K. Digestion of pAT 9.6 with BamH 1 generated a 6.5-kb fragment (AT 6.5) that 
contained human gene sequences. A human ß-actin complementary DNA (cDNA) probe was 
used as an internal standard. The ß-actin probe was a 1.9-kb cDNA in the BamH 1 site of plasmid PUC 9B 
(supplied by Dr T. Ley, Jewish Hospital, St Louis, Missouri, U.S.A.). Both probes were cloned in E. coli prior 
to dot-blot analysis. 
2.10.1. General Purpose Molecular Biology Solutions and Reagents 
1. TE buffer: 10 mmol/L Tris HCl and 1 mmol/l EDTA; pH 7.5 
This solution was made up in distilled water with stock solutions of 1 mol/L Tris HCl; pH 7.5, 
and 0.5 mol/L EDTA; pH 8.0. 
2. Tris-saturated phenol 
Solid phenol was redistilled at 180°C and stored at -20°C in aliquots until required. When 
needed, phenol (400 ml) was removed from the freezer, allowed to warm to room temperature and 
melted at 68°C. Hydroxyquinohe (800 mg) was dissolved in the molten phenol and 500 ml of an 
aqueous solvent were added (50 mmol/L Tris HCl containing 10 mmol/L EDTA and 10 mmol/L NaCl; 
pH 8.0). The mixture was shaken and allowed to settle into layers. When the term "phenol" is used 
subsequently, this means Tris-saturated phenol. 
3. Chloroform/isoamyl alcohol mixture 
Chloroform (96 ml) was mixed with 4 ml of isoamyl alcohol. 
"chloroform" is used subsequently, this means chloroform/isoamyl alcohol mixture. 
When the term 
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2.10.2. Transformation of E. Coli 
Media, Reagents and buffers 
1. L.B. (Luria-Bertani) medium 
reagents: bacto-tryptone (10 g) 
yeast extract (5 g) 
NaCl (10 g) 
The above reagents were dissolved in 800 mi of distilled water and the pH was adjusted to 7.5 
with a 10 mol/L NaOH solution. The volume was adjusted to 1 L and the medium was sterilised by 
autoclaving. For preparation of the L.B. plates, 1.5% [w/v] bacto agar was added to L.B. medium prior 
to autoclaving. For plates and media containing ampicillin, this was added as a stock solution (500 
mg/ml of ampicillin in sterile water) to a final concentration of 50 after the autoclaved solution 
had cooled to 50°C. Agar plates were poured in 85 mm Petri dishes (30 ml per plate). 
2. SOB medium 
reagents: bacto-tryptone (20 g) 
yeast extract (5 g) 
NaCl (4 mi of a 2.5 mol/L stock solution) 
KCl (2.5 ml of a 1 mol/L stock solution) 
The above reagents were dissolved in 1 L of distilled water and the medium was autoclaved. 
Ten millilitres of a 2 mol/L stock solution of (1 mol/L and 1 mol/L 
filtered using a 0.2 filter) were added to make the medium 20 mmol/L in The final pH was 
6.8 to 7.0. 
3. SOC medium 
This medium was made by adding 20 nmol/L glucose to SOB medium. 
4. Stock K-MES (0.5 mol/L) 
MES (1.95 g) was dissolved in 16 ml of distilled water and the pH was adjusted to 6.3 using 
a solution of potassium hydroxide. The volume was adjusted to 20 ml, and the solution was filtered 
(0.2 filter) and stored at -20°C. 
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5. TFB (transformation buffer) 
Reagents: KCl (7.4 g) 
(7.5 g) 
K-MES 20 ml of a 0.5 mol/L stock (pH 6.3) 
The reagents were dissolved in 1 L of distilled water. The solution was filtered (0.2 filter) and 
stored at 4°C. 
Method 
The transformation technique of Mandel and Higa (285) was employed using E. coli strain HB101, 
which was kindly provided by Dr K.Docherty, Dept of Medicine, University of Birmingham, U.K., as a fresh 
streak culture on L.B. agar. Five colonies, 2 to 3 mm in diameter, were picked off the plate using a flame- 
sterilised tungsten loop, and dispersed in 1 ml of SOB medium using a Vortex mixer. The dispersed cells were 
inoculated into 50 ml of SOB in an Erlenmeyer flask. The culture was incubated at 37°C on a plate shaker until 
it was mid-way through the logarithmic phase of growth and contained about 4 x to 9 x cells/ml. 
The culture was collected into 50 ml polypropylene tubes and chiíled on ice for 30 min. The cells were 
centrifuged (750 g for 15 min at 4°C), the supematant was decanted and the tube was inverted briefly on paper 
towels to remove remaining fluid. The cells were re-suspended in 4 ml of TFB and 200 aiiquots were 
pipetted into each of five polypropylene tubes (17 x 100 mm). Plasmid DNA (10 ng in a volume of 20 was 
added to four of the tubes, and no plasmid DNA was added to a fifth tube which served as a control. The 
suspensions were mixed and incubated on ice for 30 min. The cells were heat shocked by placing the tubes in 
a 42°C water bath for 90 s, then chilled immediately by returning the tubes onto crushed ice. 
SOC medium (800 was added and the tubes were incubated at 37°C for 60 min with moderate 
agitation. A 10 aliquot of each culture was pipetted into a 100 pool of SOB medium on each of four L.B. 
ampicillin plates, and the plates were incubated overnight at 37°C. The control plate showed no growth. Two 
discrete colonies were picked from each of the other plates and used for a plasmid "mini-prep". 
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2.10.3. Plasmid Analysis 
2.10.3.1. Plasmid mini-preparation (mini-prep) 
Solutions and Buffers 
1. Lysozyme stock solution 
Lysozyme (500 mg) was dissolved in 10 ml of distilled water, dispensed into aliquots and stored 
at -2O°C. 
2. Mini-prep Solution A 
Reagents: glucose (225 of a 20% [w/v] stock solution) 
EDTA (100 of a 0.5 mol/L stock solution; pH 8.0) 
Tris HCI (125 of a 1 mol/L stock solution; pH 8.0) 
Lysozyme (400 of the stock solution) 
The solution was made up immediately before use in distilled water to a final volume of 5 ml. 
3. Mini-prep solution B 
Reagents: potassium acetate (60 ml of a 5 mol/L stock solution) 
glacial acetic acid (115 mi) 
distilled water (28.5 mi) 
The solutions were mixed together. The final pH of the solution was approximately 4.8. 
Method 
To confirm that the bacterial colonies contained the plasmid, small-scale plasmid preparations ("mini- 
preps") were performed using a modification of the alkaline lysis method (394). Five millilitres of L.B. medium 
(containing 50 of ampicillin) in a 10 ml plypropylene tube were inoculated with a single bacterial colony, 
and incubated overnight at 37°C with vigorous shaking. An aliquot (1.5 mi) of the culture was placed in an 
Eppendorf tube, centrifuged for 1 min at room temperature in an Eppendorf centrifuge and the supernatant was 
removed. The remainder of the overnight culture was stored at 4°C. 
The bacterial pellet was re-suspended in 100 of ice-cold mini-prep solution A using a Vortex mixer, 
and incubated at room temperature for 5 min. Two hundred microlitres of a freshly-prepared solution of 0.2 
mol/L NaOH containing 1% [w/v] sodium dodecyl sulphate (SDS) were added and the Eppendorf tube was 
inverted several times. The tube was stored on ice for 5 min and 150 of ice cold mini-prep solution B were 
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added. The Eppendorf tube was held in an inverted position and the contents were mixed for 10 s using a 
Vortex mixer. The tube was then held on ice for 5 min and centrifuged in an Eppendorf centrifuge for 5 min. 
The supernatant was transferred to a fresh Eppendorf tube, an equal volume of phenol/chloroform was 
added and the solution was mixed briefly using a Vortex mixer. The tube was centrifuged for 2 min and the 
supernatant was transferred to a fresh tube. Two volumes of absolute ethanol were added. The solution was 
mixed, allowed to stand at room temperature for 2 min and centrifuged in an Eppendorf centrifuge for 5 min. 
The supernatant was discarded and the tube was inverted on a paper towel to remove residual fluid. Ethanol 
(1 mi of a 70% solution) was added, the solution was mixed using a Vortex mixer and centrifuged for 5 min. 
The supernatant was removed and the pellet was freeze-dried (Speedvac). TE buffer (pH 8.0,50 containing 
DNAse-free pancreatic RNAse (20 was added and the solution was mixed briefly. This solution was 
then used in a restriction digest reaction in order to confirm the identity of the plasmid. 
A 10 aliquot of the solution was pipetted into a fresh Eppendorf tube, and 12 of restriction buffer 
and 1 of BamH 1 were added. The reaction mixture was incubated at 37°C for 6 h. The restriction digest 
was then analysed on an agarose mini-gel. 
2.10.3.2. Agarose Gel Electrophoresis 
Buff ers 
1 Tris-borate-EDTA (TBE) stock solution (5X). 
Reagents: Tris base (54 g) 
27.5 g of boric acid 
EDTA (20 ml of a 0.5 mol/L solution; pH 8.0) 
The salts were dissolved in 500 ml of distilled water. The EDTA solution was added and the 
volume was adjusted to 1 L with distilled water. 
2 Loading buffer. 
Reagents: SDS solution (500 of a 10% [w/v] solution) 
bromophenol blue (50 of a 10% [w/v] solution) 
sucrose (125 g) 
EDTA (1 ml of 0.5 mol/L solution; pH 8.0) 
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Tris HCL (500 of 1 mol/L solution [w/v]; pH 8.0) 
The reagents were dissolved in 10 ml of distilled water and 1 ml aliquots were stored at 4°C. 
Method 
Electrophoresis of the restriction digest was performed using a submerged mini-gel electrophoresis 
apparatus (B.R.L., Uxbridge, Middlesex, U.K.). Five hundred millilitres of 1X TBE solution were prepared 
from the stock TBE solution. Agarose (800 mg) was dissolved in 100 ml of 1X TBE solution by boiling for 5 
min. The solution was allowed to cool to 50°C, 5 of ethidium bromide solution (10 mg/ml) were added and 
the solution was mixed by stirring. The solution was poured into the gel-casting tray with a 10-well comb. The 
gel was cooled at 4°C until set. The comb was removed and the gel was placed in the electrophoresis apparatus. 
Ethidim bromide solution (40 was added to the remaining TBE solution, which was poured into the 
electrophoresis apparatus to submerge the gel. 
The plasmid digest and Hind III-digested lambda DNA molecular weight markers (4 were each 
mixed with 6 of loading buffer, and the volumes were made up to 36 ml with distilled water. The molecular 
weight markers were heated to 65°C in a water bath for 15 min. The gel was loaded with the restriction digest 
samples and the molecular weight markers, and electrophoresis was performed at 50 V, 25 mA, for 6 h. The 
gel was examined on an ultraviolet transilluminator (U.V.P. Inc., U.K.) to confirm: 1) complete digestion of the 
sample (an even smear of DNA); and 2) adequate separation of the molecular weight markers (the 560 base- 
pair marker had moved approximately 10 cm from the origin). 
2.10.3.3. Large Scale Plasmid preparation 
Buffers 
1. Tris-sucrose solution (TS) 
Reagents: Tris HCI (5 ml of a 1 mol/L solution; pH 8.0) 
sucrose (25 g) 
This solution was made up to 100 ml in distilled water. 
2. Tris-EDTA-Triton solution (TET) 
Reagents: Tris HCI (25 ml of a 1 mol/L stock solution; pH 8.0) 
EDTA (6.62 of a 0.5 mol/L stock solution; pH 8.0) 
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Triton X-100 (200 
This solution was made up in distilled water to 100 ml. 
Method 
Aliquots (2 ml) of the culture from which the mini-prep sample was taken, were inoculated into two 
20 ml polypropylene tubes containing 10 ml of L.B. medium with 50 of ampiciilin. The tubes were 
incubated overnight with vigorous agitation at 37°C. Aliquots (5 ml) of this overnight culture were inoculated 
into four 2 L conical flasks c o n t a m  400 ml of L.B. medium containing 50 of ampiciilin. The flasks 
were incubated with vigorous agitation overnight at 37°C. The culture fluid was poured into 50 ml 
polypropylene tubes and centrifuged at 4°C for 20 min at 5000 rpm (GSA rotor, Sorvall centrifuge) to pellet 
the bacteria. After centrifugation, the pellets were re-suspended in a total volume of 150 ml of cold, sterile TE 
buffer (10 mmol/L Tris and 1 mmol/L EDTA; pH 8.0) and re-centrifuged at 4°C for 20 min at 5000 rpm. 
The pellets were re-suspended in a total volume of 16 ml of TS solution and held on ice for 5 min. The 
bacterial suspension was divided equally and transferred to two 30 ml polypropylene centrifugation tubes. 
Lysozyme (100 mg or 2 ml of the stock solution) was added to each tube, the tubes were held on ice for 20 min 
and the contents were then mixed gently by swirling. Four millilitres of 0.5 mol/L EDTA solution (pH 8.8) 
were added, the solution was mixed gently and held on ice for 5 min. TET solution (13.3 ml) was added, the 
tubes were mixed by inversion and held on ice for 15 min. The tubes were centrifuged at 19000 rpm for 60 
min at 4°C (SS-34 rotor, Sorvall centrifuge). The supernatants from each tube were carefully transferred with 
a pasteur pipette into a 50 ml measuring cylinder, and the volume was made up to 31 ml with TE buffer. The 
two supernatants were transferred to two 100 ml conical flasks, CsCl (31 g) and 3.1 ml of ethidium bromide 
solution (10 mg/ml stock solution) were added to each flask, and the contents were stirred until the CsCl was 
dissolved. The contents of each flask were transferred to two 30 ml polypropylene ultracentrifugation tubes 
(Beckman-RIIC Ltd., High Wycomb, Buckinghamshire, U.K.) and the weights were matched to within 0.1 g. 
The tubes were centrifuged at 55,000 rpm for 16 h at 20°C (Ti 70 rotor, Beckman ultracentrifuge, Beckman- 
RIIC Ltd.). 
After centrifugation, the tubes were examined under ultraviolet light. Two bands of DNA were 
observed; the upper band corresponded to linear bacterial DNA and the lower band corresponded to closed 
circular plasmid DNA. The band of plasmid DNA was removed by puncturing the sides of the tubes at a point 
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just below the plasmid DNA band, using an 18-gauge needle attached to a 5 ml syringe. The plasmid DNA was 
then removed by slowly withdrawing the plunger of the syringe, taking care not to contaminate the sample with 
bacterial DNA. The plasmid DNA samples were then combined. 
Ethidium bromide was removed from the sample by extracting twice with water-saturated N-butanol. 
Dialysis tubing (10 cm length, 2 cm width) was prepared by boiling for 10 min in a solution of 2% [w/v] 
containing 1 mmol/L EDTA. The dialysis tubing was then rinsed in distilied water, boiled for 10 min 
in 1 mmol/L EDTA and allowed to cool. The DNA solution was dialysed overnight against 2 L of TE buffer 
(pH 8.0) at room temperature to remove the CsCl. This step was repeated with 2 L of fresh TE (pH 8.0) for 
a further 4 h. 
RNA was removed from the plasmid DNA by centrifugation through 1 mol/L NaCl (394). The volume 
of the DNA solution was measured and 0.1 volumes of 3 mol/L sodium acetate (pH 5.2) were added. Two 
volumes of ethanol were added, the solution was mixed well and allowed to stand at -20°C for 2 h. The DNA 
was recovered by centrifugation. The ethanol was discarded and the DNA pellet was dried in a vacuum 
desiccator. The DNA was dissolved in 500 of TE buffer (pH 8.0), DNAse-free RNAse was added to a final 
concentration of 10 and the solution was incubated for i h at room temperature. A Beckman centrifuge 
tube (SW 50.1) containing 4 ml of 1 mol/L NaCl in TE buffer was prepared. The RNAse-treated plasmid DNA 
solution was layered on top of the NaCl solution, and the tube was centrifuged at 40,000 rpm for 6 h at 20°C 
in a Beckman SW 50.1 rotor. The supematant was discarded and the pellet of plasmid DNA was dissolved in 
400 of TE buffer (pH 8.0). 
The solution was transferred to an Eppendorf tube and an equal volume of phenol was added. The 
solution was mixed gently (Vortex mixer) and centrifuged for 5 min at room temperature in an Eppendorf 
centrifuge. The upper (aqueous) layer was pipetted into a new Eppendorf tube; care was taken to leave any 
particulate material at the interface. Water-saturated ether (1 mi) was added, the solution was mixed gently 
(Vortex mixer) and the sample was centrifuged at room temperature for 5 min. The upper (ether) layer was 
discarded, and the sample was heated to 60°C for 10 min then cooled on ice. 
The volume of the sample was measured, 1/10 of the volume of 3 mol/L sodium acetate (pH 5.2) was 
added and the sample was mixed by gently flicking the Eppendorf tube. Twice the new volume of ice-cold 
ethanol was added and the sample was mixed gently, as described above. The tube was held at -2O°C for 60 
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min then centrifuged in an Eppendorf centrifuge at 4°C for 30 min. The supernatant was carefully removed and 
ice-cold 70% ethanol (500 was added without disturbing the pellet. The tube was held at -20°C for 15 min, 
centrifuged for 30 min at 4°C and the supernatant was removed without disturbing the pellet. The pellet was 
freeze-dried (Speedvac) and re-suspended in 400 of TE buffer (pH 8.0). The pellet was allowed to dissolve 
completely at room temperature and the solution was divided into 10 aliquots and stored at -70°C. 
A 5 aliquot of the sample was added to 1 ml of distilied water and mixed thoroughly. The 
absorbance was read at 260 nM and 280 nM in a spectrophotometer. Multiplication of the absorbance value 
at 260 nM by 50 gave the DNA concentration in and the ratio of the absorbance at 260 nM to that at 
280 nM provided an estimate of the purity of the DNA sample. 
To separate the probe insert from the plasmid DNA, a restriction digest of 2 of the sample was 
performed, as described previously. Agarose gel electrophoresis was performed on the restriction digest using 
a 1% low melting point agarose gel stained with ethidium bromide (Figure 7). The gel was viewed under an 
ultraviolet transilluminator, and the band corresponding to the probe insert DNA was excised with a minimum 
amount of excess agarose. The yield of insert was estimated and distilied water was added to give a final DNA 
concentration of approximately 5 The sample was boiled for 10 min to melt the agarose and denature 
the DNA. The sample was cooled to 37°C for 30 min and stored in 10 aliquots at -70°C. 
2.10.4. Extraction and Purification of RNA 
Steady-state concentrations of and ß-actin messenger RNA (mRNA) in human monocytes 
were measured by the cytoplasmic dot-blot method (489). During all procedures where RNA was being 
handled, care was taken to minimise RNAse contamination of the samples. For example: 
1) glassware was sealed with aluminium foil and baked at 200°C for 6 h prior to use; 
2) sterile disposable plastic tubes were used and plastic pipette tips were autoclaved; 
3) all chemicals were molecular biology grade and solutions were made with sterile RNAse-free water; 
and 
4) gloves were worn at all times. 
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2.10.4.1. Purification of RNA from Human Liver 
To obtain a positive control sample for mRNA, RNA was extracted and purified from 
normal human liver using the guanidinium/hot phenol method, as described previously (394). 
Reagents and buffers 
1. 4 mol/L guanidinium isothiocyanate mixture 
reagents: guanidinium isothiocyanate (100 g) 
deionised water (100 ml) 
1 mol/L Tris HCl; pH 7.6 (10.6 ml) 
0.2 mol/L EDTA; pH 8.0 (600 
20% [w/v] solution of sodium lauryl sarkosinate (21.2 ml) 
ß-mercaptoethanol (2.1 ml) 
The water and Tris HCl and EDTA solutions were added to 100 g of guanidinium 
isothiocyanate, and the solution was stirred overnight at room temperature. The solution was stirred 
while warmed to 60 to 70°C for 10 min to assist dissolution. Residual insoluble material was removed 
by centrifugation at 3000 g for 10 min at 20°C. The sodium lauryl sarkosinate and ß mercaptoethanol 
were added to the supematant, and the volume was adjusted to 212 ml with sterile water. The solution 
was stored at 4°C protected from light. 
2. STE buffer 
Reagents: 0.1 mol/L solution of sodium acetate; pH 5.2 
10 mmol/L Tris HCl; pH 7.4 
1 mmol/L EDTA 
3. TSES buffer 
Reagents: 0.1 mol/L Tris HCl; pH 7.4 
50 nmol/L NaCl 
10 mmol/L EDTA 
0.2% [w/v] solution of SDS 
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Method 
Normal human liver was supplied by Dr. D.A. Adams, Liver Research Laboratories, Queen Elizabeth 
Hospital, Birmingham U.K. The 4 mol/L guanidinium mixture (10 mi) was added to 2 g of normal human liver 
in a plastic disposable centrifuge tube. The liver was homogenized in an omnimixer. The mixture was heated 
to 60°C in a water bath. While maintaining this temperature, the suspension was repeatedly drawn into, and 
expressed from a syringe fitted with an 18-gauge needle until the viscosity of the suspension was reduced by 
shearing of the liberated chromosomal DNA. An equal volume of phenol preheated to 60°C was added and 
the emulsion was passed through the syringe several times. 
STE buffer (0.5 volumes) and an equal volume of chloroform were added. The solution was shaken 
vigorously while maintaining the temperature at 60°C. The solution was then cooled on ice and centrifuged at 
2000 g for 10 min at 4°C. The aqueous phase was recovered and re-extracted with phenol/chloroform. The 
solution was centrifuged, the aqueous phase was recovered and re-extracted twice with chloroform. Two 
volumes of ethanol were added and the solution was stored at -20°C for 1 to 2 h. The RNA was recovered by 
centrifugation at 12,000 g for 20 min at 4°C, and the pellet was dissolved in 10 ml of TSES solution. Protehase 
K was added (200 and the solution was incubated for 1 to 2 h at 37°C. 
The solution was heated to 60°C, 0.5 volumes of phenol preheated to 60°C were added and the solution 
was mixed. Chloroform (0.5 volumes) was added and the solution was mixed vigorously at 60°C for 10 min. 
The solution was cooled on ice and centrifuged at 200 g for 10 min at 4°C. The solution was extracted once 
more with phenol/chloroform at 60°C, then extracted twice with chloroform at room temperature. The RNA 
was precipitated with absolute ethanol by centrifugation and the RNA pellet was rinsed with 70% [v/v] ethanol. 
The yield of RNA was approximately 5 mg (determined by dissolving the RNA in sterile, distilled water and 
measuring the absorbance of the solution at 260 nM). The liver RNA sample was stored in aliquots at -70°C. 
For dot-blot analysis, the liver RNA sample was diluted in TE buffer (pH 7.5) and applied to Gene-screen TM 
membrane, as described in 2.10.6. 
2.10.42. Purification of Cytosolic RNA from Monocytes, U937 Cells, Lymphocytes and Nentrophils 
Cytosolic RNA was extracted and purified from monocytes, the U937 promonocytic cell line, neutrophils 
and lymphocytes, as described previously (489). 
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Buffers 
1. Stock SSC (20X) 
Reagents: NaCI (175.3 g) 
sodium citrate (88.2 g) 
The salts were dissolved in 800 ml of distilled water. The pH was adjusted to 7.0 with dilute 
HCl and the volume was adjusted to 1 L. 
2. Lysing buffer 
Reagents: TE buffer; pH 7.5 (100 mi) 
Nonidet P40 (0.5 mi) 
The solutions were mixed, and the buffer was filtered (0.2 filter) and autoclaved. 
Method 
Cells were transferred to Eppendorf tubes (1.8 mi) and washed with 1.5 ml of an RNAase-free solution 
of 0.15 mol/L NaCl. Two hundred microlitres of TE buffer (pH 8.0) containing 0.5% [v/v] Nonidet P40 and 
ribonucleoside vanadyl complexes (20 mmol/L final concentration) were added and the cells were held on ice 
for 5 min. Nonidet P40 (5 of a 5% [v/v] solution in RNAse-free water) was added, and the samples were 
held on ice for a further 2 min. The tubes were centrifuged in an Eppendorf centrifuge for 5 min to pellet the 
nuclei. 
The supernatants were transferred to fresh Eppendorf tubes, 0.5 volumes of phenol and 0.5 volumes 
of chloroform were added, and the solution was mixed vigorously using a Vortex mixer. After centrifugation 
for 5 min in an Eppendorf centrifuge, the supernatants were transferred to fresh tubes and an equal volume of 
chloroform was added. The solution was mixed gently and centrifuged for a further 5 min. The supernatants 
were transferred to fresh tubes, and 1/10 of the volume of 3 mol/L sodium acetate (pH 6.0) and 2.5 volumes 
of absolute ethanol were added. The samples were stored at -70°C overnight to precipitate the RNA. 
The samples were again centrifuged in an Eppendorf centrifuge for 20 min and the supernatant was 
removed. The RNA pellets were re-suspended in 100 of TE (pH 8.0) and allowed to dissolve completely 
on ice. Sixty microlitres of 20X SSC and 40 of formaldehyde were added and the samples were incubated 
at 60°C in a water bath for 15 min and then stored at -70°C until dot-blot analysis was performed (2.10.6.) 
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2.10.5. Radiolabelling of the DNA probes 
The and ß-actin DNA probes were radiolabelied by the oligonucleotide primer method 
(161) using a commercial kit (Boehringer Mannheim U.K., Lewes, East Sussex, U.K.). For each labelling 
reaction, a 5 aliquot of insert was removed from the freezer and allowed to warm to room temperature. The 
DNA was denatured by boiling in a water bath for 10 min and cooled on ice. The following reagents were 
mixed in an Eppendorf tube on ice: 
1. 5 of denatured DNA 
2 . 1  each of dATP, dGTP and dTTP 
3.2  of reaction mixture 
4. 5 of (50 
5.4 of distilled water 
Klenow enzyme (1 was added and the reagents were mixed by flicking the tube. The contents of 
the tube were brought to the bottom by brief centrifugation and the tube was incubated at 37°C for 30 min. 
The reaction was stopped by heating to 65°C for 10 min. 
The percentage incorporation of into the DNA was determined by trichloroacetic acid (TCA) 
precipitation. One microlitre of the reaction mixture was removed into an Eppendorf tube containing salmon 
sperm DNA (3 of a 10 mg/ml solution) and 96 of distilled water. The tube contents were mixed 
thoroughly and a 20 aliquot was placed on a dry glass fibre filter disc (GF/C 2.5 cm, Whatman) which was 
placed in a scintillation vial containing 5 ml of scintillation fluid (Scintran Cocktail O). A further 20 aliquot 
was placed in an Eppendorf tube containing salmon sperm DNA (3 of a 10 mg/ml solution) with 500 of 
distilled water, and the contents of the tube were mixed thoroughly. TCA (150 of a 50% [w/v] solution) was 
added and the solution was mixed thoroughly. The tube was held on ice for 20 min and the sample was filtered 
through a 2.5 cm GF/C disc. The disc was flushed through with 50 ml of ice-cold 5% [w/v] TCA solution and 
10 ml of ice-cold absolute ethanol. The disc was placed in a scintillation vial with 5 ml of scintillation fluid, and 
both discs were counted in a liquid scintillation counter (Beckman RIIC Ltd., High Wycombe, Buckinghamshire, 
U.K.). The percentage incorporation of into the DNA was calculated from the ratio of the counts obtained 
from the TCA-treated sample to the counts from the non-treated sample. Typical incorporation of into the 
DNA was approximately 60% (2 x 
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After successful labelling, non-incorporated deoxyribonucleotide triphosphates were removed by 
chromatography on a Sephadex column. Sephadex G-50 (10 g) was swollen with distilled water and poured into 
a 1 ml syringe that had been plugged with glass wool. The column was equilibrated with STE buffer (10 
mmol/L Tris HCl containing 150 mmol/L NaCl and 1 mmol/L EDTA; pH 8.0), the syringe was placed inside 
a polypropylene test-tube and centrifuged at 500 g for 5 min. This procedure was repeated three times, and then 
50 of STE were pipetted onto the column which was centrifuged at 500 g for 5 min. The volume of the 
eluant was measured and, if it was approximately 50 the radiolabelled DNA mixture was made up to 50 
with STE, pipetted onto the column and the column was centrifuged again for 5 min. The eluant containing the 
radiolabelled DNA was stored at -20°C until used and the column containing the unincorporated nucleotides was 
discarded. 
2.10.6. Dot-Blot Analysis of and Beta-Actin mRNA 
2.10.6.1. Method 
Analysis of and ß-actin mRNA in human liver, human peripheral blood monocytes, 
neutrophils and lymphocytes, and the U937 promonocytic cell line was performed by the dot-blot technique, as 
described previously (489). 
Reagents 
1. Deionised formamide 
Formamide (20 ml) was mixed with 1 g of AG 501-X8 Mixed Bed Resin, stirred for 30 min 
at room temperature and filtered to remove resin. 
2. Denhardt’s solution 100X 
Reagents: BSA (2 g) 
ficoll (2 g) 
polyvinylpyrrolidone (2 g) 
The reagents were dissolved in 100 ml of distilled water and stored at -20°C in 5 ml aliquots. 
3. Denatured salmon sperm DNA 
Salmon sperm DNA (10 mg/ml) was passed repeatedly through an 18-gauge needle to shear 
the DNA. The solution was boiled for 10 min prior to use. 
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4. Hybridisation buffer 
50% deionised formamide, 10% [w/v] dextran sulphate, 10X Denhardt’s solution, 0.05 mol/L 
Tris HCl (pH 7.5),1.0 mol/L NaCI, 0.1% [w/v] sodium pyrophosphate, 1% [w/v] SDS and denatured 
salmon sperm DNA (100 
Method 
Gene-screen TM membrane was cut to the size of a dot-blot manifold (B.R.L., Bethesda, Maryland, 
U.S.A.) and soaked in 15X SSC buffer. The membrane was inserted into the manifold which was connected 
to a vacuum, and 100 of each RNA sample was pipetted into separate wells. The samples were washed 
through with 100 of 15X SSC. The membrane was removed from the manifold and placed dot side down 
on an ultraviolet transilluminator for 5 min to fix RNA onto the membrane. 
The membrane was placed inside a plastic bag and 10 mí of hybridisation buffer were added. The bag 
was sealed and incubated overnight with constant agitation in a shaking water bath at 42°C. The membrane was 
probed with the ß-actin cDNA probe. The ß-actin probe was radiolabelled and denatured by boiling in a water 
bath for 10 min and cooled on ice. The probe was added to the bag which was resealed. The bag was 
incubated with constant agitation overnight at 42°C. The hybridisation fluid was then removed and the 
membrane was washed in a sandwich box as follows: 
1) twice in 200 mí of 2X SSC at room temperature for 5 min with constant agitation; 
2) twice in 200 ml of 2X SSC containing 1% [w/v] SDS at 65°C for 30 min with constant agitation; 
3) twice in 200 ml of 0.1X SSC at room temperature for 30 min with constant agitation. 
The membrane was air-dried, wrapped in Saran wrap, subjected to autoradiography for 3 to 4 days at - 
70°C. The membrane was then stripped by washing in 200 ml of 0.1% [w/v] SDS solution at 75°C for 3 h with 
constant agitation. Following this, the membrane was exposed to the probe using the above 
hybridisation protocol, with the exception that the second washing step was performed at 55°C instead of 65°C. 
The membrane was subjected to autoradiography for 7 to 10 days at -70°C. The autoradiograms were scanned 
With a laser densitometer (L.K.B., Milton Keynes, U.K.). 
2.10.6.2. Reproducibility and Specificity of the Dot-Blot Technique 
To assess the reproducibility of the dot-blot technique, RNA was extracted from 6 x monocytes and 
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re-suspended in a final volume of 600 of TE buffer. One hundred microlitre aliquots were pipetted into six 
Eppendorf tubes and the RNA was denatured, as described previously. The samples were applied to Gene- 
screen TM membrane, probed with radiolabelled DNA probe, subjected to autoradiography and 
scanned with a laser densitometer (L.K.B., Milton Keynes, U.K.). 
To confirm that the and B actin DNA probes hybridised to RNA species rather than to 
any DNA that may have contaminated the samples, RNA samples purified from human liver, monocytes, 
lymphocytes, neutrophils and U937 cells were incubated with and without RNAse. RNA extracted from each 
cell type. was re-suspended in 200 of TE buffer and 100 were pipetted into two Eppendorf tubes. DNAse- 
free RNAse was added to one tube at a final concentration of 10 and the tubes were incubated at room 
temperature for 1 h. The samples were denatured as described previously, applied to Gene-screen TM 
membrane, probed with the ß actin cDNA probe and subjected to autoradiography. The blot was stripped, 
reprobed with the genomic probe and subjected to autoradiography. 
2.10.6.3. Quantification of and Beta-Actin mRNA using the Dot-Blot Technique 
To confirm that there is a correlation between the amount of RNA applied to the membrane and the 
autoradiogram signai, varying amounts of RNA were applied to Gene-screen TM membranes. RNA was 
extracted from 4 x monocytes, re-suspended in 400 of TE buffer and denatured as described previously. 
Serial dilutions of the RNA sample were made in TE buffer and RNA from the equivalent of to 4 x 
monocytes was then applied to two Gene-screen TM membranes. The blots were probed with the ß-actin and 
DNA probes, subjected to autoradiography and scanned with a laser densitometer (L.K.B., Milton 
Keynes, U.K.). 
2.10.6.4. Comparison of Steady-State Alpha ,-Antitrypsin mRNA Levels in Monocyte Subpopdations 
Spontaneously adherent and non-spontaneously adherent monocytes were isolated from 11 healthy 
donors and incubated in supplemented RPMI medium (1 ml) at 37°C in a humidified atmosphere of 95% air 
and 5% CO,. After overnight incubation, fresh medium was added and the cells were cultured for a further 
48 h under basal conditions. Cells were harvested at 24 h intervals and RNA was extracted, as described in 
2.10.4.2. Dot-blot analysis of the RNA samples was performed using the ß-actin DNA probe and the blots were 
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subjected to autoradiography for 3 to 4 days. The blots were then stripped, reprobed with the 
DNA probe and subjected to autoradiography for 7 to 10 days. The autoradiograms were scanned with the laser 
densitometer (L.K.B., Milton Keynes, U.K.). The densitometry results for mRNA were expressed 
as ratios to the values obtained for ß-actin mRNA to correct for any variation in the yield of RNA. 
2.10.6.5. Effect of LPS and Cyokines on Steady-State Concentrations in Monocytes 
Spontaneously adherent and non-spontaneously adherent monocytes were isolated from eight healthy 
donors and incubated in supplemented RPMI medium (1 ml) at 37°C in a humidified atmosphere of 95% air 
and 5% CO,. After overnight incubation, fresh medium was added and the cells were incubated for a further 
24 h with and without TNF (1000 units/ml), IFN (1000 units/ml), GM-CSF (50 units/ml) and LPS from E. coli 
0111:B4 (1 The cells were harvested and RNA was extracted as described in 2.10.4.2. Dot-blot analysis 
of the RNA samples was performed using the ß-actin and DNA probes, the blots were subjected 
to autoradiography and the autoradiograms were scanned with the laser densitometer, as described above. The 
densitometry results for mRNA were expressed as ratios to the values obtained for ß-actin mRNA 
to correct for any variation in the yield of RNA. 
2.11. Statistical Analysis 
All data were expressed as mean SEM or mean SD. Results were compared Using the Wilcoxon 
test for paired samples and the Wilcoxon rank sign test for non-parametric data. P values less than 0.05 were 
considered significant. 
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Chapter 3 
Results 
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Aims of the Study 
Mononuclear phagocytes play a critical role in the host response to pulmonary infection and 
inflammation. To participate in these responses, monocytes must be recruited into the lung. It is clear that 
regulated and reversible adherence of monocytes to extracellular matrix components is a prerequisite for their 
recruitment into sites of inflammation (172,423). However, the pathological and physiological factors that 
regulate monocyte adherence and the mechanisms involved have not been fully elucidated. 
To begin to address the pathobiological importance of alterations in monocyte adherence to extracellular 
matrix in inflammatory lung diseases, the adherence properties of monocytes from healthy donors and from 
patients with an inflammatory lung disease (bronchiectasis) to a representative extracellular matrix component 
(fibronectin) were compared. In addition, the effects upon monocyte adherence of various signals (LPS and 
cytokines) that are likely to be released at sites of infection and inflammation were assessed. The role of 
CD11/CD18 integrins in mediating monocyte adherence to fibronectin was investigated. Finally, the possibility 
was tested that there is a relationship between the adherence properties of monocytes and phenotypes that relate 
to important biological or pathological activities at sites of infection and inflammation. 
3.1. Optimisation of the Monocyte Isolation Procedure 
Preliminary studies were undertaken to optimise the monocyte isolation procedure. Although counter 
current centrifugal elutriation (CCE) is widely regarded as the gold standard method for monocyte isolation, the 
equipment that is required for this technique is expensive and not widely available. Therefore, most 
investigators isolate monocytes by the ficoll-Hypaque density gradient method. The ficoll-Hypaque technique 
involves centrifugation of blood through ficoll-Hypaque gradient medium to isolate mononuclear cells (59). An 
adherence step is then performed to separate the monocytes, which are assumed to be adherent cells, from the 
lymphocytes which are assumed to be the non-adherent cells (4,372). 
The ficoll-Hypaque method was used to isolate monocytes for preliminary experiments. The yields of 
mononuclear cells following the ficoll-Hypaque density gradient step were always close to the expected yields, 
as determined by total and differential white blood cells counts (approximately 2.5 x mononuclear cells per 
millilitre of whole blood). However, consistently poor yields of monocytes were obtained following the 
adherence step. Typically, monocytes were isolated per millilitre of whole blood which represented only 
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about 30% of the potential yield of monocytes. Similar results were obtained when mononuclear cells were 
isolated by the Percoll density gradient technique (229) instead of the ficoll-Hypaque method. One possible 
explanation for these findings is that only a proportion of monocytes have the capacity to adhere. The ficoll- 
Hypaque method, therefore, may select a minor and possibly unrepresentative subpopulation of cells for study. 
This hypothesis is supported by the findings of Chen et al. (107) that: 1) the yield of adherent monocytes 
purified by density gradient centrifugation is increased 3-fold by conducting the adherence step in the presence 
of bacterial endotoxin; and 2) 5 to 25% of non-adherent mononuclear cells are monocytes. To test the 
hypothesis that the ficoll-Hypaque method recovers only a minor subpopulation of monocytes, the average yield 
of monocytes isolated from six healthy donors by the conventional ficoll-Hypaque method (with an adherence 
step) was compared with that isolated by Nycodenz osmotic and density gradient centrifugation, an alternative 
method that does not involve an adherence step (60). 
3.1.1. Comparison of The Ficoll-Hypaque And Nycodenz Isolation Methods 
The average yield of mononuclear cells following ficoll-Hypaque density gradient centrifugation was 
2.46 SEM 0.04) x cells per millilitre of blood, which represented 89.2% SEM 5.7%) of the potential 
yield of mononuclear cells, as determined by total and differential white blood cell counts. The mononuclear 
cells were then subjected to an adherence step, detached from the tissue culture dishes, as described in Methods, 
and counted. The yield of adherent monocytes was 1.32 SEM 0.46) x cells per millilitre of whole blood, 
which represented only 36.5% SEM 7.3%) of the potential yield of monocytes (figure 8). The adherent 
monocytes were 90 to 95% viable, as assessed by exclusion of trypan blue dye, and greater than 90% pure, as 
assessed by modified Wright’s staining of cytocentrifuge preparations. Among the mononuclear cells than did 
not adhere during the adherence step, greater than 99% excluded trypan blue dye indicating that they were 
viable. 
The yield of monocytes from the Nycodenz method was substantially greater (p < 0.025) than that of 
the ficoll-Hypaque method. On average, the Nycodenz method recovered 2.37 SEM O.%) x cells per 
millilitre of whole blood which represented 69.0% SEM 18.4%) of the potential yield of monocytes (figure 
8). The Nycodenz-isolated monocytes were greater than 99% viable, as assessed by exclusion of trypan blue 
dye, and greater than 90% pure, as assessed by modified Wright’s staining of cytocentrifuge preparations. Since 
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a greater proportion of the potential yield of monocytes was recovered by the Nycodenz method, this method 
was used to isolate monocytes for subsequent experiments. 
3.1.2. Fate of Monocytes Not Recovered by Nycodenz 
The Nycodenz isolation method failed to recover about 30% of monocytes in the initial blood samples. 
It is unlikely that this was due to adherence of monocytes to the isolation vessels since measures were taken to 
minimise adherence of cells during the isolation procedure. For example, all of the solutions used in the isolation 
procedure, with the exception of the final washing solution contained EDTA. In addition, all of the steps were 
performed at 4°C apart from the initial dextran sedimentation step. 
Monocytes are heterogeneous in their density (16). It is possible, therefore, that the fraction of cells 
with the highest density are separated from the remainder during centrifugation through Nycodenz. To test this 
possibility, the cells remaining in the pellet following the Nycodenz separation were subjected to Percoll density 
gradient centrifugation to separate the mononuclear cells from the erythrocytes and neutrophils. A 
cytocentrifuge preparation of these mononuclear cells, stained for non-specific esterase, confirmed that a 
proportion of monocytes sediment through the Nycodenz gradient during centrifugation (figure 9). Therefore, 
it is likely that at least some of monocytes that were not recovered by the Nycodenz method were lost because 
of their physical Characteristics rather than their adherence properties. 
3.1.3. Confirmation of the Purity of Monocytes Isolated by the Nycodenz Method 
To assess the purity of cells isolated by the Nycodenz method, smears of monocytes were stained 
routinely with modified Wright’s stain (figure 10 a) and for non-specific esterase activity (figure 10 b). The 
monocyte preparations were greater than 92% pure and contained less than 0.5% neutrophils, as determined 
by these methods. 
Smears of monocytes from five subjects were also stained by immunohistochemistry with a murine 
monoclonal antibody to p150/95 (figure 11 a) which is expressed by the majority of monocytes but not by 
lymphocytes (205). To determine the percentage of contaminating lymphocytes, duplicate smears were stained 
with a murine monoclonal antibodies to CD22 and CD3, which are pan B and pan T lymphocyte markers, 
respectively (figure 11 b). Non-hmune murine ascites was used as a negative control (figure 11 c). The 
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percentage of positive cells was determined for each staining procedure. On average, 91% SEM 1%) of the 
cells stained for p150/95,7% SEM 1%) of the cells stained for the lymphocyte markers, and less than 0.5% 
of the cells showed non-specific staining with the non-immune murine ascites. These results confirmed that: 1) 
the monocytes preparations were greater than 90% pure; and 2) the remaining nucleated cells were 
predominantly lymphocytes. 
Monocytes isolated by the Nycodenz method were always contaminated with platelets, as illustrated by 
figures 10 and 11. However, there was considerable donor-to-donor variability in the extent of platelet 
contamination of the monocyte preparations ranging from about 20 to 200 platelets per monocyte. This platelet 
contamination could be reduced to 5 to 20 platelets per monocyte by centrifuging the cells through autologous 
plasma. However, this step was associated with a 25 to 30% reduction in monocyte yield and, therefore, was 
not performed on a routine basis. 
3.1.4. Assessment of Endotoxin Contamination of Nycodenz Reagents and Culture Media 
Bacterial lipopolysaccharide (LPS) has been shown to affect many aspects of leukocyte function 
(188,190,451,468). Since one aim of these studies was to investigate the effects of LPS on monocyte adherence, 
care was taken to minimise LPS contamination during isolation and subsequent culture of the cells. In addition, 
all of the solutions used in the Nycodenz isolation and culture of monocytes were assayed for LPS using a 
commercial limulus amoebocyte lysate kit, as described in Methods. The results confirmed that all of the 
solutions used in the Nycodenz isolation procedure and the culture media contained endotoxin concentrations 
that were less than the lower limit of detection of the assay (i.e. less than 10 pg/ml of LPS). 
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3.2. Monocyte Adherence Assay 
3.2.1. Adherence of Monocytes to Fibronectin-Coated Plastic 
The adherence of monocytes to a representative extracellular matrix component (fibronectin) was 
assessed. Monocytes were isolated from healthy subjects and incubated in tissue culture dishes that had been 
pre-coated with purified human serum fibronectin at concentrations ranging from 0 to 50 A dose-related 
increase in monocyte adherence was observed (figure 12) with a maximum of 24.5% SEM 1.3%) of the cells 
adhering to dishes that had been coated with 20 of fibronectin. Most of the platelets that contaminated 
the monocyte preparations did not adhere to the fibronectin Substrate. 
3 2 2 .  Specificity of Monocyte Adherence to Fibronectin 
Specificity of monocyte binding to fibronectin was confirmed by a control experiment in which 4.7% 
SEM 0.4%) of monocytes adhered non-specifically to plastic and 2.0% SEM 02%) of monocytes adhered 
to dishes coated with human serum albumin; n = 3. Monocytes were also incubated in fibronectin-coated dishes 
that had been pre-incubated with varying concentrations of rabbit anti-human fibronectin or non-immune 
rabbit Pre-incubation of the dishes with the rabbit anti-human fibronectin almost completely 
inhibited subsequent binding of monocytes. in marked contrast, non-immune had no effect (figure 13). 
These data confirmed that monocytes adhered specifically to fibronectin in the assay. 
3 2 3 .  Optimisation of Monocyte Adherence to Fibronectin 
3.2.3.1. Comparison of different sources of fibronectin 
Some investigators have used autologous serum or autologous plasma as a source of fibronectin for 
adherence assays (140,412). Therefore, monocyte adherence to the following sources of fibronectin was 
compared: 1) the optimal concentration of fibronectin purified from human serum (20 2) complement- 
depleted (by incubation at 56°C for 30 min) autologous plasma; and 3) complement-depleted autologous serum. 
A greater proportion of monocytes adhered to dishes coated with fibronectin (22.7% SEM 1.9%) than to 
dishes coated with complement-depleted autologous plasma (14.2% SEM 1.9%) or serum (12.7% SEM 
0.9%); n = 3 donors. Therefore, fibronectin purified from human serum was used as the adherence Substrate 
in all subsequent assays. 
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Figure 12 Monocytes were incubated for 1 h at 37°C in dishes that had been coated with varying 
concentrations of fibronectin and the percentage of adherent cells was determined. Error bars represent SEM; 
n = 3 donors. 
Figure 13 Fibronectin-coated dishes were incubated for 1 h with varying concentrations of rabbit anti-human 
fibronectin (solid circles) or non-immune rabbit (closed circles). Monocytes were incubated for 1 h 
in the dishes and the percentage of adherent cells was determined. Error bars represent SEM; n = 3 donors. 
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33.3.2. Effect of Different Culture Medium Additives 
Although adherence assays are most commonly conducted in the presence of 10% [v/v] complement- 
depleted fetal calf serum (FCS), some investigators use alternative culture medium additives including: 1) 
complement-depleted human serum (35,44,322); 2) human serum albumin (HSA), (54,261,419); or 3) 
concentrations of serum as high as 20 to 25% [v/v], (107,219,390,398). Therefore, the adherence properties of 
cells suspended medium containing the following additives were compared: 1) 10% and 25% [v/v] complement- 
depleted FCS; 2) 10% and 25% [v/v] complement-depleted autologous serum; and 3) 0.5% [w/v] HSA. 
A similar proportion of monocytes adhered in the presence of 10% [v/v] FCS, 10% [v/v] autologous 
serum and 0.5% [w/v] HSA (figure 14). However, increasing the concentration of FCS from 10% [v/v] to 25% 
[v/v] resulted in a 30% reduction in the proportion of adherent cells. A similar reduction in the proportion of 
adherent monocytes was observed when the concentration of autologous serum was increased from 10% [v/v] 
to 25% [v/v]. Among the monocytes that did not adhere in the presence of 25% [v/v] serum, greater than 99% 
excluded trypan blue dye indicating that they were viable. All subsequent adherence assays were conducted on 
monocytes suspended in medium supplemented with 10% [v/v] FCS. 
3.2.3.3. Effect of Monocyte Number 
The effect of dispensing different numbers of monocytes into fibronectin-coated dishes on monocyte 
adherence was assessed. Varying numbers of monocytes (5 x to 3 x cells) were incubated in fibronectin- 
coated dishes for 1 h and the absolute number of adherent cells was determined. A correlation was observed 
between the number of monocytes dispensed into the dishes and the number of adherent cells, r = 0.998 (figure 
15). The percentage of adherent cells was about 20% for all of the monocyte concentrations tested. Visual 
assessment of the monocyte preparations was performed by phase-contrast microscopy and confirmed: 1) the 
integrity of the underlying monocytes since the cells in all of the dishes adhered in an evenly distributed and 
non-aggregated pattern; and 2) that only a small proportion of the platelets that contaminated the monocytes 
adhered to the fibronectin Substrate. These data indicate that the addition of up to 3 x monocytes to 
fibronectin-coated dishes does not alter either the proportion of adherent cells or the appearance of the cells that 
are adherent to the dishes. In subsequent assays to 2 x monocytes were added to fibronectin-coated 
dishes. 
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Figure 14 
Monocyte Adherence To Fibronectin: Effect of Culture Medium Additives 
Figure 14 Monocytes were suspended in medium supplemented with: 1) 10% [v/v] FCS; 2) 25% [v/v] 
FCS; 3) 10% [v/v] autologous serum (AS); 4) 25% [v/v] AS; or 5) 0.5% [w/v] human serum albumin (HSA). 
Error bars represent SEM; n = 3 donors. 
Figure 15 Varying numbers of monocytes were suspended in 1 ml of medium and incubated for 1 h at 
37°C in fibronectin-coated dishes. The absolute number of adherent cells was determined. Error bars are SEM; 
n = 3 donors. 
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3.2.3.4. Effect of Proteinase Inhibitors on Monocyte Adherence 
Monocytes contain proteinases that are capable of degrading fibronectin (81). To exclude the possibility 
that monocyte-derived proteinases degrade the fibronectin Substrate, and thereby limit cell binding during the 
adherence assay, monocytes were incubated in fibronectin-coated dishes with and without and 
macroglobulin. The proportions of monocytes that adhered to fibronectin in the presence of alone 
(23.8% SEM 1.4%) and in the presence of and a,-macroglobulin together (24.7% SEM 
0.6%) were similar to the proportion of cells that adhered in the absence of proteinase inhibitors (21.7% SEM 
1.9%); n = 3. These data indicate that any degradation of the fibronectin Substrate that occurs during the assay 
does not limit monocyte binding to fibronectin. 
3.2.3.5. Reproducibility of the Adherence Assay 
To assess the reproducibility of the assay, monocytes were incubated in five fibronectin-coated 
dishes for 1 h at 37°C, the proportion of adherent monocytes was determined and the within-batch coefficient 
of variation (C.V.) was calculated. The within-batch C.V. for the assay was 3.7%. Monocytes were then 
isolated from the same donor on six different occasions and the proportion of adherent cells was determined. 
The proportion of adherent monocytes ranged from 17 to 21% and the C.V. for monocyte adherence was 8.4% 
(donor B, table 5 a). These data indicate that the adherence assay is reproducible. 
3.2.4. Comparison of the Adherence Properties of Monocytes Isolated by the Nycodenz Method and 
by Countercurrent Centrifugal Elutriation 
Three potential problems were identified in using the Nycodenz method to isolate monocytes for 
assessment of their adherence properties. First, Nycodenz-isolated monocytes are always contaminated with 
platelets and one platelet product (platelet derived growth factor) has been shown increase the adherence of 
monocytes to endothelial cells (309). Therefore, it is possible that either the contaminating platelets or their 
products may affect monocyte adherence to fibronectin. Second, it is possible that the adherence properties of 
the cells recovered by the Nycodenz method are not representative of all monocytes since the Nycodenz 
procedure fails to recover about 30% of the potential yield of monocytes. Third, the adherence properties of 
monocytes isolated by the Nycodenz method may reflect a functional alteration in the cells induced by the 
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Nycodenz isolation procedure. To investigate these possibilities, the adherence properties of monocytes isolated 
from four healthy donors by the standard Nycodenz procedure were compared with those of cells isolated by: 
1) Nycodenz method followed by centrifuging the cells through autologous plasma to remove contaminating 
platelets; and 2) CCE, the gold standard method for isolating monocytes, which provides almost 100% of the 
potential yield of monocytes (personal communication; Professor E.J. Campbell, University of Utah, Salt Lake 
City, Utah, U.S.A.). 
The proportion of monocytes that adhered spontaneously to fibronectin was similar for cells isolated 
by the Nycodenz method and by the Nycodenz method followed by centrifuging the cells through plasma (figure 
16). These data indicated that neither the contaminating platelets nor their products affect the adherence of 
Nycodenz-isolated monocytes to fibronectin. in addition, the adherence properties of monocytes isolated by 
Nycodenz were similar to those of cells isolated by CCE, indicating that: 1) the Nycodenz isolation procedure 
per se does not alter the adherence properties of monocytes; and 2) the adherence properties of monocytes 
recovered by the Nycodenz method are representative of all monocytes. 
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Figure 16 
Monocyte Adherence to Fibronectin 
Comparison of Different Monocyte Isolation Methods 
Figure 16 Monocytes were isolated by the standard Nycodenz method (Nycodenz), the Nycodenz method and 
removal of platelets by centrifuging the cells at low speed through plasma (Nycodenz + plasma) and by 
countercurrent centrifugal elutriation (CCE). Monocytes were incubated in fibronectin-coated dishes for 1 h 
at 37°C. Error bars represent SEM; n = 4 donors. 
120 
3.3. Adherence Properties of Monocytes from Healthy Subjects 
3.3.1. Spontaneous Adherence of Monocytes to Fibronectin 
To assess the adherence properties of monocytes from healthy subjects, cells were isolated from six 
healthy donors on six different occasions and the proportion of monocytes that adhered spontaneously to 
fibronectin under optimal assay conditions was determined (i.e. monocytes suspended in medium 
supplemented with 10% [v/v] FCS were dispensed into tissue culture dishes that had been pre-coated with 20 
of fibronectin). Only a minor subpopulation (17 to 28%) of monocytes from these subjects adhered to 
fibronectin under basal conditions. Moreover, there was minimal day-to-day variability in the mean proportion 
of spontaneously adherent monocytes from the six donors since this proportion only varied between 20.0% and 
22.8% when celis were isolated on six different occasions (table 5 a). There was also minimal within-donor 
variability in monocyte adherence since the coefficient of variation for monocyte adherence when the cells were 
isolated from the same donor on different occasions ranged from 6.7% to 10.3% (table 5 a). However, 
between-donor variability in monocyte adherence to fibronectin was observed since the proportion of adherent 
celis from two donors (A and F) was consistently greater than that of the other donors. 
3.3.2. Comparison of Monocyte Adherence to Fibronectin and to Endothelial Cells 
To be recruited from the vasculature into tissues, monocytes must first adhere to endothelial celis. 
Therefore, to assess whether the capacity of monocytes to adhere to fibronectin is related to their capacity to 
be recruited into tissues, the adherence of monocytes from healthy subjects to fibronectin and to human 
umbilical vein endothelial cell (HUVEC) monolayers was compared Preliminary results, presented in Appendix 
3, showed that a similar proportion of monocytes adhered to fibronectin and HUVEC monolayers. These data 
support the hypothesis that the capacity of monocytes to adhere to fibronectin in vitro is related to their 
potential to be recruited from the vasculature into tissues in vivo. 
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Table 5 a 
Donor Variability in Monocyte Adherence: Spontaneous Adherence 
Monocytes were isolated from six different donors (A to F) on six different occasions (1 to 6). The 
proportion of cells that adhered spontaneously to fibronectin was determined and the coefficient of variation 
(C.V.) for monocyte adherence was calculated. 
Table 5 b 
Donor Variability in Monocyte Adherence: LPS-Stimulated Adherence 
Monocytes were isolated from four different donors (A to D) on four different occasions (1 to 4). The 
proportion of cells that adhered in the presence of LPS from E. coli 0111:B4 ( was determined and the 
coefficient of variation (C.V.) for monocyte adherence was calculated. 
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3.4. Comparison of the Adherence Properties of Monocytes 
from Healthy Subjects and Patients with Bronchiectasis 
To investigate whether the adherence of monocytes to the extracellular matrix is increased in 
inflammation, the adherence properties of monocytes from healthy subjects to fibronectin were compared with 
those of cells from patients with an inflammatory lung disease (bronchiectasis). The patients with bronchiectasis 
were subdivided into three groups according to sputum characteristics (patients producing mucoid, mucopurulent 
and purulent sputum, respectively) which are related to the severity of airway inflammation in bronchiectasis 
(200). Under basal conditions, 20% of monocytes from healthy subjects adhered to fibronectin-coated plastic 
within 1 h (figure 17). A greater proportion of monocytes from all three patient groups with bronchiectasis 
adhered spontaneously to fibronectin compared with monocytes from healthy subjects. in addition, there was 
a relationship between monocyte adherence and the degree of airway inflammation as assessed by sputum 
characteristics. The proportion of adherent monocytes was greater in patients producing purulent sputum (65% 
SEM 5%) compared with cells from patients producing mucopurulent sputum (50% SEM 3%) which was 
similar to that of patients producing mucoid sputum (40% SEM 8%). 
3.5. Plasma Endotoxin Concentrations 
The possibility that bacterial endotoxin (LPS) is one in vivo mediator of the increased adherence of 
monocytes obtained from patients with bronchiectasis was tested since the lungs of these patients are colonised 
frequently with gram negative bacteria which are the source of LPS. Moreover, LPS has been shown to 
enhance the accumulation of leukocytes at sites of inflammation in vivo (140,308) and to increase the adherence 
of monocytes to endothelial cells in vitro (486). 
Plasma samples from healthy subjects and patients with bronchiectasis were assayed for endotoxin 
activity. The plasma endotoxin levels of the healthy subjects (figure 18) were all below the lower limit of 
detection of the assay (10 pg/ml). In marked contrast, endotoxin activity was detected in all of the patient 
samples. A wide range in plasma concentrations was observed (25 to 990 pg/ml) which related to the clinical 
features of the patient populations. The average concentration in 10 patients who produced mucoid sputum 
regularly was 76.6 SEM 10.8) pg/ml. This was similar to the concentrations in plasma from six patients who 
produced mucopurulent sputum (682 SEM 21.8 pg/ml), but both groups were lower (p < 0.01) than the 
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Figure 17 
Adherence of Monocytes from Healthy subjects and Patients With Bronchiectasis 
Figure 17 Monocytes from control subjects and patients with bronchiectasis producing mucoid, mucopurulent 
and purulent sputum were incubated for 1 h at 37°C in fibronectin-coated dishes. Error bars represent SEM; 
n = 6 donors for each group. Asterisk indicates p < 0.025 compared with cells from healthy subjects; **, p < 
0.025 compared with patients producing mucoid and mucopurulent sputum 
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patients who produced purulent sputum (714.8 SEM 88.4 pg/ml). 
To test the relationship between plasma endotoxin activity and monocyte adherence further, both were 
measured in a subset of the control subjects and patients with bronchiectasis (figure 19). A striking correlation 
was observed between plasma endotoxin activity and monocyte adherence when only patient data were 
considered (plasma endotoxin activity was less than the lower limit of detection of the assay in all control 
subjects); the correlation coefficient was 0.83. 
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Figure 18 
Plasma Endotoxin Activity: Healthy Subjects and Patients with Bronchiectasis 
Figure 18 
for endotoxin activity using a commercial limulus amoebocvte Iysate assay, as described in Methods. 
Plasma samples from control subjects and the patient groups detailed in figure 17, were assayed 
Figure 19 
Monocyte Activation in Bronchiectasis: Relationship to Plasma Endotoxin Activity 
Figure 19 Plasma endotoxin activity and monocyte adherence were measured in patients with bronchiectasis 
producing mucoid (solid squares), mucopurulent (solid triangles) and purulent sputum (solid circles). The plasma 
endotoxin activity of five control subjects (open triangles), shown as a reference were all below the lower limit 
of detection of the assay (10 pg/ml). 
3.6. Effect of Pro-Inflammatory Mediators on Monocyte Adherence 
3.6.1. Effect of LPS on the Adherence of Monocytes from Healthy Subjects 
To explore the potential role of endotoxin in vivo in increasing monocyte adherence in the patients with 
bronchiectasis, monocytes from healthy subjects were incubated with LPS from E. coli 0111:B4 at concentrations 
ranging from 0.01 to 10 Exposure of monocytes from healthy subjects to LPS resulted in a dose-related 
increase in monocyte adherence at all concentrations tested, with a maximum of 56.4% of monocytes adhering 
in the presence of 1 of LPS (figure 20). This was similar to the proportion of monocytes from patients 
producing purulent sputum that adhered spontaneously to fibronectin (figure 17). Visual assessment of the 
monocytes by phase-contrast microscopy confirmed the integrity of the underlying monocytes which adhered 
in an evenly distributed and non-aggregated pattern. 
To compare the effects of LPS purified from different bacterial species on monocyte adherence to 
fibronectin, cells were incubated with LPS from E. coli 0111:B4 and H .  influenzae at concentrations ranging 
from 0.10 to 10 LPS from both bacterial species produced dose-related increases in monocyte adherence 
to fibronectin, with a maximum of about 65% of cells adhering in the presence of 1 of LPS (figure 21). 
However, at sub-optimal concentrations of LPS, monocytes were more responsive to the effects of LPS from 
H. influenzae compared with LPS from E. coli. For example, similar proportions of monocytes were adherent 
in the presence of 10 ng/ml of LPS from H .  influenzae (53.4%) and 100 ng/ml of LPS from E. coli (55.4%). 
3.6.2. Reproducibility of the Effect of LPS on Monocyte Adherence 
The within-batch coefficient of variation (C.V.) for the monocyte adherence assay conducted in the 
presence of LPS from E. cdi 0111:B4 was 3.8% (n = 5), indicating that LPS-adherence assay is reproducible. 
To assess donor variability in LPS-stimulated adherence of monocytes to fibronectin, monocytes were isolated 
from four healthy donors on four different occasions and the proportion of cells that adhered in the presence 
of 1 of LPS from E. coli 01111:B4 was determined. There was minimal day-to day variability in the 
mean proportion of monocytes from the four donors that adhered in the presence of LPS since this proportion 
only varied between 57.0% and 632% when cells were isolated on different occasions (table 5 b). In addition, 
there was minimal within-donor variability in the effect of LPS on monocyte adherence since the C.V. for 
monocyte adherence in the presence of LPS ranged from 3.6 to 8.0% when cells were isolated from the same 
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Figure 20 
Effect of LPS on Monocyte Adherence: Healthy Subjects 
Figure 20 Monocytes from healthy subjects were incubated for 1 h in fibronectin-coated dishes with varying 
concentrations of LPS from E. coli 0111:B4 and the percentage of adherent cells was determined. Error bars 
represent SEM: n = 6 donors. 
Figure 21 
Effect of LPS from Different Bacterial Species on Monocyte adherence 
Figure 21 Monocytes from were incubated for 1 h with LPS from E. cdi 0111:B4 (open circles) and LPS from 
H. influenzae (solid circles) at varying concentrations (O to 10 Error bars are SEM; n = 5 donors, *, 
indicates p < 0.05 compared with cells incubated with the same concentration of LPS from E. coli 0111:B4 
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donor on different occasions. However, between-donor variability in the responsiveness of monocytes to LPS 
was observed since the proportion of monocytes from one donor (donor D) that adhered in the presence of LPS 
was consistently higher than that of the other donors (table 5 b). 
3.6.3. Effect of Incubation Time on Monocyte Adherence to Fibronectin 
To assess the effect of incubation time on monocyte adherence to fibronectin, cells from healthy subjects 
were incubated with and without LPS from E. coli 0111:B4 (1 for 30 min to 24 h. Both spontaneous 
and LPS-stimulated adherence were maximal by 30 min and remained at that level for the entire 24 h incubation 
period (figure 22). These results indicate that the standard incubation time used in the current studies (1 h) 
would result in maximal monocyte adherence for each assay. 
3.6.4. Effect of LPS on the Adherence Properties of Monocytes from Patients with Bronchiectasis 
Monocytes from patients with bronchiectasis were also incubated with and without LPS (0.1 and 1 
Exposure of monocytes from patients with bronchiectasis to 0.1 of LPS resulted in an increase 
in the adherence of monocytes from all of the patient groups (figure 23). Moreover, LPS at 0.1 increased 
the proportion of adherent monocytes from the mucoid and mucopurulent groups to a level similar to that 
observed for the purulent patient group under basal conditions. However, in the presence of 1 there was 
there was a further increase in the proportion of adherent cells from the mucoid patient group only. These data 
suggest that monocytes from patients with bronchiectasis have already been partially activated by exposure to 
endotoxin in vivo However, in the presence of optimal concentrations of LPS, a greater proportion of 
monocytes from the mucopurulent and purulent patient groups adhered to fibronectin when compared with that 
of LPS-exposed cells from healthy subjects. The latter observation suggested that other factors may be involved 
in up-regulating the adherence of monocytes from these patients with intense airway inflammation: 
3.6.5. Effect of Recombinant Cytokines on Monocyte Adherence 
Cytokines are released from activated host cells at sites of inflammation. Moreover, several cytokines 
have been detected in plasma from patients with bronchiectasis due to cystic fibrosis (434). To test the 
possibility that cytokines also activate monocytes from patients with bronchiectasis in vivo, resulting in increased 
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Figure 22 
Effect of Incubation Time on Monocyte Adherence to Fibronectin 
Figure 22 Monocytes were incubated at 37°C for 30 min, 6 h and 24 h in fibronectin-coated dishes. Cells were 
unstimulated (cross-hatched bars) or stimulated with 1 of LPS from E.  coli 0111:B4 (solid bars). Error 
bars represent SEM; n = 6 donors. Asterisk indicates p c 0.025 compared with unstimulated cells. 
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Figure 23 
Effect of LPS on Monocyte Adherence to Fibronectin 
Patients with Bronchiectasis 
Figure 23 Monocytes from control subjects and the patient groups detailed in figure 17 were incubated 
for 1 h at 37°C in fibronectin-coated dishes. Cells were either unstimulated (open bars), or were stimulated with 
0.1 or 1 of LPS from E. coli 0111:B4 (cross-hatched and solid bars, respectively). Error bars 
represent SEM; n = 6 donors in each group. Asterisk indicates p < 0.05; **, p < 0.025 compared with 
unstimulated cells; ***, p < 0.025 compared with cells stimulated with 0.1 of LPS. 
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adherence of their monocytes to fibronectin in vitro, cells from healthy subjects were incubated with 
recombinant cytokines during the adherence assay. In an initial experiment, monocytes were incubated with 
varying concentrations of TNF (10 to 10,000 units/ml). Exposure to TNF produced a dose-related increase in 
monocyte adherence to fibronectin with a maximum of 56.0% SEM 1.2%) of cells adhering in the presence 
of 1000 units/ml (figure 24). 
Monocytes were then incubated with several recombinant cytokines during the adherence assay. 
Exposure of monocytes to IFN, GM-CSF and TNF increased the proportion of adherent monocytes compared 
with unstimulated cells (figure 25). In contrast, exposure of monocytes to IL-1 had no effect on monocyte 
adherence. 
3.6.6. Effect of LPS and Recombinant Cytokines on Monocyte Adherence 
The effect of LPS (1 on monocyte adherence to fibronectin was compared with that of two of 
the cytokines (IFN and TNF). The proportion of monocytes from healthy subjects that adhered to fibronectin 
in the presence of LPS alone (58.3% SEM 2.0%) was greater than the proportion that adhered in the 
presence of IFN alone (38.6% SEM 1.3%) or TNF alone (46.8% SEM 1.9%; n = 6, figure 26 b). 
Monocytes from healthy subjects were also incubated with optimal concentration of LPS and cytokines 
together during the adherence assay. When the optimal concentration of TNF was added with the optimal 
concentration of LPS, an additive effect on monocyte adherence was observed (figure 26 a) compared with cells 
incubated in the presence TNF alone (46.7% SEM 0.9%) or LPS alone (59.8% SEM 1.9%) since LPS and 
TNF together increased the proportion of adherent monocytes to 70.7% SEM 1.2%); n = 6. However, there 
was no further increase in the proportion of monocytes when two cytokines (TNF and IFN) were added with 
the optimal concentration of LPS during the adherence assay (71.6% SEM 2.3%), figure 26 b. Among the 
cells that failed to adhere in the presence of LPS and cytokines, greater than 99% excluded trypan blue dye 
indicating that they were viable. These data demonstrated that cytokines and LPS produce additive effects on 
monocyte adherence to fibronectin. Moreover, the results suggest that: 1) LPS and cytokines up-regulate 
monocyte adherence to fibronectin by different mechanisms; and 2) TNF and IFN up-regulate monocyte 
adherence by similar mechanisms. 
132 
Figure 24 Monocytes were incubated in fibronectin-coated dishes for 1 h in the presence of varying 
concentrations of TNF and the percentage of adherent cells was determined. Error bars represent SEM; n = 
3 donors. 
Figure 25 Monocytes were incubated for 1 h in fibronectin-coated dishes. Cells were unstimulated (control) 
or were stimulated with IL-1 (25 units/ml), GM-CSF (50 units/ml), IFN (1000 units/ml) and TNF (1000 
units/ml). Error bars represent SEM; n = 5 donors. Asterisk indicates p < 0.05 compared with control cells. 
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Figure 26 
Effect of LPS and Cytokines on Monocyte Adherence 
a. 
b. 
Figure 26 Monocytes were incubated at 37°C for 1 h in fibronectin-coated dishes. Cells were unstimulated 
(control) or stimulated with cytokines and LPS from E. coli 0111:B4 a. Cells were stimulated with TNF (1000 
units/ml), LPS (1 or with TNF and LPS together (TNF + LPS); n = 6 donors. Asterisk and ** indicate 
p < 0.025 compared with unstimulated cells, ***, p < 0.025 compared with cells incubated with TNF alone or 
LPS alone. b. Cells were stimulated with IFN (1000 units/ml), TNF (1000 unit/ml), LPS (1 or with 
the cytokines and LPS together (IFN + TNF + LPS); n = 6 donors. Asterisk indicates p < 0.025 compared 
with unstimulated cells; **, p < 0.025 compared with cells incubated with IFN and TNF, ***, p < 0.025 
compared with all other groups. Error bars represent SEM. 
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3.7. Mechanisms Involved in Monocyte Adherence to Fibronectin 
3.7.1. Adherence of Monocytes from Healthy Subjects to Fibronectin 
The role of CD11\CD18 integrins in mediating both basal and LPS-stimulated monocyte adherence to 
fibronectin was investigated since: 1) it had been demonstrated that a specific anti-VLA-5 antibody produces 
only 40% inhibition of spontaneous adherence of monocytes to fibronectin (256), indicating that other integrins 
may be involved; and 2) LPS up-regulated monocyte adherence to fibronectin in the current study and LPS has 
been shown previously to increase the expression of CD11/CD18 integrins in vitro (419). 
Unstimulated and LPS-stimulated monocytes from healthy subjects were incubated with an anti-CD18 
murine monoclonal antibody during the adherence assay. The antibody produced a dose-dependent inhibition 
of monocyte adherence to fibronectin (figure 27 a). Maximal inhibition of basal and LPS-stimulated adherence 
was observed at a concentration of 4 of anti-CD18 (57% and 69% inhibition of basal and LPS-stimulated 
monocyte adherence, respectively). 
To exclude the possibility that the anti-CD18 antibody inhibited monocyte adherence by non-specific 
mechanisms, monocytes were incubated with two murine monoclonal antibodies (I3 and MY7), both of which 
bind to monocyte surface antigens that are irrelevant to the adherence process. Neither antibody inhibited basal 
or LPS-stimulated adherence of monocytes to fibronectin (figure 27 b). When monocytes were incubated with 
non-binding antibodies of the same immunoglobulin subclass as the CD18 antibody (non-immune murine IgG1), 
no inhibition of monocyte adherence was observed (figure 27 b). 
To test the possibility that recognition of RGD sequences is involved in the adherence of monocytes 
to fibronectin, monocytes were incubated with a synthetic RGDS tetrapeptide prior to and during the adherence 
assay. The RGDS peptide produced a dosedependent inhibition of both basal and LPS-stimulated adherence 
of monocytes to fibronectin (figure 28 a). Maximal inhibition of both basal and LPS-stimulated adherence was 
observed at an RGDS concentration of 1 mg/ml (72% and 67% inhibition of control adherence, respectively). 
in contrast, a control tetrapeptide (RGES) did not inhibit either basal or LPS-stimulated adherence of monocytes 
to fibronectin (figure 28 b). These data indicate that recognition of RGD sequences is important in mediating 
both basal and LPS-stimulated adherence of monocytes to fibronectin. 
Since some CD11\CD18 adherence events are RGD-dependent (498), monocytes were incubated with 
optimal concentrations of anti-CD18 and RGDS to determine whether an additive effect on inhibition of 
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Figure 27 a 
Effect of Anti-CD18 Antibody on Monocyte Adherence: Healthy Subjects 
Figure 27 a Monocytes were unstimulated (cross-hatched bars) or stimulated with 1 of LPS from E. 
coli 0111:B4 (solid bars). Cells were incubated for 1 h with varying concentrations of anti-CD18 in fibronectin- 
coated dishes and the percentage of adherent cells was determined. Error bars are SEM; n = 3 donors. 
Figure 27 b 
Specificity of Anti-CD18 Inhibition: Healthy Subjects 
Figure 27 b Monocytes were unstimulated (cross-hatched bars) or stimulated with 1 of LPS (solid bars). 
Cells were incubated in fibronectin-coated dishes for 1 h with and without anti-CD1û (4 and the 
following control antibodies: I3 (40 and MY7 (25 antibodies that bind to the monocyte surface; 
and non-immune murine IgG1 (MsIgC, 50 as a non-binding control. Error bars are SEM, n = 3 donors. 
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Figure 28 a 
Effect of RGDS Peptide on Monocyte Adherence: Healthy Subjects 
Figure 28 a Cells were unstimulated (cross-hatched bars) or stimulated with 1 of LPS from E. coli 
0111:B4 (solid bars). Monocytes were incubated for 1 h with varying concentrations of RGDS peptide in 
fibronectin-coated dishes. Error bars represent SEM; n = 3 donors. 
Figure 28 b 
Specificity of Inhibition by RGDS Peptide: Healthy Subjects 
Figure 28 b Monocytes were unstimulated (cross-hatched bars) or stimulated with 1 of LPS (solid bars). 
Cells were incubated with and without RGDS (1 mg/ml) or a control RGES peptide (1 mg/ml). Error bars 
represent SEM; n = 6 donors. Asterisk indicates p < 025 compared with cells incubated without peptide. 
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monocyte adherence could be achieved. The antibody and peptide together produced greater inhibition of both 
basal and LPS-stimulated adherence than either alone (figure 29). 
3.7.2. Mechanisms Involved in the Adherence of Monocytes from Patients with Bronchiectasis to 
Fibronectin 
To investigate the mechanisms involved in the adherence of monocytes from patients with bronchiectasis 
to fibronectin, monocytes from six patients with bronchiectasis (two from each patient group, as defined by their 
sputum characteristics) were incubated with optimal concentrations of RGDS peptide and the anti-CD18 
monoclonal antibody (figure 30 a). On average, 50% of the patients’ monocytes adhered spontaneously to 
fibronectin. The RGDS peptide and the anti-CD18 antibody both produced substantial but incomplete inhibition 
of monocyte adherence. The RGDS produced greater inhibition (68%) of monocyte adherence than did the 
anti-CD18 antibody (53%). in addition, the peptide and antibody together produced greater inhibition of 
monocyte adherence (78%) than either alone. in contrast, the control peptide (RGES) and a control antibody 
did not affect monocyte adherence (figure 30 b). 
138 
Figure 29 
Additive Effects of Anti-CD18 and RGDS on Monocyte Adherence 
Healthy Subjects 
Figure 29 Monocytes were incubated for 1 h at 37°C with and without anti-CD18 antibody alone (CD18; 
4 RGDS peptide alone (1 mg/ml) or the antibody and peptide together (CD18 + RGDS) in fibronectin- 
coated dishes and the percentage of adherent cells was determined. Cells were unstimulated (cross-hatched 
bars) or stimulated with 1 of LPS from E. coli 0111:B4 (solid bars). Error bars represent SEM; n = 
6 donors. Asterisk indicates p < 0.025 compared with control cells; **, p < 0.025 compared with CD18 alone 
and RGDS alone. 
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Figure 30 a 
Effect of Anti-CD18 and RGDS on Monocyte Adherence 
Patients with Bronchiectasis 
Figure 30 a Monocytes from six patients with bronchiectasis were incubated in fibronectin-coated dishes for 
1 h with and without anti-CD18 antibody (4 RGDS peptide (1 mg/ml) and the antibody and peptide 
together. Error bars represent SEM. Asterisk indicates p < 0.025 compared with control cells; **, p < 0.025 
compared with anti-CD18 alone and RGDS alone. 
Figure 30 b 
Specificity of Inhibition by Anti-CD18 and RGDS 
Patients with Bronchiectasis 
Figure 30 b Monocytes from patients with bronchiectasis were incubated for 1 h in fibronectin-coated dishes 
with and without anti-CD18 (4 the control antibody (13, 40 RGDS peptide (1 mg/ml) and 
RGES peptide (1 mg/ml). Error bars represent SEM; n = 2 donors. 
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3.8. Monocyte Phenotype Evaluations 
The initial results showed that, on average, only 20 to 25% of monocytes adhered spontaneously to 
fibronectin and that a further 35 to 40% of the cells could be stimulated by LPS to adhere to fibronectin (figure 
2). Therefore, four subpopulations of human monocytes were identified by their differential adherence 
properties: 
1) spontaneously adherent monocytes; 
2) non-spontaneously adherent monocytes; 
3) LPS-adherent monocytes; and 
4) non-adherent monocytes. 
Further experiments were conducted to test the authenticity of the monocyte subpopulations and to 
determine whether various functional properties of monocytes are related to their capacity to adhere to 
fibronectin. Several important antimicrobial functions (phagocytic activity, superoxide anion release and 
peroxidase content), an immune modulatory function (HLA-DR antigen expression) and the total protein content 
were compared. 
3.8.1. Authenticity of the monocyte subpopulations 
To test the authenticity of the monocyte subpopulations, cells were isolated from three healthy subjects 
and applied to a second identical adherence assay. Non-spontaneously adherent cells were transferred 
immediately to a second fibronectin-coated culture dish. After incubation for an additional 60 min, 6.9% 
SEM 0.6%) of these cells adhered to fibronectin. Spontaneously adherent cells were detached from the plate 
(by incubating the cells with 5 mmol/L EDTA in a 0.15 mol/L NaCl solution for 45 min at 4°C, followed by 
gentle scraping with a rubber policeman) then subjected to a second adherence assay. In marked contrast, 
85.3% SEM 1.2%) of these cells adhered to fibronectin. Among the cells that did not adhere in the latter 
assay, 69.7% SEM 3.7%) failed to exclude trypan blue dye, suggesting that these cells had been damaged 
by the detachment process. 
The LPS-adherent and non-adherent monocytes were also subjected to a second adherence assay in the 
presence of 1 of LPS from E. coli 0111:B4 Only 2.1% SEM 15%) of the non-adherent cells adhered 
to fibronectin in the second assay. In marked contrast, 90.0% SEM 0.9%) of the LPS-adherent cells adhered 
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to fibronectin in the second adherence assay. Among cells that did not adhere in the latter assay, 65.3% (+- 
SEM 5.2%) failed to exclude trypan blue dye, suggesting that these cells had been damaged by the detachment 
process. These data confirmed the authenticity of the monocyte subpopulations. 
3.8.2. Antimicrobial Functions 
3.8.2.1. Phagocytic Activities of the Monocyte Subpopulations 
The phagocytic index of the spontaneously adherent monocytes (197 SEM 12.8) was 8-fold greater 
than that of the non-spontaneously adherent cells (figure 31). In addition, the phagocytic index of the 
spontaneously adherent cells was 2-fold greater than that of the LPS-adherent cells, which in turn was 7-fold 
greater than that of the non-adherent cells. These differences were maintained when the results were expressed 
as the fraction of cells that were positive or as mean number of beads per cell. To control for possible direct 
effects of LPS on phagocytosis, spontaneously adherent monocytes were also pre-incubated with LPS prior to 
assessment of their phagocytic activity. Although the phagocytic index of spontaneously adherent monocytes 
was decreased by pre-incubation with LPS, these cells remained more actively phagocytic than the other groups 
(figure 31). 
3.8.2.2. Superoxide Anion Production 
The spontaneously adherent monocytes released 18.3 SEM 4.2) nmol of superoxide anion cells 
which was 3-fold greater than that released by the non-spontaneously adherent cells (figure 32). in addition, 
the spontaneously adherent monocytes released 2.8-fold more superoxide anion than the LPS-adherent cells, 
which in turn, released an amount of superoxide anion that was similar to that released by the non-adherent 
cells. To control for possible direct effects of LPS on subsequent superoxide anion release, spontaneously 
adherent monocytes were also pre-incubated with LPS; this pre-incubation did not alter their superoxide anion 
release (figure 32). 
3.8.2.3. Peroxidase Activity 
Spontaneously adherent monocytes contained 182 SEM 4.2) mU cells of peroxidase activity 
which was 6-fold greater that contained in the non-spontaneously adherent cells (figure 33). Furthermore, the 
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Figure 31 
Phagocytic Activity of Monocyte Subpopulations 
Figure 31 Monocyte subpopulations were incubated with latex beads (3 for 40 min at 37°C. Phagocytic 
indices were determined on Wright’s stained cytocentrifuge preparations, as described in Methods. Error bars 
represent SEM; n = 5 donors. Asterisk indicates p < 0.05 compared with non-adherent monocytes; **, p < 
0.05 compared with LPS-adherent cells; ***, p < 0.05 compared with non-spontaneously adherent monocytes 
and LPS-stimulated spontaneously adherent cells. 
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Figure 32 
Superoxide Anion Production by Monocyte Subpopulations 
Figure 32 Cells were incubated for 1 h at 37°C and superoxide anion released into the culture media was 
measured as the superoxide dismutase inhibitable reduction of cytochrome c. Error bars represent SEM; n = 
7 donors. Asterisk indicates p < 0.05 compared with LPS-adherent and non-adherent monocytes; **, p < 0.05 
compared with non-spontaneously adherent monocytes. 
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spontaneously adherent monocytes contained 10-fold more peroxidase activity than the LPS-adherent cells which, 
in turn, contained 2-fold more peroxidase activity than the non-adherent cells. Pre-incubation of the 
spontaneously adherent monocytes with LPS did not alter their peroxidase activity (figure 33). Extracts of 
platelets from two donors were assayed for peroxidase activity since Nycodenz-isolated monocytes were 
contaminated with platelets. Platelets did not contain peroxidase activity. 
To exclude the possibility that the differences in peroxidase content of the monocyte subpopulations 
could be due to differential release of enzyme into the culture media, all of the culture supernatants were 
assayed for peroxidase activity. During the spontaneous adherence step, 0.79 SEM 0.32) mU cells of 
peroxidase activity were released in 1 h. This was similar to that released by spontaneously adherent cells pre- 
incubated with LPS (0.84 SEM 0.37 mU cells/h) and greater than that released during the second 
adherence assay to separate the LPS-adherent and the non-adherent cells (0.36 SEM 0.11 mU cells/h). 
These data indicate that monocyte release of peroxidase during adherence and LPS incubation was minimal; 
furthermore, the differences among the monocyte subpopulations were not due to varying peroxidase release. 
3.8.2.4. HLA-DR Antigen Expression 
To compare the immune regulatory function of the monocyte subpopulations, their expression of HLA- 
DR antigens was assessed since the amount of HLA-DR antigen expressed by mononuclear phagocytes 
correlates directly with their capacity to present antigen (454,296,507). Monocytes were labelled with I3, a 
murine monoclonal antibody that recognises a non-polymorphic HLA-DR antigen expressed by monocytes (443). 
In an initial experiment, the binding of I3 antibody by pool monocytes was assessed by epifluorescence 
microscopy. Although greater than 90% of the pool monocytes were labelled with I3 antibody, there was 
marked heterogeneity in the intensity of staining of the cells. HLA-DR antigen expression by pool, 
spontaneously adherent and non-spontaneously adherent monocytes was then quantified by flow cytometry. 
Similar proportions of cells from each group were labelled with I3 antibody (92%, 98% and 98% for pool, 
spontaneously adherent and non-spontaneously adherent cells, respectively). However, the monocyte 
subpopulations differed markedly in their intensity of staining for i3 antibody. The mean fluorescent intensity 
of the non-spontaneously adherent cells was 304 SD 3) which was 3-fold greater than that of the 
spontaneously adherent cells (figure 34). In contrast, only 3% of pool cells were labelled with a control 
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Figure 33 
Peroxidase Content of Monocyte Subpopulations 
Figure 33 Cells were extracted with PBS containing 0.04% [v/v] Triton X-100, 1 mol/L NaCl, pH 7.4, then 
assayed for peroxidase activity, as described in Methods. Error bars represent SEM; n = 5 donors. Asterisk 
indicates p < 0.05 compared with non-adherent cells; **, p < 0.05 compared with LPS-adherent monocytes; ***, 
p < 0.05 compared with non-spontaneously adherent monocytes. 
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antibody (non-immune murine IgG) and the mean fluorescent intensity of this group of cells was 4 SD 2). 
These data excluded the possibility that I3 bound to monocytes by a non-specific mechanism. 
The mean fluorescent intensity of the spontaneously adherent and non-spontaneously adherent 
monocytes was 2-fold and 6-fold greater than that of the pool cells, respectively. It is possible that this was a 
temperature-related phenomenon since the adherence step to separate the monocyte subpopulations was 
conducted at 37°C for 1 h, whereas the pool monocytes were held at 4°C for the duration of this assay. To test 
possibility that incubation of monocytes at 37°C during the adherence assay increased the expression of HLA- 
DR antigen by the monocyte subpopulations, pool monocytes were incubated at 4°C and at 37°C for 1 h prior 
to labelling with I3 antibody. Incubation of the pool cells at 37°C for 1 h increased their expression of HLA-DR 
antigen 2-fold when compared with cells held at 4°C (figure 35). Therefore, in subsequent experiments pool 
cells were incubated at 37°C for the duration of the adherence assays to separate the monocyte subpopulations. 
HLA-DR antigen expression by pool, non-spontaneously adherent, LPS-adherent and non-adherent 
monocytes was compared. A similar proportion of cells from each monocyte population were labelled with I3 
antibody (99.4%, 99.3%, 99.8% and 98.8% of the pool, non-spontaneously adherent, LPS-adherent and non- 
adherent, respectively). The mean fluorescent intensity of the LPS-adherent and non-adherent cells was similar 
to that of the non-spontaneously adherent cells (which were incubated at 37°C for the duration of the LPS- 
adherence assay). In addition, the mean fluorescent intensity of the pool cells (which were incubated at 37°C 
for the duration of both adherence assays) was similar to that of the non-spontaneously adherent monocytes. 
There was minimal non-specific binding of the control antibody (non-immune murine IgG) to pool monocytes 
(figure 36). To control for possible effects of LPS on HLA-DR antigen expression, pool cells were pre- 
incubated for 1 h with 1 of LPS prior to labelling with I3 antibody. Exposure of pool cells to LPS did 
not alter their expression of HLA-DR antigen (figure 36). 
3.835. Total Protein Content 
The total protein content of the monocyte pool was 36.2 SEM 7.5) cells (figure 37) which 
was similar to the that of the non-spontaneously adherent (30.0 SEM 1.9 cells), LPS-adherent (28.4 
SEM 2.5 cells) and non-adherent monocytes (32.9 SEM 4.5 cells). However, the total 
protein content of the spontaneously adherent cells was 46.7 SEM 6.8 cells, which was greater than 
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Figure 34 
HLA-DR Antigen Expression by Monocytes 
Figure 34 The indirect immunofluorescence technique was used to assess the binding of I3, a murine 
monoclonal antibody that recognises a non-polymorphic HLA-DR antigen. Non-immune murine IgG was used 
instead of I3 as the control antibody (control). Antibody binding was quantified by flow cytometry. Figure 
shows the results of a typical experiment; cells were analysed in each group. Error bars represent SD. 
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Figure 35 
Effect of Incubation Temperature on HLA-DR Antigen Expression by Monocytes 
Figure 35 Pool monocytes were incubated at 4°C or at 37°C for 1 h then labelled with I3 antibody. Non- 
immune mouse IgG was used as the control antibody (control). Figure shows the results of a typical experiment; 
cells were analysed in each group by flow cytometry. Error bars represent SD. 
Figure 36 Pool, non-spontaneously adherent, LPS-adherent and non-adherent monocytes were labelled with 
I3 antibody. Non-immune murine IgG was used as the control antibody (control). To assess the effect of LPS 
on HLA-DR antigen expression, pool monocytes were pre-incubated with LPS for 1 h. Figure shows the results 
of a typical experiment; cells were analysed in each group by flow cytometry. Error bars represent SD. 
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that of the other subpopulations (p < 0.05). Prior to preparation of cell extracts, all of the monocyte 
populations were greater than 99% viable, as assessed by exclusion of trypan blue dye. Therefore, it is unlikely 
that the differences in total protein content among the monocyte subpopulations were due to differences in cell 
viability. 
Extracts of the adherent subpopulations for assay were prepared within the fibronectin-coated dishes. 
To exclude the possibility that the greater total protein content of the spontaneously adherent cells was due to 
solubilisation of the fibronectin Substrate during preparation of the cells extracts, lysing buffer was added to 
three fibronectin-coated dishes that had not been incubated with cells, and the total protein content of these 
extracts was determined. The fibronectin extracts contained 4.4 SEM 0.1) protein per equivalent of 
spontaneously adherent monocytes which was less than 10% of the mean total protein content of these cells. 
These data confirm that the greater total protein content of the spontaneously adherent cells, when compared 
with the other monocyte populations, was not due entirely to solubilisation of the fibronectin Substrate during 
the preparation of the cell extracts. 
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Figure 37 
Total Protein Content of Monocyte Subpopulations 
Figure 37 Extracts of the monocyte subpopulations were assayed for total protein content using the Sedmak 
assay. Error bars represent SEM; n = 5 donors. Asterisk indicates p < 0.05 compared with all other monocyte 
subpopulations. 
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3.9. Expression of Human Leukocyte Elastase and by Monocytes 
Tissue destruction in chronic obstructive pulmonary diseases (COPD) is thought to result from an 
imbalance between lung proteinases and their inhibitors that favors excessive activity of the proteinases. in this 
respect human leukocyte elastase (HLE) is thought to be the most important proteinase, and is 
its major inhibitor. It is possible that mononuclear phagocytes play an important role in the pathogenesis of 
COPD since: 1) these cells are present in greatly increased numbers at strategic locations in the lungs of patients 
with COPD (334); and 2) monocytes contain HLE (81) and synthesise (32). It is of particular 
interest that monocytes have been shown recently to be heterogeneous with respect to their content of HLE. 
Karg and coworkers (242) demonstrated that only 20% of monocytes stain intensely for HLE. In addition, 
Campbell et (81) showed that only 20% of monocytes produce HLE-mediated proteolysis of an extracellular 
matrix component in the presence of proteinase inhibitors. 
The possibility was tested that there is a relationship between the adherence properties of monocytes 
and their HLE content since: 1) the proportion of monocytes that adhered spontaneously to fibronectin in the 
current study (20 to 25%) was similar to the proportion of monocytes (20%) that is replete with HLE (81,242); 
and 2) HLE is stored within the peroxidase positive granules of monocytes (242) and there was a striking direct 
relationship between the capacity of cells to adhere and their peroxidase content in the current study. The 
content of the monocyte subpopulations was also compared and the effect of several pro- antitrypsin 
inflammatory mediators on the accumulation of by monocytes was investigated. 
3.9.1. Expression of HLE by Monocytes 
3.9.1.1. Comparison of the HLE Content of Monocyte Subpopulations 
The mean HLE content of the spontaneously adherent was 454 SEM 108 ng HLE cells which 
was 3-fold greater than that of the pool cells, 8 to 9-fold greater than that of the non-spontaneously adherent 
and LPS-adherent cells, and 22-fold greater than that of the non-adherent cells (figure 38). To control for 
possible effects of LPS on the EILE content of monocytes, spontaneously adherent cells were also incubated with 
LPS. Pre-incubation of spontaneously adherent cells with LPS did not affect their HLE content (figure 38). 
To exclude the possibility that the differences in HLE content of the monocyte subpopulations were 
due to differential release of enzyme into the culture media, all of the culture supernatants were assayed for 
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immunoreactive HLE. During the 1 h adherence step to separate the spontaneously adherent and non- 
spontaneously adherent monocytes, 1.3 (+- SEM 1.1) cells of immunoreactive HLE were released. When 
the spontaneously adherent cells were pre-incubated with LPS for 1 h, 21.4 SEM 4.8 ng cells of HLE 
were released into the culture media and 0.2 SEM 0.2) ng cells of HLE were released during the second 
adherence assay to separate the LPS-adherent and the non-adherent cells. These data indicate that differences 
observed in HLE content among the monocyte subpopulations were not due to varying release of HLE during 
adherence or in response to exposure to LPS. 
To exclude the possibility that the differences among the monocyte subpopulations were due to variable 
contamination of the subpopulations with platelets, extracts of platelets isolated from three donors were assayed 
for HLE. Platelets did not contain immunoreactive HLE. To exclude the possibility that the Nycodenz 
isolation procedure, per se, altered the HLE content of monocytes, cells were isolated from a further three 
donors by both the Nycodenz method and CCE, and extracts of pool, spontaneously adherent and non- 
spontaneously adherent monocytes were assayed for immunoreactive HLE. The HLE content of the monocyte 
populations isolated by the Nycodenz isolation procedure were similar to those of cells isolated by CCE (figure 
39). Moreover, the HLE content of the spontaneously adherent cells (66.1 SEM 10.9 and 632 SEM 7.7 
cells, for Nycodenz and CCE-isolated cells, respectively) was again substantially greater (7-fold) than that 
of the non-spontaneously adherent cells (9.5 SEM 5.0 and 15.9 SEM 1.6 cells, for Nycodenz and 
CCE-isolated cells, respectively). These data indicate that the differences among the monocyte subpopulation 
were not a consequence of the Nycodenz isolation procedure. 
To compare the relative amounts of HLE contained within monocytes and neutrophils, blood was drawn 
from three healthy donors, monocytes were isolated by the Nycodenz method, neutrophils were isolated by the 
Percoll method, and cell extracts were assayed for immunoreactive HLE. The pool monocytes contained 78.1 
SEM 23.0) ng cells which represented 4.6% SEM 0.4%) of the amount of HLE contained 
within neutrophils from the same donor. 
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Figure 38 
HLE Content of Monocyte Subpopulations 
Figure 38 Monocytes were isolated by the Nycodenz method, monocyte subpopulations were separated 
and cell extracts were assayed for HLE using an indirect binding ELISA. Error bars represent SEM; n = 3 
donors. 
Figure 39 
HLE Content of Monocytes: Comparison of Monocyte Isolation Methods 
Figure 39 Monocytes were isolated by the Nycodenz method (cross-hatched bars) and by CCE (solid bars), 
extracts of pool, spontaneously adherent and non-spontaneously adherent cells were assayed for HLE using an 
indirect binding ELISA. Error bars represent SEM; n = 3 donors. 
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3.9.1.2. Within-Donor and Between-Donor Variability in the HLE Content of Monocytes 
The absolute amounts of HLE contained within pool, spontaneously adherent and non-spontaneously 
adherent cells varied considerably when monocytes were isolated from different donors on different occasions 
(figures 38 and 39). It is unlikely that these differences were due entirely to intra-assay or inter-assay variability 
since: 1) the within-batch coefficient of variation (C.V.) for the monocyte adherence assay conducted under basal 
conditions was 3.7%, and the C.V. for spontaneous adherence of monocytes, when cells were isolated from the 
same donor on different occasions, was 6.7 to 10.3% (table 5 a); and 2) the within- and between-batch C.V.s 
for the HLE indirect binding ELISA were 5.6% and 14.2%, respectively. 
To test the possibility that the differences in HLE content among the monocyte subpopulations were 
due to between-donor variability in the HLE content of monocytes, the HLE content of pool, spontaneously 
adherent and non-spontaneously adherent cells isolated from an additional seven donors were compared. There 
was considerable variability in the HLE content of the monocyte populations isolated from different donors 
(table 6 a). However, the relative differences in HLE content between the monocyte subpopulations were 
similar to those in figures 38 and 39. The spontaneously adherent cells, on average, contained 7-fold more HLE 
than the non-spontaneously adherent cells (p < 0.01). 
To investigate whether the variability in HLE content of the subpopulation also reflected within-donor 
variability, the HLE content of monocyte populations obtained from the same donor on different occasions were 
compared. There was considerable within-donor variability in HLE content of the monocyte populations (table 
6 b). It is possible that these differences are due to day-to-day variation in the HLE content of circulating 
monocytes. This may reflect variations in the maturational stages of circulating monocytes since maturation 
results in a loss of the expression of HLE by monocytes (438). Alternatively, these differences may be due to 
day-to-day variation in the release of HLE during monocyte isolation which may relate to slight differences in 
the temperature or composition of the solutions used, or in the duration of the monocyte isolation.procedure 
performed on different occasions. 
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Table 6 a 
HLE Content? of Monocyte populations: Between-Donor Variability 
Results are expressed as ng cells. The samples were assayed in triplicate. Data are mean values 
SEM. Asterisk indicates p < 0.01 compared with non-spontaneously adherent cells 
Table 6 b 
HLE Content? of Monocyte Populations: Within-Donor Variability 
† Results are expressed as ng cells. The samples were assayed in triplicate. Data are mean values 
SEM. A = occasion number 1; B = occasion number 2. 
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3.9.2. Content of Monocytes 
3.9.2.1. Comparison of the Content of Monocyte Subpopulations 
Preliminary studies were undertaken to determine whether platelets contain since the 
Nycodenz-isolated monocytes are always contaminated variably with platelets. Platelets were prepared from 
four healthy donors by CCE and celi extracts were assayed for immunoreactivity using a direct 
binding ELISA. Platelets contained 0.6 (i SEM 0.3) ng of cells. Therefore, to compare the 
content of the monocyte subpopulations, monocytes were isolated by CCE since this method 
provides monocytes that are not contaminated with platelets. 
The mean content of the spontaneously adherent celis was 99 SEM 11) cells 
which was 2-fold greater than that of the pool cells, 4.5-fold greater than that of the non-spontaneously adherent 
cells and 7-fold greater than that of the LPS-adherent and non-adherent celis; n = 3 (figure 40). To control for 
possible effects of LPS on the content of monocytes, spontaneously adherent cells were also pre- 
incubated with LPS. Pre-incubation of the spontaneously adherent celis with LPS resulted in a 29% reduction 
in the their content of however, these cells contained more compared with the other 
subpopulations even after exposure to LPS (figure 40). This latter result was due, in part, to the release of 
antitrypsin by spontaneously adherent monocytes since 18 SEM 17) ng cells were detected 
in the culture supernatants of spontaneously adherent cells that had been pre-incubated with LPS for 1 h. In 
contrast, differential release of by monocyte subpopulations could not explain the differences in 
content between the spontaneously adherent and other monocyte subpopulations since only 5 
SEM 3) ng cells were released during the spontaneous adherence step and only 5 (i SEM 
5) ng cells were released during the second adherence assay to separate the LPS-adherent and 
non-adherent cells. 
3.9.2.2. Within- and Between-Donor Variability in the Content of Monocytes 
Donor variability in the content of monocytes was assessed since there was considerable 
donor variability in their HLE content. To assess between-donor variability, the content of pool, 
spontaneously adherent and non-spontaneously adherent cells isolated from an additional seven donors was 
determined. Although between-donor variability of content of monocytes was observed (table 
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Figure 40 
Content of Monocyte subpopulations 
Figure 40 Monocytes were isolated from healthy donors by CCE. The monocyte subpopulations were 
separated, and cell extracts were assayed for using the direct binding ELISA. The results are 
expressed as ng cells. Error bars represent SEM; n = 3 donors. 
7 a), it was less marked that observed for HLE (table 6 a). In addition, the relative differences in the mean 
antitrypsin content of the monocyte populations were the same as those shown in figure 40. The spontaneously 
adherent cells, on average, contained 2-fold more than the pool cells (p < 0.025) and 4-fold more 
than the non-spontaneously adherent celis (p < 0.01). 
The content of monocyte populations obtained from the same donor on different occasions 
were also compared. Although within-donor variability in the content of monocytes was observed 
(table 7 b), it was again less marked than that observed for HLE (table 6 b). 
3.9.3. Comparison of the HLE and Content of the Monocyte Subpopulations 
To compare the amounts of HLE and contained within the monocyte subpopulations, 
monocytes were isolated from three healthy donors by CCE, the subpopulations were separated and cell extracts 
were assayed for both immunoreactive HLE and The results were expressed as pmol cells 
and the molar ratios of HLE to were calculated. 
Ail of the monocyte populations contained a molar excess of HLE compared with 
however, the magnitude of the molar excess of HLE varied considerably (table 8 a). The pool monocytes and 
spontaneously adherent cells contained a substantial molar excess of HLE relative to (8-fold and 
10-fold, respectively). in contrast, the non-spontaneously adherent cells contained only a 5-fold molar excess 
of HLE. However, the non-spontaneously adherent cells were heterogeneous in this respect since the LPS- 
adherent cells contained a molar excess of HLE that was similar to that of the spontaneously adherent cells (11- 
fold), whereas the non-adherent cells contained only a 3-fold molar excess of HLE relative to 
This latter result was due to the fact that the LPS-adherent cells contained 3-fold more HLE but similar amounts 
of when compared with the non-adherent monocytes (table 8 a). 
The molar ratio of HLE was also determined for pool, spontaneously adherent and non- 
spontaneously adherent cells isolated from seven donors. The results confirmed that the spontaneously adherent 
cells contained a significantly greater excess of HLE compared with non-spontaneously adherent cells (p < 0.01; 
table 8 b). 
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Table 7 a 
Content† of Monocyte Populations: Between Donor Variability 
Table 7 b 
Content† of Monocyte Populations: Within-Donor Variability 
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Table 8 a 
HLE and Content? of Monocyte Populations 
Table 8 b 
Molar Ratio† of HLE and in Monocyte Populations 
† Data are ratios of HLE (pmol cells) (pmol cells) for 7 donors. 
Asterisk indicates p < 0.01 compared with non-spontaneously adherent monocytes. 
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3.9.4. Accumulation by Monocytes 
Although de novo synthesis of by monocytes has been demonstrated by biosynthetic 
labelling and immunoprecipitation studies (32), the absolute amount of synthesised by monocytes 
has not been quantified previously. In this study, an indirect binding ELISA was used to quantify 
immunoreactive in monocyte extracts and culture supernatants. However, these data represent 
the net balance between the synthesis and the catabolism of this protein by the cells. Therefore, the results of 
this study were expressed as amounts of accumulated by monocytes. 
3.9.4.1. Experimental Design 
Monocytes were isolated by the Nycodenz method for these studies since the CCE method was not 
available. One potential problem in using Nycodenz-isolated monocytes for these experiments is that the cells 
are always contaminated with platelets, and platelets contain (3.9.2.1). However, it is unlikely that 
platelets synthesise de novo since: 1) platelets contain negligible amounts of DNA and RNA, and 
2) any RNA that is present within platelets is in a metabolically inactive form (1). To overcome the problem 
of platelet contamination, the experiments were designed as follows. The monocyte subpopulations were 
separated and, after overnight culture, one set of cells (monocytes and their contaminating platelets) from each 
subpopulation were harvested (time = O, control cells). Thereafter, cells and supernatants were harvested at 
intervals, concentrations were measured in the samples by direct binding ELISA and the results 
were expressed as ng monocytes. The amount of contained within the time = 
O, control cells (monocytes and their contaminating Platelets) was subtracted from the sum of the results for the 
cell extracts and culture supernatants for each time interval. This value represented the amount of 
that was accumulated by the monocytes. 
3.9.4.2. Effects of Culture and LPS on the Accumulation of by Monocytes 
The effects of culture and LPS exposure on the accumulation of by the four monocyte 
subpopulations were assessed. To obtain a sufficient number of cells for study, large volumes of blood had to 
be drawn from the donors and, therefore, the experiment was conducted in two stages. Initially, spontaneously 
adherent and non-spontaneously adherent cells were isolated from six healthy donors and cultured with and 
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without LPS. LPS-adherent and non-adherent cells were isolated from an additional five donors at a later date 
and cultured with and without LPS. To compare the results for monocyte subpopulations isolated from different 
donors, the amount of accumulated by monocytes was expressed as percentage of the amount of 
contained within the time = O, control cells, as described in Methods. 
Spontaneously adherent cells After culture for 24 and 48 h under basal conditions, the spontaneously 
adherent cells accumulated 522% and 975% more respectively, than the amount contained within 
the time = O, control cells (figure 41 a). LPS increased accumulation by the spontaneously 
adherent cells by 1.4-fold after both 24 h and 48 h compared with unstimulated cells. 
Non-spontaneously adherent cells After culture for 24 and 48 h under basal conditions, the non- 
spontaneously adherent cells accumulated 122% and 150% more respectively, than the amount 
contained within the time = O, control cells (figure 41 b). In contrast to the spontaneously adherent monocytes, 
LPS did not alter accumulation by non-spontaneously adherent cells. 
LPS-adherent cells After culture for 24 and 48 h under basal conditions, the LPS-adherent cells 
accumulated 135% and 287% more respectively, than the amount contained within the time = 
O, control cells (figure 42 a). LPS did not alter accumulation by LPS-adherent monocytes. 
Non-adherent cells After culture for 24 and 48 h under basal conditions, the non-adherent cells 
accumulated 25% and 75% more respectively, than the amount contained within the time = O, 
control cells (figure 42 b). LPS did not alter accumulation by the non-adherent cells. 
These data indicate that maturation in vitro increases the accumulation of by all of the 
monocyte subpopulations. However, LPS exposure up-regulates the accumulation of by only the 
spontaneously adherent cells. 
The data also suggested that the adherent monocyte subpopulations accumulate more 
during culture under basal conditions when compared with the non-adherent subpopulations. However, it is 
possible that this latter result is an artefact since: 1) the results were expressed as percentage of the amount of 
contained within the time = O, control cells; and 2) the content of the time = O, 
control cells for the adherent monocyte subpopulations were substantially lower than those for the non-adherent 
subpopulations (65 SEM 11 and 387 SEM 105 ng of cells for the spontaneously 
adherent and non-spontaneously adherent cells, respectively [p c 0.0251; and 16 SEM 6 and 190 SEM 
6 
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Figure 41 
Effect of Culture and LPS on Accumulation 
a. Spontaneously Adherent Monocytes 
b. Non-Spontaneously Adherent Monocytes 
Figure 41 a. Spontaneously adherent and b. non-spontaneously adherent monocytes were cultured for 24 h 
and 48 h. Cells were unstimulated (cross-hatched bars) or stimulated with 1 of LPS from E. coli 0111:B4 
(solid bars). was measured in the cell extracts and culture supernatants by a direct binding 
ELISA and the amount of accumulated was expressed as a percentage of the amount contained 
within the time = O, control cells, as described in Methods. Error bars represent SEM; n = 6 donors. Asterisk 
indicates p < 0.05; **, p < 0.025 compared with unstimulated cells. 
164 
Fi-re 42 
Effect of Culture and LPS on Accumulation 
a. LPS-Adherent Monocytes 
b. Non-Adherent Monocytes 
Figure 42 a. LPS-adherent and b. non-adherent monocytes were isolated from five donors and cultured for 
24 h and 48 h. Cells were unstimulated (cross-hatched bars) or stimulated with 1 of LPS (solid bars). 
was measured in the cell extracts and culture supernatants by a direct binding ELISA and 
the amount of accumulated was expressed as a percentage of the amount contained within the time 
= O, control cells, as described in Methods. Error bars represent SEM. 
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33 ng of cells for the LPS-adherent and non-adherent cells, respectively (p < 0.051). To 
investigate this possibility, spontaneously adherent and non-spontaneously adherent cells were isolated from the 
same donors, cultured for 24 h under basal conditions and the absolute amounts of accumulated 
by the cells were measured. The spontaneously adherent and non-spontaneously adherent cells accumulated 
similar amounts of after culture for 24 h (52 SEM 7 and 72 SEM 8 ng cells more than 
amount contained within the time = O, control cells, respectively). 
Since these preliminary experiments demonstrated that the pattern of accumulation by 
the LPS-adherent and non-adherent monocytes was similar to that of the non-spontaneously adherent cells, 
subsequent experiments were conducted on only spontaneously adherent and non-spontaneously adherent 
monocytes. 
3.9.4.3. Effect of Time on Accumulation by Spontaneously Adherent Monocytes 
To assess the effect of time on their accumulation of spontaneously adherent monocytes, 
cells were incubated with and without LPS (1 for 6 h, 12 h and 24 h (figure 43). LPS increased 
antitrypsin accumulation by spontaneously adherent cells within 12 h. Monocytes exposed to LPS accumulated 
1.4 fold more after 24 h compared with unstimulated cells (p < 0.05). 
3.9.4.4. Effect of Cytokines on Accumulation by Monocyte Subpopulations 
To assess the effects of cytokines on accumulation, spontaneously adherent and non- 
spontaneously adherent cells were incubated for 24 h with and without three recombinant cytokines (TNF, IFN, 
and GM-CSF). Exposure to TNF, IFN and GM-CSF for 24 h stimulated similar increases in 
accumulation by spontaneously adherent monocytes (1.3 fold, 1.5 fold and 1.6 fold, respectively) compared with 
unstimulated cells (figure 44 a). in contrast, TNF, IFN and GM-CSF had no effect on 
accumulation by non-spontaneously adherent cells (figure 44 b). To determine whether the increase in 
antitrypsin accumulation induced by cytokines was dose-related, spontaneously adherent monocytes were 
incubated for 24 h with GM-CSF at concentrations ranging from 10 to 75 units/ml. GM-CSF produced a dose- 
related increase in accumulation by spontaneously adherent monocytes with a maximal 1.8 fold 
increase in the presence of 50 units/ml of GM-CSF (figure 45). 
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Figure 43 
Effect of Incubation Time on Accumulation 
Spontaneously Adherent Monocytes 
Figure 43 Spontaneously adherent monocytes were cultured for 6 h, 12 h and 24 h. Cells were unstimulated 
(open circles) or stimulated with 1 of LPS from E. coli 0111:B4 (solid circles). was 
quantified in cell extracts and culture supernatants using a direct binding ELISA and the amount of 
that accumulated (in excess of the amount contained within the time = O, control cells) was calculated. Results 
are expressed in ng cells. Error bars represent SEM; n = 5 donors. Astensk indicates p < 
0.05. 
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Figure 44 
Effect of Cytokines on Accumulation by Monocytes 
a. Spontaneously Adherent Monocytes 
Figure 44 a. Spontaneously adherent and b. non-spontaneously adherent monocytes were cultured for 24 h. 
Cells were unstimulated (control) or stimulated with TNF (1000 units/ml), IF” (1000 units/ml) and GM-CSF 
(50 units/ml). was measured in the cells extracts and culture supematants using a direct 
binding ELISA and the amount of that accumulated (in excess of the amount contained within 
the time = O control cells) was determined. Error bars represent SEM; n = 6 donors. Asterisk indicates p < 
0.05; **, p < 0.025 compared with unstimulated cells. 
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Figure 45 
Effect of GM-CSF on Accumulation 
Spontaneously Adherent Monocytes 
Figure 45 Spontaneously adherent monocytes were cultured for 24 h with concentrations of GM-CSF ranging 
from O to 75 units/ml. was quantified in cell extracts and culture supematants using a direct 
binding ELISA. The amount of that accumulated (in excess of the amount contained within the 
time = O, control cells) was determined. The results were expressed as ng of 
cells. Error bars represent SEM; n = 5 donors. Asterisk indicates p < 0.05 compared with unstimulated cells. 
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3.10. Expression of the Gene by Monocytes 
To assess whether LPS and cytokines up-regulated accumulation by spontaneously 
adherent cells by stimulating the transcription of the gene, cytoplasmic RNA was extracted from 
monocytes and subjected to dot-blot analysis using and ß-actin DNA probes. The results for 
antitrypsin mRNA were expressed as ratios to the value obtained for ß-actin to correct for any variation in RNA 
yields. Preliminary experiments were conducted to: 1) assess the reproducibility and specificity of the dot-blot 
technique; and 2) confirm that there is a correlation between the amount of RNA applied to the membrane and 
the autoradiogram signal obtained using both the and ß-actin DNA probes. 
3.10.1. Reproducibility and Specificity of the Dot-Blot Technique 
from 
To assess the reproducibility of the dot-blot technique, cytoplasmic RNA extracted the equivalent of 
cells was dotted onto Gene-screen TM membrane six times. The blot was probed with the 
DNA probe, subjected to autoradiography and the autoradiogram (figure 46) was scanned with a laser 
densitometer. The mean autoradiogram signai was 49043 SD 2588) arbitrary densitometry units and the 
within-batch C.V. for the assay was 5.3%. These data confirmed that the dot-blot technique was reproducible. 
To confirm the specificity of hybridisation of the probe, RNA extracted from the 
following cell types and subjected to dot-blot analysis using the and ß-actin DNA probes: 1) 
hepatocytes, monocytes and U937 cells, cells that express the gene (1,312); 2) neutrophils which 
contain mRNA at a low copy number per cell (148); and 3) lymphocytes as a negative control. 
To confirm that the DNA probes hybridised to RNA species rather than to any DNA molecules that may have 
contaminated the sample, an identical aliquot of RNA purified from each cell type was incubated with RNAase 
for 1 h at 37°C and also subjected to dot-blot analysis using the and ß-actin DNA probes. 
The autoradiogram of the blot hybridised to the ß-actin probe demonstrated that all of the RNA 
samples tested contained ß-actin mRNA transcripts (figure 47 a). However, monocytes contained ß-actin 
transcripts at a higher copy number per cell than U937 cells and lymphocytes which, in turn, contained ß-actin 
transcripts at a higher copy number per cell than neutrophils. Incubation of identical samples with RNAase 
almost completely abrogated the all the autoradiogram signals (figure 47 a), thus confirming that the ß-actin 
probe hybridised to RNA rather than any DNA that may have contaminated the samples. 
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The autoradiogram of the membrane hybridised to the probe demonstrated that: 1) 
monocytes contained mRNA transcripts at a high copy number per celi; and 2) neutrophils and 
U937 contained relatively low numbers of mRNA transcripts per cell when compared with 
monocytes (figure 47 b). A faint autoradiogram signal was obtained for lymphocytes which may be due to low 
level expression of the gene by lymphocytes or reflect that the lymphocyte preparation contained 
about 5% contaminating monocytes. RNAase treatment of the samples prior to dot-blot analysis almost 
completely abrogated ali of the autoradiogram signals, which confirmed that the a, -antitrypsin probe hybridised 
to RNA rather than any DNA that may have contaminated the samples (figure 47 b). 
3.10.2. Quantification of and Beta-Actin mRNA in Monocytes using the Dot-Blot 
Technique 
To confirm that there is a relationship between amount of and ß-actin mRNA applied to 
the membrane and the autoradiogram signal, cytoplasmic RNA was extracted from varying numbers of 
monocytes to 4 x and dotted onto two Gene-screen TM membranes. The blots were incubated with 
the or ß-actin DNA probes, subjected to autoradiography and scanned with a laser densitometer. 
There was a correlation between cell number and the intensity of the autoradiogram signal obtained using both 
the and ß-actin DNA probes when cytoplasmic RNA from up to 4 x monocytes was applied 
to the membrane; r = 0.985 and 0.990, respectively (figures 48 and 49). These data support the validity of using 
the dot-blot technique to quantify and ß-actin mRNA concentrations in monocytes. 
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Fienre 48 
Quantification of mRNA in Monocytes 
Figure 48 Cytoplasmic RNA was purified from varying numbers of monocytes to 4 x and applied 
to Gene-screen TM membrane. The membrane was hybridised to the genomic DNA probe, 
subjected to autoradiography for 7 days and scanned with a laser densitometer. a. Autoradiogram of the dot- 
blot b. Quantification of mRNA by densitometry scanning. The signals were scanned in triplicate. 
Error bars represent SEM, r = 0.985. 
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3.10.3. Comparison of Steady State mRNA Levels in Monocyte Subpopulations 
To compare their steady state mRNA concentrations, spontaneously adherent and 
non-spontaneously adherent monocytes were cultured under basal conditions for 48 h. Cytoplasmic RNA was 
extracted from the cells after culture for 24 h and 48 h, and dot-blot analysis was performed with the 
antitrypsin and ß-actin DNA probes. The dot-blots were subjected to autoradiography and the autoradiograms 
were scanned with a laser densitometer. Spontaneously adherent and non-spontaneously adherent monocytes 
contained similar steady state concentrations of mRNA after culture for 24 h (figure 50). 
Moreover, culture for up to 48 h under basal conditions did not alter steady state mRNA 
concentrations levels in either the spontaneously adherent or non-spontaneously adherent monocytes. 
3.10.4. Effect of LPS and Cytokines on Steady State Concentrations of mRNA in 
Monocyte Subpopulations 
To investigate whether LPS and cytokines increased monocyte by increasing the 
transcription of the gene, spontaneously adherent and non-spontaneously adherent cells were 
incubated for 24 h with and without LPS, TNF, IFN and GM-CSF. Cytoplasmic RNA was extracted and dot- 
blot analysis was performed using the and ß-actin DNA probes. LPS and cytokines did not alter 
steady state mRNA concentrations in either the spontaneously adherent or non-spontaneously 
adherent monocytes (figures 51 and 52). 
These data suggest that LPS and cytokines up-regulate accumulation in spontaneously 
adherent monocytes by translational or post-translational mechanisms rather than by increasing the transcription 
of the gene. 
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Figure 50 
Steady State mRNA Concentrations in Monocytes 
Figure 50 Spontaneously adherent (cross hatched bars) and non-spontaneously adherent monocytes (solid bars) 
were cultured under basal conditions up to 48 h. Cytoplasmic RNA was extracted and subjected to dot-blot 
analysis using the and ß-actin DNA probes. The results for mRNA were expressed 
as ratios to the values for ß-actin mRNA to correct for variation in RNA yield. Error bars are SEM; n = 11 
donors. 
Figure 51 
Effect of LPS on Steady-State -Antitrypsin mRNA Levels in Monocytes 
Figure 51 Spontaneously adherent monocytes (cross hatched bars) and non-spontaneously adherent monocytes 
(solid bars) were cultured for 24 h. Cells were unstimulated (control) or stimulated with 1 of LPS. 
Cytoplasmic RNA was extracted and subjected to dot-blot analysis using the and ß-actin DNA 
probes. The results for mRNA were expressed as ratios to the values for ß-actin mRNA to 
correct for variation in RNA yield. Error bars represent SEM; n = 8 donors. 
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Figure 52 
Steady State Levels of mRNA in Monocytes 
Effect of Cytokines 
a. Spontaneously Adherent Monocytes 
b. Non-Spontaneously Adherent Monocytes 
Figure 52 a. Spontaneously adherent and b. non-spontaneously adherent monocytes were cultured for 24 h. 
Cells were unstimulated (control) or stimulated with TNF (1000 units/ml), IFN (1000 units/ml) or GM-CSF 
(50 units/ml). Cytoplasmic RNA was extracted and dot-blot analysis was performed using the 
and ß-actin probes. The results for mRNA were expressed as ratios to the values obtained for 
ß-actin mRNA to correct for variation in RNA yield. Error bars represent SEM; n = 8 donors. 
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Chapter 4 
Discussion 
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4.1. Overview 
In order for monocytes to participate in inflammatory responses, it is necessary for them to be recruited 
from the vasculature into tissues. This process involves directional migration of monocytes in response to 
chemoattractant factors released from inflammatory foci, and reversible adherence of monocytes to endothelial 
cells. The next barriers that monocytes encounter, as they migrate into sites of inflammation, are the 
extracellular matrix components of the basement membrane and the subendothelial space. It is clear that 
regulated and reversible adherence of monocytes to extracellular matrix macromolecules is also a prerequisite 
for the accumulation of these cells at sites of tissue inflammation (172,423). However, the biological and 
pathological factors that regulate monocyte adherence to extracellular matrix, and the mechanisms involved have 
not been fully elucidated. 
To begin to assess the pathobiological importance of alterations in monocyte adherence to extracellular 
matrix in inflammatory diseases, the adherence properties of monocytes from patients with an inflammatory lung 
disease (bronchiectasis) and healthy subjects to a representative matrix component (fibronectin) were compared. 
in addition, the effects upon monocyte adherence of various signal (LPS and cytokines) that are likely to be 
released at sites of infection and inflammation were assessed. The potential role of CD11/CD18 integrins in 
mediating monocyte adherence to fibronectin was investigated. Finally, the possibility was tested that there is 
a relationship between the adherence properties of monocytes and monocyte functions that are of biological and 
pathological importance at sites of inflammation. 
A minor subpopulation (20 to 25%) of monocytes from healthy subjects adhered spontaneously to 
fibronectin. The proportion of adherent monocytes from patients with bronchiectasis was 2 to 3-fold greater 
than that of healthy subjects. Moreover, the adherence properties of monocytes from patients with 
bronchiectasis were related to the severity of pulmonary infiammation in the patients. LPS and several cytokines 
up-regulated monocyte adherence to fibronectin. Furthermore, CD11/CD18 integrins were involved in 
mediating the adherence of monocytes from the patients and healthy subjects to fibronectin. Finally, there was 
a striking relationship between the adherence properties of monocytes and functions that are of biological and 
pathological importance at sites of inflammation. Adherent monocytes had an "inflammatory effector" phenotype 
and non-adherent monocytes had an "immune-modulatory'' phenotype. These data begin to provide insight into 
the mechanisms involved in the accumulation of monocytes at sites of infection and inflammation. 
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4.2. Monocyte Isolation 
To study the adherence properties of monocytes, it was necessary, first, to optimise the monocyte 
isolation procedure. Although countercurrent centrifugal elutriation (CCE) is the gold standard method for 
isolating monocytes (293,395), the equipment that is required for this technique is expensive and not universally 
available. Most investigators, therefore, isolate monocytes by the two step ficoll-Hypaque method which exploits 
differences in the densities and the adherence properties of monocytes when compared with other blood cells. 
The first step in the ficoll-Hypaque method involves centrifugation of blood through ficoll-Hypaque which is 
a continuous density gradient medium. This step separates the mononuclear cells from the other cellular 
components of blood, since monocytes and lymphocytes have similar densities which are lower than those of 
granulocytes and erythrocytes (59). An adherence step is then performed to separate monocytes, which are 
assumed to be adherent cells (4,169), from lymphocytes which are predominantly non-adherent cells (256). 
When the ficoll-Hypaque method was used to isolate monocytes for preliminary experiments, the yield 
of mononuclear cells provided by the ficoll-Hypaque density gradient step was close to the expected yield. 
However, only about 30% of the potential yield of monocytes were recovered following the adherence step. 
These data suggested that: 1) not all monocytes have the capacity to adhere in vitro; and 2) the use of an 
adherence step in the isolation procedure may result in the selection of a subpopulation of monocytes for study. 
To test the hypothesis that the use of an adherence step in the monocyte isolation procedure reduces 
the monocyte yield, the yield of monocytes isolated by the ficou-Hypaque method was compared with that 
obtained using Nycodenz osmotic and density gradient centrifugation, an alternative method that does not 
involve an adherence step (60). Nycodenz is a sterile solution of a tri-iodinated derivative of benzoic acid and 
is slightly hyperosmotic relative to plasma (mean osmolality 337 5 mOsmol). The Nycodenz procedure 
exploits the fact that although the densities of monocytes and lymphocytes overlap (and, therefore, it is not 
possible to establish a satisfactory separation using a continuous density gradient alone), monocytes have a lower 
mean density than lymphocytes. When blood cells are subjected to hyperosmotic conditions during Nycodenz 
gradient centrifugation, they expel water, shrink, and their density increases. In this respect, lymphocytes are 
more sensitive than monocytes and sediment to the bottom of the test-tube along with the erythrocytes and 
granulocytes, leaving the monocytes at the top of the gradient. The Nycodenz method, therefore, does not 
require an adherence step to separate monocytes from lymphocytes. 
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Monocytes were isolated from six healthy subjects by both the ficoll-Hypaque and Nycodenz methods. 
The average yield of monocytes from the Nycodenz method (2.4 x cells per millilitre of whole blood) was 
2-fold greater than that from the ficoll-Hypaque method (1.3 x cells per millilitre of whole blood) and 
represented 69% of the potential yield of monocytes. These monocyte yields are in excellent agreement with 
those reported by other investigators for both the Nycodenz (60,442) and ficoll-Hypaque (39) methods. 
The differences in the yield of monocytes isolated by the ficoll-Hypaque and Nycodenz methods could 
not be attributed to differences in the extent of lymphocyte or neutrophil contamination of the monocyte 
preparations since both methods provided monocytes that were greater than 90% pure, as assessed by modified 
Wright’s stained cytocentrifuge preparations. in addition, it is unlikely that the low yield of monocytes using 
the ficoll-Hypaque method was due to a reduction in the viability of the cells recovered by this technique since 
greater than 99% of the cells that failed to adhere during the adherence step were viable, as assessed by 
exclusion of trypan blue dye. It is likely that the lower yield of monocytes obtained by the ficoll-Hypaque 
method, when compared with the Nycodenz technique, is due to the fact that not all monocytes have the 
capacity to adhere in vitro since: 1) the yield of mononuclear cells obtained by ficoll-Hypaque gradient 
centrifugation was approximately 90% of the potential yield of mononuclear cells; and 2) only 36% of the 
potential yield of monocytes was recovered by the adherence step. This hypothesis is supported by the previous 
findings of Chen and coworkers (107) that: 1) 5 to 25% of non-adherent mononuclear cells are monocytes; and 
2) the yield of monocytes isolated by density gradient centrifugation and an adherence step can be increased 
3-fold by conducting the adherence step in the presence of LPS. These data indicate that the use of an 
adherence step in the monocyte isolation procedure results in the selection of a minor subpopulation of cells for 
study. 
The Nycodenz method failed to recover about 30% of the potential yield of monocytes. One possible 
explanation for this loss of monocytes is that these cells adhered to the vessels used in the isolation procedure. 
However, this possibility is unlikely since two measures are taken to minimise adherence of monocytes during 
isolation. First, all of the solutions used in the Nycodenz method (with the exception of the final washing 
solution) contain EDTA to chelate divalent cations. The rational for this is that the adherence properties of 
monocytes are dependent upon the presence of divalent cations (44). Second, the entire Nycodenz isolation 
procedure (with the exception of the initial dextran sedimentation step) is performed at 4°C which inhibits the 
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adherence of monocytes to biological substrates (363). An alternative explanation for the failure of the 
Nycodenz method to recover 30% of monocytes could be related to the fact that monocytes are heterogeneous 
in their densities (246,357). It is possible that the fraction of monocytes with the highest density sediments to 
the bottom of the test-tube along with the other cellular components of blood during the Nycodenz gradient step. 
To test this possibility, the cells that sedimented to the bottom of the test-tube during the Nycodenz isolation 
procedure were subjected to density gradient centrifugation to separate the mononuclear cells from the 
erythrocytes and granulocytes. Smears of these mononuclear cells stained for non-specific esterase activity 
confirmed that monocytes were present in this mononuclear cell layer. These data indicate that at least some 
of the monocytes that were not recovered by the Nycodenz method were lost as a result of their physical 
characteristics rather than their adherence properties. 
The Nycodenz isolation procedure was used, instead of the ficoll-Hypaque technique, to isolate 
monocytes for assessment of their adherence properties for three reasons. First, the adherence properties of 
Nycodenz-isolated monocytes are more likely to be representative of all monocytes than cells isolated by the 
ficoll-Hypaque method since: 1) the Nycodenz technique recovers about 70% of the potential yield of 
monocytes, whereas the ficoll-Hypaque recovers only a minor subpopulation (about 36%) of monocytes; and 
2) the ficoll-Hypaque method involves an adherence step and, therefore, selects for monocytes that have the 
capacity to adhere in vitro Second, to assess the adherence properties of ficoll-Hypaque-isolated monocytes, 
it would be necessary to detach the adherent monocytes by mechanical scraping (62,257) or chemical methods 
such as exposure to chelating agents (270) or local anaesthetics (371,377). These procedures could induce 
functional changes in the cells. In contrast, the Nycodenz method does not involve an adherence step and the 
adherence properties of these cells can be assessed directly. Third, it is likely that monocytes are exposed to 
LPS during the ficoll-Hypaque isolation procedure and this may influence their adherence properties in vitro 
since: i )  ficoll-Hypaque gradient medium is frequently contaminated with LPS (190); and 2) LPS’has been 
shown to affect the adherence properties of monocytes (141,390,486). In contrast, all of the solutions used in 
the Nycodenz isolation procedure contained concentrations of LPS that were below the lower limit of detection 
of the limulus amoebocyte lysate assay (10 pg/ml). 
To confirm the purity of Nycodenz-isolated monocytes, smears of monocytes were stained routinely with 
modified Wright’s stain and for non-specific esterase activity. The monocyte preparations were always greater 
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than 90% pure and contained less than 0.5% neutrophils, as assessed by these methods. In addition, 
immunohistochemistry was performed on smears of monocytes isolated from five donors, using monoclonal 
antibodies that recognise monocyte and lymphocyte surface antigens. The results confirmed that the monocyte 
preparations were greater than 90% pure and that the contaminating nucleated cells were predominantly 
lymphocytes. 
Monocytes isolated by the Nycodenz method are always contaminated with platelets but the extent of 
platelet contamination varies considerably from donor to donor. Although this platelet contamination can be 
reduced substantially by centrifuging the cells through autologous plasma, this step reduces the monocyte yield 
by 25 to 30% and, therefore, was not employed on a routine basis in this study. In all subsequent studies of 
monocyte function, additional experiments were undertaken to exclude the possibility that contaminating platelets 
interfered in the assays. 
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4.3. Monocyte Adherence Assay 
A quantitative assay was developed to assess the adherence of monocytes from healthy subjects and 
patients with bronchiectasis to a representative extracellular matrix component (fibronectin). Monocytes 
cells) were incubated in fibronectin-coated tissue culture dishes for 1 h at 37°C. The non-adherent cells were 
removed by washing the dishes in a standardised manner. The non-adherent cells were counted using a 
haemocytometer, and the percentage of adherent cells was calculated from this number and the initial number 
of cells. Preliminary experiments were conducted to optimise the monocyte adherence assay. 
4.3.1. Optimisation of the Monocyte adherence Assay 
Fìbronectin Substrate 
To determine the optimal coating concentration of fibronectin, monocytes were incubated in dishes 
coated with varying concentrations of fibronectin purified from human serum. A dose-related increase in 
monocyte adherence to fibronectin was observed with a maximum of 25% of the cells adhering to dishes coated 
with 20 of fibronectin. Specificity of monocyte binding to fibronectin was confirmed by control 
experiments in which 1) only 2% of monocytes adhered to dishes with human serum albumin; and 2) incubating 
fibronectin-coated dishes with rabbit anti-human fibronectin almost completely abrogated the subsequent 
adherence of monocytes, whereas non-immune rabbit had no effect. The addition of proteinase inhibitors 
to the adherence assay did not alter the proportion of adherent monocytes when compared with cells incubated 
in medium alone. These data indicate that the binding of monocytes to fibronectin is not limited by any 
degradation of the fibronectin Substrate that may be mediated by monocyte-derived proteinases during the assay. 
Other investigators have reported similar optimal coating concentrations of fibronectin for monocyte 
adherence (390). Moreover, the data on the adherence of monocytes from healthy subjects to fibronectin in 
this study are in close agreement to the previous findings of Brown and coworkers (63) that 25% of monocytes 
adhere spontaneously to fibronectin-coated plastic. The latter studies were performed using an alternative 
method to quantified monocyte adherence; monocytes were radiolabelled with "'Indium and the proportion of 
adherent cells was determined directly using a gamma counter. The results of Brown et al., therefore, support 
the validity of quantifying monocyte adherence by the indirect method that was used in the current study. 
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Alternative Sources of Fibronectin 
Several investigators have studied monocyte adherence to plastic coated with autologous serum or 
plasma (107,139,140). Human plasma and serum contain several proteins to which monocytes adhere including: 
i )  fibronectin (4463,390); 2) fibrinogen (500); 3) albumin (4%); 4) serum amyloid P component (4%); and 5) 
complement components (498). However, Bevilacqua et al. (44) showed by elegant depletion-repletion studies 
that when monocytes adhere to plastic coated with plasma or serum, they bind to the fibronectin component. 
Therefore, the adherence properties of monocyte to the following sources of human fibronectin were compared: 
1) fibronectin purified from human serum; 2) complement-depleted autologous serum; and 3) complement- 
depleted autologous plasma. A greater proportion of monocytes adhered to plastic coated with purified human 
serum fibronectin (22%) compared with autologous serum (15%) or plasma (14%). These data are in 
agreement with the findings of Setiadi et al. (412) that a greater number of monocytes adheres to tissue culture 
plastic that has been coated with purified human fibronectin compared with homologous plasma (412). 
It was surprising that a greater proportion of monocytes adhered to dishes coated with purified human 
serum fibronectin than to dishes coated with autologous serum or plasma, since the concentration of fibronectin 
in human plasma is 15 to 20-fold greater than the coating concentration of purified fibronectin that was used 
in this study (209). One possible explanation for these data is that when plastic is coated with plasma or serum, 
the albumin component competes with fibronectin for binding sites on the plastic surface, and thereby limits 
monocyte adherence. This hypothesis is supported by two observations: 1) the concentration of albumin is 100 
to 200-fold greater than the concentration of fibronectin in serum and plasma (129); and 2) the proportion of 
monocytes that adhered to human serum albumin was 10 to 12-fold lower than the proportion that adhered to 
fibronectin in the current study. This possibility could be investigated by comparing the proportion of monocytes 
that adhere to dishes coated with purified human fibronectin and purified human fibronectin that has been 
spiked with varying concentrations of human serum albumin. Since a greater proportion of monocyte adhered 
to purified human serum fibronectin compared with autologous serum or plasma, dishes were coated with the 
optimal concentration of purified human serum fibronectin (20 in all subsequent experiments. 
Culture Medium Additives 
Human monocytes are usually cultured in serum-containing media since they are fastidious cells and 
they are difficult to maintain in a viable state when culture in the absence of serum (8,234). Adherence assays 
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are most commonly performed in the presence of 10% [v/v] complement-depleted fetal calf serum (FCS); 
however, some investigators use alternative medium additives including: 1) human serum (35,44,322); 2) human 
serum albumin (HSA), (54,261,419); and 3) concentrations of autologous, homologous or heterologous serum 
as high as 20 to 25% [v/v], (107,219,390,398). To assess whether the source, type or concentration of culture 
medium additive affects monocyte adherence to fibronectin, the adherence properties of cells suspended in 
medium containing the following supplements were compared: 1) 10% and 25% [v/v] FCS; 2) 10% and 25% 
[v/v] autologous serum; and 3) 0.5% [w/v] HSA. 
A similar proportion of monocytes adhered to fibronectin in the presence of 10% [v/v] FCS, 10% [v/v] 
autologous serum and 0.5% [w/v] HSA. However, the proportion of adherent monocytes was reduced by 30% 
when the concentration of both FCS and autologous serum was increased from 10% [v/v] to 25% [v/v]. These 
data indicate that the concentration, rather than the source, of serum influences the adherence properties of 
monocytes in vitro These findings are in agreement with the findings of Doherty et a¿. (139) that there was 
a 70% reduction in the proportion of adherent monocytes when the adherence assay was conducted in the 
presence of 50% [v/v] plasma when compared cells incubated in the presence of with 10% [v/v] plasma or in 
the absence of plasma. 
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It is likely that inhibition of monocyte adherence occurs in the presence of relatively high concentrations 
of serum (25% [v/v] or higher) but in not the presence of 10% [v/v] serum since: 1) a similar proportion of 
monocytes adhered to fibronectin in the presence of 10% [v/v] FCS and 0.5% [w/v] HSA in the current study; 
and 2) a similar proportion of monocytes adhered to serum-coated plastic in the presence 10% [v/v] plasma and 
in the absence of plasma in Doherty’s study (139). The reduction in monocyte adherence that was induced by 
conducting the adherence assay in the presence of 25% [v/v] serum could be the result of plasma protein 
inhibition by a direct effect such as a stoichiometric competition for adherence sites on the monocyte, or a down- 
regulation of adherence sites on monocytes. The plasma protein(s) responsible for this inhibitory effect are not 
known but are unlikely to be: 1) components of the complement system since complement was 
inactivated (by heating to 56°C for 30 min) prior to assay; or 2) fibrinogen since inhibition of monocyte 
adherence was observed both in the presence of plasma in Doherty’s study (139), and in the presence of serum 
in the current study. It is possible that the fibronectin component of serum-containing medium binds to 
monocyte fibronectin receptors, and thereby inhibits monocyte adherence to the fibronectin immobilised on the 
186 
dish. Serum contains monovalent fibronectin whereas fibronectin adsorbs onto plastic in a multivalent form, 
and cells bind to immobilised, multivalent fibronectin with substantially greater affinity than to soluble 
monomeric fibronectin (254). Therefore, one possible explanation for the finding that inhibition of monocyte 
adherence occurred in the presence of 25% [v/v] serum but not in the presence of 10% [v/v] serum is that there 
is a sufficient concentration of soluble, monomeric fibronectin in medium containing 25% [v/v] serum (but not 
in medium supplemented with 10% [v/v] serum) to inhibit monocyte binding to immobilised fibronectin. 
Effect of Monocyte Number 
To assess the effect of dispensing different numbers of monocytes into fibronectin-coated dishes on 
monocyte adherence, 5 x to 3 x monocytes were incubated in fibronectin-coated dishes and the 
proportion of adherent monocytes was determined. When 5 x monocytes were added, 20% of the cells 
adhered to fibronectin-coated dishes. Visual assessment of the monocytes by phase-contrast microscopy 
confirmed the integrity of the underlying monocytes which adhered in an evenly distributed and non-aggregated 
pattern. The addition of up to 3 x monocytes did not alter either the proportion of adherent cells or the 
appearance of the cells that were adherent to the dishes. 
These data suggest that: 1) a minor subset of monocytes is intrinsically more adherent when compared 
with other monocytes; and 2) about 80% of monocytes remain in suspension during the assay because they have 
do not have the capacity to adhere spontaneously to fibronectin, rather than because there is insufficient 
fibronectin Substrate available to allow all of the cells to adhere. in view of these results, to 2 x 
monocytes were added to fibronectin-coated tissue culture dishes in subsequent experiments. 
4.32. Comparison of the Adherence Properties of Monocytes Isolated by Nycodenz and CCE 
Two potential problems were identified in assessing the adherence properties of monocytes isolated by 
the Nycodenz method. First, Nycodenz-isolated monocytes are always contaminated with platelets and one 
platelet product (platelet derived growth factor) has been shown to enhance monocyte adherence to endothelial 
cells (309). Therefore, it is possible that either the contaminating platelets or their products may influence the 
adherence of Nycodenz-isolated monocytes to fibronectin in vitro Second, it is possible that the adherence 
properties of Nycodenz-isolated monocytes reflect a functional alteration in the cells induced by the Nycodenz 
isolation procedure, rather than intrinsic differences in their adherence properties. Third, the Nycodenz 
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procedure fails to recover about 30% of the potential yield of cells, and it is possible that the adherence 
properties of the cells recovered by the Nycodenz method are not representative of all monocytes. 
investigate these possibilities, the adherence properties of monocytes isolated from healthy subjects by Nycodenz 
method were compared with those of monocytes isolated by: 1) the Nycodenz method followed by centrifugation 
through autologous plasma to remove platelets; and 2) CCE, which is the gold standard method for isolating 
monocytes. The proportion of monocytes that adhered spontaneously to fibronectin was similar for cells isolated 
by the three methods (20 to 25%). These results indicate that: 1) the contaminating platelets do not influence 
the adherence of Nycodenz-isolated monocytes to fibronectin in vitro; and 2) the Nycodenz procedure itself does 
not alter the subsequent adherence of monocytes to fibronectin in vitro Moreover, since CCE recovers a higher 
To 
proportion 
of the potential yield of monocytes (personal communication; Professor EJ. Campbell, University of Utah, 
Salt Lake City, Utah, U.S.A.), these data indicate that the adherence properties of the monocytes recovered by 
Nycodenz (about 70% of the potential yield) are representative of all monocytes. 
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4.4. Comparison of the Adherence Properties of Monocytes from Healthy Subjects 
and Patients with Bronchiectasis 
4.4.1. Adherence Properties of Monocytes from Healthy subjects 
To investigate the adherence properties of monocytes from healthy subjects, cells were isolated from 
six healthy donors on six occasions and the proportion of monocytes that adhered spontaneously to fibronectin 
under optimal assay conditions was determined monocytes suspended in medium supplemented with 10% 
[v/v] FCS were dispensed into dishes coated with 20 of fibronectin). The mean proportion of adherent 
monocytes from the six donors only varied between 20.0% and 22.8% when the cells were isolated on different 
occasions. Moreover, there was minimal within-donor variability in the adherence properties of monocytes from 
these donors. Although between-donor variability in spontaneous monocyte adherence to fibronectin was 
observed, the proportion of adherent monocytes only varied between 17 to 28%. These data indicate that only 
a minor subpopulation of monocytes from healthy subjects adheres spontaneously to fibronectin in vitro. 
Monocyte adherence to endothelial cells is a prerequisite for their recruitment from the vasculature into 
tissues. Therefore, to assess whether the capacity of monocytes to adhere to fibronectin in vitro reflects their 
potential to be recruited into tissues in vivo, monocyte adherence to fibronectin and human umbilical vein 
endothelial cell (HUVEC) monolayers was compared. Preliminary data, presented in Appendix 3, showed that 
a similar proportion (25%) of monocytes adhered spontaneously to fibronectin and to HUVEC monolayers. 
These data support the hypothesis that the capacity of monocytes to adhere to fibronectin in vitro reflects their 
potential to accumulate in tissues in vivo. Moreover, the data indicate that monocytes from healthy subjects are 
heterogeneous in their capacity to be recruited into tissues in vivo. 
4.4.2. Adherence Properties of Monocytes from Patients with Bronchiectasis 
To assess the effect of inflammation on monocyte adherence, the adherence properties of monocytes 
from healthy donors and patients with an inflammatory lung disease (bronchiectasis) to fibronectin were 
compared. On average, 20% of monocytes from healthy subjects adhered spontaneously to fibronectin. in 
comparison, the proportion of adherent monocytes from patients with bronchiectasis was 2 to 3-fold greater than 
that of healthy subjects. Moreover, the adherence properties of monocytes from bronchiectasis patients were 
related to the nature of the sputum produced by the patients, which in turn, has been shown to reflect the 
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severity of pulmonary inflammation (200). A greater proportion of monocytes from patients producing purulent 
sputum adhered to fibronectin compared with cells from patients producing mucoid or mucopurulent sputum. 
These data suggest that the increased adherence properties of monocytes may enhance the recruitment of 
monocytes into the lungs of patients with bronchiectasis. 
It is possible that soluble mediators that are released from sites of pulmonary infection and inflammation 
up-regulated the adherence of the patients’ monocytes to fibronectin since bacterial endotoxin has been shown 
to enhance the accumulation of leukocytes in vivo (140,308). Since the lungs of patients with bronchiectasis are 
often colonised with gram negative bacteria which are the source of endotoxin, plasma samples from patients 
with bronchiectasis were assayed for endotoxin activity. The data show that endotoxin activity was detected in 
all of the plasma samples from patients with bronchiectasis but not in plasma from healthy subjects. These 
results suggest that endotoxin is released from the lungs of patients with bronchiectasis and plays a role in 
activating circulating monocytes to adhere to fibronectin in vitro. This hypothesis is strengthened by the 
additional findings that: 1) plasma endotoxin concentrations increased with increasing chical evidence of airway 
inflammation; and 2) there was a striking correlation between the level of endotoxaemia in bronchiectasis and 
the capacity of the patients’ monocytes to adhere to fibronectin in vitro. 
4.43. Effect of Pro-Inflammatory Mediators on Monocyte Adherence 
To explore the potential role of LPS in vivo in increasing monocyte adherence in the patients, 
monocytes from healthy subjects were incubated with LPS. LPS exposure in vitro stimulated monocytes from 
healthy subjects to adhere to fibronectin. LPS from E. coli 0111:B4 produced a dose-related increase in the 
adherence of healthy monocytes to fibronectin with a maximum of 56 to 65% of cells adhering in the presence 
of 1 of LPS. This was similar to the proportion of monocytes from purulent patient group that adhered 
spontaneously. These data provide further support for the hypothesis that monocytes from patients with 
bronchiectasis may have been activated to adhere to fibronectin in vitro by exposure to LPS in vivo. 
The effects of LPS from E. coli 0111:B4 and H .  influenzae on monocyte adherence to fibronectin were 
compared since: 1) the lungs of patients with bronchiectasis are usually colonised with several bacterial species 
and it is likely that circulating monocytes of patients with bronchiectasis are exposed to LPS from more than 
one bacterial species in vivo; and 2) LPS from different bacterial species have different regulatory effects on 
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several neutrophil functions in vitro (247). LPS from both bacterial species produced a dose-related increase 
in monocyte adherence to fibronectin and stimulated a maximum of about 65% of monocytes to adhere at a 
concentration of 1 However, at suboptimal concentrations of LPS, monocytes were found to be more 
responsive to the effects of LPS from H. influenzae when compared with LPS from E. coli. This latter finding 
was of particular interest since H.  influenzae is a common pathogen in bronchiectasis (297) and the biological 
effects of LPS from this bacterial species are likely to be relevant to the pathophysiology of bronchiectasis. It 
is likely that monocytes also vary in their responsiveness to LPS released from other gram negative bacterial 
species that colonise the lungs of patients with bronchiectasis. 
The effect of LPS from E. coli 0111:B4 on the adherence of monocytes from patients with 
bronchiectasis was also assessed. LPS stimulated further increases in the adherence of monocytes from patients 
with bronchiectasis, indicating that monocytes from the patients had been less than maximally activated in vivo. 
However, even in the presence of optimal concentrations of LPS, a greater proportion of monocytes from the 
patients adhered to fibronectin compared with LPS-treated cells from healthy subjects. These data indicate that 
factors in addition to LPS may have activated the patients’ monocytes in vivo. 
To begin to address the importance of additive effects of in vivo signals, the effect of several 
recombinant cytokines on monocyte adherence to fibronectin were assessed. GM-CSF, IFN and TNF increased 
the adherence of monocytes from healthy subjects to fibronectin. Moreover, cytokines (TNF and IFN) and LPS 
produced additive effects on monocyte adherence. These results suggest that LPS and various cytokines, when 
released from foci of infection and inflammation in the Iungs of patients with bronchiectasis, activate circulating 
monocytes to produce increased adherence of the cells to extracellular matrix components. 
The data show that the adherence of monocytes from patients with bronchiectasis is greater than cells 
from healthy subjects and is related to the severity of airway inflammation in bronchiectasis. Aithough it has 
been shown previously that a greater proportion of monocytes from patients with insulin-dependent diabetes 
mellitus adhere to fibronectin compared with monocytes from healthy subjects (412), there have been no 
previous studies of monocyte adherence in inflammatory disease states. It is unlikely that the results in the 
current study are due to the age difference between the patients and healthy controls (Methods, section 2.6.) 
since Setiadi et a¿. (412) showed that the age of the donor does not affect monocyte adherence to fibronectin. 
It is likely that the increased adherence of monocytes from patients with bronchiectasis in vitro is the result of 
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the release of LPS and cytokines from sites of airway infection and inflammation in vivo. 
In the current study endotoxin activity was measured in plasma from all of the patients with 
bronchiectasis and was related to the severity of airway inflammation. Other investigators have used a 
qualitative limulus assay to demonstrate that endotoxin activity was present in plasma from 50% of patients with 
bronchiectasis (208). However, endotoxin concentrations in plasma from bronchiectatic patients have not been 
quantified previously, or related to the severity of airway inflammation. 
Two problems have been identified when the limulus assay is used to measure LPS concentrations in 
plasma. First, plasma samples frequently contain non-specific activators and inhibitors of the limulus enzyme 
(115). However, in this study, measures were taken to minimise the effects of these factors; dilution and heat 
inactivation of the plasma samples (115). Second, LPS from different bacterial species differ in their capacity 
to activate the limulus enzyme (115). Although the lungs of patients with bronchiectasis are usually colonised 
with several gram negative bacterial species, LPS from E. coli 0111:B4 was used as the only reference standard 
in the assay. Therefore, the results in the current study do not necessarily reflect the absolute quantity of 
circulating endotoxin in our patients. However, the results demonstrate clearly that endotoxin activity is present 
in the plasma of bronchiectatic subjects and is related to the severity of airway inflammation. 
In the current study, LPS stimulated a 3-fold increase in the proportion of adherent monocytes. These 
data are in agreement with the studies of Chen and coworkers (107) who showed that LPS exposure results in 
a 3-fold increase in the yield of monocytes isolated by adherence to serum-coated plastic. Recent data from 
Roth and coworkers (390) differed somewhat from the results of the current study since they found monocyte 
adherence to be less responsive to LPS; they reported only a 2-fold increase in adherence following exposure 
to a 50-fold higher LPS concentration than were maximally effective in the current study. These differences 
were not due to the use of LPS from different bacterial species since Roth and coworkers also investigated the 
effects LPS from E. coli 0111:B4 on monocyte adherence. It is likely that technical differences in the monocyte 
separation procedures explain the relatively lower LPS responsiveness reported by Roth and coworkers. In their 
report: 1) the monocyte separation procedure itself involved an adherence step; and 2) the separation procedure 
included exposure to ficoll-Hypaque which is contaminated frequently with LPS (190). Thus, it is likely that 
the monocytes in the study of Roth and coworkers were partially activated during isolation and were 
consequently less responsive to LPS in the subsequent fibronectin adherence assay. 
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The different responsiveness of monocytes to LPS from E. coli and H .  influenzae is not surprising since 
Kharazmi et al. (247) showed recently that LPS purified from multiple strains of a single bacterial species (P. 
aeruginosa) produces different regulatory effects on neutrophil function in vitro. The differences in the 
biological effects of LPS from the different bacterial strains in Kharazmi’s study were related to differences in 
the chemical composition of LPS, in particular: i) in the rhamnose and heptose content of the 0-group sugar 
side chain; and 2) in the alanine content of the core region. It has been postulated that the chemical structure 
of LPS plays a decisive role in the binding of LPS by leukocytes (240). LPS has been shown to bind to 
monocytes by specific and non-specific mechanisms (314). Specific interactions result from the binding of LPS 
to specific receptors on the plasma membrane of the monocyte and are believed to be mediated by the 0- 
antigen and core polysaccharide components of the LPS molecule. Non-specific binding of LPS to the plasma 
membrane is probably the most common mechanism by which LPS enters the monocyte (NO), and probably 
results from the interaction of the hydrophobic lipid A portion of the LPS with the plasma membrane 
phospholipids, leading to solubilisation of the LPS lipids into the membrane (413). It has been postulated that 
differences in the carbohydrate and lipid composition of LPS result in differences in the capacity of LPS to bind 
to monocytes which, in turn, may account for the different biological activities of LPS from different species and 
strains of bacteria (489). It is likely that differences in the chemical composition of LPS from E. coli and H .  
influenzae account for differences in monocyte responsiveness in the current studies. 
The endotoxin activity measured in plasma from the bronchiectatic patients was three orders of 
magnitude lower than that required to stimulate maximal adherence of healthy monocytes. There are several 
possible explanations for this discrepancy. First, monocytes passing through the pulmonary circulation in patients 
with bronchiectasis are likely to be exposed to higher local concentrations of LPS than were measured in plasma 
derived from venous blood. Second, it is likely that circulating monocytes in patients with bronchiectasis are 
exposed to LPS from bacterial species and strains other than those studied here, and it is possible that these 
endotoxins are more potent at activating monocytes in vivo than LPS from E. coli and Haemophilus influenzae. 
Third, the concentrations of endotoxin measured in the plasma from patients with bronchiectasis may not reflect 
the absolute quantity of circulating endotoxin, for the reasons stated previously. Fourth, it is likely that 
circulating monocytes in patients with bronchiectasis are also activated by cytokines that are released from the 
inflammatory sites, since several cytokines stimulated monocyte adherence in vitro and had additive effects with 
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LPS in the current study. Further support for this latter possibility is provided by the findings of Suter et a¿. 
(434) who detected several cytokines (TNF, and in plasma from patients with 
bronchiectasis due to cystic fibrosis. Local release of such cytokines in patients with chronic airway 
inflammation can be expected to have a variety of other effects, including amplifying the inflammatory response 
(310), and stimulating degranulation of inflammatory cells (253). In addition, LPS stimulates the release of 
cytokines such as TNF, GM-CSF from mononuclear phagocytes in vitro (106,441). Thus endotoxin released at 
sites of airway infection and infiammation may also increase the adherence of circulating monocytes indirectly, 
by stimulating the release of cytokines from monocytes and macrophages located in the airways and 
peribronchial space in patients with bronchiectasis. 
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4.5. Mechanisms Involved in Monocyte Adherence to Fibronectin 
The mechanisms involved monocyte adherence to fibronectin were investigated. Monocyte adherence 
to extracellular matrix components has been thought to be mediated predominantly by the B1 or "very late 
antigens" (VLA) subfamily of heterodimeric integrin receptors (216,300). The VLA receptors share a common 
ß1 chain which associates with different a chains ( a l  to (197). For example, VLA 5 is thought to 
be the most important integrin that mediates monocyte adherence to fibronectin by binding to Arg-Gly-Asp 
(RGD) sequences in the cell-binding domain of fibronectin (63,195,256,368). However, recent studies have 
shown that specific anti-VLA 5 antibodies and RGD-containing peptides fail to inhibit monocyte adherence to 
fibronectin completely, indicating that other integrins may also be involved (256). 
The CD11/CD18 or ß2 subfamily of integrins is involved in mediating the adherence of monocytes to 
endothelial cells (216). The possibility that CD11/CD18 integrins are involved in mediating monocyte adherence 
to fibronectin was considered since: 1) LPS, TNF and GM-CSF stimulated monocytes to adhere to fibronectin 
in the current study; and 2) other investigators have shown that LPS, TNF and GM-CSF increase monocyte cell- 
surface expression of CD11/CD18 integrins (309,419). Moreover, Bohnsack et al. (55) demonstrated that 
CD11/CD18 integrins are involved in mediating the adherence of stimulated (but not unstimulated) neutrophils 
to several extracellular matrix components. 
The data in the current study show clearly that CD11/CD18 integrins are involved in mediating 
monocyte adherence to fibronectin, since an anti-CD18 antibody produced substantial inhibition of both basal 
and LPS-stimulated adherence of monocytes to fibronectin. In contrast, control antibodies that bind to other 
monocyte surface antigens had no effect on monocyte adherence. Similarly, non-immune murine IgG also failed 
to inhibit monocyte adherence. Together, these control experiments exclude the possibilities that the anti-CD18 
antibody blocked monocyte adherence non-specifically, for example by stearic hinderance or through Fc receptor 
interactions. Inhibition of monocyte adherence by anti-CD18 was incomplete, indicating that either: 1) the CD18 
antibody is not 100% efficient; or 2) other integrins also play a role in monocyte adherence to fibronectin. 
Many integrins recognise and bind to RGD sequences within ligands, and some CD11/CD18 
recognition events have been shown to be RGD-dependent (498). To assess the role of RGD-dependent 
integrins, monocytes were incubated with a synthetic RGDS peptide. RGDS, but not a control peptide, 
produced a dose-dependent inhibition of both basal and LPS-stimulated adherence of monocytes to fibronectin. 
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However, RGDS also failed to inhibit monocyte adherence to fibronectin completely, suggesting that monocyte 
adherence to fibronectin has both RGD-dependent and RGD-independent components. Furthermore, since 
optimal concentrations of RGDS and anti-CD18 together resulted in greater inhibition of basal and LPS- 
stimulated adherence than either alone, CD11/CD18-mediated monocyte adherence to fibronectin is, at least 
in part, RGD-independent. 
The mechanisms involved in the adherence of monocytes from patients with bronchiectasis to fibronectin 
were also investigated. The data showed that CD11/CD18 integrins are also involved in mediating the 
adherence of monocytes from the patients to fibronectin since the anti-CD18 antibody, but not a control 
antibody, produced substantial inhibition of the adherence of monocytes from patients with bronchiectasis to 
fibronectin. However, anti-CD18 mediated inhibition was again incomplete, indicating that other integrins may 
be involved. In addition, RGDS (but not a control peptide), also resulted in substantial but incomplete inhibition 
monocyte adherence to fibronectin. Furthermore, optimal concentrations of anti-CD18 and RGDS together 
resulted in greater inhibition than either alone. These data indicate that monocytes from patients with 
bronchiectasis adhere to fibronectin by both RGD-dependent and RGD-independent mechanisms, and that 
CD11/CD18-mediated adherence of the patients’ monocytes to fibronectin is, at least in part, RGD-independent. 
The mechanism(s) by which LPS and cytokines up-regulate the adherence of monocytes to fibronectin 
is unknown. However, LPS and cytokine-stimulated adherence of normal monocytes to fibronectin was maximal 
within 30 min and is likely to be independent of new protein synthesis. Monocytes have been shown to have 
an intracellular store of preformed CD11/CD18 integrins within peroxidase negative granules (309,419). 
Furthermore LPS, GM-CSF and TNF increase the expression of CD11/CD18 integrins rapidly by stimulating 
the fusion of these granules with the plasmalemma (182,309,419). It is possible that exposure of monocytes to 
LPS and cytokines in vitro or in vivo increases the expression of CD11/CD18 integrins, resulting in increased 
adherence of monocytes to fibronectin. This concept is supported by the findings of Setiadi et al. (412) that 
monocytes from diabetic subjects adhere in greater numbers to fibronectin and have increased expression of 
CD11b/CD18 compared with cells from healthy subjects. 
Cytokines and optimal concentration of LPS produced additive effects on the adherence of monocytes 
to fibronectin, indicating that LPS and cytokines stimulate monocyte adherence through different mechanisms. 
In this respect it is of interest that CD11/CD18 integrins possess a binding site for LPS that is distinct from the 
196 
RGD-binding site (497). It is possible that binding of LPS to this site results in increased receptor affinity for 
fibronectin rather than increased receptor expression. 
In summary, these data show that soluble mediators that are released from sites of infection and 
inflammation have the capacity to alter monocyte adherence to extracellular matrix components, and thereby 
may regulate the accumulation of monocytes in the lungs of patients with bronchiectasis. The activation of 
circulating monocytes may promote resolution of tissue infection and inflammation. However, the lungs of 
patients with bronchiectasis remain colonised with bacteria despite the increased capacity of monocytes to 
adhere. Since monocytes contain proteolytic enzymes that are capable of degrading connective tissue (81), it 
is possible that excessive recruitment of monocytes may initiate or potentiate tissue damage. Moreover, once 
tissue damage has been established, the disease may progress in some patients with bronchiectasis as a result 
of a continuing "vicious circle". Tissue damage impairs mucociliary clearance leading to mucous retention (279). 
Bacterial colonisation and phagocyte recruitment into the lung then ensue (124) which result in tissue damage, 
thereby completing the vicious circle. 
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4.6. Monocyte Phenotype Evaluations 
The initial data showed that monocytes from healthy subjects are heterogeneous in their capacity to 
adhere to fibronectin. Since movement of cells through tissues depends upon regulated adherence of the cells 
to extracellular matrix macromolecules (172,423), the data suggest that monocytes are heterogeneous in their 
ability to accumulate at sites of infection and inflammation. This hypothesis is supported by the preliminary 
finding that a similar proportion of monocytes adhered to fibronectin and to endothelial cell monolayers in vitro 
(Appendix 3). 
Four subpopulations of monocytes were identified by their differential adherent properties. A minor 
subpopulation of monocytes (20 to 25%) adheres spontaneously to fibronectin (spontaneously adherent 
monocytes); of the monocytes that do not adhere to fibronectin under basal conditions (non-spontaneously 
adherent cells), a proportion (41 to 56%) can be stimulated to adhere by LPS (LPS-adherent monocytes), while 
the remainder cannot (non-adherent monocytes). The authenticity of these subpopulations was confirmed by 
the finding that each retained its original adherence properties when subjected to a second identical adherence 
assay. To assess the biological relevance of these monocytes subpopulations, further studies were conducted 
to determine whether there is a relationship between the capacity of monocytes to adhere to fibronectin and 
phenotypes that are of biological importance at sites of infection and inflammation. 
Antimicrobial Function of the Monocyte Subpopulations 
The antimicrobial phenotypes of the monocyte subpopulations were compared since monocytes have 
important antimicrobial functions at sites of infection and inflammation (236,267). The antimicrobial phenotypes 
evaluated were phagocytic activity, and primary and secondary oxidative responses (superoxide anion release 
and peroxidase activity, respectively). The capacity of monocytes to adhere to fibronectin was related to these 
antimicrobial functions. The spontaneously adherent monocytes were more active than the non-adherent 
monocytes with respect to phagocytosis, superoxide release and peroxidase content (14-fold, 2-fold and 20-fold, 
respectively). Furthermore, the LPS-adherent cells had an intermediate antimicrobial phenotype; the LPS- 
adherent cells were 4-fold more actively phagocytic, contained 2-fold more peroxidase activity, but released 
similar amounts of superoxide anion when compared with the non-adherent monocytes. 
To control for possible direct effects of LPS on the non-spontaneously adherent cells, spontaneously 
adherent monocytes were also pre-incubated with LPS prior to assessment of their antimicrobial function. Pre- 
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incubation with LPS did not alter superoxide release or Peroxidase content of the spontaneously adherent cells. 
LPS exposure did result in a significant reduction in phagocytic activity; however, the LPS-stimulated 
spontaneously adherent cells were still more actively phagocytic than the non-spontaneously adherent, LPS- 
adherent and non-adherent monocytes. LPS may be somewhat toxic to freshly-isolated monocytes since it has 
been reported to decrease the synthesis of intracellular and secreted proteins (77). Although exposure of 
monocytes to LPS was not associated with a reduction in cell viability, as assessed by exclusion of trypan blue, 
the reduction in phagocytic activity of the spontaneously adherent cells on exposure to LPS could represent a 
more subtle toxic effect of LPS. These data indicate that circulating monocytes are heterogeneous with respect 
to antimicrobial functions, and that there is a relationship between these and the adherence properties of 
monocytes. 
The differences in antimicrobial functions between the monocyte subpopulations could not be explained 
by differences in cell viability or by neutrophil or lymphocyte contamination of the monocyte preparations (less 
than 0.5% and 9%, respectively). It is possible that a subpopulation of monocytes could have been activated 
differentially during the Nycodenz isolation procedure. However, this is unlikely since preliminary results on 
monocytes isolated by CCE confirm that a minor subpopulation of monocytes adheres spontaneously to 
fibronectin and that there is a relationship between monocyte adherence and superoxide anion release (Appendix 
4). The possibility remains that the subpopulation of monocytes that did not adhere in the presence of LPS 
were damaged despite their viability, as assessed by exclusion of trypan blue dye. 
Although the phagocytic activity of adherent and non-adherent monocytes has not been compared 
previously, it has been shown that monocytes adherent to immobilised fibronectin have enhanced C3-mediated 
phagocytic activity compared with cells adherent to human serum albumin (4%). It is possible that the 
interaction of fibronectin receptors with immobilised fibronectin on the basal surface of the monocyte serves 
to activate or to increase the expression of receptors for phagocytosis on the apical surface, resulting in increased 
phagocytic activity of the adherent monocyte subpopulations. Whatever the explanation for these differences, 
the data suggest that LPS released from gram negative bacteria at sites of inflammation, may stimulate the 
accumulation of a subpopulation of monocytes with an enhanced capacity to ingest microbes, tissue debris and 
effete cells, and thereby promote the resolution of tissue infection and inflammation. 
Although superoxide release by the spontaneously adherent cells in this study was similar to values 
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reported for superoxide release by monocytes adherent to plastic and collagen (330), superoxide release by non- 
adherent monocytes has not been measured previously. B-cytochrome, which is involved in superoxide 
generation, is located within the same intracellular granules as ß2 integrins (56). It is possible that monocytes 
with the capacity to adhere to fibronectin spontaneously are enriched for these granules. Alternatively, it is 
possible that spontaneously adherent monocytes have been activated in vivo, resulting in the translocation of 
these granules to the plasmalemma. This, in turn, could not only increase their surface expression of fibronectin 
receptors and promote their adherence to fibronectin, but also facilitate interaction of b-cytochrome with the 
plasmalemma-associated NADPH oxidase system, and thereby increase superoxide anion release by these cells. 
The peroxidase content of adherent and non-adherent monocytes has not been compared previously. 
However, marked heterogeneity in monocyte staining for peroxidase has been demonstrated; 20% of monocytes 
stain intensely for peroxidase activity, 60% of monocytes are unstained and the remainder vary greatly in 
staining intensity (242). The mechanism for the differences between the subpopulations in the current study 
is not known; however, it is unlikely to be due to differential release of peroxidase activity during the adherence 
assays, since minimal enzyme activity was detected in the culture supernatants. It is possible that monocytes 
with the capacity to adhere are enriched for peroxidase containing granules since it has been shown that 
monocytes are heterogeneous in their content of peroxidase positive granules (9). This possibility could be 
tested by performing peroxidase histochemistry on cytocentrifuge preparations of the monocyte subpopulations. 
Whatever the explanation for the differences in superoxide anion production and peroxidase content 
among the monocyte subpopulations, the data suggest that LPS released from gram negative bacteria at sites 
of infection, may stimulate the accumulation of a subpopulation of monocytes with an enhanced capacity to kill 
microbes, and thereby promote resolution of tissue infection and inflammation. 
The data demonstrate that there is a striking relationship between the adherence properties of 
monocytes and several important antimicrobial functions. It is possible that functionally distinct subpopulations 
of monocytes exist, with adherent cells possessing an "inflammatory effector" phenotype. Alternatively, the 
subpopulations may represent a continuous spectrum of monocyte function. These functional differences could 
be related to differences in maturation, differentiation or activation. These possibilities are discussed later (4.8.). 
in conclusion, the data show clearly that monocytes are heterogeneous with respect to their adherence 
properties. In addition, there is a striking relationship between: 1) the capacity of monocytes to adhere to 
200 
fibronectin in vitro, which may relate to their potential to be recruited into tissues in vivo; and 2) various 
antimicrobial functions that are of biological importance at sites of infection and inflammation. Furthermore, 
LPS released from gram negative bacteria at sites of inflammation may stimulate the recruitment of cells with 
an "inflammatory effector" phenotype, and thereby promote the resolution of tissue infection and inflammation. 
HLA-DR Antigen Expression by the Monocyte Subpopulations 
Mononuclear phagocytes are important antigen presenting cells for T lymphocytes and play a critical 
role in the regulation of immunological responses (454). It has been shown that the amount of HLA-DR antigen 
expressed by the mononuclear phagocyte correlates directly with their antigen presenting capacity (454,296,507). 
Therefore, to assess whether the ability of monocytes to adhere to fibronectin is related to their capacity to 
present antigen to lymphocytes, monocytes were labelled with I3, a murine monoclonal antibody that recognises 
non-polymorphic HLA-DR antigen (443), using the indirect immunofluorescence technique. 
An initial assessment of HLA-DR antigen expression by pool monocytes by phase-contrast and 
epifluorescence microscopy demonstrated that the majority of monocytes (greater than 90%) expressed HLA- 
DR antigen. However, there was marked heterogeneity in HLA-DR antigen expression by monocytes. The 
monocyte subpopulations were subsequently labelled with i3 antibody, and I3 binding was quantified by flow 
cytometry. There was an indirect relationship between the capacity of monocytes to adhere spontaneously to 
fibronectin and the expression of the HLA-DR antigen recognised by I3 since the mean fluorescent intensity 
of the non-spontaneously adherent monocytes was 3-fold greater than that of the spontaneously adherent cells. 
Moreover, the non-spontaneously adherent and spontaneously adherent monocytes expressed 6-f old and 2-f old 
more HLA-DR antigen, respectively, than the pool monocytes. However, there were no significant differences 
in the expression of HLA-DR antigen by non-spontaneously adherent, LPS-adherent and non-adherent 
monocytes. There was minimal staining of pool cells that were incubated with non-immune murine IgG which 
excluded the possibility that I3 antibody bound to monocytes by a non-specific mechanism such as Fc receptor 
interactions. To control for possible direct effects of LPS on HLA-DR antigen expression by non-spontaneously 
adherent monocytes, pool monocytes were pre-incubated with LPS. Pre-incubation of pool monocytes with LPS 
did not alter their expression of HLA-DR antigen. 
In the initial experiment, the spontaneously adherent and non-spontaneously adherent monocytes 
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expressed more HLA-DR antigen than the pool monocytes. It is possible that this increased HLA-DR antigen 
expression by the monocyte subpopulations was temperature-related since: 1) the adherence assay to separate 
the spontaneously adherent and non-spontaneously adherent cells was performed at 37°C whereas the pool cells 
were held at 4°C for the duration of this assay; and 2) it has been shown previously that incubation of 
monocytes at 37°C alters their expression of several surface antigens (146). To test the hypothesis that 
incubation of monocytes at 37°C induces their expression of HLA-DR antigen, pool monocytes were incubated 
at 4°C and 37°C for 1 h prior to labelling with I3 antibody. Monocytes incubated at 37°C expressed 2-fold more 
HLA-DR antigen than cells incubated at 4°C. These data support the hypothesis that the expression of HLA- 
DR antigen by monocytes is influenced by incubation temperature. This hypothesis is supported further by the 
subsequent finding that the expression of HLA-DR antigen by pool monocytes was similar to that of the non- 
spontaneously adherent, LPS-adherent and non-adherent monocytes when the pool cells were incubated at 37°C 
for the duration of the adherence assays. 
These data indicate that: 1) monocytes are heterogeneous in their capacity to present antigen to 
lymphocytes; 2) there is a striking indirect relationship between the capacity of monocytes to adhere 
spontaneously to fibronectin in vitro and their capacity to present antigen to lymphocytes; and 3) HLA-DR 
antigen expression by monocytes is influenced by incubation temperature during short-term culture. Other 
investigators have demonstrated that all monocytes express HLA-DR antigens in widely varying amounts (421); 
however, HLA-DR antigen expression by adherent and non-adherent monocytes has not been compared 
previously. The data on the effects of temperature on HLA-DR antigen expression by monocytes in the current 
study are in agreement with the previous findings of Smith et al. (421) that: 1) the expression of HLA-DR 
antigen by monocytes increases 2 to 3-fold when monocytes are incubated for 12 h at 37°C compared with 
freshly-isolated cells; and 2) this increase in HLA-DR antigen expression can be inhibited by incubating the cells 
at 2°C. 
Exposure to LPS did not alter HLA-DR antigen expression by monocytes in the current study. In 
contrast, Steeg et al. (427) reported that LPS inhibits HLA-DR antigen expression by macrophages. It is likely 
that technical factors may explain these differences in LPS responsiveness since: 1) Steeg and coworkers studied 
murine macrophages that had been stimulated with IFN, whereas unstimulated human monocytes were used in 
the current study; and 2) Steeg and coworkers incubated their cells with LPS for 48 h, whereas monocytes were 
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incubated with LPS for only 1 h in the current study. 
The difference in HLA-DR antigen expression between the spontaneously adherent and non- 
spontaneously adherent monocytes could not be attributed to differences in cell viability, or by neutrophil or 
lymphocyte contamination of the monocyte preparations (less than 0.5% and 9%, respectively). In addition, 
the difference in HLA-DR antigen between spontaneously adherent and non-spontaneously adherent monocytes 
was not temperature-related since both subpopulations were incubated under identical conditions during isolation 
and labelling with I3 antibody. In addition, these differences are unlikely to be due to differences in cell size 
between the subpopulations of monocytes since: 1) there were no significant differences in mean forward scatter 
for the subpopulations; and 2) Dransfield et al. (146) showed that the mean cell volume of adherent monocytes 
is similar to that of pool monocytes. 
The mechanism(s) for the differences in HLA-DR antigen expression by the spontaneously adherent 
and non-spontaneously adherent monocytes are not known. However, it is possible that these differences reflect 
variations in the states of activation of the cells since the pro-inflammatory mediators that stimulated monocytes 
to adhere to fibronectin in this study (LPS, TNF, GM-CSF and IFN) have also been shown to regulate HLA-DR 
antigen expression by monocytes (159,202,277,427,469). Therefore, it is possible that the differences in the 
adherence and immune regulatory properties among the monocytes subpopulations reflect differences in the 
profile of mediators to which these subpopulations were exposed in vivo. Alternatively, these differences may 
reflect variations in the maturational states of the cells since there is a progressive reduction in HLA-DR antigen 
expression by monocytes during maturation in vitro for greater than 24 h (421,463). Finally, it is possible that 
distinct subpopulations of monocytes exist, with the non-spontaneously adherent cells possessing an "immune 
modulatory" phenotype. These possibilities are discussed later (4.8) 
Whatever the explanation for the differences in HLA-DR antigen expression between spontaneously 
adherent and non-spontaneously adherent monocytes, it is clear that monocytes are heterogeneous in their 
capacity to present antigen to lymphocytes. In addition, there is an striking indirect relationship between the 
ability of monocytes to adhere to fibronectin (which may be related to their capacity to be recruited into 
inflammatory foci) and their capacity to present antigen to lymphocytes. Moreover, LPS and other mediators 
that are released from sites of inflammation may stimulate the recruitment of monocytes with an "immune 
modulatory" phenotype, and thereby promote the resolution of tissue infection and inflammation. 
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Total Protein Content of the Monocyte Subpopulations 
There was also a relationship between the adherence properties of monocytes and their total protein 
content. The spontaneously adherent cells contained 50% more protein than the non-spontaneously adherent 
cells which contained similar amounts when compared with pool, LPS-adherent and non-adherent monocytes. 
Although the total protein content of adherent and non-adherent monocytes has not been quantified 
previously, other investigators have shown that monocytes are heterogeneous in their content of protein (10). 
The higher total protein content of spontaneously adherent monocytes could not be explained by differences in 
cell viability, since all of the monocytes subpopulations were greater than 99%, as assessed by exclusion of 
trypan blue dye. In addition, the results could not be explained by contamination of the monocyte preparations 
with platelets or other leukocytes since: 1) the monocytes were isolated by CCE and were not contaminated with 
platelets; and 2) the monocytes preparations all contained less than 0.5% neutrophils and less than 9% 
lymphocytes. Furthermore, the higher total protein content of the spontaneously adherent cells could not be 
attributed to solubilisation of the fibronectin substrate along with the cells during preparation of the cell extracts 
since: 1) minimal amounts of protein were detected in extracts made in identical fibronectin-coated dishes that 
had not been incubated with monocytes; and 2) LPS-adherent cells contained similar amounts of protein when 
compared with the pool, non-spontaneously adherent and non-adherent monocytes. 
It is unlikely that the differences in total protein content of the monocyte subpopulations was due to 
differential rates of synthesis of protein by monocytes during the initial adherence assay, since this would require 
that the spontaneously adherent cells increase their protein content by 50% in 1 h. In addition, it is unlikely that 
these differences are duc to the secretion of protein by the non-spontaneously adherent monocytes during the 
adherence assays because these cells contained similar amounts of protein when compared with pool monocytes 
which were not cultured prior to preparation of cell extracts. 
Thus, it is likely that circulating monocytes are heterogeneous in their total protein content and that 
there is a relationship between the adherence properties of monocytes and their total protein content. Although 
the mechanism(s) for these differences are unknown, it is possible that they reflect variations in the activation 
states or maturational stages of these subpopulations since the protein content of monocytes has been shown 
to increase in response to activation (327) and maturation (322) in vitro. These possibilities are discussed later 
(4.8). 
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4.7. Potential Role of Monocytes in the Pathogenesis 
of Chronic Inflammatory Lung Diseases 
Although mononuclear phagocytes play a critical role in the host defence, these cells may also contribute 
to tissue damage at sites of inflammation because they contain proteolytic enzymes that are capable of degrading 
a variety of extracellular matrix macromolecules (81,409,483). Proteolytic destruction of connective tissue is the 
central pathological feature of one chronic inflammatory lung disease (pulmonary emphysema), and is thought 
to be mediated by enzymes released by inflammatory cells that are recruited into the lungs of these patients 
(223,333). Human leukocyte elastase (HLE) is widely believed to be the most important enzyme involved in 
the pathogenesis of emphysema. 
Mononuclear phagocytes may be involved in the pathogenesis of emphysema since: 1) they are present 
in greatly increased numbers at strategic locations within the lungs of cigarette smokers who are at risk of 
developing emphysema (334); and 2) monocytes contain and release HLE (81). However, mononuclear 
phagocytes synthesise and secrete -antitrypsin, the major physiological inhibitor of HLE (32,312). Therefore, 
the balance between the release of HLE and -antitrypsin by monocytes, as they are recruited into the lung 
and pass through the interstitial space, may be an important determinant of lung elastin injury and resultant 
emphysema. 
HLE Content of the Monocyte Subpopulations 
The possibility that there is a relationship between the adherence properties of monocytes and their 
HLE content was tested since: 1) Campbell et a¿. (81) reported that only 20% of monocytes from healthy 
donors are replete with HLE; 2) a similar proportion of monocytes from healthy subjects adhered spontaneously 
to fibronectin in the current study; and 3) these spontaneously adherent monocytes were replete with peroxidase 
which is located within the same intracellular granules as HLE (242). 
The HLE content of the pool monocytes was 4.6% of that contained within neutrophils from the same 
donor. Monocytes were heterogeneous in their content of HLE since there was a striking relationship between 
the capacity of monocytes to adhere to fibronectin and their HLE content. The spontaneously adherent cells, 
on average, contained 7 to 9-fold more HLE than the non-spontaneously adherent and LPS-adherent monocytes 
and 22-fold more HLE than the non-adherent cells. 
To control for possible direct effects of LPS on the HLE content of non-spontaneously adherent cells, 
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spontaneously adherent monocytes were also pre-incubated with LPS. Exposure to LPS did not alter the HLE 
content of spontaneously adherent cells. These data indicate that: 1) freshly-isolated monocytes are 
heterogeneous in their content of HLE; and 2) there is a direct relationship between the adherence properties 
of monocytes and their HLE content. Thus, monocytes that may have the capacity to accumulate at sites of 
infection and inflammation may also possess an enhanced capacity to contribute to HLE-mediated tissue damage. 
Although the amount of HLE contained within pool monocytes in the current study is similar to that 
reported by other investigators (81,408), the HLE content of adherent and non-adherent cells has not been 
assessed previously. However, these data are in agreement with the findings of Campbell et al. (81) and Kargi 
and coworkers (242) that only 20% of monocytes from healthy subjects are replete with HLE. 
The differences in the HLE content of the monocyte subpopulations did not simply reflect differences 
in the total protein content of monocytes since: 1) the total protein content of the spontaneously adherent 
monocytes was only 50% greater than that of the non-spontaneously adherent cells whereas the spontaneously 
adherent cells contained about 700% more HLE compared with the non-spontaneously adherent cells; and 2) 
the total protein content of the LPS-adherent and non-adherent cells were similar whereas the LPS-adherent 
cells contained 3-fold more HLE than the non-adherent cells. The differences in HLE content among the 
monocyte subpopulations could not be explained by differences in cell viability or by neutrophil contamination 
(less than 0.5%) of the monocyte preparations. Furthermore, the differences in HLE content of the monocyte 
subpopulations could not be attributed to differential release of HLE during culture, since minimal amounts of 
HLE were detected in the culture supernatants. In addition, these differences were not due to platelet 
contamination of Nycodenz-isolated monocytes since: 1) HLE was not detected in platelet extracts; and 2) 
monocyte subpopulations prepared from Nycodenz-isolated cells contained similar amounts of HLE when 
compared with monocyte subpopulations prepared from CCE-isolated cells which were not contaminated with 
platelets. It is also unlikely that a proportion of monocytes were activated differentially to release HLE during 
the Nycodenz isolation procedure since similar amounts of HLE were contained within monocytes isolated by 
the Nycodenz method and by CCE. Finally, the difference in HLE content between the monocyte 
subpopulations are also unlikely to be due to differential rates of synthesis of HLE by monocytes during 
isolation or culture since peripheral blood monocytes do not contain mRNA for HLE indicating that endogenous 
synthesis of this enzyme has been completed prior to release of the cells from the bone marrow (438). 
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It is possible that the differences in the HLE content of the monocyte subpopulations reflect variations 
in the number of peroxidase positive granules within the cells since: 1) HLE is located within the peroxidase 
positive granules of monocytes (242); 2) the relationship between the adherence properties of monocytes and 
their HLE content was similar to the relationship between the adherence properties of monocytes and their 
peroxidase content (spontaneously adherent monocytes contained 9-fold more HLE and 10-fold more peroxidase 
than the LPS-adherent cells, and 22-fold more HLE and 20-fold more peroxidase than non-adherent cells); and 
3) monocytes have been shown to be heterogeneous in their content of peroxidase positive granules (9). This 
possibility could be investigated by performing combined immunogold localisation of HLE and peroxidase 
histochemistry on cytocentrifuge preparations of the monocyte subpopulations. 
The mechanism for the differences in HLE content of the monocyte subpopulations is not known. 
However, it is possible that these differences are due to variations in the maturational stages of the monocyte 
subpopulations since maturation of mononuclear phagocytes is associated with the rapid loss of the expression 
of the HLE gene (438). Thus, spontaneously adherent monocytes could be immature cells, non-adherent 
monocytes could be the most mature subset of circulating monocytes, and LPS-adherent monocytes could be 
cells at an intermediate maturational stage. Alternatively, it is possible that these differences reflect variations 
in the states of activation of monocytes, since activation of monocytes is associated with the release of HLE 
(81,236). Thus, spontaneously adherent cells could be unstimulated cells, non-adherent could be activated cells 
and LPS-adherent monocytes may have been partially activated in vivo or during isolation in vitro. Finally, it 
is possible that distinct subpopulations of monocytes exist, with spontaneously adherent cells possessing a 
"inflammatory effector" phenotype. These possibilities are discussed later (4.8). 
In summary, the data suggest that monocytes that may have the capacity to be recruited into the lung 
may also have the potential to cause tissue damage at sites of pulmonary inflammation. Moreover, LPS released 
from sites of pulmonary infection and inflammation may promote the accumulation of cells with an enhanced 
capacity to degrade matrix macromolecules, and thereby potentiating lung injury. 
Content of the Monocyte Subpopulations 
The amounts of antitrypsin contained within the monocyte subpopulations were compared since 
monocytes synthesise and secrete -antitrypsin, the major physiological inhibitor of HLE (32,312), and this may 
influence their capacity to cause tissue damage. Monocytes were prepared by CCE for these studies since 
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platelets were found to contain and Nycodenz-isolated monocytes are contaminated variably with 
platelets. 
There was a striking relationship between the adherence properties of monocytes and their content of 
Spontaneously adherent cells contained 4-fold more than the non-spontaneously 
adherent cells, which in turn contained 1.6-fold more when compared with LPS-adherent and non- 
adherent monocytes. To control for the possible effects of LPS on the of non-spontaneously 
adherent cells, spontaneously adherent monocytes were also pre-incubated with LPS. Although LPS exposure 
resulted in a 30% reduction in their content, LPS-stimulated spontaneously adherent monocytes 
still contained more than the other monocyte subpopulations. The latter results was due, at least 
in part, to the release of by the spontaneously adherent cells since immunoreactive 
was detected in the culture supernatants. These data indicate that the monocyte subpopulations are also 
heterogeneous in their content of and this may influence their capacity to degrade matrix 
components at sites of infection and inflammation. 
The absolute amount of contained within monocytes has not been quantified previously. 
The mechanism for the differences in content among the monocyte subpopulations is not known 
but, as with HLE, did not simply reflect differences in the total protein content of the subpopulations and could 
not be attributed to differences in celi viability or to neutrophil or lymphocyte contamination of the preparations 
(less than 0.5% and 9%, respectively). The differences in content of the non-spontaneously 
adherent cells and that of the monocyte subpopulations that were derived by incubating these cells with LPS 
(i.e. the LPS-adherent and non-adherent cells) were probably due to the release of by the non- 
spontaneously adherent cells during the LPS-adherence assay since immunoreactive was detected 
in these culture supernatants. Moreover, it is likely that LPS stimulated the non-spontaneously adherent cells 
to release during this assay since exposure to LPS induced the spontaneously adherent cells to 
release 
in contrast, the difference in the content of the spontaneously adherent and non- 
spontaneously adherent monocytes is unlikely to be due to differential release of alone since only 
minimal amounts of were released into the culture supernatants during this adherence assay. In 
addition, this difference is unlikely to be due to differential rates of synthesis of since this would 
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require that the spontaneously adherent subset increase their content 4-fold during the 1 h 
adherence assay. It is possible that the difference in the content of spontaneously adherent and 
non-spontaneously adherent monocytes is related to variations in the maturational states of the monocyte 
subpopulations since maturation of monocytes is associated with an increase in the expression of the 
antitrypsin gene (312). Thus, the spontaneously adherent cells could be a more mature population of cells 
compared with the non-spontaneously adherent monocytes. However, this would not be consistent with the 
HLE data which suggested that the spontaneously adherent cells were an immature subpopulation of monocytes. 
Alternatively, the difference in content of these monocyte subpopulations could be related to 
variations in their states of activation since activation of monocytes in vitro increases their expression of 
antitrypsin (32,352). Thus, it is possible that the spontaneously adherent monocytes are cells had been activated 
in vivo or during their isolation in vitro resulting in the ability to adhere spontaneously to fibronectin and an 
increase in their content when compared with other monocytes. These possibilities are discussed 
later (4.8). 
Whatever the explanation for the difference in content of the monocyte subpopulations, 
the data demonstrate that circulating monocytes are also heterogeneous with respect to their content of 
antitrypsin and this is related to their capacity to adhere spontaneously to fibronectin in vitro. Moreover, it is 
possible that synthesis and release of by monocytes that accumulate in the lung during episodes 
of infection and inflammation, influences their capacity to degrade lung connective tissue. 
Comparison of the HLE and Content of the Monocyte Subpopulations 
To assess the potential of the monocyte subpopulations to degrade extracellular matrix components 
further, the relative amounts of HLE and contained within the monocyte subpopulations were 
compared. Monocytes for these studies were isolated by CCE to overcome the problem of platelet 
contamination. In addition, HLE and immunoassays were performed on the same cell extract 
samples to overcome the problem of day-to-day variability in the HLE and content of monocytes. 
AU of the monocyte subpopulations contained a molar excess of HLE relative to 
However, there were striking differences in the magnitude of the molar ratios of HLE to which 
were related to the adherence properties of the cells. In particular, the mean molar ratio of HLE to 
antitrypsin in spontaneously adherent monocytes was 10 which was 2-fold greater than that in non-spontaneously 
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adherent cells. However, the latter subpopulation was heterogeneous in this respect since the mean molar ratio 
of HLE to in LPS-adherent monocytes was 11 (which was similar to that of the spontaneously 
adherent cells) whereas that in non-adherent cells was only 3. The latter result was due the fact that LPS- 
adherent cells contained 3-fold more HLE but similar amounts of when compared with non- 
adherent cells. 
The amounts of HLE and contained within monocytes have not been compared 
previously. However, it is of considerable interest that Campbell et al. (81) demonstrated that: 1) 20% of 
monocytes express marked but localised HLE-mediated proteolysis of fibronectin in the presence of proteinase 
inhibitors; and 2) there was is striking indirect relationship between the HLE-mediated proteolytic activity of 
monocytes and their cell-surface expression of the HLA-DR antigen recognised by I3 monoclonal antibody. It 
is likely that the 20 to 25% of monocytes that adhered spontaneously to fibronectin in the current study are 
identical to the "proteolytic" subpopulation of monocytes identified by Campbell and coworkers since: 1) the 
spontaneously adherent monocytes were replete with HLE; and 2) there was a striking indirect relationship 
between the capacity of monocytes to adhere to fibronectin and their cell-surface expression of the HLA-DR 
antigen recognised by I3 antibody in this study. This possibility could be investigated further by comparing the 
proteolytic activities of the monocyte subpopulations against: 1) methoxy-succinyl-alanyl-alanyl-prolyl-valyl-p- 
nitroanaiide (MSAPN), a Substrate that is specific for HLE (50,%); and 2) components of the 
extracellular matrix such as elastin and fibronectin by methods that have been described previously (29,79,83). 
It is likely that tight adhesion between the cells and the subjacent Substrate is one mechanism that may 
facilitate extracellular proteolysis of Substrate immediately subjacent to the "proteolytic" monocytes identified 
by Campbell and coworkers (81). Although not the focus of the present work, several possible mechanisms for 
this observation have been suggested. First, high concentrations of proteinases may be attained as a result of 
discharge of granule contents into the subcellular cleft (75). Second, phagocytes that are adherent to substrate 
may create a closed compartment between the cells and the Substrate. This compartment may exclude 
antitrypsin and other proteinases inhibitors from this subcellular cleft, and thereby protect proteinases released 
from the cell from inactivation by these proteinase inhibitors (75,79). This hypothesis is supported by the 
previous finding that macrophages that are adherent to a Substrate exclude proteins larger than 50,000 MW from 
the phagocyte-Substrate interface (499). Third, reactive oxygen metabolites that are released by monocytes into 
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the subcellular cleft may result in oxidative inactivation of that has been released by the cell into 
this compartment. The latter possibility is supported by the previous finding that neutrophils use oxygen 
metabolites and elastase cooperatively to negate the protective effects of to attack extracellular 
matrix components (476). 
In summary, the data indicate that a minor subpopulation of monocytes (20 to 25%), identified by its 
adherence properties, may be unable or poorly capable of participating in antigen presentation to lymphocytes, 
but is replete with HLE. The HLE content of these cells may confer unique capabilities upon them that are 
beneficial to the host such as the ability to penetrate tissue barriers in order to reach sites of infection and 
inflammation rapidly, or the capacity to participate in tissue remodelling and repair. Alternatively, it is possible 
that the release of HLE by these cells, as they are recruited into the lung and pass through the interstitial space, 
may contribute to tissue injury. This latter possibility is supported by the previous findings of Campbell et al. 
(81) that the minor subpopulation of monocytes that is replete with HLE produces extensive HLE-mediated 
proteolysis of a matrix macromolecule, even in the presence of proteinase inhibitors. Finally, the data suggest 
that LPS released during episodes of pulmonary infection and infiammation may promote the accumulation of 
a subset of monocytes that are replete with HLE, and thereby may potentiate HLE-mediated lung injury. 
Accumulation of by the Monocyte Subpopulations 
Studies were conducted to determine whether the expression of can be modulated in vitro 
by maturation or exposure to pro-inflammatory mediators. Monocytes were isolated by the Nycodenz method 
for these studies since the CCE technique was not available. One potential problem in using the Nycodenz 
method to isolate monocytes for these studies is that Nycodenz-isolated monocytes are always contaminated with 
platelets and platelets were found to contain in amounts that were consistent with the results from 
a previous study (320). However, it is unlikely that de novo synthesis of by platelets occurs during 
culture of the cells since: 1) platelets contain negligible amounts of DNA and RNA; and 2) any RNA that is 
present is in a metaboiically inactive form (1). To overcome the problem of platelet contamination, monocytes 
and their contaminating platelets were harvested at the start of the experiment (time = O, control cells) and cells 
and culture supernatants were harvested at intervals thereafter. The amount of contained within 
these samples was quantified using a direct binding ELISA and the results were expressed an ng 
cells. The value for the time = O, control cells was subtracted from the sum of the amounts 
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contained within cell extracts and culture supernatants harvested for each time interval. The results obtained 
represented the amount of accumulated by the monocytes. The results were expressed as amounts 
of accumulated by monocytes since the values obtained reflect the net balance between the rate 
of synthesis and the rate of catabolism of this protein by the cells. 
The effect of cellular maturation on the expression of by adherent and non-adherent 
monocytes was assessed since maturation of monocytes results in the loss of their expression of the HLE gene 
(77). Culture for 48 h resulted in a progressive increase in the amount of accumulated by all of 
the monocyte subpopulations. After culture for 48 h the spontaneously adherent, LPS-adherent, non- 
spontaneously adherent and non-adherent cells accumulated 975%, 287% 150% and 75% more 
respectively, when compared with the amount of contained within the time = O, control cells. 
These initial data suggested that the adherent monocyte subpopulations accumulated more after 
48 h than the non-adherent monocyte subpopulations. However, in a subsequent experiment, the spontaneously 
adherent monocytes accumulated similar absolute amounts of when compared with the non- 
spontaneously adherent cells. It is likely that the results of the initial experiment are artifacts since: 1) these 
results were expressed as a percentage of the amount of contained within the time = O, control 
cells; and 2) the time = O, control cells for the adherent monocyte subpopulations contained substantially lower 
amounts of than the control cells for the non-adherent monocyte subpopulations. The latter 
finding probably reflects the fact that platelets contain and contaminate the non-adherent fraction 
of monocytes predominantly. 
The data indicate that maturation is associated with an increase in the expression of by 
monocytes. Moreover, it has been shown previously that maturation in vitro for 48 h results in the complete 
loss of the expression of HLE by monocytes (77). Together, these data indicate that maturation of monocytes 
results in a dramatic change in the balance between their expression of HLE and and thereby 
alters their capacity to degrade connective tissue during homeostasis and tissue injury. Therefore, it is likely that 
monocytes only contribute to HLE-mediated lung injury during and shortly after they are recruited into the lung. 
Further maturation of monocytes within the lung probably results in a loss of the capacity of these cells to 
produce HLE-mediated lung injury. 
To determine whether recruitment of monocytes into inflammatory foci modulates their expression of 
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monocytes were exposed to several pro-inflammatory mediators that are likely to be released at 
sites of infection and inflammation (LPS, TNF, IFN and GM-CSF). Exposure of spontaneously adherent 
monocytes to LPS and cytokines resulted in 1.4 to 1.8 fold increases in their accumulation of 
compared with unstimulated cells. LPS induced a time-dependent increase in accumulation by 
spontaneously adherent monocytes since accumulation increased within 12 h and the effect of LPS 
was still evident after 24 h. In addition, the increase in accumulation by spontaneously adherent 
monocytes that was induced by GM-CSF was concentration-dependent. In contrast, LPS and cytokines had no 
effect on accumulation by the non-spontaneously adherent cells. These data indicate that there 
is a relationship between the adherence properties of monocytes and their capacity to accumulate 
in response to pro-inflammatory mediators. 
De novo synthesis and secretion of by monocytes has been demonstrated previously using 
the biosynthetic labelling and immunoprecipitation technique (32); however, the absolute amounts of 
antitrypsin synthesised or accumulated by monocytes has not been quantified previously. Maturation of 
monocytes was associated with an increase in the accumulation of by monocytes in the current 
study. These data are in agreement with the previous findings of Mornex et al. (312) that maturation of 
monocytes in vitro is associated with a dramatic increase in their expression of the gene. 
Although the effect of mediators on accumulation by adherent and non-adherent 
monocytes has not been compared previously, the results in the current study are in agreement with the findings 
of Barbey-Morel et al. (32) that LPS stimulates a time-dependent increase in synthesis by adherent 
monocytes. However, the data of Barbey-Morel and coworkers differed somewhat from the results of the 
current study since they found that LPS induced 8 to 9-fold increases in the rate of synthesis of 
by adherent monocytes compared with unstimulated cells, which was substantially g ra te r  than the 1.4-fold 
increase in the accumulation of by adherent monocytes that was induced by LPS in the current 
study. These differences were not due to differences in the concentration or source of LPS, or the duration of 
exposure to LPS since monocytes were incubated with 1 of LPS from E. coli 0111:B4 for 24 h in both 
studies. i t  is likely that differences in the methods used to quantify explain the differences in the 
results of the two studies. In Barbey-Morel's study, the rate of de novo synthesis of by monocytes 
was measured by the biosynthetic labelling and immunoprecipitation technique. In contrast, the absolute 
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quantities of in cell extracts and culture supernatants were measured by direct binding ELISA in 
the current study, and these data reflected both the rate of synthesis and the rate of catabolism of 
by the cells. Together, the results of Barbey-Morel’s study and the current study suggest that the amount of a,- 
antitrypsin synthesised de novo by monocytes in response to LPS is small relative to the amount of 
accumulated by the cells. Alternatively, LPS may stimulate an increase in the rate of synthesis and a slightly 
lower increase in the rate of catabolism of by spontaneously adherent cells, and thereby result in 
a small net increase in the amount of accumulated by the cells. To investigate the latter 
possibility, the effect of LPS on both the rate of synthesis and the half-life of in spontaneously 
adherent monocytes could be assessed using the biosynthetic, immunoprecipitation and SDS-PAGE technique 
(32) and long-term pulse-chase studies (273), respectively. 
Perlmutter et al. (352) investigated the effect of cytokines on the expression of by 
adherent monocytes. However, the results of Perlmutter and coworkers were not in agreement with the findings 
of the current study since these investigators found that TNF and IFN had no effect on expression 
by adherent monocytes, whereas these mediators stimulated 1.4 to 1.8 fold increases in 
accumulation by adherent cells in the current study. These differences probably also reflect technical differences 
in the two studies. First, it is possible that different populations of monocytes were studied since monocytes 
were isolated by adherence of dextran-purified leukocytes to charged tissue culture plastic in Perlmutter’s study, 
whereas Nycodenz-isolated monocytes were allowed to adhere to fibronectin-coated dishes in the current study. 
This possibility could be investigated by comparing the accumulation of by monocytes isolated by 
both methods. Second, the concentrations of cytokines that were used in Perlmutter’s study were 10-fold lower 
than those used in the current study, and this could account for the lack of responsiveness of monocytes to 
cytokines in Perlmutter’s study. This possibility could be investigated by incubating adherent monocytes with 
and without optimal concentrations of cytokines and measuring their rate of synthesis of using the 
techniques of Perlmutter and coworkers. Third, Perlmutter et al. measured the rate of de novo synthesis of 
antitrypsin by monocytes using the biosynthetic labelling and immunoprecipitation technique, whereas the net 
amount of accumulated by monocytes was measured in the current study. It is possible that 
cytokines increased the net accumulation of by spontaneously adherent monocytes by reducing 
their rate of catabolism of rather than by increasing their rate of synthesis of this protein. This 
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possibility could assessed by comparing the effects of cytokines on both the rate of synthesis and the haif-life 
of in spontaneously adherent monocytes using the biosynthetic labelling and immunoprecipitation 
technique (32,352) and long-term pulse-chase studies (273), respectively. 
The mechanism for the differences in the capacity of adherent and non-adherent monocytes to 
accumulate in response to pro-inflammatory mediators is not known. However, these differences 
could not be attributed to differences in cell viability, or to neutrophil or lymphocyte contamination of the 
monocyte preparations (less than 0.5% and 9%, respectively). Whatever the mechanisms involved, the results 
suggest that following the accumulation of monocytes at sites of pulmonary infection and inflammation, exposure 
to cytokines may increase their expression of and thereby may alter their capacity to degrade 
matrix components and contribute to lung injury. 
Expression of the Gene by Monocyte Subpopulations 
To assess whether maturation in vitro and exposure to pro-inflammatory mediators up-regulated 
antitrypsin accumulation in monocytes by a transcriptional mechanism, spontaneously adherent and non- 
spontaneously adherent monocytes were incubated for 24 h with and without LPS and cytokines, and their 
steady state mRNA concentrations were compared by dot-blot analysis. Hybridisation 
was performed using a human genomic DNA probe and a ß-actin cDNA probe. Alpha,- 
antitrypsin mRNA concentrations were expressed as a ratio to the values obtained for ß-actin to correct for any 
variability in RNA yields. The data showed that: 1) freshly-isolated spontaneously adherent and non- 
spontaneously adherent monocytes contained similar steady state concentrations of mRNA; 
2) culture for 48 h did not alter the steady state concentrations of mRNA in either of 
these monocyte subpopulations; and 3) exposure to LPS and cytokines did not alter 
mRNA levels in the monocyte subpopulations when compared with unstimulated cells. The data indicate that 
the increases in monocyte accumulation that were induced by short-term culture and exposure to 
LPS and cytokines are likely to be mediated by either: 1) a translational mechanism such as an increase in the 
efficiency of translation of mRNA transcripts; or 2) a post-translational mechanism such as a 
decrease in the rate of catabolism of protein. 
A human genomic DNA probe was used to quantify mRNA 
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concentrations in monocytes. It is unlikely that this probe hybridised to DNA sequences that may 
have contaminated the monocyte cytoplasmic RNA samples, since pre-incubation of one of these samples with 
RNAase prior to dot-blot analysis, almost completely abrogated the autoradiogram signal. In addition, it is 
unlikely that the genomic probe hybridised to ribosomal or transfer RNA molecules rather than 
mRNA species since other investigators have demonstrated that genomic DNA probes hybridise specifically to 
mRNA transcripts in blots of total cellular RNA samples (109,393). Therefore, it is likely that the 
genomic probe hybridised to mRNA transcripts in the monocyte cytoplasmic RNA 
samples in the current study. This could be confirmed by: 1) purifying the poly (A)' RNA fraction by oligo 
(dT) column chromatography prior to dot-blot analysis using the genomic probe; 2) repeating these 
experiment using an cDNA probe instead of the genomic probe; or 3) performing Northern blot 
analysis of monocyte cytoplasmic RNA samples using the genomic DNA probe. 
Steady state concentrations of mRNA in adherent and non-adherent monocytes have not 
been compared previously. However, other investigators have studied the effects of maturation and LPS on the 
expression of the gene by adherent monocytes. Mornex et al. (312) reported that maturation of 
adherent monocytes in vitro results in a 10-fold increase in steady state concentrations of mRNA. 
These data are not in agreement with the findings in the current study that in vitro maturation of adherent 
monocytes had no effect on monocyte mRNA levels and may reflect several technical differences 
between the two studies. First, Mornex and coworkers cultured their monocytes for 15 days, whereas monocytes 
were cultured for only 48 h in the current study. This possibility could be investigated by performing longer 
studies. Second, Mornex and coworkers used an cDNA probe to quantify 
mRNA concentrations whereas an genomic DNA probe was used in the current study. The 
potential problems in using a genomic DNA to measure mRNA concentrations have been discussed previously. 
Third, different methods were used to control for any variation in RNA yield; Mornex and coworkers' measured 
DNA concentrations whereas a ß-actin cDNA probe was used in the current study. It is possible that 
maturation of monocytes is associated with similar increases in and ß-actin mRNA concentrations 
which, therefore, would not alter the ratio of to ß-actin mRNA concentrations. To investigate 
these possibilities it would be necessary to repeat the experiments using the protocols of Mornex and coworkers 
to measure steady-state concentrations of mRNA in monocytes. In addition, the effect of cellular 
216 
maturation on the expression of the ß-actin gene by monocytes should be assessed. 
Exposure to LPS, TNF, IFN and GM-CSF for 24 h did not alter steady-state mRNA 
concentrations in adherent and non-adherent monocytes. These data are in agreement with the previous finding 
of Barbey-More1 et al. (32) that exposure to LPS for 24 h resulted in no change, or only minimal increases in 
steady state concentrations of mRNA in adherent monocytes (32). The effects of TNF, IFN and 
GM-CSF on the expression of the gene by monocytes have not been assessed previously. 
These data suggest that LPS and cytokines up-regulated expression in adherent monocytes 
by translational or post-translational mechanisms rather than by increasing the transcription of the -antitrypsin 
gene. This hypothesis could be tested further by assessing the effects of LPS and cytokines on the rate of 
transcription of in monocytes using the nuclear run-off technique. However, the possibility 
remains that LPS and cytokines stimulated early, transient increases in mRNA levels in adherent 
monocytes which were missed because the cells were harvested only after culture for 24 h. Although this 
possibility is unlikely, since other investigators have reported that exposure of monocytes to LPS for 12 h did 
not alter mRNA concentrations in monocytes (32), it could be investigated by performing shorter 
studies. Alternatively, LPS and cytokines may have stimulated similar increases in monocyte and 
ß-actin mRNA levels which would not change the ratio of to ß-actin mRNA concentrations in 
monocytes. This possibility could be investigated by assessing the effect of LPS and cytokines on the expression 
of the ß-actin gene by monocytes. 
In summary, mononuclear phagocytes may be an important source of within the lung since 
the expression of by monocytes is up-regulated by cellular maturation. in addition, Signals that 
arise from inflammatory foci (LPS and several cytokines) increase the expression of by 
spontaneously adherent monocytes which may have the potential to be recruited into sites of inflammation. 
These data suggest that following the recruitment of monocytes into foci of pulmonary infection and 
inflammation, exposure to pro-inflammatory mediators up-regulates their expression of and 
thereby may limit proteinas-mediated lung injury. 
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Conclusions 
The data presented above may provide further insight into the mechanisms that may be involved in the 
pathogenesis of chronic inflammatory lung diseases such as emphysema and bronchiectasis. Preliminary data 
(presented in Appendix 3) suggest that there is a minor subpopulation of monocytes that may be recruited 
readily into the lung since: 1) 20 to 25% of monocytes adhered spontaneously to HUVEC monolayers and 
fibronectin in vitro; and 2) reversible adherence of monocytes to endothelial cells and components of the 
extracellular matrix is a prerequisite for the accumulation of these cells at sites of inflammation (172,423). These 
spontaneously adherent monocytes contained a substantial molar excess of HLE relative to It 
is possible that the HLE content of spontaneously adherent monocytes may confer capabilities upon them that 
are beneficial to the host including: 1) the ability to penetrate tissue barriers in order to migrate into sites of 
inflammation; and 2) the capacity to participate in tissue remodelling and repair. Alternatively, it is possible 
that the release of HLE by this subpopulation of monocytes, as they are recruited into the lung and pass through 
the interstitial space, may contribute to HLE-mediated lung injury. This latter possibility is supported by the 
previous findings of Campbell et al. (1988) that a similar proportion of monocytes (20%) produces HLE- 
mediated proteolysis of an extracellular matrix component even in the presence of proteinase inhibitors (81). 
Moreover, reactive oxygen metabolites released by these spontaneously adherent monocytes may contribute to 
local oxidative inactivation of within the lung, and thereby facilitate HLE-mediated tissue injury. 
LPS-adherent monocytes also contained a substantial molar excess of HLE relative to 
These data suggest that LPS released during episodes of pulmonary infection and inflammation, may promote 
the accumulation of a another subset of monocytes that has an enhanced capacity to degrade lung connective 
tissue, and thereby potentiate lung injury. 
It is likely that monocytcs only contribute to HLE-mediated lung injury during, or shortly after, the 
process of recruitment into the lung since maturation of monocytes is associated with a rapid loss of-HLE (77) 
and resulted in an increase in their expression of in this study. In addition, the capacity of 
monocytes to contribute to tissue damage may be modulated by mechanisms other than maturation since pro- 
inflammatory mediators up-regulated the expression adherent monocytes in this study and HLE (353,354) and 
IL-6 (352) have been shown previously to up-regulate the synthesis of by adherent monocytes. 
Thus, exposure of monocytes to pro-inflammatory mediators and HLE, as they are recruited into sites of 
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pulmonary infection and inflammation, may up-regulate their expression of and thereby limit 
connective tissue degradation at sites of pulmonary inflammation. 
The current study only compared the expression of HLE and by monocytes. However, 
these cells contain other proteolytic enzymes and proteinase inhibitors that may contribute to the protease anti- 
proteinase balance in the lower respiratory tract. For example, mononuclear phagocytes contain enzymes, other 
than HLE, that have the capacity to degrade matrix components including: 1) other serine proteinases such as 
cathepsin G (77,81); 2) metalloproteinases (77); 3) cysteine proteinases such as cathepsin L (294); and 4) 
plasminogen activator (100,101,103,104,294). Mononuclear phagocytes express proteinase inhibitors, other than 
that may contribute to the anti-elastase screen including: 1) (32); 2) 
plasminogen-activator inhibitor (462); 3) tissue inhibitor of metalloproteinase (77); and 4) 
(39). Moreover, the expression of some of these proteinases and anti-proteinases is regulated by cellular 
differentiation and activation (32,76,77,81,479). Thus, the capacity of mononuclear phagocytes to contribute to 
tissue damage depends upon the balance between their expression of all of their proteinases and anti-proteinases 
which, in turn, depends upon their state of activation and maturational stage. To investigate the capacity of 
adherent and non-adherent monocytes to contribute to tissue damage further, their expression of other 
proteinases and anti-proteinases and their capacity to degrade matrix components in vitro could be investigated. 
In addition, the effects of cellular activation and maturation on the capacity of these monocyte subpopulations 
to degrade matrix components in vitro could be assessed. 
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4.8. Hypotheses for Monocyte Heterogeneity 
The data presented in 3.8, 3.9 and 3.10 indicate that human monocytes are heterogeneous in their 
antimicrobial and immune modulatory functions and also in their expression of HLE and In 
particular, the capacity of monocytes to adhere to fibronectin is related directly to several antimicrobial functions 
and their expression of HLE and In addition, there is an indirect relationship between the 
capacity of monocytes to adhere to fibronectin and one aspect of their immune regulatory function (HLA-DR 
antigen expression). 
There is a substantial literature regarding human monocyte heterogeneity which is summarised in table 
4. Although the biological relevance of this heterogeneity is not understood, several investigators have 
postdated that heterogeneity of monocyte function relates to differences in the degree of maturation, 
differentiation or activation of monocytes (144,146,449). 
A particular strength of the present work is that it demonstrated that there is a relationship between 
adherence (which probably relates to the ability of cells to reach sites of inflammation) and various phenotypes 
that are related to important biological activities at sites of infection and inflammation. The mechanism for the 
functional differences between the monocyte subpopulations is not known. It is possible that these functional 
differences are artifacts. For example, a subpopulation of monocytes could have been activated differentially 
during the Nycodenz isolation procedure. However, this is unlikely since preliminary results on monocytes 
isolated by CCE confirm that a minor subpopulation of monocytes adheres spontaneously to fibronectin and that 
there is a relationship between monocyte adherence and superoxide anion release (Appendix 4). In addition, 
the functional differences between the monocyte subpopulations could not be explained by neutrophil or 
lymphocyte contamination of the monocyte preparations (less than 0.5% and 9%, respectively). However, the 
possibility remains that the subpopulation of monocytes that did not adhere spontaneously to fibronectin were 
damaged, despite their viability, as assessed by exclusion of trypan blue dye. 
An alternative explanation for the functional differences between the monocyte subpopulations is that 
the monocyte subpopulations represent a continuous spectrum of monocyte function. These functional 
differences could be related to variations in their states of activation or maturational stages. For example, it is 
possible that spontaneously adherent monocytes are a subpopulation of monocytes that have been activated in 
vivo and non-adherent monocytes are unstimulated cells since: 1) activation of monocytes is associated with 
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increases in phagocytic activity, the release of superoxide anion (236,267), total protein content (327) and the 
synthesis of (32,352); and 2) spontaneously adherent cells are more actively phagocytic, release 
more superoxide anion and contain more protein and than non-adherent monocytes. LPS-adherent 
cells may represent cells that have been partially activated in vivo since they had an intermediate antimicrobial 
phenotype. However, activation of monocytes is usually associated with an increase in their expression of HLA- 
DR antigen (236) and a decrease in their HLE content (81), whereas the spontaneously adherent cells express 
relatively low levels of HLA-DR antigen and contain substantial quantities of HLE. Therefore, it is unlikely 
that these subpopulations simply reflect differences in the states of activation of circulating monocytes. 
Alternatively, the spontaneously adherent cells may represent a more mature subpopulation of cells than 
non-adherent cells since maturation of monocyte is associated with increases in phagocytic activity (267), total 
protein content (322), and the expression of (312), but a reduction in HLA-DR antigen expression 
(421). However, it is unlikely that these monocyte subpopulations simply reflect differences in maturational 
stages of circulating monocytes since maturation of monocytes is also associated with a loss of peroxidase activity 
and HLE expression (438 458), whereas spontaneously adherent cells contain substantial amounts of peroxidase 
activity and HLE and the non-adherent monocytes contain only minimal amounts of these enzymes. 
Other investigators have proposed that distinct subpopulations of monocytes exist on the basis of 
differences in the expression of HLA-DQ (177), complement receptors (487) and 5' nucleotidase activity (67). 
The possibility remains that functionally distinct subpopulations of monocytes exist: adherent monocytes 
possessing an "inflammatory effector” phenotype and the non-adherent cells an "immune modulatory" phenotype. 
While the distinction between these phenotypes is not absolute, as in the T and B lymphocyte subset model, it 
is quite definite. Further studies are required to investigate this possibility, as discussed later (4.10). 
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4.9. Conclusions and Implications 
Initial studies demonstrated that the yield of monocytes isolated by the Nycodenz method was 2-fold 
greater than that isolated by the conventional ficoll-Hypaque technique followed by adherence of monocytes 
to fibronectin. Moreover, only a minor subpopulation (20 to 25%) of monocytes isolated from healthy subjects 
by the Nycodenz method and by CCE adhered spontaneously to fibronectin. Since most investigators isolate 
monocytes by methods employing an adherence step, these data indicate that many previous studies of monocyte 
function may have been conducted on a minor, possibly unrepresentative subpopulation of monocytes. 
Additional studies demonstrated that the spontaneous adherence of monocytes from patients with a 
chronic inflammatory lung disease (bronchiectasis) to a representative extracellular matrix component 
(fibronectin) was 2 to 3-fold higher than that of cells from healthy subjects, and was correlated with the severity 
of airway inflammation. Since movement of cells through tissues depends upon regulated adherence of the cells 
to extracellular matrix macromolecules (172,423), the data suggest that circulating monocytes are heterogeneous 
in their ability to accumulate at sites of inflammation. It is likely that endotoxin and cytokines released from 
foci of pulmonary infection were responsible for the observed activation of the patients' monocytes since: 1) 
endotoxin was detected in plasma from all of the patients but none of the controls; and 2) LPS and cytokines 
stimulated the adherence of monocyte to fibronectin in vitro. These data indicate that signals arising from foci 
of infection and inflammation can influence the adherence properties of monocytes, and are likely determinants 
of the accumulation of mononuclear phagocytes in the lungs of patients with chronic inflammatory lung diseases. 
The adherence of monocytes from healthy subjects and patients with bronchiectasis to fibronectin was 
mediated substantially by CD11/CD18 integrins. This is the first report to document the involvement of 
CD11/CD18 integrins in monocyte adherence to a component of the extracellular matrix. These data provide 
further insight into the factors that regulate the recruitment of monocytes into inflammatory sites and the 
mechanisms involved. 
There was a striking relationship between the capacity of monocytes to adhere to fibronectin and 
phenotypes that are of biological importance at sites of infection and inflammation. Spontaneously adherent 
monocytes had an "inflammatory effector" phenotype, non-adherent cells had an "immune modulatory" 
phenotype and LPS-adherent cells had an intermediate phenotype. These data indicate that LPS released from 
the lungs of patients with chronic inflammatory pulmonary diseases, may stimulate the accumulation of a 
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subpopulation of monocytes with an enhanced capacity to eliminate microbes, and may thereby promote the 
resolution of pulmonary infection and inflammation. 
Patients with bronchiectasis remain colonised with bacteria, and progressive lung damage occurs in some 
patients with bronchiectasis and emphysema despite the increased recruitment of mononuclear phagocytes into 
the lungs of these patients. It is possible that excessive recruitment of mononuclear phagocytes into the lungs 
of patients with chronic inflammatory lung diseases may initiate or perpetuate HLE-mediated tissue, since 
monocytes that may have the capacity to be recruited into the lung are replete with HLE. Moreover, these cells 
produce large amounts of reactive oxygen metabolites which may contribute to local inactivation of 
antitrypsin, and thereby may lower the anti-elastase screen in the lower respiratory tract. 
It is likely that monocytes only contribute directly to HLE-mediated lung injury during or shortly after 
their recruitment into the lung since: 1) maturation of monocytes is associated with a rapid loss of the expression 
of HLE (77); and 2) maturation of monocytes was associated with a progressive increase in their expression of 
in the current study. Moreover, several pro-inflammatory mediators also increased the expression 
of by adherent monocytes. Therefore, it is likely that exposure of monocytes to pro-inflammatory 
mediators, following their accumulation at sites of pulmonary infection and inflammation, also limits their 
capacity to produce HLE-mediated lung injury directly. However, mononuclear phagocytes may perpetuate lung 
injury subsequently by two mechanisms. First, these cells may contribute indirectly to HLE-mediated lung 
injury since LPS released from inflammatory foci stimulates monocytes to release TNF (106) which is 
chemotactic for neutrophils (310), and also stimulates the release of proteolytic enzymes from neutrophil 
granules (253). Second, mononuclear phagocytes contain proteolytic enzymes, other than HLE, that are capable 
of degrading connective tissue components in vitro (76,77,81,125,479). In addition, the expression of some of 
these proteinases is up-regulated by cellular maturation and activation (77,125,479). 
Finally, if monocyte recruitment is an important determinant of the outcome of chronic inflammatory 
lung diseases, factors that alter monocyte adherence to biologically relevant substrates may have a role in the 
management of these diseases. 
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4.10. Further Studies 
These studies have provided insight into: 1) the factors that regulate monocyte adherence to fibronectin; 
2) the mechanisms involved; and 3) the relationship between the adherence properties of monocytes and other 
monocyte functions that are of biological and pathological importance at sites of infection and inflammation. 
However, several questions remain to be answered. The following account outlines studies that could be 
performed to address these uncertainties. 
Adherence Properties of Monocyles 
1. Preliminary data, presented in Appendix 3, suggest that the capacity of monocytes to adhere to fibronectin 
reflects their potential to be recruited into tissues. To test this hypothesis, monocytes could be isolated from 
additional donors, and their adherence to fibronectin and HUVEC monolayers under basal conditions and in 
response to pro-inflammatory mediators could be compared. In addition, the chemotactic responsiveness of 
adherent and non-adherent monocytes could be compared since the recruitment of monocytes from the 
vasculature into inflammatory foci involves monocyte Chemotaxis in addition to the adherence properties of these 
cells. The chemotactic responsiveness of adherent and non-adherent monocytes to chemoattractants such as f- 
MLP and C5a could be compared using standard techniques (110). 
2. The data suggested that pro-inflammatory mediators released from the lungs of patients with bronchiectasis 
increase the adherence properties of their monocytes and this may enhance the recruitment of these cells into 
the lungs of these patients. To test this hypothesis, the adherence properties and chemotactic responsiveness 
of monocytes isolated from patients with other inflammatory lung diseases such as emphysema, acute bacterial 
pneumonia, cystic fibrosis and pulmonary fibrosis could be compared with those of cells isolated from age- 
matched healthy subjects and patients with a non-inflammatory lung disease such as carcinoma of the bronchus. 
3. What are the relative roles of CD18 and VLA-5 integrins in mediating monocyte adherence to fibronectin? 
This question could be addressed by comparing the effect of the anti-CD18 and an anti-VLA-5 antibodies on 
basal and LPS-stimulated adherence of monocytes from healthy subjects and patients with bronchiectasis. In 
addition, the expression of CD11/CD18 and VLA-5 integrins by monocytes from healthy subjects and patients 
with bronchiectasis could be assessed. Cells could be labelled with the anti-CD18 and anti-VLA-5 antibodies 
by the indirect immunofluorexence technique and receptor expression quantified by flow cytometry. 
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Monocyte Subpopulations 
1. It is possible that the monocyte subpopulations identified in this study represent differences in the states of 
activation of the cells. To test this hypothesis, adherent and non-adherent monocyte subpopulations could be 
separated and assayed for their specific activities of two enzymes that are markers of mononuclear phagocyte 
activation: 5’ nucleotidase and acid phosphatase (67,357). In addition, the monocyte subpopulations could be 
activated in vitro to determine whether cellular activation induces non-adherent monocytes to develop the 
characteristics of adherent cells or vice versa. Cells could be exposed to stimuli such as LPS, TNF and IFN, and 
their antimicrobial function and expression of HLA-DR antigen could be quantified, as described in Methods. 
2. It is possible that the monocyte subpopulations represent differences in the maturational stages of monocytes. 
To test this hypothesis, the expression of surface antigens that are correlates of mononuclear phagocyte 
maturation by the monocyte subpopulations could be compared. Cells could be labelled with the following 
monoclonal antibodies by the indirect immunofluorescence technique: 1) KB23, which recognises p150/95 (203); 
2) UCHM1 which reacts with a monocyte marker; and 3) RFD7 which reacts with a macrophage marker 
(204,227). The expression of these surface antigens by adherent and non-adherent monocytes could be 
quantified by flow cytometry. In addition, the monocyte subpopulations could be assayed for their specific 
activities of two enzymes that are markers of mononuclear phagocyte maturation: macrophage tissue 
transglutaminase (317) and cathepsin B (66). The monocyte subpopulations could also be matured in vitro to 
determine whether non-adherent monocytes develop some of the characteristics of adherent monocytes when 
induced to mature or vice versa. The monocyte subpopulations could be cultured for one to three weeks with 
and without PMA, and their antimicrobial function and expression of HLA-DR antigen could be quantified at 
intervals, as described in Methods. 
3. It is possible that functionally distinct subpopulations of monocytes exist. If the studies outlined above failed 
to demonstrate that there are differences in the states of activation or maturational stages of the monocyte 
subpopulations, this would support the hypothesis that functionally distinct subsets of monocytes exist. In 
addition, human mononuclear phagocyte bone marrow precursor cells could be studied to determine whether 
they have distinct pro-inflammatory and immune-modulatory phenotypes. Mononuclear phagocyte precursor 
cells could be isolated, as described previously (233,315) and stained for: 1) HLE and peroxidase by combined 
immunogold localisation and enzyme histochemistry (242); and 2) HLA-DR antigen by the indirect 
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immunofluorescence technique, as described in Methods. 
Monocyte Proieinases and Anti-Proteinases 
1. The data presented in this thesis suggested that a minor subpopulation of monocytes may have the capacity 
to contribute to tissue injury during or shortly after their recruitment into the lung. To investigate this 
possibility, the following experiments could be performed. 
a. The proteolytic activities of the monocyte subpopulations isolated from healthy subjects could be compared. 
Extracts of the monocyte subpopulations could be prepared and their elastase activity could be measured against 
MSAPN, a chromogenic substrate that is specific for HLE (50,96) and (29,83). In addition, the 
proteolytic activity of viable cells could be assessed in the presence of proteinase inhibitors using a solid phase 
fibronectin assay (79). 
b. The effect of maturation in vitro and pro-inflammatory mediators on the expression of by 
monocyte subpopulations could be assessed further. Monocytes could be isolated by CCE instead of the 
Nycodenz method to circumvent the problem of platelet contamination. To gain further insight into the 
mechanisms involved in the increased expression of induced by maturation and pro-inflammatory 
mediators, cells could be cultured for up to 15 days with and without pro-inflammatory mediators and the 
following measured: 1) the accumulation of by direct binding ELISA; 2) the rate of de novo 
synthesis of by the biosynthetic labelling and immunoprecipitation technique; 3) the haif-life of 
in monocytes by long-term pulse-chase studies; 4) steady-state mRNA 
concentrations by dot-blot and Northern blot analyses using an cDNA probe and DNA 
concentrations to correct for any vanations in RNA yield; and 5) the rate of gene transcription 
by nuclear run-off assays. 
c. To assess the capacity of adherent and non-adherent monocytes to contribute to lung injury further, their 
expression of other proteinases and anti-proteinases could be compared since: 1) mononuclear phagocytes 
express proteinases, other than HLE, that may degrade matrix macromolecules (76,77,184,479); and 2) these 
cells contain proteinase inhibitors, other than that may contribute to the anti-proteinase screen 
in the lower respiratory tract (32,39,77,462). In addition, the effects of cellular activation and maturation on 
the capacity of these cells to degrade matrix components in vitro could be investigated since the expression of 
several of these proteins is modulated by activation and maturation of monocytes (32,39,77,125,479). 
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d. To assess the capacity of monocytes from patients with chronic inflammatory lung diseases to contribute to 
lung injury, adherent and non-adherent monocytes could be isolated from healthy subjects and patients with 
bronchiectasis and emphysema and the following could be compared: 1) their HLE and content; 
2) the effect of maturation and pro-inflammatory mediators on expression; 3) their expression of 
other proteinases and anti-proteinases that contribute to the proteinase-antiproteinase balance in the lower 
respiratory tract; and 4) their capacity to degrade a variety of matrix macromolecules in vitra. 
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Appendix 1 
Materials and Suppliers 
Material Supplier 
acetic acid (giaciai) 
actinomycin D 
agarose 
alkaline phosphatase - anti-alkaline phosphatase (APAAP) complex 
(human) 
ampicil tin 
bacto-tryptone 
BamH 1 restriction enzyme 
boric acid 
bovine serum albumin 
bromophenol blue 
N-butanol 
caesium chloride 
calcium chloride 
CD3, CD18, CD22 and p150/95 monoclonal antibodies 
chloroform 
Coomassie brilliant blue G250 dye 
cytochrome c 
dextran T 500 
Odianisidine (3,3’-dimethoxy benzidine) 
N,N-dimethyl formamide 
Eppendorf tubes 
ether Sigma Chemical Company, Poole, Dorset, U.K. 
ethidium bromide 
ethylene diamine tetracetic acid 
fast red substrate 
fetal calf serum 
ficoll 
ficoll-Hypaque Pharmacia, Uppsala, Sweden 
Sigma Chemical Company, Poole, Dorset, U.K. 
Flow Laboratories, Irvine, Scotland, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Dakopatts, High Wycomb, U.K. 
B.D.S. Biologicals Ltd., Birmingham, U.K. 
Beecham Research Laboratories, Brentford, Middlesex, U.K. 
Difco Laboratories Limited, East Mosely, Surrey. U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company. Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company. Poole. Dorset, U.K. 
Dakopatts, High Wycombe U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Eastman Kodac Co, Rochester, New York, U.S.A. 
Sigma Chemical Company, Poole, Dorset. U.K. 
Pharmacia, Uppsala, Sweden. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
LIP (Equipment and Suppliers) Ltd, Shipley, Yorkshire, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Flow Laboratories, Irvine, Scotland, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
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Sigma Chemical Company, Poole, Dorset, U.K. 
Organon Teknika-Cappe1 Corporation, Durham, NC, U.S.A. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
NEN Research, Boston, MA, U.S.A. 
Flow Laboratories. Irvine, Scotland, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Flow Laboratories, Irvine, Scotland, U.K. 
Dakopatts, High Wycomb, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Coulter Immunology, Hialeah, Fionda, U.S.A. 
Organon Teknika-Cappeli, West Chester, Pensylvania, U.S.A. 
Genzyme, Boston, MA, U.S.A. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Hoechst U.K. Limited, Hounslow. Middlesex, U.K. 
Sigma Chemical Company. Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Dr. EJ. Campbell Salt Lake City, Utah, U.S.A. 
American Red Cross, Washington D.C. U.S.A. 
Fisher Scientific, Salt Lake City, Utah, U.S.A. 
Sigma Chemical Company. Poole, Dorset. U.K. 
Winthrop Laboratories-Breon Laboratories, New York, U.S.A. 
Coulter Immunology, Hialeah, Florida, U.S.A. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Genzyme, Boston, MA, U.S.A. 
Genzyme, Boston, MA, U.S.A. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
KabiVitrum, Stockholm, Sweden 
Sigma Chemical Company, Poole, Dorset, U.K. 
Dr R. Wilson. National Heart and Lung Institute, London U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
B.D.S. Biologicals Ltd., Birmingham, U.K.. 
fibronectin (human) 
rabbit anti-human fibronectin 
formaldehyde 
formamide 
Gene-screen TM membrane 
gentamicin 
glacial acetic acid 
glucose 
glutamine 
glycagel 
glycerol 
goat anti-mouse-FITC 
goat IgG 
granulocyte-macrophage colony stimulating factor 
guanidinium isothiocyanate 
haemaccel 
Hind III lambda DNA digest (DNA molecular weight markers) 
horse radish peroxidase type IV (HRP) 
human leukocyte elastase (HLE) purified from sputum 
human serum albumin (HSA) 
hydrogen peroxide 
hydroxyquinolone 
Hypave  
I3 monoclonal antibody and I3 conjugated to FITC 
isoamyl alcohol 
interferon gamma 
interleukin-1 ß 
latex beads (3 diameter) 
levamnisole 
limulus amoebocyte lysate kit (Coatest) 
lipopolysaccharide from E. Coli 0111 B4 
lipopolysaccharide from H. Influenzae 
lysozyme 
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Sigma Chemical Company, Poole. Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset. U.K. 
NUNC, LIP Ltd, Shipley, Yorkshire, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Travenol Laboratories, Compton, U.K. 
Liver Research Laboratories, Queen Elizabeth Hospital, 
Birmingham, U.K. 
Coulter Immunology, Hialeah. Florida, U.S.A. 
Flow Laboratories, Irvine, Scotland, U.K. 
Coulter Immunology, Hialeah, Florida, U.S.A. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
magnesium chloride 
ß mercaptoethanol 
microtitre plates (96 well) 
2-N-morpholinoethane sulphonic acid (MES) 
modified Wright's stain (Diff Quik) 
murine ascites (non-immune) 
murine IgG (non-immune) 
multi-test slides 
MY7 monoclonal antibody 
napthol As-Mx phosphate 
Nonidet P40 
nonspecific esterase kit 
Nycodenz Nycomed, Birmingham, U.K. 
pancreatic RNAse 
paraformaldehyde 
perchloric acid 
Percoll Pharmacia. Uppsala, Sweden 
polyoxyethylenesorbitan monolaurate (Tween-20) 
polypropylene RIA vials 
polypropylene tubes 
polyvinylpyrrolidone 
potassium chloride (KCI) 
potassium dihydrogen phosphate (K 
potassium hydroxide (KOH) 
phenol 
proteinase K 
rabbit anti-mouse immunoglobulin 
rabbit anti-sheep IgG conjugated to horse radish peroxidase 
rabbit (non-immune) 
random primer DNA labelling kit 
RGDS and RGES peptides 
ribonucleoside vanadyl complexes 
Amersham International PLC. Aylesbury, Bucks, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
J.T. Baker, Phillipsburg. New Jersey, U.S.A. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sarstedt, Princeton, NJ, U.S.A. 
Becton Dickinson Labware, Lincoln Park, NJ, U.S.A. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company. Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Dakopatts, High Wycomb, U.K. 
Organon Teknika-Cappel Corporation, Durham, N.C., U.S.A. 
Organon Teknika-Cappel Corporation, Durham, N.C., U.S.A. 
Boehringer Mannheim U.K., Lewes, East Sussex, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
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Sigma Chemical Company, Poole, Dorset, U.K. 
Flow Laboratories, Irvine, Scotland 
Sigma Chemical Company, Poole, Dorset, U.K. 
Pharmacia. Uppsala, Sweden 
B.D.S. Biologicals Ltd., Birmingham, U.K. 
B.D.S. Biologicals Ltd., Birmingham, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical company, Poole, Dorset, U.K. 
Phoenix Pharmaceuticals, Gloucester, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole. Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Becton Dickenson, Lincoln Park, New Jersey, U.S.A. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Sigma Chemical Company, Poole, Dorset, U.K. 
Genzyme, Boston, MA, U.S.A. 
Phoenix Pharmaceuticals, Gloucester, U.K. 
Difco Laboratories Ltd, East Mosely, Surrey, U.K. 
RNAase 
RPMI 1640 medium 
salmon sperm DNA 
sephadex G50 
sheep anti-human (highly purified IgG fraction) 
sheep anti-human HLE plyclonal antiserum 
sodium acetate 
sodium azide 
sodium borohydride 
sodium carbonate 
sodium chloride (NaCI) 
sodium chloride solution (sterile, 0.15 mol/l) 
sodium citrate 
sodium hydroxide 
sodium dihydrogen phosphate (Na 
sodium dodecyl sulphate (SDS) 
sodium hydrogen carbonate (Na 
sodium lauryl sarkosinate 
sodium periodate 
sodium pyrophosphate 
sucrose 
sulphuric acid 
superoxide dismutase 
thiomersal 
tissue culture dishes (35 x 10 mm) 
tris (hydroxymethyl-aminomethane) 
trichloroacetic acid (TCA) 
Triton X-100 
trypan blue 
tumour necrosis (TNF) 
water (sterile distilled) 
yeast extract 
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Appendix 2 
Demographic and Spirometrie Data for Patients with Bronchiectasis 
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Appendix 3 
Comparison of Monocyte Adherence to Fibronectin and to Endothelial cells 
Methods 
Adherence Substrates 
Tissue culture dishes were coated with the optimal concentration of human fibronectin, as described in 
Methods. Human umbilical vein endothelial cells (HWEC) were grown to confluence in 24 well tissue culture 
dishes, as described previously (309). The HUVEC monolayers were kindly supplied by Dr. A. Sturrock, 
Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, 
Utah, U.S.A. The monolayers were cultured overnight in RPMI medium supplemented with 10% [v/v] FCS 
and gentamicin (20 and the culture supernatants were discarded immediately prior to the adherence 
assay. 
Monocyte Isolation and Adherence Assays 
Monocytes were isolated from two healthy donors by the Nycodenz method, as described in Methods. 
The monocyte preparations were greater than 92% pure, as assessed by modified Wright’s staining, and greater 
than 99% viable, as assessed by exclusion of trypan blue dye. Monocytes were suspended at a concentration 
of cells/ml in supplemented RPMI medium and 1 ml aliquots of the cell suspension were dispensed into two 
wells containing HUVEC monolayers and two fibronectin-coated tissue culture dishes. The cells were incubated 
for 1 h at 37°C in a humidified atmosphere of 95% O, and 5% CO,. Non-adherent cells were removed by 
vigorous washing with sterile, ice-cold 0.15 mol/L NaCl solution, centrifuged (600 g for 5 min), re-suspended 
in medium and counted using a haemocytometer. The proportion of adherent cells was calculated from the 
initial number of cells added to the assay and the number of non-adherent cells. 
Results and Discussion 
The results showed that similar proportions of monocytes adhered to fibronectin-coated dishes and to 
HUVEC monolayers (table 9). To exclude the possibility that HUVEC had been detached along with non- 
adherent monocytes during the washing procedure, cytocentrifuge preparations of the non-adherent cells 
obtained from the HUVEC-containing wells were prepared. The cytocentrifuge preparations were stained with 
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modified Wright’s stain and examined under oil immersion. Less than 0.5% of the non-adherent cells were 
HUVEC. These data indicate that a similar proportion of monocytes from healthy subjects adheres 
spontaneously to fibronectin and to HUVEC monolayers in vitro. 
Since monocyte adherence to endothelial cells is a prerequisite for their recruitment from the vasculature 
in vivo, these preliminary data suggest that the capacity of monocytes to adhere to fibronectin in vitro is related 
to their capacity to be recruited into tissues in vivo. 
Table 9 
Comparison of Monocyte Adherence to Fibronectin and HUVEC Monolayers 
Monocytes were isolated from two healthy donors and the proportion of cells that adhered 
spontaneously to fibronectin and HUVEC monolayers was compared. 
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Appendix 4 
Adherence Properties and Superoxide Anion Release by CCE-isolated Monocytes 
Appendix 4 Figure shows the relationship between monocyte adherence to fibronectin and superoxide 
production by monocytes. Monocytes were isolated by CCE and incubated in fibronectin-coated dishes for 1 
h at 37°C to separate the spontaneously adherent and non-spontaneously adherent cells, as described in Methods. 
Superoxide anion production by pool monocytes and the monocyte subpopulations was measured in triplicate, 
as the superoxide dismutase-inhibitable reduction of cytochrome c, as described in Methods. Cells were 
unstimulated (cross-hatched bars) or stimulated with phorbol myristate acetate (PMA) at a final concentration 
of 50 ng/ml (solid bars). Note the relationship between monocyte adherence to fibronectin and superoxide 
anion production. The spontaneously adherent cells produced more superoxide than the non-spontaneously 
adherent cells both under basal conditions and in response to stimulation with PMA. Data are mean values; 
error bars represent SEM; n = 3 donors. 
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